data_2jnv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jnv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.83 0.262 . . . . 73.209999999999994 112.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.3 122.39 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.7 p -132.04 172.07 12.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 75.030000000000001 111.13 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.56 -30.21 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 64.200000000000003 111.089 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.62 -61.24 2.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 70.010000000000005 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 74.400000000000006 110.894 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.11 -31.23 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 75.200000000000003 111.156 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.88 -24.13 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -74.06 -44.28 54.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.856 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.02 -34.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 111.16 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mp -71.61 -20.11 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 75.530000000000001 110.898 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.15 -26.6 28.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.836 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -74.03 -42.51 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.430000000000007 110.918 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.23 -13.87 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 62.030000000000001 111.165 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.517 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.8 ttt180 -51.45 -58.67 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.583 0.706 . . . . 73.230000000000004 110.835 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -8.32 23.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.246 . . . . 75.430000000000007 112.353 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -98.47 -19.27 17.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 75.5 110.922 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 -40.21 7.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 110.905 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 p -69.94 -16.21 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 111.121 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -54.88 24.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 64.519999999999996 111.066 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -131.54 40.14 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 110.879 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -149.87 -63.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 61.439999999999998 112.476 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.61 -71.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 74.400000000000006 112.464 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.54 168.93 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 60.130000000000003 110.896 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.02 166.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 111.17 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.35 141.7 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 62.310000000000002 111.093 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.6 tp -86.85 115.32 24.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.982 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.13 -73.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.87 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -131.76 169.08 16.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.34 110.52 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 71.25 111.15 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.47 -173.96 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.117 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.34 -89.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.728 -0.749 . . . . 74.549999999999997 112.501 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.43 23.73 5.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 74.129999999999995 110.891 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.93 150.55 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.67 129.61 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 75.310000000000002 111.126 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 mtp85 -89.46 103.39 16.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.839 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mt -116.35 142.84 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.944 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.35 104.76 16.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.340000000000003 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.5 mt -113.54 128.98 56.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 73.340000000000003 110.913 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 87.66 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.439999999999998 110.935 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 70.219999999999999 112.522 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.894 0.378 . . . . 72.109999999999999 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -51.84 -49.78 62.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.922 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -70.2 -32.57 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.4 m -66.87 -39.65 87.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.164 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.08 -26.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.430000000000007 111.144 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -51.17 -48.09 61.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.942 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.56 -25.0 65.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 71.120000000000005 110.817 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.95 -60.28 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 54.5 112.462 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.2 -53.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 74.540000000000006 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.26 -32.3 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -76.38 -30.5 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -79.09 -33.8 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 110.856 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -52.68 22.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.925 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -30.11 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.519999999999996 110.886 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.6 -27.01 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.863 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -113.29 -45.65 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.12 75.71 2.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 74.200000000000003 111.132 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -11.77 31.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 72.420000000000002 112.358 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -51.99 -30.69 26.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 64.129999999999995 110.85 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.79 149.26 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.019999999999996 111.122 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.34 -36.16 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 74.510000000000005 111.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.46 -175.31 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.31 153.91 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.891 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.828 0.262 . . . . 72.329999999999998 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.42 131.13 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 110.932 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -129.31 160.91 31.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 111.149 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.89 -27.85 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 45.43 111.133 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.69 -39.13 22.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 72.019999999999996 112.48 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 79' ' ' ASN . 1.5 m-80 -76.43 -46.89 25.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 74.329999999999998 110.907 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.58 -31.36 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.105 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -45.06 91.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 110.949 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -61.88 -36.21 80.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.439999999999998 110.845 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.28 -39.98 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 62.229999999999997 111.14 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mp -71.08 -19.03 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.912 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -26.84 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.019999999999996 110.878 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -75.22 -42.97 54.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 73.109999999999999 110.874 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 p -81.01 -11.8 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 111.133 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 14.1 ttt180 -54.79 -58.67 13.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.588 0.709 . . . . 73.430000000000007 110.881 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.83 -16.06 37.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.226 . . . . 74.519999999999996 112.343 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -88.2 -23.91 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 71.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.1 -53.23 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.913 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -52.73 -42.44 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.148 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.97 67.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 63.310000000000002 111.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -76.24 -38.08 56.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 110.813 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.0 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 61.109999999999999 112.524 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.96 -131.18 1.98 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.209999999999994 112.506 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -179.33 -176.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 72.519999999999996 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.4 140.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 111.118 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.96 137.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 111.098 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -78.69 137.01 37.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 73.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -103.14 -45.67 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.894 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -171.9 168.09 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 72.25 110.906 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.19 119.63 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.450000000000003 111.104 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.28 88.68 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 111.072 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.73 -120.75 18.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 60.5 112.469 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -76.09 -18.22 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 75.230000000000004 110.915 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.46 151.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.123 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.61 136.58 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -96.86 101.37 12.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.855 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 mt -117.67 130.63 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 72.030000000000001 110.902 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -81.35 105.65 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.912 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.1 mt -125.15 127.48 46.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 71.040000000000006 110.883 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -146.27 127.55 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 110.935 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 61.43 112.51 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.919 0.39 . . . . 64.450000000000003 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 tp -51.68 -35.6 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 74.299999999999997 110.949 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.75 -31.06 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.158 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -65.18 -34.36 78.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 111.101 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 pt -84.8 -30.38 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.209999999999994 111.152 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -51.47 -49.88 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 72.439999999999998 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.5 -25.14 66.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.409999999999997 110.868 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.82 -54.0 10.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 44.119999999999997 112.503 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.35 -55.02 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 72.049999999999997 111.138 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.42 -32.61 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 73.450000000000003 110.885 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.08 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 110.835 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -61.31 -42.5 98.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.855 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -31.97 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 110.944 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 19.1 mtt -67.42 -29.82 69.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.832 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.07 -53.2 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.25 110.907 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.89 -45.71 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 75.349999999999994 110.901 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.78 76.47 2.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 75.099999999999994 111.172 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -15.81 37.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 63.399999999999999 112.346 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -52.43 -46.08 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 65.319999999999993 110.877 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.29 144.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 111.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.85 -35.32 12.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 73.25 111.08 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -171.92 179.66 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 64.140000000000001 111.11 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.83 144.39 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 73.230000000000004 111.149 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 73.129999999999995 110.905 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.835 0.264 . . . . 74.340000000000003 112.343 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.6 136.69 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 110.898 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -140.68 167.35 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.155 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.88 -28.7 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 75.420000000000002 111.119 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.54 -45.8 9.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 74.230000000000004 112.462 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -69.71 -48.16 60.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 72.430000000000007 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.0 -31.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 111.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.85 -36.1 78.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.914 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -44.4 87.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 73.150000000000006 110.88 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -72.8 -43.63 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 71.400000000000006 111.146 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.09 -18.87 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 72.530000000000001 110.893 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.93 -26.18 5.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 74.150000000000006 110.901 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -74.96 -46.43 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 70.209999999999994 110.966 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -82.31 -3.5 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.135 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.514 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.5 ttp85 -61.91 -58.77 15.94 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 72.329999999999998 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.3 Cg_endo -69.75 -14.68 36.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 74.219999999999999 112.352 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.03 -55.81 3.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.886 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.3 -55.64 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.59 -34.0 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 111.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.0 -27.25 30.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.124 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.47 -38.03 20.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.129999999999995 110.833 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.82 -23.27 1.8 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 71.230000000000004 112.472 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.03 -142.05 7.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 43.450000000000003 112.44 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -171.94 -176.26 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 51.130000000000003 110.885 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.44 138.18 45.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 111.104 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.88 136.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 54.140000000000001 111.128 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.8 tp -83.05 112.96 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 71.150000000000006 110.888 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -77.71 -66.39 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.828 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -138.55 173.35 11.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.92 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.0 mt -130.25 112.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 74.099999999999994 111.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.84 -169.57 2.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.99 -89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 63.329999999999998 112.491 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.27 23.12 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 64.049999999999997 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 t -146.11 148.62 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.030000000000001 111.122 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.87 127.29 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 111.11 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -82.53 100.97 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 75.450000000000003 110.901 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.43 127.37 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.906 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -86.55 100.17 12.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 71.109999999999999 110.911 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.0 129.73 47.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 73.409999999999997 110.948 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -133.1 141.18 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.913 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 74.409999999999997 112.486 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.927 0.394 . . . . 75.430000000000007 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.9 tp -51.98 -41.12 61.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.935 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.82 -36.72 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.097 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -56.84 -38.01 72.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.116 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.77 -31.21 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 111.122 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -51.74 -42.05 62.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.948 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -25.06 60.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.329999999999998 110.891 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.65 -57.28 5.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 73.530000000000001 112.474 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -62.82 -53.46 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 74.340000000000003 111.154 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -52.19 -30.97 29.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.907 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -73.9 -34.73 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 72.400000000000006 110.848 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.5 -35.69 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 63.240000000000002 110.916 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.69 28.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 73.530000000000001 110.939 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 mtt -51.66 -31.56 26.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.892 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.43 -28.57 30.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.895 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.96 -45.43 3.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.894 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.31 75.12 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 75.019999999999996 111.119 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -8.76 24.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.724 2.283 . . . . 74.299999999999997 112.327 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.58 -51.92 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.42 144.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 -39.6 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -168.85 -175.99 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 111.08 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.65 147.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.126 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 61.43 110.9 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.78 0.241 . . . . 74.439999999999998 112.306 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -151.0 123.17 8.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 110.927 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -137.05 -177.36 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 62.420000000000002 111.146 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.24 -30.19 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.340000000000003 111.1 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.03 -61.01 2.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 72.519999999999996 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -56.77 -46.29 81.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 73.310000000000002 110.882 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.96 -31.16 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 111.119 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -61.8 -39.83 93.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 110.908 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -63.92 -39.56 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 70.400000000000006 110.839 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.78 -42.49 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.340000000000003 111.136 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mp -71.35 -18.23 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 75.540000000000006 110.925 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.04 -27.58 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.857 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -76.44 -43.56 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.947 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.46 -4.46 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 64.219999999999999 111.153 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.2 ttt-85 -60.62 -58.85 16.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 73.040000000000006 110.841 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.78 -7.29 20.7 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.692 2.262 . . . . 73.219999999999999 112.34 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -96.29 -64.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.898 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -63.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 73.230000000000004 110.94 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 p -50.41 -31.19 14.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.15 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.83 -37.95 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 111.117 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.85 -36.83 80.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 54.340000000000003 110.842 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.12 -15.21 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 63.409999999999997 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.73 -128.1 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 71.319999999999993 112.535 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -170.79 142.37 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.878 0.37 . . . . 64.519999999999996 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.68 126.38 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.135 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.71 146.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 111.105 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 tp -79.26 129.73 34.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 110.922 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -93.37 -71.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 110.857 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.05 168.05 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 75.150000000000006 110.921 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.4 mt -123.47 109.06 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.010000000000005 111.098 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.64 -171.91 3.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 62.210000000000001 111.08 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.62 -91.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.510000000000005 112.489 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.34 22.75 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 73.209999999999994 110.858 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.22 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.13 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -114.96 127.51 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.144 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -89.08 101.45 14.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.828 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.41 152.62 25.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.928 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -105.61 100.61 10.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.887 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mt -131.0 123.84 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -122.31 139.13 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.519999999999996 110.931 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.467 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.877 0.37 . . . . 74.129999999999995 110.845 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.68 -30.35 21.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.099999999999994 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.5 mm -86.82 -32.47 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 74.150000000000006 111.122 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -33.1 73.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 111.127 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.4 pt -84.82 -26.76 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 111.126 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -51.0 -44.39 60.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 75.540000000000006 110.877 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -24.81 61.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.42 -52.12 28.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 71.209999999999994 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.1 -55.52 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 72.349999999999994 111.12 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -52.24 -32.6 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -62.8 -41.34 99.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -79.07 -33.73 44.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.05 -56.72 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 110.889 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.6 tpp -56.56 -23.78 42.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 63.009999999999998 110.885 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.96 -45.28 78.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 72.010000000000005 110.882 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -84.92 -46.41 11.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.140000000000001 110.907 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.39 76.84 2.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 74.25 111.125 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -9.7 26.74 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 74.299999999999997 112.354 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.9 -36.81 50.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 t -75.37 151.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.159 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.53 -27.24 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 111.106 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.2 169.96 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.04 154.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.103 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 73.040000000000006 110.887 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.764 0.235 . . . . 74.450000000000003 112.311 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -141.42 123.68 15.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.239999999999995 110.942 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p -131.77 179.46 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.129 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.62 75.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 111.097 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.07 -47.82 7.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 64.010000000000005 112.471 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -65.68 -48.68 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 75.420000000000002 110.87 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.7 -31.03 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.152 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.44 -34.58 77.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 110.92 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -42.56 95.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 63.32 110.859 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.97 -42.05 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.409999999999997 111.148 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.88 -18.76 62.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -52.12 -25.96 10.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.210000000000001 110.875 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -82.64 -43.55 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.927 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.75 1.36 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.12 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.509 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.6 ttt180 -68.14 -58.89 6.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 110.858 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.29 23.23 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.664 2.242 . . . . 75.420000000000002 112.361 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -98.91 -12.78 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.936 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.15 -64.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 73.450000000000003 110.926 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -60.13 -19.49 53.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.099999999999994 111.139 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.66 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.109 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.15 -24.67 19.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 110.874 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.26 -17.09 2.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 70.230000000000004 112.5 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 -140.46 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 70.230000000000004 112.499 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.5 -172.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 110.864 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -148.65 136.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 111.14 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.36 122.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.299999999999997 111.122 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.0 tp -76.73 120.94 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.919 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -93.41 -73.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 110.871 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -115.94 165.98 12.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.914 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.7 mt -132.13 104.49 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 73.299999999999997 111.182 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.5 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 111.088 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.89 -81.84 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 75.140000000000001 112.481 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -91.77 13.53 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 75.530000000000001 110.874 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.0 t -145.18 151.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 71.450000000000003 111.162 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.43 128.58 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 72.140000000000001 111.113 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -79.78 100.82 8.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.0 110.848 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 mt -109.03 127.7 54.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.120000000000005 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -83.48 101.79 11.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.919 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.58 159.2 34.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 75.140000000000001 110.917 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -143.25 133.39 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.919 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 71.510000000000005 112.487 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.905 0.383 . . . . 65.209999999999994 110.838 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -51.95 -30.48 24.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.510000000000005 110.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.02 -30.84 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.409999999999997 111.134 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 m -69.37 -34.55 74.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 111.165 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.8 pt -84.05 -27.8 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 111.123 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -51.89 -41.72 62.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 110.903 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -24.67 60.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.219999999999999 110.853 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.54 -56.04 5.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 55.439999999999998 112.461 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mp -65.03 -50.76 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 74.530000000000001 111.116 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.46 -31.55 23.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.340000000000003 110.917 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.41 -44.15 83.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.420000000000002 110.874 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -75.54 -36.45 60.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 110.866 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -29.16 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 110.914 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.2 ttm -76.97 -36.42 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 110.892 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -51.98 -47.4 64.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -90.64 -48.5 7.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 75.099999999999994 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.93 76.34 2.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.66 0.743 . . . . 73.129999999999995 111.098 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.6 24.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 75.219999999999999 112.337 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.18 -27.49 69.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 62.450000000000003 110.86 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 p -88.92 144.59 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 111.098 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.4 -42.45 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.084 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.53 -177.43 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.5 m -131.42 140.72 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 72.200000000000003 111.143 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 61.329999999999998 110.931 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.814 0.256 . . . . 73.010000000000005 112.361 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.63 136.85 26.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.918 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 p -144.16 -178.25 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 111.148 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.14 76.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 111.115 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.24 -47.33 7.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 72.129999999999995 112.485 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -65.71 -48.71 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 74.329999999999998 110.846 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.46 -31.15 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 111.121 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.05 -35.45 78.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.912 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.8 t -63.08 -42.75 99.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 72.420000000000002 110.846 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -77.18 -41.74 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.54 -19.0 64.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.955 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.77 -25.47 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 110.828 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -73.33 -47.71 40.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 63.219999999999999 110.909 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.3 m -82.23 -7.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 111.113 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.4 ttt180 -56.07 -58.82 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 74.230000000000004 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -21.18 33.76 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 74.019999999999996 112.355 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -81.41 -27.75 34.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.209999999999994 110.959 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.43 -49.5 6.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 65.219999999999999 110.933 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -62.5 -21.56 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 61.310000000000002 111.107 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.09 -53.83 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.299999999999997 111.067 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.07 -36.15 83.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 75.540000000000006 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.88 -30.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 64.030000000000001 112.482 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.85 -150.75 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 64.200000000000003 112.45 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -175.3 153.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 74.430000000000007 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.7 m -116.08 135.93 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 111.115 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.12 127.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 111.087 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 tp -71.23 122.83 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 110.979 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -90.28 -48.29 7.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 63.210000000000001 110.871 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -160.6 172.52 17.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 75.299999999999997 110.913 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.1 mt -129.33 125.71 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 111.103 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.35 102.22 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 64.239999999999995 111.089 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.59 -125.09 28.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 60.210000000000001 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -77.48 -17.17 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 72.450000000000003 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.96 150.98 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.111 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.2 137.36 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 73.439999999999998 111.097 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -93.88 101.82 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 70.140000000000001 110.834 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 mt -111.65 123.92 51.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.319999999999993 110.928 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 105.62 11.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 110.937 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.9 mt -130.88 127.37 38.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 64.219999999999999 110.918 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -121.26 144.48 48.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.895 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 73.230000000000004 112.505 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 65.219999999999999 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.85 -30.21 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 71.319999999999993 110.885 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.85 -35.44 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.148 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -33.74 76.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 111.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.5 pt -81.92 -29.52 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.519999999999996 111.154 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.33 -45.57 62.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.893 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -24.91 63.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 74.049999999999997 110.885 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.24 -58.97 5.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 71.140000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -59.94 -54.93 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.129 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -51.9 -31.41 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 110.902 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -72.78 -35.69 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 110.869 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -76.08 -40.17 53.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.834 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.11 -30.26 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.963 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 22.6 mtt -69.67 -24.2 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 110.908 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -67.3 -48.51 67.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.519999999999996 110.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -84.03 -49.04 9.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 71.200000000000003 110.864 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.18 75.28 2.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 73.540000000000006 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -8.78 24.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.7 2.266 . . . . 72.140000000000001 112.346 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.12 -28.45 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.450000000000003 110.914 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.88 144.6 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 75.430000000000007 111.153 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 -39.65 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 111.09 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.7 171.83 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.200000000000003 111.084 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.79 151.94 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.125 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.7 0.762 . . . . 64.319999999999993 110.84 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.827 0.261 . . . . 71.519999999999996 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.45 130.82 39.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 p -128.65 172.79 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 75.310000000000002 111.189 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.81 -27.01 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.78 -49.29 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 64.530000000000001 112.465 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -44.5 65.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 64.239999999999995 110.897 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.43 -31.43 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 75.040000000000006 111.119 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.93 -35.21 76.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.340000000000003 110.872 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -44.22 97.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 64.540000000000006 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -77.21 -41.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.040000000000006 111.122 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mp -68.03 -19.4 64.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.912 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.21 -26.7 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 64.099999999999994 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -76.39 -44.0 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.903 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.5 -6.82 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.409999999999997 111.139 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.7 ttm180 -60.53 -58.8 16.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 74.25 110.885 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.79 -8.39 23.48 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.72 2.28 . . . . 73.200000000000003 112.354 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -94.63 -63.3 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.917 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -49.05 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.891 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -60.56 -28.53 68.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 65.430000000000007 111.137 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.79 53.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 55.039999999999999 111.117 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.16 -24.96 65.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.0 6.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 75.219999999999999 112.455 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.09 -153.79 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 61.109999999999999 112.506 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -174.77 127.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 61.409999999999997 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -100.98 134.77 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 72.329999999999998 111.092 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.37 117.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 111.094 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 tp -63.03 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.946 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -93.69 -74.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.540000000000006 110.853 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.36 171.36 9.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.140000000000001 110.915 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.23 108.19 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.099 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.39 -172.05 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 65.099999999999994 111.119 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.39 -87.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 73.450000000000003 112.486 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -94.31 20.64 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 71.209999999999994 110.902 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.09 150.83 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.549999999999997 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.15 139.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.102 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -99.4 101.05 12.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.876 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.5 mt -108.6 154.66 21.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.310000000000002 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -115.05 119.04 35.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 134.71 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 71.519999999999996 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.1 130.02 54.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.915 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.777 -0.725 . . . . 74.450000000000003 112.477 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.912 0.387 . . . . 74.519999999999996 110.841 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 pp -51.32 -30.67 19.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.329999999999998 110.929 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.72 -30.89 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.115 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -72.62 -34.64 67.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.7 pt -86.1 -30.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 72.129999999999995 111.145 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -50.85 -47.41 60.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 110.905 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -68.47 -24.77 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.869 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.78 -56.89 5.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 71.319999999999993 112.431 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -62.9 -53.24 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 74.239999999999995 111.169 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -53.21 -31.78 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 110.891 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -68.43 -32.44 72.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 72.540000000000006 110.886 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -79.09 -46.0 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.852 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -51.99 66.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.845 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 18.6 tpp -53.69 -39.4 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.88 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.1 -23.36 54.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 110.872 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -100.53 -37.88 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.239999999999995 110.867 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.83 80.23 2.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.124 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.7 2.267 . . . . 74.239999999999995 112.309 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.49 -26.79 62.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.434 . . . . 74.319999999999993 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 t -83.19 149.38 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.53 -30.08 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 111.148 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.46 -173.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 111.123 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.25 164.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 72.099999999999994 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.685 0.755 . . . . 73.409999999999997 110.853 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.86 0.275 . . . . 65.5 112.354 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.67 135.84 28.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.935 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 p -145.07 172.43 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 75.540000000000006 111.126 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.33 -30.37 18.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 111.131 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.3 -62.3 2.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 75.340000000000003 112.471 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -55.38 -47.83 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 73.239999999999995 110.863 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.64 -31.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 111.163 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.26 -37.55 83.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 73.140000000000001 110.866 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -42.7 99.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.1 -39.87 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 73.510000000000005 111.102 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -70.63 -18.69 62.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 74.310000000000002 110.909 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.15 -25.88 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.888 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.03 -47.59 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 110.916 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.64 -3.49 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 111.131 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.0 ttt180 -60.78 -58.74 17.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 73.319999999999993 110.872 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.2 Cg_endo -69.78 -10.92 29.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.65 2.234 . . . . 74.310000000000002 112.366 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.15 -32.55 14.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.943 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.94 -59.68 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 71.439999999999998 110.958 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.5 p -51.74 -39.39 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.310000000000002 111.139 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 62.020000000000003 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.69 -37.96 67.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 71.319999999999993 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.85 -38.57 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 70.420000000000002 112.525 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -73.76 -135.89 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 62.539999999999999 112.519 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -174.9 175.99 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 71.439999999999998 110.825 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.28 138.59 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.510000000000005 111.155 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.32 131.51 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 45.049999999999997 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.01 118.55 20.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.918 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -97.64 -64.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 110.865 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.43 165.08 16.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 110.882 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.8 mt -138.5 113.36 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 73.439999999999998 111.137 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.56 -169.34 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 111.094 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.37 -90.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 65.409999999999997 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -85.98 4.94 35.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 75.519999999999996 110.867 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.6 t -133.39 151.19 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.145 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.71 140.37 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.114 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 100.97 13.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.12 123.17 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.939 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -73.23 86.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.891 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mt -117.99 129.64 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 110.916 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -131.05 141.39 50.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.9 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.240000000000002 112.498 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.943 0.401 . . . . 72.129999999999995 110.861 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -54.34 -29.83 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 110.884 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.4 mm -85.11 -31.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 73.209999999999994 111.169 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.8 m -68.15 -34.36 76.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 70.129999999999995 111.124 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.03 -30.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 111.135 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -52.64 -47.1 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 72.5 110.891 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -69.11 -24.88 64.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 75.299999999999997 110.885 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.25 -57.59 6.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.681 -0.771 . . . . 74.439999999999998 112.475 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.74 -55.31 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.34 . . . . 74.299999999999997 111.114 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -51.68 -31.81 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.898 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -71.3 -36.77 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 110.908 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -79.03 -36.38 41.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 72.409999999999997 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -33.54 71.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.925 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 3.2 mtm -63.91 -27.72 69.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 75.420000000000002 110.872 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.68 -58.55 8.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 72.420000000000002 110.881 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.62 -47.41 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.881 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.56 74.33 2.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.64 0.734 . . . . 74.109999999999999 111.114 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -14.31 35.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.623 2.215 . . . . 61.109999999999999 112.372 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -38.46 55.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.876 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 p -76.04 144.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.32 111.102 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.33 -53.66 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.128 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.13 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.1 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.63 148.51 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 63.329999999999998 111.094 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.651 0.739 . . . . 74.549999999999997 110.867 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.795 0.248 . . . . 74.549999999999997 112.335 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -89.48 106.97 18.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -135.58 166.04 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 74.140000000000001 111.144 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.88 -27.39 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.530000000000001 111.086 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.16 -59.04 3.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 33.229999999999997 112.478 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -62.23 -48.02 81.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 74.219999999999999 110.909 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.6 -30.99 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 70.239999999999995 111.143 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -61.79 -38.15 87.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 72.349999999999994 110.887 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -67.38 -37.85 83.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 62.299999999999997 110.868 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.04 -39.41 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 111.147 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.1 -19.16 62.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.340000000000003 110.912 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.84 -26.89 10.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.87 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -76.35 -43.42 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.4 -7.35 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 73.319999999999993 111.086 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.7 ttm-85 -60.18 -58.79 16.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.603 0.716 . . . . 74.510000000000005 110.877 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.1 Cg_endo -69.83 -8.49 23.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.669 2.246 . . . . 74.439999999999998 112.32 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.55 -63.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.94 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -54.77 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 74.129999999999995 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -51.48 -34.77 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 111.154 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.18 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 72.129999999999995 111.06 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.89 -31.7 63.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.842 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.7 17.1 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 63.420000000000002 112.504 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.38 -135.96 8.84 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 53.409999999999997 112.477 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -179.16 136.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 74.040000000000006 110.851 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.8 m -110.13 129.45 65.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.141 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -167.8 129.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 72.239999999999995 111.098 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.5 tp -71.78 119.65 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -76.96 -72.28 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 72.010000000000005 110.877 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.75 171.1 14.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.85 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.91 121.35 59.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 70.019999999999996 111.101 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.24 -170.51 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.030000000000001 111.074 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.01 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 54.439999999999998 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 23.41 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 71.150000000000006 110.908 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.171 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.18 138.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.174 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -101.02 101.05 11.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.872 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 mt -107.91 164.62 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 70.120000000000005 110.887 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.72 115.81 19.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 72.230000000000004 110.905 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.71 137.9 37.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.894 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.38 113.13 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.898 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 73.340000000000003 112.502 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.96 0.409 . . . . 63.140000000000001 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.67 -47.67 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.340000000000003 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.57 -31.2 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 111.122 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -61.66 -39.92 93.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.14 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.1 pt -86.17 -29.99 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 111.135 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -50.75 -47.67 59.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 72.25 110.882 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.76 -24.71 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 110.839 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.15 -55.76 6.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.771 -0.728 . . . . 62.32 112.458 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp -62.87 -54.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 111.134 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -52.88 -32.6 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 110.904 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.67 -32.74 74.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.868 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -78.88 -56.42 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.0 -35.65 47.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.893 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.1 mtt -62.78 -40.35 97.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.897 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.31 -20.07 57.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -33.81 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.040000000000006 110.902 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 mm -112.34 76.89 2.05 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 73.209999999999994 111.079 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -7.6 21.48 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.439999999999998 112.378 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.94 -29.53 35.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 63.32 110.879 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.28 158.47 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.010000000000005 111.108 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.37 -47.29 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.147 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.24 -173.8 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 71.120000000000005 111.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.75 164.85 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 74.430000000000007 110.96 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.208 0 CA-C-O 120.843 0.268 . . . . 71.430000000000007 112.346 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.68 140.11 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 110.943 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 t -142.74 167.72 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 111.144 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.32 -28.35 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.07 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.88 -42.5 12.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.736 . . . . 74.120000000000005 112.472 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.65 -47.18 49.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.91 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -50.78 -30.8 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 62.509999999999998 111.136 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.94 -37.08 83.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.912 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.71 -39.57 73.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.86 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.46 -44.74 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 73.319999999999993 111.097 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.21 -18.97 62.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.93 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.8 -26.12 5.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.862 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -75.06 -45.46 41.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.892 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.62 -7.06 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.340000000000003 111.157 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 17.7 ttt-85 -58.56 -58.8 16.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 71.319999999999993 110.885 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.7 -8.85 24.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.278 . . . . 72.099999999999994 112.353 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.1 -25.47 15.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.913 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.7 -57.32 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.911 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -53.11 -36.33 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 63.43 111.155 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.59 -28.74 70.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 73.040000000000006 111.088 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -76.81 -38.05 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 72.5 110.87 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.41 -39.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 73.400000000000006 112.495 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.48 -137.77 1.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 71.129999999999995 112.464 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -174.77 -175.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 74.519999999999996 110.825 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.94 138.96 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 71.349999999999994 111.121 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.42 123.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 111.13 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.2 tp -66.12 133.59 51.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.967 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -100.18 -63.53 1.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 62.5 110.823 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -144.75 163.87 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.894 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.8 mt -123.11 114.5 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 111.16 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.43 -172.32 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 62.100000000000001 111.147 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.63 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.99 25.06 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 55.119999999999997 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -144.69 151.01 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.42 128.96 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 111.127 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -90.16 103.33 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.904 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.82 133.67 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.896 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -86.07 91.76 8.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.895 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.9 mt -119.44 131.33 55.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.510000000000005 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -127.84 127.01 42.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 72.049999999999997 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 75.120000000000005 112.468 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.907 0.384 . . . . 75.129999999999995 110.826 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -52.38 -30.12 27.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.935 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.97 -36.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 111.107 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -60.04 -34.02 72.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 111.137 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 pt -86.14 -26.83 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 111.106 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -51.07 -48.6 61.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 72.140000000000001 110.873 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -66.35 -24.7 66.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.219999999999999 110.858 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.13 -57.23 6.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.763 -0.732 . . . . 73.019999999999996 112.471 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.09 -54.54 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 75.5 111.132 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -31.74 25.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -69.27 -44.35 72.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 75.540000000000006 110.86 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -69.75 -39.98 76.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 110.852 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -47.74 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 110.935 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.7 mmt -55.11 -26.49 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.329999999999998 110.89 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.4 -62.68 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.863 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -71.84 -47.27 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.24 75.06 2.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 73.030000000000001 111.103 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -11.06 30.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.65 2.233 . . . . 75.150000000000006 112.368 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -51.92 -43.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.140000000000001 110.878 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.99 148.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 111.118 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.42 -33.0 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 111.113 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -175.56 177.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.09 147.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 64.400000000000006 111.137 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.737 . . . . 73.109999999999999 110.868 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.849 0.27 . . . . 64.510000000000005 112.363 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.95 120.14 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 71.340000000000003 110.898 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -134.51 -176.69 4.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 61.439999999999998 111.142 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.57 70.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 71.540000000000006 111.081 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.5 -52.28 4.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 71.439999999999998 112.474 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -61.22 -48.45 81.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 74.129999999999995 110.879 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.79 -30.77 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 111.171 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.34 -33.58 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 72.409999999999997 110.947 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 t -63.93 -43.93 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 72.230000000000004 110.87 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.5 -40.77 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 111.123 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mp -71.11 -18.97 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.010000000000005 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -51.26 -26.85 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.875 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -74.48 -42.23 59.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.921 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -81.96 -12.88 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.164 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.5 ttt85 -53.04 -58.59 11.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.587 0.708 . . . . 73.219999999999999 110.891 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.8 Cg_endo -69.77 -32.13 19.14 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 73.5 112.323 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -65.92 -57.7 7.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.955 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.05 -54.81 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 73.450000000000003 110.94 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -51.6 -30.57 21.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 111.094 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.96 -36.74 78.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 70.439999999999998 111.126 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.18 -38.03 61.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 63.539999999999999 110.89 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.76 -26.62 2.37 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 71.25 112.461 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.73 -136.84 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.492 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.39 -175.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 74.099999999999994 110.881 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.5 m -141.79 143.95 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.519999999999996 111.183 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.78 131.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.124 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.0 tp -53.69 114.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 75.299999999999997 110.876 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -80.78 -49.98 10.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -168.41 167.9 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.889 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -127.97 105.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 74.140000000000001 111.141 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.32 -178.08 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.019999999999996 111.092 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.16 -75.88 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.747 . . . . 71.049999999999997 112.528 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -0.14 21.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.935 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.62 152.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 111.096 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -113.78 142.85 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 111.137 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -115.13 100.42 8.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.899 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.69 146.29 27.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.895 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -102.29 124.05 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 75.340000000000003 110.892 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.4 156.97 46.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.905 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -132.78 114.72 14.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 73.519999999999996 110.925 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 60.439999999999998 112.507 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.928 0.394 . . . . 74.430000000000007 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.97 -32.86 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 74.200000000000003 110.892 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.52 -31.02 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 111.12 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -40.65 97.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.161 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.6 pt -84.01 -30.91 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.439999999999998 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -52.0 -41.66 62.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.951 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -24.81 60.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.871 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.17 -54.81 7.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 55.119999999999997 112.549 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -58.46 -50.92 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 74.340000000000003 111.106 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -58.84 -34.73 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.892 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -76.68 -30.33 56.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -79.21 -34.32 43.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.549999999999997 110.858 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -57.08 5.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.972 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.4 ttm -50.89 -30.73 15.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 71.340000000000003 110.905 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -60.38 -37.56 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.948 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -91.7 -45.37 8.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.886 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.41 73.74 2.0 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 74.420000000000002 111.117 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.87 36.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 74.219999999999999 112.347 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.71 -47.55 82.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 74.319999999999993 110.861 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.84 131.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.049999999999997 111.129 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.31 63.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 62.439999999999998 111.078 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.48 178.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 111.113 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.85 134.47 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.129 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 64.140000000000001 110.92 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.858 0.274 . . . . 71.109999999999999 112.367 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.61 134.49 25.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 72.409999999999997 110.885 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p -145.34 173.02 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.219999999999999 111.138 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.22 -30.52 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 111.094 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.08 -62.28 2.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 73.519999999999996 112.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -47.93 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 75.230000000000004 110.907 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -50.77 -30.88 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 111.112 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -61.63 -38.07 86.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.935 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -64.62 -40.39 95.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.400000000000006 110.846 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.49 -39.04 32.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 111.144 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.06 -19.4 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 110.894 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.3 -26.83 20.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 75.030000000000001 110.857 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -75.32 -43.45 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.93 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 p -81.45 -9.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 70.439999999999998 111.09 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.8 ttt180 -56.67 -58.71 15.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 72.109999999999999 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -12.57 33.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.694 2.263 . . . . 74.019999999999996 112.302 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -92.14 -25.99 18.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 72.129999999999995 110.905 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -101.0 -57.38 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.956 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.9 p -52.33 -35.92 52.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 111.167 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.81 72.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 52.009999999999998 111.113 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.08 -37.98 69.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 110.89 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.45 -35.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.762 -0.732 . . . . 72.340000000000003 112.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -141.13 1.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.771 . . . . 75.150000000000006 112.47 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -170.19 -176.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 72.329999999999998 110.821 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.93 138.43 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 62.509999999999998 111.104 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.74 137.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 52.240000000000002 111.083 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.28 135.53 39.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 64.329999999999998 110.951 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -103.5 -63.95 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 73.25 110.862 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.15 162.49 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.882 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.98 117.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 74.030000000000001 111.143 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.64 -169.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.125 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.94 -88.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 71.239999999999995 112.507 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.55 13.45 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 73.109999999999999 110.877 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.33 139.03 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.122 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.63 134.81 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 111.072 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.95 101.09 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.420000000000002 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mt -112.29 149.19 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 72.450000000000003 110.898 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -101.3 119.07 38.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.420000000000002 110.932 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.49 127.76 22.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.948 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -104.92 137.11 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 73.439999999999998 110.895 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 74.120000000000005 112.502 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.899 0.38 . . . . 75.340000000000003 110.812 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -31.08 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 74.420000000000002 110.936 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mm -88.07 -30.98 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 65.150000000000006 111.167 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 m -72.22 -33.3 67.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 111.163 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.4 pt -83.65 -30.91 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.200000000000003 111.164 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -51.8 -51.58 55.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.319999999999993 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.9 -24.93 66.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.6 -61.78 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 62.240000000000002 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 mp -55.9 -54.73 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 64.420000000000002 111.147 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -52.53 -32.45 40.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.230000000000004 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -75.44 -32.43 60.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 110.92 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -76.34 -35.63 58.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.349999999999994 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -48.12 58.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 110.914 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.96 -33.24 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.888 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.61 -55.25 23.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.9 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.06 -45.83 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.899 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.09 74.96 1.95 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.667 0.746 . . . . 75.109999999999999 111.163 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.86 33.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 75.040000000000006 112.333 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.76 -52.8 46.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 110.863 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.44 151.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 111.109 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.49 -45.75 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 111.13 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.37 -169.44 2.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.095 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.72 148.54 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 64.329999999999998 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 64.349999999999994 110.896 179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.808 0.253 . . . . 71.430000000000007 112.332 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -152.19 128.02 10.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.943 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -143.22 -178.15 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 111.167 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 54.130000000000003 111.089 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.4 -64.08 1.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 70.409999999999997 112.455 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.54 -46.73 73.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 74.120000000000005 110.846 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.24 -30.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.230000000000004 111.124 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.32 -35.62 77.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -42.3 73.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.520000000000003 110.881 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.47 -44.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 75.439999999999998 111.087 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.13 -19.43 62.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 74.049999999999997 110.904 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.19 -26.95 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.866 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -74.51 -41.38 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.895 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.8 p -83.02 -12.58 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 111.106 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 18.9 ttt180 -53.17 -58.75 11.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.709 . . . . 74.109999999999999 110.904 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -19.51 36.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 73.519999999999996 112.347 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -83.8 -24.13 31.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 110.898 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.04 -55.53 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.299999999999997 110.948 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.68 -39.35 58.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 73.519999999999996 111.112 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.68 69.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 71.329999999999998 111.116 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.17 -37.81 69.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.120000000000005 110.931 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.73 -28.0 1.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 74.209999999999994 112.484 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.86 -138.27 4.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 73.310000000000002 112.493 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -173.56 -175.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 64.219999999999999 110.838 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.09 141.33 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 75.120000000000005 111.136 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.4 132.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.209999999999994 111.094 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 117.19 10.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 75.140000000000001 110.933 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -80.8 -57.87 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.882 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -152.75 161.1 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.37 118.38 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.77 -177.08 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.131 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.39 -86.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 61.020000000000003 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.64 25.18 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 71.209999999999994 110.874 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.26 149.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 74.109999999999999 111.103 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.78 115.77 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 71.319999999999993 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -82.7 101.19 10.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.400000000000006 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.11 150.88 30.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.109999999999999 110.946 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -106.29 117.23 33.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 110.908 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.04 139.28 48.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 75.310000000000002 110.934 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -122.06 119.24 30.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.968 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 74.099999999999994 112.476 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 72.299999999999997 110.851 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.95 -29.92 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 110.888 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.59 -42.66 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 111.097 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 m -53.37 -35.94 60.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.6 pt -85.94 -30.22 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 73.25 111.138 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -51.38 -41.93 61.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 110.915 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -25.59 61.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 110.839 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.71 -57.14 6.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 74.310000000000002 112.481 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp -60.54 -54.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 63.310000000000002 111.133 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.87 -31.85 41.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -70.35 -48.28 57.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.510000000000005 110.847 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -63.34 -40.82 98.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.847 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -45.9 66.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 62.240000000000002 110.933 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.7 mtt -59.53 -23.84 63.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.230000000000004 110.876 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -71.33 -52.53 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 75.530000000000001 110.878 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -75.22 -55.12 6.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 75.200000000000003 110.895 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.95 76.03 2.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.638 0.732 . . . . 74.450000000000003 111.17 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -8.85 24.65 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 62.100000000000001 112.329 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.08 -30.73 27.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 75.519999999999996 110.847 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.43 144.18 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 72.329999999999998 111.155 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.16 -53.1 7.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.056 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.5 -169.93 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 73.120000000000005 111.128 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.21 153.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 73.140000000000001 111.11 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.129999999999995 110.909 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.78 0.242 . . . . 75.420000000000002 112.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.17 117.45 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 74.040000000000006 110.914 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 p -135.48 179.7 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.098 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.16 -30.24 16.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 43.43 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.21 -63.25 2.08 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.738 . . . . 64.299999999999997 112.511 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -54.94 -47.23 74.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 73.120000000000005 110.865 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.53 -31.14 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 111.143 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.44 -35.64 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 54.119999999999997 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -67.58 -40.22 84.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.883 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.91 -45.36 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 111.136 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 mp -72.18 -18.27 61.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.530000000000001 110.94 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -50.48 -26.8 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.349999999999994 110.889 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.4 -42.81 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 63.200000000000003 110.931 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -80.85 -14.88 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 111.096 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.3 ttp85 -51.07 -58.65 9.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.583 0.706 . . . . 70.319999999999993 110.846 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.76 -26.53 27.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.256 . . . . 74.420000000000002 112.368 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -76.15 -22.11 55.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 65.5 110.956 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.58 -51.5 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 74.310000000000002 110.866 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.5 p -56.86 -30.75 64.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 111.155 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.66 -27.21 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.129999999999995 111.046 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.03 -38.0 19.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.869 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.74 -35.75 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 45.530000000000001 112.447 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.89 -144.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 74.120000000000005 112.463 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -177.34 168.81 2.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.384 . . . . 74.010000000000005 110.855 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 m -125.23 135.62 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.167 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.17 125.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 61.100000000000001 111.098 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.68 117.65 17.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.972 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -83.77 -74.38 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 73.439999999999998 110.867 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -125.61 168.48 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 70.230000000000004 110.873 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.22 123.28 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 73.25 111.172 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.36 -169.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 111.063 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.27 -87.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 62.109999999999999 112.482 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.43 -6.59 37.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 75.430000000000007 110.852 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 t -113.9 151.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.120000000000005 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.98 133.28 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.095 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.58 102.65 15.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.858 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mt -108.44 151.08 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.329999999999998 110.91 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -104.28 90.31 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 110.939 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.8 mt -120.45 129.62 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 110.902 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -129.86 159.09 37.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.509999999999998 110.909 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 64.409999999999997 112.507 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.862 0.363 . . . . 61.049999999999997 110.858 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 pp -53.72 -28.01 31.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 110.89 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mm -81.18 -30.98 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.135 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -31.67 70.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 70.099999999999994 111.155 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.18 -28.39 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 73.400000000000006 111.073 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -52.89 -35.94 58.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.875 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -75.28 -26.25 58.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.92 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.27 -54.46 6.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.699 -0.762 . . . . 70.549999999999997 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -63.94 -44.6 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 73.549999999999997 111.16 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -64.69 -22.84 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.956 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -76.67 -51.33 11.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 74.319999999999993 110.832 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -73.41 -33.48 64.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.863 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.93 -47.5 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 70.010000000000005 110.95 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.4 ttm -68.9 -28.12 66.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.86 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -51.99 -53.83 36.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -70.56 -49.16 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.907 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.99 76.16 2.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 75.109999999999999 111.184 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.72 24.33 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.728 2.285 . . . . 72.040000000000006 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -53.11 -28.72 26.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 110.887 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.0 p -81.45 144.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 111.117 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.58 -52.57 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 111.076 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.89 -173.18 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 111.086 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.35 163.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 111.13 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.618 0.723 . . . . 74.109999999999999 110.888 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.812 0.255 . . . . 75.0 112.303 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.82 128.2 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 63.450000000000003 110.908 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.0 p -144.82 178.91 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 63.350000000000001 111.122 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.11 -30.3 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 62.119999999999997 111.073 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.97 -62.96 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 64.450000000000003 112.514 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -55.31 -47.56 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 73.5 110.947 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.23 -31.12 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 72.129999999999995 111.183 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.01 -36.69 84.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 74.219999999999999 110.901 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -66.89 -40.66 87.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 t -74.96 -45.35 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.140000000000001 111.161 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.86 -18.16 62.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.9 -26.98 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 110.849 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -74.61 -43.03 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.943 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -80.49 -14.73 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.450000000000003 111.142 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.2 ttm180 -51.6 -58.75 9.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 74.040000000000006 110.882 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.4 Cg_endo -69.74 -27.48 26.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 70.510000000000005 112.355 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -74.22 -25.01 59.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.030000000000001 110.92 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.77 -52.16 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 75.230000000000004 110.906 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.5 p -54.29 -32.5 56.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 73.5 111.132 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.77 71.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.510000000000005 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -79.7 -37.45 35.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.861 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.87 -42.66 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 61.509999999999998 112.48 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.11 -142.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 74.319999999999993 112.477 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -175.93 -177.39 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 74.420000000000002 110.858 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.6 132.96 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 111.129 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.27 123.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 73.239999999999995 111.104 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.5 116.0 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 110.896 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -75.88 -65.59 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 70.25 110.886 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.54 165.43 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 73.200000000000003 110.873 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.19 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.519999999999996 111.108 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.9 -176.44 3.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 62.229999999999997 111.094 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.47 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.461 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.28 25.46 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 110.869 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.98 150.06 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.140000000000001 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.91 117.06 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 111.139 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -82.33 100.93 10.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.836 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mt -105.22 146.52 29.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.932 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -105.78 103.1 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mt -126.58 144.11 51.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.94 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -124.7 146.8 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 110.964 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 71.439999999999998 112.446 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 75.140000000000001 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.23 -30.23 26.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.915 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.23 -38.31 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 111.151 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -35.23 76.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.6 pt -85.89 -31.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.340000000000003 111.096 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.0 -45.19 71.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.86 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -73.01 -24.84 60.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 73.219999999999999 110.877 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.17 -60.28 3.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 45.140000000000001 112.477 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 mp -59.12 -50.06 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.748 0.309 . . . . 74.519999999999996 111.094 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -57.61 -25.63 60.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.854 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -80.04 -51.55 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.200000000000003 110.863 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -64.65 -36.32 83.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 110.89 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.0 tp -70.14 -35.82 74.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 72.349999999999994 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 16.7 mtt -78.64 -29.56 45.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.540000000000006 110.893 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -51.91 -34.96 43.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.896 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -91.87 -37.6 12.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 74.549999999999997 110.852 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.34 75.12 77.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 74.099999999999994 111.103 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -8.19 22.98 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.671 2.248 . . . . 73.299999999999997 112.355 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -51.45 -30.7 20.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 110.875 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.28 144.01 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.120000000000005 111.127 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.24 -53.24 7.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.116 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -157.31 -175.68 5.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 72.549999999999997 111.124 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.13 147.9 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 111.126 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 63.149999999999999 110.927 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.819 0.258 . . . . 73.340000000000003 112.34 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.27 111.17 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 73.420000000000002 110.951 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 p -119.98 -177.67 3.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.43 . . . . 73.25 111.124 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.89 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 111.067 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 -46.13 8.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.728 . . . . 52.450000000000003 112.473 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.96 -46.74 73.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.354 . . . . 73.140000000000001 110.866 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.1 -31.16 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 111.159 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.85 -23.81 67.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 t -71.91 -45.92 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 110.835 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.08 -34.64 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 73.019999999999996 111.102 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -19.82 62.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 75.540000000000006 110.952 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -53.65 -26.66 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.420000000000002 110.855 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.62 -42.97 57.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 110.94 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.69 -14.42 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.131 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 ttt180 -51.86 -58.63 10.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.714 . . . . 74.340000000000003 110.848 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.268 . . . . 75.420000000000002 112.336 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.34 -57.39 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 64.219999999999999 110.891 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.33 -44.27 75.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 72.439999999999998 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -53.74 -29.01 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 111.117 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.48 67.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 72.319999999999993 111.107 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.31 -37.99 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.873 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.26 -15.2 3.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 53.420000000000002 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.19 -143.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 74.450000000000003 112.511 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -173.51 173.49 3.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.845 0.355 . . . . 61.210000000000001 110.844 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.27 128.46 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.165 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.15 116.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 111.133 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 113.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 110.954 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -75.07 -65.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 75.400000000000006 110.865 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -141.76 166.15 25.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 71.329999999999998 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 55.1 mt -124.53 114.59 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.18 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.37 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 111.102 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.27 -91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 75.5 112.519 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.58 24.0 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 73.510000000000005 110.869 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.13 150.18 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 75.530000000000001 111.112 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.1 t -118.79 131.82 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -98.79 100.93 12.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 74.140000000000001 110.87 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.09 144.44 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.888 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -92.81 102.97 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 62.219999999999999 110.868 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.09 147.94 44.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 75.230000000000004 110.914 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.41 141.37 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 71.010000000000005 110.973 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 71.109999999999999 112.468 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.929 0.395 . . . . 55.43 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.88 -30.81 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 62.109999999999999 110.895 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mm -90.08 -30.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 74.409999999999997 111.168 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 m -64.67 -45.08 88.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 75.219999999999999 111.168 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.5 pt -76.0 -26.65 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.510000000000005 111.082 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -51.56 -54.68 24.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 110.851 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -24.91 68.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 75.450000000000003 110.864 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.52 -60.33 4.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.524 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.56 -54.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 73.230000000000004 111.129 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.66 -32.38 41.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.915 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -77.9 -30.71 50.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.826 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -78.93 -33.59 45.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 72.209999999999994 110.898 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -54.93 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 70.439999999999998 110.885 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -29.34 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.86 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.7 -26.1 55.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.905 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -44.22 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 63.439999999999998 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.05 75.84 2.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 111.127 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.44 34.73 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 75.510000000000005 112.358 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.91 -39.45 59.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 110.864 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.09 144.44 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 61.43 111.16 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.54 -44.56 18.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.083 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.49 -171.99 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 52.549999999999997 111.092 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.3 154.0 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 65.230000000000004 111.116 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 64.549999999999997 110.897 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 120.837 0.265 . . . . 70.219999999999999 112.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.74 114.27 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.9 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -122.45 -177.13 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.010000000000005 111.128 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.87 -34.37 75.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.101 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.2 -46.44 8.18 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 74.129999999999995 112.483 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -67.3 -46.9 72.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 73.450000000000003 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.4 -31.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 111.121 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.88 -23.68 67.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.919 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -69.64 -47.26 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 73.519999999999996 110.852 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.21 -35.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 73.439999999999998 111.175 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.72 -19.38 62.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.938 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.53 -26.71 8.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.858 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -74.44 -41.74 60.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 110.893 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.98 -11.42 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.030000000000001 111.144 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.4 ttt85 -54.38 -58.6 13.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 75.209999999999994 110.881 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.69 -31.75 20.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.684 2.256 . . . . 75.340000000000003 112.36 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.24 -57.99 5.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 75.540000000000006 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.66 -55.05 38.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.921 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.1 p -51.38 -41.84 60.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 111.186 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.66 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.104 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -82.86 -37.77 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.549999999999997 110.891 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 142.21 -17.04 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.765 -0.731 . . . . 63.43 112.473 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.31 -145.45 16.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 75.200000000000003 112.476 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -167.12 -179.95 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 71.310000000000002 110.837 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.74 139.53 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 111.11 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.61 134.02 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 111.082 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.6 tp -81.4 119.49 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 72.209999999999994 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -88.51 -71.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.530000000000001 110.83 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -124.63 168.79 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 55.32 110.866 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.2 mt -131.58 125.75 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 111.118 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.11 -176.05 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 64.010000000000005 111.095 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.51 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 74.129999999999995 112.511 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.01 25.32 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 72.430000000000007 110.882 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -145.78 149.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.549999999999997 111.122 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.2 t -119.63 135.56 59.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 70.349999999999994 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 101.0 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.889 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 mt -110.59 126.16 54.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 73.540000000000006 110.879 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -79.62 101.64 8.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.91 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mt -123.34 129.69 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.230000000000004 110.934 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -121.73 129.78 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.892 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 73.099999999999994 112.52 179.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.929 0.395 . . . . 63.130000000000003 110.873 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.78 -30.1 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 74.409999999999997 110.87 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.34 -32.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.07 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -74.36 -35.99 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.099999999999994 111.152 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -76.83 -29.06 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 71.129999999999995 111.109 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -51.2 -58.13 6.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.896 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -68.39 -24.3 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.85 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.53 -59.3 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 64.400000000000006 112.514 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.03 -54.93 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 75.439999999999998 111.102 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -50.56 -31.39 15.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -78.4 -37.15 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 65.420000000000002 110.883 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -72.92 -32.0 65.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 75.549999999999997 110.92 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -51.61 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 110.926 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.3 mtt -51.82 -31.16 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.44 -27.3 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -46.82 3.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 73.319999999999993 110.908 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.39 74.75 2.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 73.319999999999993 111.167 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -13.21 34.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 70.310000000000002 112.353 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.13 -33.84 58.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.832 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.59 144.42 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 72.310000000000002 111.095 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.44 18.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 61.450000000000003 111.1 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -166.32 -170.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.310000000000002 111.109 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.22 149.76 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 74.0 111.151 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 72.219999999999999 110.885 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.775 0.24 . . . . 74.230000000000004 112.347 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.41 139.91 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 70.299999999999997 110.957 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -148.45 169.87 19.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 73.099999999999994 111.161 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.38 -29.09 9.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 111.113 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.29 -55.08 4.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 72.349999999999994 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.67 -47.56 84.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 64.109999999999999 110.837 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.16 -31.37 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 63.240000000000002 111.146 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.39 -30.67 71.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.857 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -39.93 63.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.76 -44.47 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 mp -71.52 -18.6 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.919 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.34 -25.78 4.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.87 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -73.26 -45.28 56.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 m -81.13 -13.62 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 75.150000000000006 111.154 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 ttt180 -50.51 -58.67 9.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.61 0.719 . . . . 73.120000000000005 110.905 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.74 -35.11 13.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.746 2.297 . . . . 73.049999999999997 112.326 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -67.32 -25.45 66.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.93 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.82 -49.06 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.329999999999998 110.941 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -61.73 -29.22 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 111.124 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.36 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 62.399999999999999 111.146 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.75 -38.01 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 110.899 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.22 -40.36 0.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 73.319999999999993 112.464 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.38 -148.53 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.779 -0.724 . . . . 65.450000000000003 112.448 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -178.28 -176.65 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 62.310000000000002 110.88 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.25 133.14 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 111.096 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.02 105.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 71.530000000000001 111.074 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.84 119.94 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.959 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -78.9 -54.49 6.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 110.888 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.91 172.58 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.859 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.13 121.03 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 111.132 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.28 95.63 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 74.319999999999993 111.093 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.4 -123.39 27.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 74.329999999999998 112.489 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.02 -17.58 58.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 71.5 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.96 150.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 111.148 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.65 123.66 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 111.069 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 110.861 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.17 155.36 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 72.120000000000005 110.956 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -111.82 84.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.916 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mt -109.65 139.61 44.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 75.109999999999999 110.874 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -131.36 140.67 49.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 110.907 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 71.439999999999998 112.464 -179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.949 0.404 . . . . 63.119999999999997 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.42 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 75.129999999999995 110.912 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.1 mt -80.47 -38.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 111.155 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -52.45 -39.76 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 73.230000000000004 111.099 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.1 pt -86.36 -27.69 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 74.430000000000007 111.088 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -43.63 66.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.852 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -24.91 61.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.877 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.59 -57.75 5.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.010000000000005 112.53 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -63.35 -53.3 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 75.420000000000002 111.164 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -52.02 -29.99 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.520000000000003 110.896 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -75.44 -50.66 15.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 110.887 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -63.66 -35.87 81.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 60.399999999999999 110.852 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.25 -35.52 73.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.9 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.897 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.8 -38.27 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 62.100000000000001 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -32.02 14.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.895 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.99 76.56 77.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 70.209999999999994 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -8.64 24.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 72.120000000000005 112.365 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -56.2 -25.99 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.150000000000006 110.858 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.1 150.08 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.104 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.86 -51.12 5.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.510000000000005 111.043 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.78 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 75.099999999999994 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.2 153.21 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 72.349999999999994 111.145 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.622 0.725 . . . . 72.150000000000006 110.924 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.804 0.252 . . . . 71.25 112.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.06 139.81 29.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 75.430000000000007 110.924 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -153.5 169.62 22.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 61.530000000000001 111.18 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.3 -29.56 10.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.098 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.44 -62.44 2.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 72.340000000000003 112.526 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -56.23 -48.22 76.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 65.239999999999995 110.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.22 -31.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.125 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.35 -36.67 82.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.868 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -63.81 -41.55 97.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 53.409999999999997 110.875 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.02 -42.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.200000000000003 111.127 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.67 -18.85 62.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 110.915 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -51.58 -26.88 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.881 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -78.5 -43.89 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.89 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.38 -1.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.132 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.51 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.3 ttt180 -65.88 -58.79 10.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.706 . . . . 74.310000000000002 110.843 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.72 -8.17 22.91 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.653 2.235 . . . . 73.310000000000002 112.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -12.61 20.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.899 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.21 -66.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 64.140000000000001 110.934 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -58.51 -20.1 43.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 111.116 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.23 -29.85 15.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 74.5 111.111 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.24 -31.64 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 110.889 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.22 -16.96 0.89 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 74.150000000000006 112.503 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.12 -138.89 2.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 64.430000000000007 112.518 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 179.85 -175.96 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 73.530000000000001 110.921 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.17 127.06 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 111.143 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.69 133.42 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 63.210000000000001 111.16 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.34 112.91 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.120000000000005 110.913 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -74.56 -73.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.896 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.62 171.14 13.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.901 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.6 mt -129.74 110.82 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.409999999999997 111.108 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.33 179.73 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.085 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.473 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.77 23.56 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 65.010000000000005 110.946 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -145.54 149.4 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -123.07 133.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.123 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -96.86 100.84 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 110.854 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.64 130.56 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.884 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -82.99 118.63 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.916 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.3 mt -142.19 123.69 14.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 110.928 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -111.79 115.29 28.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.120000000000005 110.957 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 72.120000000000005 112.48 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.86 0.362 . . . . 45.310000000000002 110.881 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.11 -29.9 23.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.128 -0.487 . . . . 72.120000000000005 110.903 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.1 mm -87.1 -39.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 71.340000000000003 111.099 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -57.78 -34.01 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.329999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -86.13 -29.91 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 64.340000000000003 111.136 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -49.87 -58.31 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.88 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -24.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.06 -50.05 19.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 52.450000000000003 112.452 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.51 -55.6 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 73.530000000000001 111.127 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.4 -32.05 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.849 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.94 -40.89 95.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 110.905 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -72.29 -37.34 69.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 75.349999999999994 110.891 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -38.89 92.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 73.049999999999997 110.926 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.4 ttm -67.9 -25.46 65.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.239999999999995 110.86 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.84 -59.4 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -73.24 -51.2 18.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 74.530000000000001 110.865 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.86 76.15 2.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 71.230000000000004 111.137 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.8 33.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.254 . . . . 74.510000000000005 112.331 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.83 -36.18 47.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.86 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 p -76.13 144.1 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.299999999999997 111.13 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.75 -51.45 8.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.064 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.84 -170.16 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 111.066 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.0 144.06 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 111.168 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 73.510000000000005 110.909 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.849 0.271 . . . . 73.239999999999995 112.36 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.54 106.61 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 110.914 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -129.76 175.66 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.123 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.7 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.08 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.96 -43.76 10.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 71.129999999999995 112.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -71.83 -47.43 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 74.519999999999996 110.893 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.61 -31.13 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 111.144 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.25 -39.9 92.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.844 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -41.1 95.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 110.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -77.28 -39.57 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.122 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.87 -19.43 63.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.931 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -52.35 -27.08 14.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.853 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -76.85 -43.65 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.896 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.34 -4.51 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.153 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.3 ttp85 -61.26 -58.72 16.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 74.420000000000002 110.892 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.78 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 71.439999999999998 112.353 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.23 -46.95 6.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 72.450000000000003 110.914 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -43.56 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 73.219999999999999 110.963 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.5 p -65.63 -23.16 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.19 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.68 -51.99 62.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 111.091 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -63.7 -29.25 70.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.843 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.47 19.21 3.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 74.019999999999996 112.467 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.58 -135.91 8.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.708 -0.758 . . . . 75.099999999999994 112.497 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -179.37 139.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 73.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.54 133.04 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 111.108 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.89 138.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 61.299999999999997 111.092 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.81 126.71 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 65.219999999999999 110.892 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -88.36 -71.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.871 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -134.58 174.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 73.25 110.922 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 53.5 mt -132.35 110.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.9 -170.21 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 111.132 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.55 -89.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 71.140000000000001 112.467 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.12 21.04 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 72.420000000000002 110.886 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.26 150.28 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 111.141 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.46 139.83 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.120000000000005 111.155 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 100.87 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.430000000000007 110.848 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.92 178.17 4.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.922 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -134.01 120.25 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.329999999999998 110.909 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 mt -138.25 143.15 39.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 71.530000000000001 110.945 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -118.99 106.71 12.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.916 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 73.239999999999995 112.461 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.894 0.378 . . . . 75.230000000000004 110.837 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.86 -31.72 29.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.519999999999996 110.928 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.8 mm -79.49 -38.07 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.094 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.85 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.145 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.8 pt -86.09 -26.97 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 73.400000000000006 111.116 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -50.68 54.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 75.140000000000001 110.902 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -24.83 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 110.858 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.66 -51.91 18.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 62.020000000000003 112.463 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.06 -56.41 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.728 0.299 . . . . 73.329999999999998 111.13 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.49 -33.32 44.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.933 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -63.51 -33.54 75.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 75.219999999999999 110.859 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -77.02 -56.57 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.894 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.32 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.914 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 32.7 ttm -55.15 -39.43 69.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 65.230000000000004 110.879 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.37 -19.38 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.040000000000006 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 -33.13 9.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.129999999999995 110.932 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 mm -111.49 78.8 2.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 71.129999999999995 111.132 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -8.13 22.82 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.242 . . . . 71.310000000000002 112.324 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -33.89 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 74.040000000000006 110.895 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.43 155.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 111.149 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.41 -45.11 8.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 62.130000000000003 111.115 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.12 -169.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.36 160.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 70.430000000000007 111.121 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.758 . . . . 74.140000000000001 110.887 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.789 0.328 . . . . 72.310000000000002 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.56 -110.32 4.0 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 75.5 112.486 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.9 159.31 64.55 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.623 0.725 . . . . 72.430000000000007 110.911 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -29.99 23.03 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.696 2.264 . . . . 73.209999999999994 112.337 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.3 122.39 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.7 p -132.04 172.07 12.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 75.030000000000001 111.13 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.56 -30.21 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 64.200000000000003 111.089 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.62 -61.24 2.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 70.010000000000005 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 74.400000000000006 110.894 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.11 -31.23 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 75.200000000000003 111.156 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.88 -24.13 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -74.06 -44.28 54.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.856 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.02 -34.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 111.16 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mp -71.61 -20.11 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 75.530000000000001 110.898 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.15 -26.6 28.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.836 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -74.03 -42.51 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.430000000000007 110.918 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.23 -13.87 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 62.030000000000001 111.165 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.517 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.8 ttt180 -51.45 -58.67 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.583 0.706 . . . . 73.230000000000004 110.835 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -8.32 23.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.246 . . . . 75.430000000000007 112.353 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -98.47 -19.27 17.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 75.5 110.922 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 -40.21 7.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 110.905 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 p -69.94 -16.21 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 111.121 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -54.88 24.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 64.519999999999996 111.066 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -131.54 40.14 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 110.879 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -149.87 -63.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 61.439999999999998 112.476 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.61 -71.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 74.400000000000006 112.464 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.54 168.93 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 60.130000000000003 110.896 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.02 166.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 111.17 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.35 141.7 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 62.310000000000002 111.093 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.6 tp -86.85 115.32 24.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.982 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.13 -73.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.87 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -131.76 169.08 16.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.34 110.52 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 71.25 111.15 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.47 -173.96 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.117 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.34 -89.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.728 -0.749 . . . . 74.549999999999997 112.501 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.43 23.73 5.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 74.129999999999995 110.891 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.93 150.55 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.67 129.61 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 75.310000000000002 111.126 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 mtp85 -89.46 103.39 16.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.839 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mt -116.35 142.84 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.944 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.35 104.76 16.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 65.340000000000003 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.5 mt -113.54 128.98 56.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 73.340000000000003 110.913 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 87.66 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.439999999999998 110.935 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.3 -72.21 0.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 70.219999999999999 112.522 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.92 132.0 41.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 74.340000000000003 111.11 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.4 t -73.6 101.54 3.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.019999999999996 110.893 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.49 -166.21 37.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 71.209999999999994 112.502 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -92.45 -28.66 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 73.409999999999997 110.869 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.7 t -124.08 72.63 55.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.594 0.711 . . . . 75.340000000000003 110.876 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 132.97 24.49 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.263 . . . . 73.25 112.346 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.2 p -110.12 -33.49 6.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 74.150000000000006 110.848 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 t -61.72 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.109999999999999 110.877 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -51.84 -49.78 62.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.922 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -70.2 -32.57 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.4 m -66.87 -39.65 87.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.164 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.08 -26.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.430000000000007 111.144 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -51.17 -48.09 61.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.942 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.56 -25.0 65.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 71.120000000000005 110.817 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.95 -60.28 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 54.5 112.462 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.2 -53.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 74.540000000000006 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.26 -32.3 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -76.38 -30.5 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -79.09 -33.8 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 110.856 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -52.68 22.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.925 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -30.11 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.519999999999996 110.886 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.6 -27.01 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.863 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -113.29 -45.65 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.12 75.71 2.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 74.200000000000003 111.132 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -11.77 31.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 72.420000000000002 112.358 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -51.99 -30.69 26.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 64.129999999999995 110.85 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.79 149.26 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.019999999999996 111.122 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.34 -36.16 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 74.510000000000005 111.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.46 -175.31 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.31 153.91 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -136.37 160.23 67.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 71.129999999999995 112.333 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.72 -24.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 75.140000000000001 111.142 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 p -137.33 -177.48 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 111.165 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.11 82.18 8.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.340000000000003 110.88 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -139.93 26.57 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 75.219999999999999 110.88 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -104.65 -44.22 4.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 72.519999999999996 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.0 t -110.51 73.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 111.195 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 72.129999999999995 112.462 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.8 mtp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.786 0.327 . . . . 74.409999999999997 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.28 97.94 0.25 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 71.219999999999999 112.505 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.83 160.55 46.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.632 0.729 . . . . 74.129999999999995 110.879 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -37.62 8.78 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.689 2.259 . . . . 72.329999999999998 112.349 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -133.42 131.13 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 110.932 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 t -129.31 160.91 31.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 111.149 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.89 -27.85 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 45.43 111.133 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.69 -39.13 22.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 72.019999999999996 112.48 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 79' ' ' ASN . 1.5 m-80 -76.43 -46.89 25.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 74.329999999999998 110.907 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.58 -31.36 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.105 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -45.06 91.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 110.949 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -61.88 -36.21 80.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.439999999999998 110.845 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.28 -39.98 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 62.229999999999997 111.14 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mp -71.08 -19.03 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.912 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -26.84 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.019999999999996 110.878 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -75.22 -42.97 54.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 73.109999999999999 110.874 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 p -81.01 -11.8 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 111.133 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 14.1 ttt180 -54.79 -58.67 13.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.588 0.709 . . . . 73.430000000000007 110.881 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.83 -16.06 37.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.226 . . . . 74.519999999999996 112.343 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -88.2 -23.91 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 71.0 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.1 -53.23 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.913 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.2 p -52.73 -42.44 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.148 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.97 67.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 63.310000000000002 111.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -76.24 -38.08 56.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 110.813 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.0 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 61.109999999999999 112.524 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.96 -131.18 1.98 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.209999999999994 112.506 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -179.33 -176.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 72.519999999999996 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.4 140.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 111.118 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.96 137.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 111.098 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -78.69 137.01 37.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 73.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -103.14 -45.67 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.894 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -171.9 168.09 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 72.25 110.906 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.19 119.63 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.450000000000003 111.104 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.28 88.68 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 111.072 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.73 -120.75 18.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 60.5 112.469 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -76.09 -18.22 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 75.230000000000004 110.915 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.46 151.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.123 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.61 136.58 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.2 mtp85 -96.86 101.37 12.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.855 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 mt -117.67 130.63 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 72.030000000000001 110.902 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -81.35 105.65 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.912 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 10.1 mt -125.15 127.48 46.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 71.040000000000006 110.883 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -146.27 127.55 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 110.935 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.21 -22.59 12.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 61.43 112.51 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -178.4 145.49 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 55.520000000000003 111.131 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.41 -75.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.912 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.6 -167.63 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.743 -0.741 . . . . 74.140000000000001 112.519 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 m -98.02 -26.31 14.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 71.329999999999998 110.859 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.8 t -166.11 68.67 1.13 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.714 . . . . 73.219999999999999 110.863 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.69 67.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 71.230000000000004 112.376 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 t -115.93 -21.92 9.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 64.430000000000007 110.833 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.5 m -55.57 -25.96 40.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 64.450000000000003 110.872 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 tp -51.68 -35.6 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 74.299999999999997 110.949 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.75 -31.06 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.158 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -65.18 -34.36 78.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 111.101 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 pt -84.8 -30.38 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.209999999999994 111.152 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -51.47 -49.88 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 72.439999999999998 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.5 -25.14 66.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.409999999999997 110.868 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.82 -54.0 10.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 44.119999999999997 112.503 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.35 -55.02 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 72.049999999999997 111.138 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.42 -32.61 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 73.450000000000003 110.885 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.08 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 110.835 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -61.31 -42.5 98.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.855 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -31.97 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 110.944 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 19.1 mtt -67.42 -29.82 69.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.832 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.07 -53.2 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.25 110.907 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.89 -45.71 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 75.349999999999994 110.901 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.78 76.47 2.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 75.099999999999994 111.172 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -15.81 37.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 63.399999999999999 112.346 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -52.43 -46.08 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 65.319999999999993 110.877 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 p -52.29 144.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 111.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.85 -35.32 12.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 73.25 111.08 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -171.92 179.66 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 64.140000000000001 111.11 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.83 144.39 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 73.230000000000004 111.149 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.17 159.91 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 73.129999999999995 110.905 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -170.87 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.704 2.27 . . . . 74.409999999999997 112.298 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.0 m -91.26 -32.25 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 111.12 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 p -104.86 22.2 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 111.146 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 51.9 30.29 7.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.851 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -99.3 97.42 8.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 110.876 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.88 -46.62 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.329999999999998 110.905 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 150.0 23.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 75.239999999999995 111.181 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 72.409999999999997 112.488 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.3 mtm . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.834 0.349 . . . . 72.420000000000002 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.07 -146.28 16.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 63.340000000000003 112.514 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 160.73 50.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 72.340000000000003 110.907 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -29.85 23.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 74.340000000000003 112.343 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.6 136.69 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 110.898 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -140.68 167.35 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.155 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.88 -28.7 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 75.420000000000002 111.119 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.54 -45.8 9.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 74.230000000000004 112.462 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -69.71 -48.16 60.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 72.430000000000007 110.888 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.0 -31.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 111.153 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.85 -36.1 78.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.914 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -44.4 87.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 73.150000000000006 110.88 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -72.8 -43.63 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 71.400000000000006 111.146 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.09 -18.87 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 72.530000000000001 110.893 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.93 -26.18 5.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 74.150000000000006 110.901 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -74.96 -46.43 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 70.209999999999994 110.966 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -82.31 -3.5 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.135 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.514 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.5 ttp85 -61.91 -58.77 15.94 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 72.329999999999998 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.3 Cg_endo -69.75 -14.68 36.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 74.219999999999999 112.352 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.03 -55.81 3.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.886 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.3 -55.64 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.901 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.59 -34.0 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 111.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.0 -27.25 30.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.124 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.47 -38.03 20.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.129999999999995 110.833 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.82 -23.27 1.8 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 71.230000000000004 112.472 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.03 -142.05 7.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 43.450000000000003 112.44 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -171.94 -176.26 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 51.130000000000003 110.885 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.44 138.18 45.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 111.104 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.88 136.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 54.140000000000001 111.128 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.8 tp -83.05 112.96 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 71.150000000000006 110.888 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -77.71 -66.39 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.828 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -138.55 173.35 11.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.92 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.0 mt -130.25 112.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 74.099999999999994 111.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.84 -169.57 2.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.99 -89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 63.329999999999998 112.491 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.27 23.12 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 64.049999999999997 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 t -146.11 148.62 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.030000000000001 111.122 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.87 127.29 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 111.11 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -82.53 100.97 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 75.450000000000003 110.901 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -116.43 127.37 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.906 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -86.55 100.17 12.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 71.109999999999999 110.911 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.0 129.73 47.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 73.409999999999997 110.948 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -133.1 141.18 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.913 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.24 -161.77 10.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 74.409999999999997 112.486 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.56 144.88 47.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 73.540000000000006 111.083 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.1 t -59.31 147.13 37.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 60.409999999999997 110.895 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -179.85 -98.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.764 -0.731 . . . . 74.049999999999997 112.498 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 p -58.03 -58.02 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 110.887 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.25 160.57 25.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.562 0.696 . . . . 74.349999999999994 110.856 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.16 37.65 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.699 2.266 . . . . 75.310000000000002 112.314 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 m -130.64 88.03 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 64.409999999999997 110.891 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.92 -31.53 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 75.430000000000007 110.863 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.9 tp -51.98 -41.12 61.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.935 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.82 -36.72 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.097 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -56.84 -38.01 72.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.116 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.77 -31.21 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 111.122 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -51.74 -42.05 62.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.948 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -25.06 60.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.329999999999998 110.891 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.65 -57.28 5.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 73.530000000000001 112.474 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -62.82 -53.46 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 74.340000000000003 111.154 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -52.19 -30.97 29.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.907 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -73.9 -34.73 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 72.400000000000006 110.848 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.5 -35.69 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 63.240000000000002 110.916 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.69 28.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 73.530000000000001 110.939 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 mtt -51.66 -31.56 26.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.892 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.43 -28.57 30.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.895 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.96 -45.43 3.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.894 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.31 75.12 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 75.019999999999996 111.119 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -8.76 24.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.724 2.283 . . . . 74.299999999999997 112.327 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.58 -51.92 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.42 144.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 -39.6 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -168.85 -175.99 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 111.08 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.65 147.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.126 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -131.42 160.25 68.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 61.43 110.9 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -170.84 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 74.540000000000006 112.353 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.57 -25.74 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 73.219999999999999 111.118 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.0 p -85.25 -174.34 5.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.540000000000006 111.147 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -53.72 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.89 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -140.26 -175.31 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.219999999999999 110.867 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.3 160.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 72.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -87.75 153.53 21.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 73.030000000000001 111.143 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 51.439999999999998 112.49 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 mtp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.782 0.325 . . . . 65.25 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.83 -107.73 2.62 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 74.019999999999996 112.52 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 160.52 36.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 74.400000000000006 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -27.72 26.19 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.662 2.242 . . . . 74.439999999999998 112.306 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -151.0 123.17 8.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 110.927 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -137.05 -177.36 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 62.420000000000002 111.146 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.24 -30.19 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 65.340000000000003 111.1 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.03 -61.01 2.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 72.519999999999996 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -56.77 -46.29 81.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 73.310000000000002 110.882 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.96 -31.16 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 111.119 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -61.8 -39.83 93.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 110.908 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -63.92 -39.56 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 70.400000000000006 110.839 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.78 -42.49 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.340000000000003 111.136 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mp -71.35 -18.23 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 75.540000000000006 110.925 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.04 -27.58 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.857 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -76.44 -43.56 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.947 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.46 -4.46 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 64.219999999999999 111.153 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.2 ttt-85 -60.62 -58.85 16.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 73.040000000000006 110.841 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.78 -7.29 20.7 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.692 2.262 . . . . 73.219999999999999 112.34 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -96.29 -64.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.898 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.48 -63.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 73.230000000000004 110.94 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 p -50.41 -31.19 14.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.15 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.83 -37.95 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 111.117 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.85 -36.83 80.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 54.340000000000003 110.842 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.12 -15.21 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 63.409999999999997 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.73 -128.1 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 71.319999999999993 112.535 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -170.79 142.37 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.878 0.37 . . . . 64.519999999999996 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.68 126.38 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.135 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.71 146.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 111.105 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 tp -79.26 129.73 34.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 110.922 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -93.37 -71.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 110.857 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.05 168.05 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 75.150000000000006 110.921 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.4 mt -123.47 109.06 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.010000000000005 111.098 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.64 -171.91 3.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 62.210000000000001 111.08 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.62 -91.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.510000000000005 112.489 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.34 22.75 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 73.209999999999994 110.858 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.22 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.13 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -114.96 127.51 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.144 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -89.08 101.45 14.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.828 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.41 152.62 25.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.928 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -105.61 100.61 10.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.887 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mt -131.0 123.84 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -122.31 139.13 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.519999999999996 110.931 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -66.09 2.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.467 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 61.09 33.45 19.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 70.439999999999998 111.077 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.7 p -55.23 -30.21 59.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 54.509999999999998 110.893 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.57 -72.33 0.42 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 71.310000000000002 112.482 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 p -53.46 -71.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 74.319999999999993 110.825 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.7 m -144.56 160.63 47.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.635 0.731 . . . . 75.030000000000001 110.822 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 75.120000000000005 112.35 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.7 p -120.6 -32.55 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.888 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -19.07 64.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 74.129999999999995 110.845 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.68 -30.35 21.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.099999999999994 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.5 mm -86.82 -32.47 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 74.150000000000006 111.122 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -33.1 73.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 111.127 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.4 pt -84.82 -26.76 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 111.126 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -51.0 -44.39 60.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 75.540000000000006 110.877 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -24.81 61.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.42 -52.12 28.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 71.209999999999994 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.1 -55.52 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 72.349999999999994 111.12 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -52.24 -32.6 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -62.8 -41.34 99.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -79.07 -33.73 44.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.05 -56.72 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 110.889 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.6 tpp -56.56 -23.78 42.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 63.009999999999998 110.885 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.96 -45.28 78.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 72.010000000000005 110.882 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -84.92 -46.41 11.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.140000000000001 110.907 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.39 76.84 2.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 74.25 111.125 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -9.7 26.74 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 74.299999999999997 112.354 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.9 -36.81 50.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.3 t -75.37 151.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.159 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.53 -27.24 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 111.106 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.2 169.96 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.04 154.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.103 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.27 160.22 68.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 73.040000000000006 110.887 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -172.41 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.599 2.199 . . . . 73.219999999999999 112.382 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.87 -28.87 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 74.230000000000004 111.133 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -156.81 177.59 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 70.549999999999997 111.146 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.03 87.8 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 73.340000000000003 110.859 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -119.67 -33.7 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.120000000000005 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -51.99 119.51 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 75.019999999999996 110.838 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -99.58 -29.95 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 71.120000000000005 111.12 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 55.039999999999999 112.467 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.3 mtm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.841 0.353 . . . . 72.150000000000006 110.873 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.97 -24.4 2.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 75.299999999999997 112.488 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.68 160.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.613 0.721 . . . . 73.439999999999998 110.915 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -29.76 23.25 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.693 2.262 . . . . 74.450000000000003 112.311 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -141.42 123.68 15.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 75.239999999999995 110.942 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p -131.77 179.46 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.129 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.62 75.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 111.097 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.07 -47.82 7.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 64.010000000000005 112.471 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -65.68 -48.68 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 75.420000000000002 110.87 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.7 -31.03 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.152 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.44 -34.58 77.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 110.92 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -42.56 95.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 63.32 110.859 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.97 -42.05 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.409999999999997 111.148 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.88 -18.76 62.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -52.12 -25.96 10.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.210000000000001 110.875 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -82.64 -43.55 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.927 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.75 1.36 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.12 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.509 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.6 ttt180 -68.14 -58.89 6.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 110.858 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.29 23.23 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.664 2.242 . . . . 75.420000000000002 112.361 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -98.91 -12.78 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.936 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.15 -64.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 73.450000000000003 110.926 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -60.13 -19.49 53.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.099999999999994 111.139 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.25 -32.66 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.109 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.15 -24.67 19.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 110.874 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.26 -17.09 2.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 70.230000000000004 112.5 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 -140.46 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 70.230000000000004 112.499 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.5 -172.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 110.864 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -148.65 136.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 111.14 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.36 122.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.299999999999997 111.122 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.0 tp -76.73 120.94 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.919 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -93.41 -73.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 110.871 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -115.94 165.98 12.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.914 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 10.7 mt -132.13 104.49 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 73.299999999999997 111.182 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.5 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 111.088 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.89 -81.84 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 75.140000000000001 112.481 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -91.77 13.53 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 75.530000000000001 110.874 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.0 t -145.18 151.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 71.450000000000003 111.162 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.43 128.58 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 72.140000000000001 111.113 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -79.78 100.82 8.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.0 110.848 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 mt -109.03 127.7 54.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.120000000000005 110.926 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -83.48 101.79 11.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.919 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.58 159.2 34.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 75.140000000000001 110.917 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -143.25 133.39 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.919 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.36 19.49 4.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 71.510000000000005 112.487 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 110.22 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.815 0.34 . . . . 74.340000000000003 111.095 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.3 t -175.93 117.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.883 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.12 -151.2 21.42 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 t -94.86 20.21 9.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 73.430000000000007 110.852 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.5 p -123.73 73.42 53.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 75.430000000000007 110.908 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -12.46 32.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.6 2.2 . . . . 73.340000000000003 112.37 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 57.5 p -94.05 40.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.849 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -80.76 -25.97 37.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 65.209999999999994 110.838 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -51.95 -30.48 24.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.510000000000005 110.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.02 -30.84 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.409999999999997 111.134 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 m -69.37 -34.55 74.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 111.165 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.8 pt -84.05 -27.8 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 111.123 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -51.89 -41.72 62.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 110.903 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -24.67 60.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.219999999999999 110.853 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.54 -56.04 5.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 55.439999999999998 112.461 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mp -65.03 -50.76 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 74.530000000000001 111.116 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.46 -31.55 23.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.340000000000003 110.917 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.41 -44.15 83.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.420000000000002 110.874 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -75.54 -36.45 60.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 110.866 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -29.16 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 110.914 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.2 ttm -76.97 -36.42 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 110.892 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -51.98 -47.4 64.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -90.64 -48.5 7.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 75.099999999999994 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.93 76.34 2.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.66 0.743 . . . . 73.129999999999995 111.098 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.6 24.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 75.219999999999999 112.337 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.18 -27.49 69.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 62.450000000000003 110.86 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 p -88.92 144.59 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 111.098 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.4 -42.45 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.084 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.53 -177.43 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.5 m -131.42 140.72 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 72.200000000000003 111.143 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -128.86 159.72 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 61.329999999999998 110.931 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.653 2.235 . . . . 75.420000000000002 112.388 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.45 -28.8 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.158 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.2 p -140.4 173.36 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 75.150000000000006 111.148 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.76 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.903 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp 51.54 30.09 6.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 64.400000000000006 110.915 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.82 -54.44 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 110.868 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -109.2 139.17 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 111.158 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 63.0 112.492 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.9 mtp . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.856 0.36 . . . . 72.019999999999996 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.97 -28.17 1.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 32.399999999999999 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.11 160.58 26.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 75.209999999999994 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.69 24.72 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.239 . . . . 73.010000000000005 112.361 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.63 136.85 26.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.918 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 p -144.16 -178.25 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 111.148 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.14 76.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 111.115 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.24 -47.33 7.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 72.129999999999995 112.485 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -65.71 -48.71 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 74.329999999999998 110.846 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.46 -31.15 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 111.121 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.05 -35.45 78.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.912 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.8 t -63.08 -42.75 99.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 72.420000000000002 110.846 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -77.18 -41.74 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.143 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.54 -19.0 64.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.955 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.77 -25.47 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 110.828 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -73.33 -47.71 40.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 63.219999999999999 110.909 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.3 m -82.23 -7.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 111.113 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.4 ttt180 -56.07 -58.82 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 74.230000000000004 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -21.18 33.76 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 74.019999999999996 112.355 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -81.41 -27.75 34.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.209999999999994 110.959 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.43 -49.5 6.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 65.219999999999999 110.933 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -62.5 -21.56 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 61.310000000000002 111.107 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.09 -53.83 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.299999999999997 111.067 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.07 -36.15 83.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 75.540000000000006 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.88 -30.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 64.030000000000001 112.482 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.85 -150.75 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 64.200000000000003 112.45 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -175.3 153.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 74.430000000000007 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.7 m -116.08 135.93 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 111.115 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.12 127.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 111.087 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.9 tp -71.23 122.83 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 110.979 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -90.28 -48.29 7.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 63.210000000000001 110.871 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -160.6 172.52 17.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 75.299999999999997 110.913 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.1 mt -129.33 125.71 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 111.103 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.35 102.22 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 64.239999999999995 111.089 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.59 -125.09 28.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 60.210000000000001 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -77.48 -17.17 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 72.450000000000003 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.96 150.98 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.111 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.2 137.36 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 73.439999999999998 111.097 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -93.88 101.82 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 70.140000000000001 110.834 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 mt -111.65 123.92 51.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 71.319999999999993 110.928 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 105.62 11.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 110.937 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.9 mt -130.88 127.37 38.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 64.219999999999999 110.918 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -121.26 144.48 48.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.895 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.53 -146.83 18.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 73.230000000000004 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.94 150.83 47.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 74.209999999999994 111.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.04 136.54 48.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 74.400000000000006 110.876 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.47 -169.96 41.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 73.400000000000006 112.517 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.44 -25.37 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 33.299999999999997 110.845 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.8 p -119.53 73.59 16.07 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.589 0.709 . . . . 74.340000000000003 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 104.87 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.662 2.242 . . . . 71.299999999999997 112.339 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -108.92 -23.13 11.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.129999999999995 110.817 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.0 -24.39 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 65.219999999999999 110.846 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.85 -30.21 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 71.319999999999993 110.885 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.85 -35.44 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.148 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -33.74 76.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 111.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.5 pt -81.92 -29.52 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.519999999999996 111.154 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.33 -45.57 62.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.893 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -24.91 63.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 74.049999999999997 110.885 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.24 -58.97 5.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 71.140000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -59.94 -54.93 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.129 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -51.9 -31.41 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 110.902 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -72.78 -35.69 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 110.869 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -76.08 -40.17 53.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.834 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.11 -30.26 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.963 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 22.6 mtt -69.67 -24.2 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 110.908 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -67.3 -48.51 67.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.519999999999996 110.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -84.03 -49.04 9.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 71.200000000000003 110.864 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.18 75.28 2.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 73.540000000000006 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -8.78 24.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.7 2.266 . . . . 72.140000000000001 112.346 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.12 -28.45 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.450000000000003 110.914 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.88 144.6 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 75.430000000000007 111.153 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 -39.65 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 111.09 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.7 171.83 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.200000000000003 111.084 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.79 151.94 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 111.125 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -132.32 160.08 69.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.7 0.762 . . . . 64.319999999999993 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 174.51 9.41 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.717 2.278 . . . . 74.530000000000001 112.301 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.48 -24.36 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 111.144 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.8 p -98.52 -172.04 2.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 111.132 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.97 -67.78 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.530000000000001 110.832 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -136.54 -170.86 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.519999999999996 110.935 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -52.19 -32.72 37.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 71.219999999999999 110.88 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.0 t -113.03 26.67 10.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 111.166 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.743 . . . . 73.200000000000003 112.471 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.811 0.338 . . . . 75.209999999999994 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.04 -28.52 8.34 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 64.530000000000001 112.537 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.02 160.74 30.28 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 74.340000000000003 110.915 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -45.73 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.726 2.284 . . . . 71.519999999999996 112.344 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.45 130.82 39.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.872 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 p -128.65 172.79 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 75.310000000000002 111.189 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.81 -27.01 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 111.079 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.78 -49.29 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 64.530000000000001 112.465 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -44.5 65.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 64.239999999999995 110.897 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.43 -31.43 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 75.040000000000006 111.119 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.93 -35.21 76.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.340000000000003 110.872 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -44.22 97.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 64.540000000000006 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -77.21 -41.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.040000000000006 111.122 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mp -68.03 -19.4 64.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.912 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.21 -26.7 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 64.099999999999994 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -76.39 -44.0 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.903 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.5 -6.82 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.409999999999997 111.139 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.7 ttm180 -60.53 -58.8 16.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 74.25 110.885 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.79 -8.39 23.48 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.72 2.28 . . . . 73.200000000000003 112.354 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -94.63 -63.3 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.917 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -49.05 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.891 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -60.56 -28.53 68.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 65.430000000000007 111.137 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.88 -53.79 53.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 55.039999999999999 111.117 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.16 -24.96 65.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.0 6.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 75.219999999999999 112.455 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.09 -153.79 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 61.109999999999999 112.506 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -174.77 127.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 61.409999999999997 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -100.98 134.77 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 72.329999999999998 111.092 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.37 117.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 111.094 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 tp -63.03 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.946 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -93.69 -74.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.540000000000006 110.853 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.36 171.36 9.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.140000000000001 110.915 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.23 108.19 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.099 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.39 -172.05 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 65.099999999999994 111.119 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.39 -87.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 73.450000000000003 112.486 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -94.31 20.64 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 71.209999999999994 110.902 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.09 150.83 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.549999999999997 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.15 139.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.102 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -99.4 101.05 12.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.876 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.5 mt -108.6 154.66 21.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.310000000000002 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -115.05 119.04 35.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.13 134.71 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 71.519999999999996 110.921 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.1 130.02 54.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.915 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.0 90.94 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.777 -0.725 . . . . 74.450000000000003 112.477 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.11 -59.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 71.409999999999997 111.118 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.0 m -66.9 118.84 10.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.873 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.21 -144.37 11.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.672 -0.775 . . . . 75.409999999999997 112.426 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -73.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 74.239999999999995 110.845 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.85 160.64 25.61 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 121.639 0.733 . . . . 72.340000000000003 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -17.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 72.010000000000005 112.355 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p -113.19 60.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 110.851 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.82 -19.23 60.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.519999999999996 110.841 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 pp -51.32 -30.67 19.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 74.329999999999998 110.929 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.72 -30.89 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.115 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -72.62 -34.64 67.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.7 pt -86.1 -30.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 72.129999999999995 111.145 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -50.85 -47.41 60.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 110.905 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -68.47 -24.77 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.869 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.78 -56.89 5.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 71.319999999999993 112.431 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -62.9 -53.24 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 74.239999999999995 111.169 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -53.21 -31.78 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 110.891 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -68.43 -32.44 72.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 72.540000000000006 110.886 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -79.09 -46.0 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.852 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -51.99 66.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.845 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 18.6 tpp -53.69 -39.4 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.88 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.1 -23.36 54.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 110.872 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -100.53 -37.88 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.239999999999995 110.867 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.83 80.23 2.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.124 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.7 2.267 . . . . 74.239999999999995 112.309 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.49 -26.79 62.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.434 . . . . 74.319999999999993 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 t -83.19 149.38 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.53 -30.08 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 111.148 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.46 -173.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 111.123 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.25 164.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 72.099999999999994 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -144.69 160.13 48.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.685 0.755 . . . . 73.409999999999997 110.853 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.83 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.249 . . . . 75.340000000000003 112.334 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.15 -28.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 111.181 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.5 p -117.01 -26.16 6.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 73.540000000000006 111.138 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.32 48.26 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 61.539999999999999 110.88 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -127.98 76.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 110.911 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.4 148.51 51.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 70.030000000000001 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.3 p -115.99 152.23 33.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.138 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 63.0 112.504 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.84 0.353 . . . . 73.530000000000001 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.61 143.82 4.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 72.209999999999994 112.476 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt 61.04 159.55 0.11 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 110.941 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -30.65 21.76 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 65.5 112.354 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.67 135.84 28.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.935 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.4 p -145.07 172.43 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 75.540000000000006 111.126 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.33 -30.37 18.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 111.131 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.3 -62.3 2.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 75.340000000000003 112.471 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -55.38 -47.83 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 73.239999999999995 110.863 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -50.64 -31.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 111.163 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.26 -37.55 83.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 73.140000000000001 110.866 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -42.7 99.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.1 -39.87 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 73.510000000000005 111.102 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mp -70.63 -18.69 62.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 74.310000000000002 110.909 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.15 -25.88 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.888 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.03 -47.59 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 110.916 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.64 -3.49 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 111.131 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.0 ttt180 -60.78 -58.74 17.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 73.319999999999993 110.872 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.2 Cg_endo -69.78 -10.92 29.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.65 2.234 . . . . 74.310000000000002 112.366 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.15 -32.55 14.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.943 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.94 -59.68 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 71.439999999999998 110.958 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.5 p -51.74 -39.39 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.310000000000002 111.139 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 62.020000000000003 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.69 -37.96 67.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 71.319999999999993 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.85 -38.57 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 70.420000000000002 112.525 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -73.76 -135.89 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 62.539999999999999 112.519 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -174.9 175.99 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 71.439999999999998 110.825 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.28 138.59 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.510000000000005 111.155 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.32 131.51 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 45.049999999999997 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.01 118.55 20.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.918 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -97.64 -64.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 110.865 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.43 165.08 16.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 110.882 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.8 mt -138.5 113.36 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 73.439999999999998 111.137 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.56 -169.34 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 111.094 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.37 -90.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 65.409999999999997 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -85.98 4.94 35.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 75.519999999999996 110.867 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.6 t -133.39 151.19 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.145 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.71 140.37 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.114 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 100.97 13.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.12 123.17 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.939 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -73.23 86.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.891 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mt -117.99 129.64 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 110.916 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -131.05 141.39 50.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.9 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.69 173.32 14.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.240000000000002 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.01 154.89 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 74.310000000000002 111.115 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 10.3 m -130.96 147.66 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 75.349999999999994 110.899 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 136.25 -97.85 0.28 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 62.450000000000003 112.489 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -79.58 -26.79 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 63.140000000000001 110.848 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.6 p -131.43 70.78 81.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.618 0.723 . . . . 75.099999999999994 110.89 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -174.5 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.661 2.241 . . . . 72.510000000000005 112.303 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.7 p 56.49 28.43 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 72.040000000000006 110.848 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -69.38 -28.14 65.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.861 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -54.34 -29.83 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 110.884 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.4 mm -85.11 -31.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 73.209999999999994 111.169 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.8 m -68.15 -34.36 76.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 70.129999999999995 111.124 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.03 -30.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 111.135 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -52.64 -47.1 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 72.5 110.891 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -69.11 -24.88 64.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 75.299999999999997 110.885 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.25 -57.59 6.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.681 -0.771 . . . . 74.439999999999998 112.475 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.74 -55.31 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.34 . . . . 74.299999999999997 111.114 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -51.68 -31.81 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.898 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -71.3 -36.77 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 110.908 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -79.03 -36.38 41.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 72.409999999999997 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -33.54 71.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.925 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 3.2 mtm -63.91 -27.72 69.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 75.420000000000002 110.872 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.68 -58.55 8.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 72.420000000000002 110.881 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.62 -47.41 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.881 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.56 74.33 2.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.64 0.734 . . . . 74.109999999999999 111.114 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -14.31 35.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.623 2.215 . . . . 61.109999999999999 112.372 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -38.46 55.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.876 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 p -76.04 144.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.32 111.102 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.33 -53.66 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.128 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.13 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.1 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.63 148.51 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 63.329999999999998 111.094 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.04 159.71 60.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.651 0.739 . . . . 74.549999999999997 110.867 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -177.51 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.667 2.245 . . . . 72.219999999999999 112.339 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.0 m -101.22 25.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 63.350000000000001 111.087 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.3 t -155.42 -179.91 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.108 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.46 159.52 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 110.836 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -55.2 175.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.922 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.91 -72.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.891 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.8 p -103.25 133.15 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.400000000000006 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.698 -0.763 . . . . 61.509999999999998 112.47 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ttm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.82 0.343 . . . . 71.430000000000007 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.31 -156.18 18.49 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 70.219999999999999 112.502 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.42 160.47 66.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 75.310000000000002 110.877 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -47.84 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.712 2.275 . . . . 74.549999999999997 112.335 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -89.48 106.97 18.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 t -135.58 166.04 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 74.140000000000001 111.144 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.88 -27.39 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.530000000000001 111.086 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.16 -59.04 3.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 33.229999999999997 112.478 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -62.23 -48.02 81.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 74.219999999999999 110.909 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.6 -30.99 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 70.239999999999995 111.143 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -61.79 -38.15 87.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 72.349999999999994 110.887 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -67.38 -37.85 83.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 62.299999999999997 110.868 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.04 -39.41 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 111.147 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.1 -19.16 62.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.340000000000003 110.912 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.84 -26.89 10.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.87 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -76.35 -43.42 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.4 -7.35 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 73.319999999999993 111.086 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.7 ttm-85 -60.18 -58.79 16.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.603 0.716 . . . . 74.510000000000005 110.877 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.1 Cg_endo -69.83 -8.49 23.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.669 2.246 . . . . 74.439999999999998 112.32 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.55 -63.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.94 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -54.77 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 74.129999999999995 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -51.48 -34.77 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 111.154 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.18 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 72.129999999999995 111.06 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.89 -31.7 63.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.842 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.7 17.1 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 63.420000000000002 112.504 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.38 -135.96 8.84 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 53.409999999999997 112.477 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -179.16 136.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 74.040000000000006 110.851 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.8 m -110.13 129.45 65.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.141 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -167.8 129.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 72.239999999999995 111.098 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.5 tp -71.78 119.65 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.921 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -76.96 -72.28 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 72.010000000000005 110.877 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.75 171.1 14.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.85 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.1 mt -125.91 121.35 59.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 70.019999999999996 111.101 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.24 -170.51 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.030000000000001 111.074 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.01 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 54.439999999999998 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 23.41 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 71.150000000000006 110.908 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.171 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.18 138.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.174 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -101.02 101.05 11.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.872 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 mt -107.91 164.62 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 70.120000000000005 110.887 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.72 115.81 19.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 72.230000000000004 110.905 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.71 137.9 37.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.894 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.38 113.13 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.898 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.29 -48.62 0.64 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 73.340000000000003 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.77 128.56 37.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.32 . . . . 72.099999999999994 111.101 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.0 t -100.24 -50.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.873 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.43 -85.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 71.120000000000005 112.501 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.2 p -75.67 -28.51 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 73.019999999999996 110.879 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.18 160.65 3.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 72.310000000000002 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 73.329999999999998 112.358 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 p -71.88 80.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.828 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -26.11 58.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 63.140000000000001 110.907 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.67 -47.67 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.340000000000003 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.57 -31.2 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 111.122 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -61.66 -39.92 93.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.14 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.1 pt -86.17 -29.99 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 111.135 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -50.75 -47.67 59.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 72.25 110.882 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.76 -24.71 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 110.839 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.15 -55.76 6.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.771 -0.728 . . . . 62.32 112.458 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mp -62.87 -54.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 111.134 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -52.88 -32.6 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 110.904 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.67 -32.74 74.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.868 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -78.88 -56.42 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.0 -35.65 47.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.893 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.1 mtt -62.78 -40.35 97.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.897 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.31 -20.07 57.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.67 -33.81 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.040000000000006 110.902 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.5 mm -112.34 76.89 2.05 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 73.209999999999994 111.079 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -7.6 21.48 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.439999999999998 112.378 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.94 -29.53 35.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 63.32 110.879 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.28 158.47 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.010000000000005 111.108 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.37 -47.29 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.147 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.24 -173.8 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 71.120000000000005 111.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.75 164.85 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -147.96 160.38 37.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 74.430000000000007 110.96 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -171.01 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.744 2.296 . . . . 71.540000000000006 112.312 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.54 -25.02 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 111.127 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.6 p -119.59 24.89 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 72.510000000000005 111.141 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 55.18 35.6 25.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 63.130000000000003 110.836 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -98.43 68.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.853 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.26 -25.79 14.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 110.88 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 p 49.87 42.65 24.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.131 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 71.209999999999994 112.486 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.8 0.334 . . . . 73.329999999999998 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.32 -146.77 5.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.782 -0.723 . . . . 70.209999999999994 112.517 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt 61.04 159.68 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.596 0.712 . . . . 74.450000000000003 110.943 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -29.28 24.35 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.678 2.252 . . . . 71.430000000000007 112.346 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.68 140.11 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 110.943 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 t -142.74 167.72 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 111.144 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.32 -28.35 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.07 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.88 -42.5 12.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.736 . . . . 74.120000000000005 112.472 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -72.65 -47.18 49.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.91 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -50.78 -30.8 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 62.509999999999998 111.136 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.94 -37.08 83.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.912 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.71 -39.57 73.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.86 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.46 -44.74 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 73.319999999999993 111.097 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.21 -18.97 62.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.93 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.8 -26.12 5.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.862 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -75.06 -45.46 41.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.892 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.62 -7.06 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.340000000000003 111.157 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 17.7 ttt-85 -58.56 -58.8 16.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 71.319999999999993 110.885 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.7 -8.85 24.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.278 . . . . 72.099999999999994 112.353 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.1 -25.47 15.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.913 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.7 -57.32 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.911 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -53.11 -36.33 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 63.43 111.155 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.59 -28.74 70.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 73.040000000000006 111.088 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -76.81 -38.05 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 72.5 110.87 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.41 -39.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 73.400000000000006 112.495 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.48 -137.77 1.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 71.129999999999995 112.464 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -174.77 -175.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 74.519999999999996 110.825 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.94 138.96 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 71.349999999999994 111.121 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.42 123.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 111.13 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.2 tp -66.12 133.59 51.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.967 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -100.18 -63.53 1.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 62.5 110.823 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -144.75 163.87 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.894 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 54.8 mt -123.11 114.5 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 111.16 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.43 -172.32 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 62.100000000000001 111.147 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.63 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.99 25.06 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 55.119999999999997 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -144.69 151.01 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.42 128.96 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 111.127 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -90.16 103.33 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.904 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 mt -112.82 133.67 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.896 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -86.07 91.76 8.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.895 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.9 mt -119.44 131.33 55.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.510000000000005 110.877 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -127.84 127.01 42.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 72.049999999999997 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -83.46 -61.76 1.86 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 75.120000000000005 112.468 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.36 139.77 18.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 60.310000000000002 111.116 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.5 t -72.62 139.59 47.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 75.150000000000006 110.879 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.68 168.97 32.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.219999999999999 112.472 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -67.11 -26.72 66.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 54.020000000000003 110.847 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.3 t -115.17 73.31 3.45 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.64 0.733 . . . . 73.099999999999994 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.652 2.235 . . . . 64.519999999999996 112.352 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.5 p -115.98 -26.5 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.845 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.52 -28.84 33.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.499 . . . . 75.129999999999995 110.826 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -52.38 -30.12 27.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.935 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.97 -36.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 111.107 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -60.04 -34.02 72.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 111.137 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 pt -86.14 -26.83 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 111.106 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -51.07 -48.6 61.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 72.140000000000001 110.873 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -66.35 -24.7 66.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.219999999999999 110.858 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.13 -57.23 6.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.763 -0.732 . . . . 73.019999999999996 112.471 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.09 -54.54 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 75.5 111.132 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -31.74 25.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -69.27 -44.35 72.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 75.540000000000006 110.86 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -69.75 -39.98 76.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 110.852 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -47.74 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 110.935 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.7 mmt -55.11 -26.49 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.329999999999998 110.89 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.4 -62.68 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.863 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -71.84 -47.27 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.885 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.24 75.06 2.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 73.030000000000001 111.103 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -11.06 30.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.65 2.233 . . . . 75.150000000000006 112.368 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -51.92 -43.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.140000000000001 110.878 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.99 148.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 111.118 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.42 -33.0 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 111.113 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -175.56 177.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.09 147.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 64.400000000000006 111.137 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -131.92 159.84 70.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.737 . . . . 73.109999999999999 110.868 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.83 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.701 2.267 . . . . 75.219999999999999 112.359 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.61 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 71.519999999999996 111.141 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.43 -32.7 27.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 74.319999999999993 111.112 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.86 -173.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 110.799 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -115.73 -177.52 3.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 74.019999999999996 110.945 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -52.15 -32.69 36.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 74.340000000000003 110.845 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.7 p -112.18 100.37 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.150000000000006 111.168 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 73.219999999999999 112.486 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.869 0.366 . . . . 74.530000000000001 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.31 -27.13 1.99 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.721 . . . . 55.329999999999998 112.507 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.59 160.67 26.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.621 0.724 . . . . 75.439999999999998 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.29 22.33 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.63 2.22 . . . . 64.510000000000005 112.363 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -144.95 120.14 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 71.340000000000003 110.898 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -134.51 -176.69 4.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 61.439999999999998 111.142 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.57 70.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 71.540000000000006 111.081 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.5 -52.28 4.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 71.439999999999998 112.474 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -61.22 -48.45 81.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 74.129999999999995 110.879 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.79 -30.77 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 111.171 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.34 -33.58 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 72.409999999999997 110.947 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 t -63.93 -43.93 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 72.230000000000004 110.87 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.5 -40.77 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 111.123 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mp -71.11 -18.97 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.010000000000005 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -51.26 -26.85 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.875 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -74.48 -42.23 59.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.921 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -81.96 -12.88 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.164 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.5 ttt85 -53.04 -58.59 11.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.587 0.708 . . . . 73.219999999999999 110.891 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.8 Cg_endo -69.77 -32.13 19.14 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 73.5 112.323 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -65.92 -57.7 7.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.955 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.05 -54.81 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 73.450000000000003 110.94 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -51.6 -30.57 21.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 111.094 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.96 -36.74 78.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 70.439999999999998 111.126 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.18 -38.03 61.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 63.539999999999999 110.89 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.76 -26.62 2.37 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 71.25 112.461 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.73 -136.84 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.492 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.39 -175.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 74.099999999999994 110.881 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.5 m -141.79 143.95 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.519999999999996 111.183 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.78 131.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.124 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.0 tp -53.69 114.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 75.299999999999997 110.876 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -80.78 -49.98 10.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -168.41 167.9 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.889 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -127.97 105.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 74.140000000000001 111.141 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.32 -178.08 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.019999999999996 111.092 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.16 -75.88 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.747 . . . . 71.049999999999997 112.528 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -0.14 21.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.935 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.3 t -119.62 152.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 111.096 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -113.78 142.85 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 111.137 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -115.13 100.42 8.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.899 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.69 146.29 27.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.895 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -102.29 124.05 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 75.340000000000003 110.892 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.4 156.97 46.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.905 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -132.78 114.72 14.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 73.519999999999996 110.925 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.97 -51.39 0.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 60.439999999999998 112.507 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.06 103.07 14.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.761 0.315 . . . . 74.150000000000006 111.131 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -75.95 -28.62 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 75.129999999999995 110.865 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 172.66 -90.07 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.310000000000002 112.487 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -63.67 -32.96 74.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.348 . . . . 73.230000000000004 110.839 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.61 160.68 2.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 73.099999999999994 110.841 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.694 2.262 . . . . 62.350000000000001 112.386 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -80.19 59.12 3.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 73.409999999999997 110.905 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -71.32 -26.16 62.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 74.430000000000007 110.846 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.97 -32.86 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 74.200000000000003 110.892 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.52 -31.02 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 111.12 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -40.65 97.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.161 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.6 pt -84.01 -30.91 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.439999999999998 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -52.0 -41.66 62.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.951 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -24.81 60.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.871 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.17 -54.81 7.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 55.119999999999997 112.549 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mp -58.46 -50.92 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 74.340000000000003 111.106 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -58.84 -34.73 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.892 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -76.68 -30.33 56.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -79.21 -34.32 43.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.549999999999997 110.858 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -57.08 5.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.972 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.4 ttm -50.89 -30.73 15.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 71.340000000000003 110.905 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -60.38 -37.56 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.948 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -91.7 -45.37 8.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.886 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.41 73.74 2.0 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 74.420000000000002 111.117 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.87 36.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 74.219999999999999 112.347 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.71 -47.55 82.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 74.319999999999993 110.861 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.84 131.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.049999999999997 111.129 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.31 63.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 62.439999999999998 111.078 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.48 178.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 111.113 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.85 134.47 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.129 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -121.38 160.06 47.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 64.140000000000001 110.92 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.67 0.34 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.665 2.243 . . . . 63.32 112.336 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.8 25.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 111.141 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.1 t -161.51 164.28 29.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.117 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -59.69 176.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.899 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -63.46 -174.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -53.55 -29.4 36.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 75.120000000000005 110.912 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 29.5 p -127.92 -40.62 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 111.127 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 53.140000000000001 112.493 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 mtm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.829 0.347 . . . . 73.129999999999995 110.892 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.51 -157.21 53.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.776 -0.726 . . . . 71.209999999999994 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.0 mt 60.96 159.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.25 110.936 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -30.78 21.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 71.109999999999999 112.367 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.61 134.49 25.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 72.409999999999997 110.885 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p -145.34 173.02 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.219999999999999 111.138 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.22 -30.52 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 111.094 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.08 -62.28 2.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 73.519999999999996 112.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -47.93 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 75.230000000000004 110.907 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -50.77 -30.88 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 111.112 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -61.63 -38.07 86.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.935 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -64.62 -40.39 95.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.400000000000006 110.846 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.49 -39.04 32.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 111.144 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.06 -19.4 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 110.894 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.3 -26.83 20.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 75.030000000000001 110.857 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -75.32 -43.45 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.93 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.2 p -81.45 -9.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 70.439999999999998 111.09 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.8 ttt180 -56.67 -58.71 15.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 72.109999999999999 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -12.57 33.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.694 2.263 . . . . 74.019999999999996 112.302 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -92.14 -25.99 18.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 72.129999999999995 110.905 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -101.0 -57.38 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.956 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.9 p -52.33 -35.92 52.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 111.167 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.81 72.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 52.009999999999998 111.113 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.08 -37.98 69.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 110.89 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.45 -35.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.762 -0.732 . . . . 72.340000000000003 112.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -141.13 1.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.771 . . . . 75.150000000000006 112.47 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -170.19 -176.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 72.329999999999998 110.821 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.93 138.43 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 62.509999999999998 111.104 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.74 137.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 52.240000000000002 111.083 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.3 tp -76.28 135.53 39.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 64.329999999999998 110.951 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -103.5 -63.95 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 73.25 110.862 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.15 162.49 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.882 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.98 117.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 74.030000000000001 111.143 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.64 -169.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.125 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.94 -88.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 71.239999999999995 112.507 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -102.55 13.45 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 73.109999999999999 110.877 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.33 139.03 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.122 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.63 134.81 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 111.072 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.95 101.09 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.420000000000002 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mt -112.29 149.19 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 72.450000000000003 110.898 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -101.3 119.07 38.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.420000000000002 110.932 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.6 mt -139.49 127.76 22.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.948 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -104.92 137.11 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 73.439999999999998 110.895 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.22 -36.22 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 74.120000000000005 112.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.11 144.35 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.805 0.336 . . . . 73.120000000000005 111.079 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.5 p -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 70.299999999999997 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.65 -40.66 0.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 73.340000000000003 112.432 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 t -94.71 20.15 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 65.329999999999998 110.881 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.7 t 54.37 68.53 2.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 72.010000000000005 110.888 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -15.78 37.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.642 2.228 . . . . 75.430000000000007 112.364 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.22 30.96 15.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 64.310000000000002 110.895 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -80.23 -24.98 39.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 75.340000000000003 110.812 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -31.08 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 74.420000000000002 110.936 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mm -88.07 -30.98 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 65.150000000000006 111.167 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 m -72.22 -33.3 67.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 111.163 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.4 pt -83.65 -30.91 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.200000000000003 111.164 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -51.8 -51.58 55.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.319999999999993 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.9 -24.93 66.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 73.430000000000007 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.6 -61.78 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 62.240000000000002 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 mp -55.9 -54.73 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 64.420000000000002 111.147 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -52.53 -32.45 40.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.230000000000004 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -75.44 -32.43 60.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 110.92 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -76.34 -35.63 58.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.349999999999994 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -48.12 58.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 110.914 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.96 -33.24 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.888 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.61 -55.25 23.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.9 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.06 -45.83 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.899 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.09 74.96 1.95 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.667 0.746 . . . . 75.109999999999999 111.163 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.86 33.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 75.040000000000006 112.333 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.76 -52.8 46.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 110.863 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.44 151.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 111.109 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.49 -45.75 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 111.13 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.37 -169.44 2.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.095 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.72 148.54 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 64.329999999999998 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -120.49 95.67 49.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 64.349999999999994 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 75.540000000000006 112.322 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.15 46.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 73.409999999999997 111.149 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.6 t -159.03 129.17 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.138 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.86 -46.25 4.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 70.450000000000003 110.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -79.11 176.59 9.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.209999999999994 110.916 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -102.09 -54.16 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 75.219999999999999 110.909 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.0 t -132.92 152.21 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 70.209999999999994 111.157 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 64.340000000000003 112.496 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.824 0.345 . . . . 74.310000000000002 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.8 -92.03 1.02 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 73.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.33 155.04 37.27 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.572 0.701 . . . . 75.430000000000007 110.923 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -23.13 31.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.706 2.271 . . . . 71.430000000000007 112.332 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -152.19 128.02 10.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.943 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -143.22 -178.15 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 111.167 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 54.130000000000003 111.089 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.4 -64.08 1.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 70.409999999999997 112.455 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.54 -46.73 73.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 74.120000000000005 110.846 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -51.24 -30.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.230000000000004 111.124 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.32 -35.62 77.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -42.3 73.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.520000000000003 110.881 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.47 -44.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 75.439999999999998 111.087 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.13 -19.43 62.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 74.049999999999997 110.904 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.19 -26.95 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.866 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -74.51 -41.38 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.895 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.8 p -83.02 -12.58 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 111.106 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 18.9 ttt180 -53.17 -58.75 11.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.709 . . . . 74.109999999999999 110.904 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -19.51 36.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 73.519999999999996 112.347 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -83.8 -24.13 31.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 110.898 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.04 -55.53 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.299999999999997 110.948 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.68 -39.35 58.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 73.519999999999996 111.112 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.68 69.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 71.329999999999998 111.116 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.17 -37.81 69.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.120000000000005 110.931 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.73 -28.0 1.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 74.209999999999994 112.484 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.86 -138.27 4.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 73.310000000000002 112.493 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -173.56 -175.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 64.219999999999999 110.838 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.09 141.33 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 75.120000000000005 111.136 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.4 132.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.209999999999994 111.094 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 117.19 10.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 75.140000000000001 110.933 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -80.8 -57.87 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.882 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -152.75 161.1 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.37 118.38 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.77 -177.08 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.131 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.39 -86.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 61.020000000000003 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.64 25.18 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 71.209999999999994 110.874 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.26 149.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 74.109999999999999 111.103 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.78 115.77 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 71.319999999999993 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -82.7 101.19 10.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.400000000000006 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.11 150.88 30.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.109999999999999 110.946 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -106.29 117.23 33.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 110.908 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.04 139.28 48.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 75.310000000000002 110.934 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -122.06 119.24 30.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.968 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.28 118.61 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 74.099999999999994 112.476 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.73 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.738 0.304 . . . . 64.450000000000003 111.085 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 p -52.25 -39.11 59.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 110.885 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 52.23 -161.01 2.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.329999999999998 112.468 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -97.67 -27.1 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 74.519999999999996 110.891 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.1 m -93.68 160.53 32.56 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.607 0.718 . . . . 71.349999999999994 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -33.05 17.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.248 . . . . 75.25 112.301 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 p -122.21 88.12 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 75.239999999999995 110.845 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.48 -37.88 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.851 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.95 -29.92 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 110.888 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.59 -42.66 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 111.097 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 m -53.37 -35.94 60.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.6 pt -85.94 -30.22 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 73.25 111.138 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -51.38 -41.93 61.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 110.915 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -25.59 61.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 110.839 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.71 -57.14 6.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 74.310000000000002 112.481 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp -60.54 -54.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 63.310000000000002 111.133 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.87 -31.85 41.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -70.35 -48.28 57.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.510000000000005 110.847 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -63.34 -40.82 98.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.847 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -45.9 66.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 62.240000000000002 110.933 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.7 mtt -59.53 -23.84 63.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.230000000000004 110.876 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -71.33 -52.53 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 75.530000000000001 110.878 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -75.22 -55.12 6.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 75.200000000000003 110.895 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.95 76.03 2.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.638 0.732 . . . . 74.450000000000003 111.17 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -8.85 24.65 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 62.100000000000001 112.329 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.08 -30.73 27.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 75.519999999999996 110.847 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.4 p -79.43 144.18 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 72.329999999999998 111.155 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.16 -53.1 7.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.056 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.5 -169.93 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 73.120000000000005 111.128 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.21 153.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 73.140000000000001 111.11 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -119.73 95.61 49.26 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.129999999999995 110.909 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 115.22 3.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.741 2.294 . . . . 43.210000000000001 112.318 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.29 148.47 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 74.510000000000005 111.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 m 59.1 34.87 23.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.450000000000003 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -84.53 57.17 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.400000000000006 110.861 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -88.68 101.69 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 75.439999999999998 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -66.91 -68.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.299999999999997 110.866 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 145.21 45.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.209999999999994 111.133 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.746 -0.74 . . . . 72.5 112.491 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.0 ptm . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.805 0.336 . . . . 74.530000000000001 110.849 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.43 26.01 6.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.796 -0.716 . . . . 74.450000000000003 112.516 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.6 159.25 55.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 75.540000000000006 110.921 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -21.77 32.81 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.641 2.227 . . . . 75.420000000000002 112.337 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -150.17 117.45 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 74.040000000000006 110.914 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 p -135.48 179.7 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.098 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.16 -30.24 16.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 43.43 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.21 -63.25 2.08 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.738 . . . . 64.299999999999997 112.511 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -54.94 -47.23 74.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 73.120000000000005 110.865 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.53 -31.14 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 111.143 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.44 -35.64 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 54.119999999999997 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -67.58 -40.22 84.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.883 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.91 -45.36 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 111.136 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 mp -72.18 -18.27 61.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.530000000000001 110.94 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -50.48 -26.8 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.349999999999994 110.889 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.4 -42.81 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 63.200000000000003 110.931 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -80.85 -14.88 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 111.096 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.3 ttp85 -51.07 -58.65 9.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.583 0.706 . . . . 70.319999999999993 110.846 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.76 -26.53 27.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.256 . . . . 74.420000000000002 112.368 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -76.15 -22.11 55.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 65.5 110.956 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.58 -51.5 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 74.310000000000002 110.866 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.5 p -56.86 -30.75 64.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 111.155 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.66 -27.21 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.129999999999995 111.046 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.03 -38.0 19.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.869 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.74 -35.75 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 45.530000000000001 112.447 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.89 -144.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 74.120000000000005 112.463 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -177.34 168.81 2.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.384 . . . . 74.010000000000005 110.855 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 m -125.23 135.62 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.167 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.17 125.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 61.100000000000001 111.098 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.68 117.65 17.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.972 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -83.77 -74.38 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 73.439999999999998 110.867 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -125.61 168.48 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 70.230000000000004 110.873 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.22 123.28 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 73.25 111.172 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.36 -169.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 111.063 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.27 -87.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 62.109999999999999 112.482 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.43 -6.59 37.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 75.430000000000007 110.852 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 t -113.9 151.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.120000000000005 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.98 133.28 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.095 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.58 102.65 15.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.858 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mt -108.44 151.08 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.329999999999998 110.91 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -104.28 90.31 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 110.939 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.8 mt -120.45 129.62 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 110.902 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -129.86 159.09 37.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.509999999999998 110.909 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.72 -89.87 1.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 64.409999999999997 112.507 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.95 -175.57 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.779 0.323 . . . . 75.219999999999999 111.065 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -134.33 122.62 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 110.916 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -171.55 -149.42 6.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 73.439999999999998 112.521 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -62.16 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.355 . . . . 72.140000000000001 110.849 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.0 t -126.65 68.33 68.78 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.607 0.718 . . . . 62.109999999999999 110.923 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 80.04 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 63.43 112.347 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -95.85 26.71 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 72.420000000000002 110.874 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m -78.48 -24.13 46.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 61.049999999999997 110.858 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 pp -53.72 -28.01 31.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 110.89 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.2 mm -81.18 -30.98 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.135 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -31.67 70.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 70.099999999999994 111.155 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.6 pt -86.18 -28.39 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 73.400000000000006 111.073 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -52.89 -35.94 58.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.875 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -75.28 -26.25 58.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.92 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.27 -54.46 6.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.699 -0.762 . . . . 70.549999999999997 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -63.94 -44.6 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 73.549999999999997 111.16 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -64.69 -22.84 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.956 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -76.67 -51.33 11.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 74.319999999999993 110.832 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -73.41 -33.48 64.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.863 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.93 -47.5 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 70.010000000000005 110.95 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.4 ttm -68.9 -28.12 66.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.86 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -51.99 -53.83 36.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -70.56 -49.16 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.907 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.3 mp -112.99 76.16 2.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 75.109999999999999 111.184 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.72 24.33 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.728 2.285 . . . . 72.040000000000006 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -53.11 -28.72 26.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 110.887 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.0 p -81.45 144.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 111.117 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.58 -52.57 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 111.076 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.89 -173.18 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 111.086 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.35 163.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 111.13 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.69 160.07 54.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.618 0.723 . . . . 74.109999999999999 110.888 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -172.23 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 65.430000000000007 112.295 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.6 m -82.39 -172.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 111.114 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.37 85.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 64.209999999999994 111.14 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -174.35 -170.84 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.877 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -125.51 133.78 52.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.875 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.73 170.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.5 t -117.09 -25.11 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 75.230000000000004 111.084 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 71.310000000000002 112.499 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttm . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.855 0.36 . . . . 72.120000000000005 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.11 -169.19 31.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.781 -0.723 . . . . 63.43 112.542 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.05 159.71 0.11 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 74.25 110.942 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.21 27.71 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.712 2.275 . . . . 75.0 112.303 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.82 128.2 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 63.450000000000003 110.908 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.0 p -144.82 178.91 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 63.350000000000001 111.122 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.11 -30.3 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 62.119999999999997 111.073 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.97 -62.96 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 64.450000000000003 112.514 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -55.31 -47.56 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 73.5 110.947 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.23 -31.12 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 72.129999999999995 111.183 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.01 -36.69 84.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 74.219999999999999 110.901 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -66.89 -40.66 87.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 t -74.96 -45.35 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.140000000000001 111.161 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.0 mp -71.86 -18.16 62.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 110.933 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.9 -26.98 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 110.849 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -74.61 -43.03 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.943 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -80.49 -14.73 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.450000000000003 111.142 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.2 ttm180 -51.6 -58.75 9.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 74.040000000000006 110.882 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.4 Cg_endo -69.74 -27.48 26.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 70.510000000000005 112.355 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -74.22 -25.01 59.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.030000000000001 110.92 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.77 -52.16 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 75.230000000000004 110.906 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.5 p -54.29 -32.5 56.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 73.5 111.132 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.77 71.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.510000000000005 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -79.7 -37.45 35.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.861 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.87 -42.66 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 61.509999999999998 112.48 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.11 -142.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 74.319999999999993 112.477 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -175.93 -177.39 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 74.420000000000002 110.858 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.6 132.96 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 111.129 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.27 123.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 73.239999999999995 111.104 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.5 116.0 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 110.896 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -75.88 -65.59 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 70.25 110.886 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.54 165.43 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 73.200000000000003 110.873 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.19 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.519999999999996 111.108 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.9 -176.44 3.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 62.229999999999997 111.094 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.47 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.461 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.28 25.46 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 110.869 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.98 150.06 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.140000000000001 111.121 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.91 117.06 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 111.139 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -82.33 100.93 10.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.836 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mt -105.22 146.52 29.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.932 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -105.78 103.1 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mt -126.58 144.11 51.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.94 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -124.7 146.8 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 110.964 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.81 -107.62 3.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 71.439999999999998 112.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -170.52 174.25 5.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 71.140000000000001 111.082 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 19.0 m -145.9 120.66 9.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 63.210000000000001 110.916 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.31 -77.59 0.32 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 65.230000000000004 112.463 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -93.59 -38.53 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 74.219999999999999 110.88 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 t -114.88 73.05 2.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.641 0.734 . . . . 73.099999999999994 110.916 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 157.17 61.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.631 2.221 . . . . 74.400000000000006 112.336 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 m 53.66 28.21 7.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.868 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 p -72.43 -26.44 61.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 75.140000000000001 110.83 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.23 -30.23 26.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.915 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.23 -38.31 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 111.151 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -35.23 76.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.6 pt -85.89 -31.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.340000000000003 111.096 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.0 -45.19 71.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.86 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -73.01 -24.84 60.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 73.219999999999999 110.877 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.17 -60.28 3.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 45.140000000000001 112.477 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 mp -59.12 -50.06 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.748 0.309 . . . . 74.519999999999996 111.094 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -57.61 -25.63 60.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.854 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -80.04 -51.55 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.200000000000003 110.863 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -64.65 -36.32 83.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 110.89 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.0 tp -70.14 -35.82 74.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 72.349999999999994 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 16.7 mtt -78.64 -29.56 45.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.540000000000006 110.893 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -51.91 -34.96 43.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.896 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -91.87 -37.6 12.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 74.549999999999997 110.852 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -127.34 75.12 77.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 74.099999999999994 111.103 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -8.19 22.98 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.671 2.248 . . . . 73.299999999999997 112.355 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -51.45 -30.7 20.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 110.875 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.28 144.01 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.120000000000005 111.127 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.24 -53.24 7.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.116 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -157.31 -175.68 5.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 72.549999999999997 111.124 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.13 147.9 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 111.126 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -112.65 95.66 33.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 63.149999999999999 110.927 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 169.26 19.28 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 73.120000000000005 112.394 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -54.86 138.03 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.310000000000002 111.154 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.1 p -75.11 133.66 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 74.0 111.125 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -176.6 179.99 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 65.530000000000001 110.871 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -92.79 118.9 31.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.923 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -98.66 26.41 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.893 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 t -110.91 -26.99 9.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 111.122 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 70.109999999999999 112.475 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.815 0.34 . . . . 74.439999999999998 110.825 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.01 19.92 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 72.219999999999999 112.507 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.91 160.69 39.7 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.605 0.717 . . . . 74.430000000000007 110.919 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -30.1 22.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.665 2.244 . . . . 73.340000000000003 112.34 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.27 111.17 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 73.420000000000002 110.951 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 p -119.98 -177.67 3.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.43 . . . . 73.25 111.124 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.89 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 111.067 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 -46.13 8.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.728 . . . . 52.450000000000003 112.473 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.96 -46.74 73.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.354 . . . . 73.140000000000001 110.866 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -54.1 -31.16 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 111.159 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.85 -23.81 67.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 t -71.91 -45.92 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 110.835 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.08 -34.64 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 73.019999999999996 111.102 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -71.58 -19.82 62.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 75.540000000000006 110.952 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -53.65 -26.66 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.420000000000002 110.855 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.62 -42.97 57.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 110.94 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.69 -14.42 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.131 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 ttt180 -51.86 -58.63 10.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.714 . . . . 74.340000000000003 110.848 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.268 . . . . 75.420000000000002 112.336 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.34 -57.39 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 64.219999999999999 110.891 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.33 -44.27 75.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 72.439999999999998 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -53.74 -29.01 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 111.117 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.48 67.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 72.319999999999993 111.107 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.31 -37.99 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.873 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.26 -15.2 3.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 53.420000000000002 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.19 -143.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 74.450000000000003 112.511 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -173.51 173.49 3.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.845 0.355 . . . . 61.210000000000001 110.844 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.9 m -139.27 128.46 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.165 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.15 116.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 111.133 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 113.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 110.954 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -75.07 -65.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 75.400000000000006 110.865 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -141.76 166.15 25.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 71.329999999999998 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 55.1 mt -124.53 114.59 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.18 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.37 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 111.102 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.27 -91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 75.5 112.519 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.58 24.0 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 73.510000000000005 110.869 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.13 150.18 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 75.530000000000001 111.112 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.1 t -118.79 131.82 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -98.79 100.93 12.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 74.140000000000001 110.87 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.09 144.44 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.888 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -92.81 102.97 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 62.219999999999999 110.868 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.09 147.94 44.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 75.230000000000004 110.914 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.41 141.37 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 71.010000000000005 110.973 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.93 29.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 71.109999999999999 112.468 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.43 113.37 23.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 70.519999999999996 111.132 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.4 t -125.46 70.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.56 -77.01 0.56 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.019999999999996 112.492 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 p -98.08 -26.47 14.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 74.040000000000006 110.829 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.8 t 54.37 67.96 3.03 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.708 . . . . 71.109999999999999 110.891 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 78.11 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.643 2.229 . . . . 75.430000000000007 112.366 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 p 46.17 36.18 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.43 110.836 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.08 -41.71 70.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 55.43 110.916 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.88 -30.81 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 62.109999999999999 110.895 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mm -90.08 -30.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 74.409999999999997 111.168 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 m -64.67 -45.08 88.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 75.219999999999999 111.168 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.5 pt -76.0 -26.65 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.510000000000005 111.082 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -51.56 -54.68 24.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 110.851 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -24.91 68.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 75.450000000000003 110.864 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.52 -60.33 4.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.524 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.56 -54.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 73.230000000000004 111.129 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.66 -32.38 41.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.915 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -77.9 -30.71 50.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.826 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -78.93 -33.59 45.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 72.209999999999994 110.898 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -54.93 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 70.439999999999998 110.885 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -29.34 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.86 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.7 -26.1 55.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.905 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -44.22 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 63.439999999999998 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.05 75.84 2.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 111.127 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.44 34.73 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 75.510000000000005 112.358 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.91 -39.45 59.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 110.864 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.4 p -73.09 144.44 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 61.43 111.16 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.54 -44.56 18.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.083 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.49 -171.99 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 52.549999999999997 111.092 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.3 154.0 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 65.230000000000004 111.116 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -134.3 95.66 16.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 64.549999999999997 110.897 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 158.78 55.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 52.350000000000001 112.352 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 m -51.58 -31.25 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 111.109 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.4 p -79.32 119.63 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 111.202 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -89.65 -61.5 1.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 64.010000000000005 110.844 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 170.48 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 70.140000000000001 110.903 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -77.85 159.12 29.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.430000000000007 110.9 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 p -113.16 130.58 56.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 75.439999999999998 111.179 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 70.109999999999999 112.466 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.4 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.851 0.358 . . . . 73.420000000000002 110.851 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.85 -28.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.209999999999994 112.474 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.14 160.66 82.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.621 0.724 . . . . 63.350000000000001 110.89 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -29.91 23.24 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.645 2.23 . . . . 70.219999999999999 112.354 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -143.74 114.27 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.9 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -122.45 -177.13 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.010000000000005 111.128 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.87 -34.37 75.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.101 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.2 -46.44 8.18 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 74.129999999999995 112.483 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -67.3 -46.9 72.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 73.450000000000003 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.4 -31.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 111.121 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.88 -23.68 67.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.919 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -69.64 -47.26 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 73.519999999999996 110.852 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.21 -35.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 73.439999999999998 111.175 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.72 -19.38 62.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.938 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.53 -26.71 8.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.858 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -74.44 -41.74 60.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 110.893 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.98 -11.42 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 75.030000000000001 111.144 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.4 ttt85 -54.38 -58.6 13.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 75.209999999999994 110.881 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.69 -31.75 20.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.684 2.256 . . . . 75.340000000000003 112.36 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.24 -57.99 5.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 75.540000000000006 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.66 -55.05 38.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.921 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.1 p -51.38 -41.84 60.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 111.186 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.66 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.104 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -82.86 -37.77 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.549999999999997 110.891 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 142.21 -17.04 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.765 -0.731 . . . . 63.43 112.473 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.31 -145.45 16.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 75.200000000000003 112.476 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -167.12 -179.95 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 71.310000000000002 110.837 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.74 139.53 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 111.11 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.61 134.02 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 111.082 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.6 tp -81.4 119.49 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 72.209999999999994 110.912 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -88.51 -71.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 74.530000000000001 110.83 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -124.63 168.79 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 55.32 110.866 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.2 mt -131.58 125.75 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 111.118 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.11 -176.05 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 64.010000000000005 111.095 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.51 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 74.129999999999995 112.511 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.01 25.32 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 72.430000000000007 110.882 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -145.78 149.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.549999999999997 111.122 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.2 t -119.63 135.56 59.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 70.349999999999994 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 101.0 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.889 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 mt -110.59 126.16 54.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 73.540000000000006 110.879 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -79.62 101.64 8.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.91 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.7 mt -123.34 129.69 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.230000000000004 110.934 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -121.73 129.78 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.892 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -83.23 -113.22 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 73.099999999999994 112.52 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -173.94 -179.19 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 72.310000000000002 111.133 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 78.7 m -142.06 112.56 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 72.140000000000001 110.911 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 170.02 -94.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 51.210000000000001 112.494 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.5 t -97.95 -25.94 14.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 74.230000000000004 110.84 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -113.99 73.12 2.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 73.209999999999994 110.875 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 164.57 34.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.688 2.258 . . . . 71.519999999999996 112.322 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m 52.43 32.31 11.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.240000000000002 110.847 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -41.85 96.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 110.873 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.78 -30.1 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 74.409999999999997 110.87 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.34 -32.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.07 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -74.36 -35.99 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.099999999999994 111.152 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -76.83 -29.06 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 71.129999999999995 111.109 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -51.2 -58.13 6.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.896 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -68.39 -24.3 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.85 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.53 -59.3 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 64.400000000000006 112.514 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.03 -54.93 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 75.439999999999998 111.102 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -50.56 -31.39 15.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -78.4 -37.15 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 65.420000000000002 110.883 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -72.92 -32.0 65.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 75.549999999999997 110.92 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -51.61 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 110.926 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.3 mtt -51.82 -31.16 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.44 -27.3 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -46.82 3.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 73.319999999999993 110.908 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.39 74.75 2.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 73.319999999999993 111.167 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -13.21 34.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 70.310000000000002 112.353 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.13 -33.84 58.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.832 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.59 144.42 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 72.310000000000002 111.095 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.44 18.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 61.450000000000003 111.1 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -166.32 -170.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.310000000000002 111.109 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.22 149.76 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 74.0 111.151 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -116.14 95.7 45.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 72.219999999999999 110.885 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 179.26 3.83 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 64.049999999999997 112.378 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.24 129.06 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 111.111 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.8 t -63.69 135.24 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 111.135 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -174.4 162.82 3.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.873 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.34 141.68 57.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.923 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.38 -32.63 20.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.9 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -76.3 138.66 40.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 74.099999999999994 111.139 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 63.340000000000003 112.444 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.9 mtm . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.817 0.341 . . . . 72.230000000000004 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.65 -27.05 17.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 45.030000000000001 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp 62.88 160.66 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 74.319999999999993 110.925 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.26 25.4 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.688 2.259 . . . . 74.230000000000004 112.347 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.41 139.91 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 70.299999999999997 110.957 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -148.45 169.87 19.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 73.099999999999994 111.161 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.38 -29.09 9.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 111.113 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.29 -55.08 4.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 72.349999999999994 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -61.67 -47.56 84.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 64.109999999999999 110.837 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.16 -31.37 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 63.240000000000002 111.146 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.39 -30.67 71.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.857 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -39.93 63.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.0 t -75.76 -44.47 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 111.144 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 mp -71.52 -18.6 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.919 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.34 -25.78 4.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.87 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -73.26 -45.28 56.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 m -81.13 -13.62 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 75.150000000000006 111.154 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 ttt180 -50.51 -58.67 9.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.61 0.719 . . . . 73.120000000000005 110.905 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.74 -35.11 13.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.746 2.297 . . . . 73.049999999999997 112.326 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -67.32 -25.45 66.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.93 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.82 -49.06 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.329999999999998 110.941 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -61.73 -29.22 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 111.124 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.36 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 62.399999999999999 111.146 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.75 -38.01 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 110.899 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.22 -40.36 0.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 73.319999999999993 112.464 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.38 -148.53 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.779 -0.724 . . . . 65.450000000000003 112.448 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -178.28 -176.65 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 62.310000000000002 110.88 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.25 133.14 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 111.096 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.02 105.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 71.530000000000001 111.074 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 tp -54.84 119.94 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.959 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -78.9 -54.49 6.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 110.888 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.91 172.58 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.859 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.13 121.03 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 111.132 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.28 95.63 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 74.319999999999993 111.093 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.4 -123.39 27.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 74.329999999999998 112.489 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.02 -17.58 58.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 71.5 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.96 150.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 111.148 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.65 123.66 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 111.069 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 110.861 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.17 155.36 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 72.120000000000005 110.956 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -111.82 84.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.916 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mt -109.65 139.61 44.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 75.109999999999999 110.874 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -131.36 140.67 49.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 110.907 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.68 -69.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 71.439999999999998 112.464 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.43 177.18 10.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 75.450000000000003 111.093 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.88 154.73 45.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 62.399999999999999 110.892 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.74 -160.45 29.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.751 . . . . 61.509999999999998 112.515 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.87 0.367 . . . . 73.140000000000001 110.876 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.1 t -143.26 70.47 18.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.595 0.712 . . . . 75.329999999999998 110.883 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.689 2.259 . . . . 64.209999999999994 112.319 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 m 61.6 26.51 16.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.71 -23.62 39.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 63.119999999999997 110.891 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.42 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 75.129999999999995 110.912 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.1 mt -80.47 -38.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 111.155 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -52.45 -39.76 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 73.230000000000004 111.099 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.1 pt -86.36 -27.69 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 74.430000000000007 111.088 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -43.63 66.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.852 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -24.91 61.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.877 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.59 -57.75 5.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.010000000000005 112.53 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -63.35 -53.3 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 75.420000000000002 111.164 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -52.02 -29.99 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.520000000000003 110.896 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -75.44 -50.66 15.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 110.887 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -63.66 -35.87 81.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 60.399999999999999 110.852 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 tp -70.25 -35.52 73.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.9 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.897 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.8 -38.27 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 62.100000000000001 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.68 -32.02 14.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.895 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 mp -129.99 76.56 77.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 70.209999999999994 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -8.64 24.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 72.120000000000005 112.365 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -56.2 -25.99 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.150000000000006 110.858 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.1 150.08 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.104 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.86 -51.12 5.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.510000000000005 111.043 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.78 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 75.099999999999994 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.2 153.21 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 72.349999999999994 111.145 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -132.64 160.25 69.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.622 0.725 . . . . 72.150000000000006 110.924 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -170.88 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 74.120000000000005 112.334 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 p -90.81 -24.91 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 72.120000000000005 111.146 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.83 166.86 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 111.115 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -64.84 120.69 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 71.129999999999995 110.866 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -146.61 -48.45 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.899 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.04 -30.01 23.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 74.430000000000007 110.899 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 t -63.5 -35.92 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 71.519999999999996 111.129 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 53.509999999999998 112.468 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.9 ttm . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.798 0.332 . . . . 75.409999999999997 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.07 -107.16 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.712 -0.756 . . . . 53.43 112.499 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.02 160.31 26.41 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.588 0.709 . . . . 74.549999999999997 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -26.16 27.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.642 2.228 . . . . 71.25 112.368 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.06 139.81 29.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 75.430000000000007 110.924 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -153.5 169.62 22.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 61.530000000000001 111.18 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.3 -29.56 10.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.098 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.44 -62.44 2.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 72.340000000000003 112.526 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -56.23 -48.22 76.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 65.239999999999995 110.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.22 -31.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.125 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.35 -36.67 82.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.868 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -63.81 -41.55 97.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 53.409999999999997 110.875 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.02 -42.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 73.200000000000003 111.127 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.67 -18.85 62.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 110.915 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -51.58 -26.88 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.881 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -78.5 -43.89 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.89 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.38 -1.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.132 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.51 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.3 ttt180 -65.88 -58.79 10.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.706 . . . . 74.310000000000002 110.843 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.72 -8.17 22.91 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.653 2.235 . . . . 73.310000000000002 112.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -12.61 20.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.899 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.21 -66.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 64.140000000000001 110.934 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -58.51 -20.1 43.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 111.116 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.23 -29.85 15.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 74.5 111.111 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.24 -31.64 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 110.889 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.22 -16.96 0.89 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 74.150000000000006 112.503 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.12 -138.89 2.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 64.430000000000007 112.518 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 179.85 -175.96 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 73.530000000000001 110.921 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.17 127.06 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 111.143 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.69 133.42 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 63.210000000000001 111.16 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -81.34 112.91 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.120000000000005 110.913 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -74.56 -73.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.896 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.62 171.14 13.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.901 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.6 mt -129.74 110.82 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.409999999999997 111.108 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.33 179.73 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.085 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.473 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.77 23.56 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 65.010000000000005 110.946 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -145.54 149.4 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -123.07 133.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.123 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -96.86 100.84 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 110.854 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.64 130.56 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.884 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -82.99 118.63 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.916 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.3 mt -142.19 123.69 14.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 110.928 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -111.79 115.29 28.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.120000000000005 110.957 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.69 -162.76 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 72.120000000000005 112.48 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.32 -75.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 60.340000000000003 111.108 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.15 -177.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.888 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.89 9.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 53.329999999999998 112.45 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.7 t -53.16 -28.87 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 71.420000000000002 110.871 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.5 p -144.07 156.54 58.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.59 0.709 . . . . 75.239999999999995 110.897 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 93.51 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 65.340000000000003 112.337 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.5 m -130.1 -39.9 1.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 73.25 110.869 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.38 -45.3 65.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 45.310000000000002 110.881 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.11 -29.9 23.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.128 -0.487 . . . . 72.120000000000005 110.903 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.1 mm -87.1 -39.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 71.340000000000003 111.099 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -57.78 -34.01 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.329999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -86.13 -29.91 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 64.340000000000003 111.136 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -49.87 -58.31 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.88 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -24.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.06 -50.05 19.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 52.450000000000003 112.452 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.51 -55.6 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 73.530000000000001 111.127 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.4 -32.05 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.849 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.94 -40.89 95.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 110.905 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -72.29 -37.34 69.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 75.349999999999994 110.891 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -38.89 92.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 73.049999999999997 110.926 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.4 ttm -67.9 -25.46 65.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.239999999999995 110.86 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.84 -59.4 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -73.24 -51.2 18.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 74.530000000000001 110.865 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.86 76.15 2.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 71.230000000000004 111.137 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.8 33.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.254 . . . . 74.510000000000005 112.331 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.83 -36.18 47.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.86 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 p -76.13 144.1 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.299999999999997 111.13 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.75 -51.45 8.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.064 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.84 -170.16 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 111.066 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.0 144.06 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 111.168 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -123.88 95.65 43.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 73.510000000000005 110.909 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -175.35 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 71.319999999999993 112.393 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.22 120.46 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.13 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 t -51.71 133.93 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 74.200000000000003 111.141 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -157.1 173.98 16.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.848 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -75.37 82.48 2.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.450000000000003 110.935 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.58 164.15 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.549999999999997 110.863 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 p -126.27 153.03 45.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 73.450000000000003 111.139 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 73.040000000000006 112.515 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.1 ttm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.819 0.342 . . . . 75.510000000000005 110.874 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.19 163.34 23.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 72.430000000000007 112.511 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 mt -78.51 159.21 75.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 74.040000000000006 110.914 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.704 2.269 . . . . 73.239999999999995 112.36 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.2 tt -94.54 106.61 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 110.914 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -129.76 175.66 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.123 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.7 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.08 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.96 -43.76 10.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 71.129999999999995 112.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -71.83 -47.43 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 74.519999999999996 110.893 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -50.61 -31.13 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 111.144 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.25 -39.9 92.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.844 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -41.1 95.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 110.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.3 t -77.28 -39.57 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.122 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mp -69.87 -19.43 63.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.931 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -52.35 -27.08 14.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.853 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -76.85 -43.65 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.896 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.34 -4.51 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.153 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.3 ttp85 -61.26 -58.72 16.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 74.420000000000002 110.892 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.78 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 71.439999999999998 112.353 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.23 -46.95 6.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 72.450000000000003 110.914 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -43.56 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 73.219999999999999 110.963 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.5 p -65.63 -23.16 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.19 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.68 -51.99 62.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 111.091 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -63.7 -29.25 70.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.843 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.47 19.21 3.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 74.019999999999996 112.467 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.58 -135.91 8.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.708 -0.758 . . . . 75.099999999999994 112.497 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -179.37 139.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 73.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.54 133.04 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 111.108 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.89 138.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 61.299999999999997 111.092 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 tp -79.81 126.71 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 65.219999999999999 110.892 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -88.36 -71.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.871 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -134.58 174.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 73.25 110.922 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 53.5 mt -132.35 110.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.9 -170.21 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 111.132 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.55 -89.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 71.140000000000001 112.467 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.12 21.04 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 72.420000000000002 110.886 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.26 150.28 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 111.141 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.46 139.83 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.120000000000005 111.155 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 100.87 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.430000000000007 110.848 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.92 178.17 4.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.922 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -134.01 120.25 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.329999999999998 110.909 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 mt -138.25 143.15 39.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 71.530000000000001 110.945 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -118.99 106.71 12.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.916 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -115.8 83.58 0.34 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 73.239999999999995 112.461 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.77 117.96 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 74.109999999999999 111.069 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.06 -47.41 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 110.85 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.6 -69.02 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 43.399999999999999 112.473 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 t -75.82 -26.58 57.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.875 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.7 t -118.73 73.36 11.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.616 0.722 . . . . 72.109999999999999 110.892 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -16.92 37.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.657 2.238 . . . . 52.43 112.336 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.8 m -96.83 31.88 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 61.409999999999997 110.883 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.6 m -79.41 -25.74 42.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 75.230000000000004 110.837 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.86 -31.72 29.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.519999999999996 110.928 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.8 mm -79.49 -38.07 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.094 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.85 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.145 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 25.8 pt -86.09 -26.97 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 73.400000000000006 111.116 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -50.68 54.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 75.140000000000001 110.902 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -24.83 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 110.858 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.66 -51.91 18.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 62.020000000000003 112.463 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.06 -56.41 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.728 0.299 . . . . 73.329999999999998 111.13 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.49 -33.32 44.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.933 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -63.51 -33.54 75.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 75.219999999999999 110.859 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -77.02 -56.57 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.894 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -47.32 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.914 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 32.7 ttm -55.15 -39.43 69.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 65.230000000000004 110.879 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.37 -19.38 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.040000000000006 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 -33.13 9.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.129999999999995 110.932 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 mm -111.49 78.8 2.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 71.129999999999995 111.132 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -8.13 22.82 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.242 . . . . 71.310000000000002 112.324 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -33.89 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 74.040000000000006 110.895 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.43 155.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 111.149 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.41 -45.11 8.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 62.130000000000003 111.115 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.12 -169.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.36 160.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 70.430000000000007 111.121 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -146.61 95.65 4.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.758 . . . . 74.140000000000001 110.887 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 179.21 3.86 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.613 2.208 . . . . 75.510000000000005 112.362 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.04 126.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 111.121 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 4.4 t -170.56 160.9 7.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 75.519999999999996 111.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.9 -50.12 6.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 110.864 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -124.31 149.89 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.450000000000003 110.924 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -157.41 129.45 7.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.918 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -163.5 135.59 5.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.510000000000005 111.173 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 63.509999999999998 112.528 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.83 0.262 . . . . 73.21 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.718 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.3 122.39 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.973 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 80' ' ' VAL . 17.7 p -132.04 172.07 12.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 63.42 111.13 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.56 -30.21 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 53.1 111.089 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.62 -61.24 2.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 70.01 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 73.12 110.894 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.077 HG22 HD13 ' A' ' 84' ' ' LEU . 8.0 p -54.11 -31.23 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 71.23 111.156 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.88 -24.13 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -74.06 -44.28 54.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.856 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.5 p -77.02 -34.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.24 111.16 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.077 HD13 HG22 ' A' ' 80' ' ' VAL . 3.7 mp -71.61 -20.11 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 75.53 110.898 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.15 -26.6 28.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.836 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -74.03 -42.51 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 65.35 110.918 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' HD23 ' A' ' 91' ' ' LEU . 9.2 p -82.23 -13.87 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 62.03 111.165 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.8 ttt180 -51.45 -58.67 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.583 0.706 . . . . 72.1 110.835 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -8.32 23.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.246 . . . . 62.55 112.353 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -98.47 -19.27 17.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 74.11 110.922 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.25 -40.21 7.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.34 110.905 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 96' ' ' GLY . 44.1 p -69.94 -16.21 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 64.53 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -54.88 24.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 55.32 111.066 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -131.54 40.14 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.02 110.879 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -149.87 -63.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 61.24 112.476 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' THR . . . 152.61 -71.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 74.4 112.464 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.54 168.93 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 60.13 110.896 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.566 ' CG2' HD23 ' A' ' 84' ' ' LEU . 27.8 m -123.02 166.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.17 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.35 141.7 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 60.31 111.093 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.727 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -86.85 115.32 24.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.982 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.13 -73.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.87 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -131.76 169.08 16.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 71.53 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.727 HD11 HD21 ' A' ' 100' ' ' LEU . 12.9 mt -129.34 110.52 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 52.04 111.15 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.47 -173.96 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 72.1 111.117 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.34 -89.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.728 -0.749 . . . . 74.55 112.501 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -95.43 23.73 5.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 74.13 110.891 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.93 150.55 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 60.22 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.67 129.61 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.32 111.126 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 100' ' ' LEU . 9.6 mtp85 -89.46 103.39 16.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.839 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD22 HD21 ' A' ' 84' ' ' LEU . 3.7 mt -116.35 142.84 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.31 110.944 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.35 104.76 16.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 62.23 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 130' ' ' ILE . 9.5 mt -113.54 128.98 56.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 73.34 110.913 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 87.66 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.935 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 64.34 112.522 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.894 0.378 . . . . 72.11 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -51.84 -49.78 62.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 72.31 110.922 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -70.2 -32.57 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 73.44 111.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.4 m -66.87 -39.65 87.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.164 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' HD12 ' A' ' 130' ' ' ILE . 24.5 pt -86.08 -26.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 64.14 111.144 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -51.17 -48.09 61.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.23 110.942 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.56 -25.0 65.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 71.12 110.817 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.95 -60.28 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 54.5 112.462 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 112' ' ' LEU . 3.1 mp -56.2 -53.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 41.22 111.159 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.26 -32.3 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -76.38 -30.5 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -79.09 -33.8 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.856 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.02 -52.68 22.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.925 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -30.11 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.52 110.886 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.6 -27.01 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.01 110.863 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -113.29 -45.65 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 55.12 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.12 75.71 2.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 74.1 111.132 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -11.77 31.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 72.42 112.358 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -51.99 -30.69 26.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 64.13 110.85 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.79 149.26 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.02 111.122 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.34 -36.16 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 61.11 111.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.46 -175.31 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.11 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.31 153.91 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 70.05 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.646 0.736 . . . . 74.13 110.891 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.828 0.262 . . . . 72.33 112.349 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.702 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -133.42 131.13 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 73.34 110.932 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 79' ' ' ASN . 1.8 t -129.31 160.91 31.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.53 111.149 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.89 -27.85 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 45.43 111.133 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.69 -39.13 22.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 60.12 112.48 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.597 ' H ' HG23 ' A' ' 76' ' ' THR . 3.1 m120 -76.43 -46.89 25.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 72.5 110.907 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -50.58 -31.36 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.23 111.105 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -45.06 91.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.54 110.949 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -61.88 -36.21 80.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.44 110.845 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 134' ' ' LEU . 33.6 t -77.28 -39.98 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 45.53 111.14 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 80' ' ' VAL . 4.5 mp -71.08 -19.03 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.912 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -26.84 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.02 110.878 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -75.22 -42.97 54.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 73.1 110.874 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.644 ' CG2' HD23 ' A' ' 91' ' ' LEU . 15.0 p -81.01 -11.8 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.133 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 14.1 ttt180 -54.79 -58.67 13.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.588 0.709 . . . . 73.31 110.881 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.83 -16.06 37.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.226 . . . . 64.31 112.343 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -88.2 -23.91 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.54 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.794 HD11 HD12 ' A' ' 126' ' ' ILE . 1.4 mm? -101.1 -53.23 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.32 110.913 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 88' ' ' ARG . 73.2 p -52.73 -42.44 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.148 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.97 67.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 52.44 111.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -76.24 -38.08 56.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 74.55 110.813 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.0 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 61.11 112.524 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.96 -131.18 1.98 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.21 112.506 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -179.33 -176.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 72.52 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.4 m -131.4 140.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.41 111.118 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.96 137.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.24 111.098 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 109' ' ' ARG . 38.1 tp -78.69 137.01 37.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 72.02 110.896 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -103.14 -45.67 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.894 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -171.9 168.09 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.906 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.19 119.63 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 72.11 111.104 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.28 88.68 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.072 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.73 -120.75 18.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 42.12 112.469 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -76.09 -18.22 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 75.23 110.915 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.46 151.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 74.41 111.123 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.61 136.58 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.01 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.609 ' O ' HD12 ' A' ' 100' ' ' LEU . 27.2 mtp85 -96.86 101.37 12.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 54.32 110.855 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD22 HD21 ' A' ' 84' ' ' LEU . 7.1 mt -117.67 130.63 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -81.35 105.65 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 60.53 110.912 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.041 HD13 HD13 ' A' ' 130' ' ' ILE . 10.1 mt -125.15 127.48 46.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 65.12 110.883 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -146.27 127.55 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 74.14 110.935 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 40.23 112.51 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.919 0.39 . . . . 53.54 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 tp -51.68 -35.6 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 74.3 110.949 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.75 -31.06 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.158 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -65.18 -34.36 78.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.101 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 91' ' ' LEU . 27.4 pt -84.8 -30.38 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.21 111.152 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -51.47 -49.88 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.14 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.5 -25.14 66.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 71.31 110.868 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.82 -54.0 10.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 44.12 112.503 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.041 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -61.35 -55.02 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 72.05 111.138 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.42 -32.61 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 50.4 110.885 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.08 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.1 110.835 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -61.31 -42.5 98.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 64.25 110.855 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.715 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.24 -31.97 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 42.02 110.944 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 19.1 mtt -67.42 -29.82 69.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.832 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.07 -53.2 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.02 110.907 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -81.89 -45.71 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 75.35 110.901 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.78 76.47 2.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 62.11 111.172 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -15.81 37.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 63.4 112.346 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -52.43 -46.08 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 65.32 110.877 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -52.29 144.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.161 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.85 -35.32 12.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 55.2 111.08 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -171.92 179.66 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 54.14 111.11 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.83 144.39 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.41 111.149 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 72.15 110.905 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.835 0.264 . . . . 61.42 112.343 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -144.6 136.69 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.898 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.544 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.9 t -140.68 167.35 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.31 111.155 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -28.7 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 75.42 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.54 -45.8 9.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 73.3 112.462 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 76' ' ' THR . 9.2 m-20 -69.71 -48.16 60.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 72.41 110.888 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.0 -31.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 55.3 111.153 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.85 -36.1 78.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 65.22 110.914 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -44.4 87.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.23 110.88 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 134' ' ' LEU . 66.3 t -72.8 -43.63 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 71.4 111.146 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 5.2 mp -71.09 -18.87 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.893 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.93 -26.18 5.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 54.54 110.901 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -74.96 -46.43 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.966 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 130' ' ' ILE . 2.8 m -82.31 -3.5 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.21 111.135 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.5 ttp85 -61.91 -58.77 15.94 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 64.13 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.3 Cg_endo -69.75 -14.68 36.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 51.22 112.352 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 2.7 m-85 -87.03 -55.81 3.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.886 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 126' ' ' ILE . 3.5 mm? -56.3 -55.64 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.44 110.901 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.59 -34.0 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -54.0 -27.25 30.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 74.33 111.124 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.47 -38.03 20.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.13 110.833 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.82 -23.27 1.8 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 71.23 112.472 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.03 -142.05 7.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 43.45 112.44 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -171.94 -176.26 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 51.13 110.885 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.65 HG11 HG23 ' A' ' 87' ' ' VAL . 19.1 m -137.44 138.18 45.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 72.52 111.104 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.88 136.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 54.14 111.128 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 77' ' ' ALA . 12.8 tp -83.05 112.96 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 71.15 110.888 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -77.71 -66.39 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.828 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -138.55 173.35 11.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.92 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 100' ' ' LEU . 58.0 mt -130.25 112.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 63.34 111.133 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.84 -169.57 2.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 34.41 111.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.99 -89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 63.33 112.491 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -95.27 23.12 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 64.05 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 t -146.11 148.62 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.4 111.122 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.87 127.29 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.12 111.11 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 100' ' ' LEU . 21.3 mtt-85 -82.53 100.97 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 72.45 110.901 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 80' ' ' VAL . 7.0 mt -116.43 127.37 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 53.03 110.906 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -86.55 100.17 12.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 71.11 110.911 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.941 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -128.0 129.73 47.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 73.1 110.948 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 91' ' ' LEU . 15.7 tt0 -133.1 141.18 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 70.34 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 74.41 112.486 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.927 0.394 . . . . 63.41 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.9 tp -51.98 -41.12 61.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.935 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.82 -36.72 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.097 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -56.84 -38.01 72.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.02 111.116 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 91' ' ' LEU . 25.2 pt -84.77 -31.21 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.122 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -51.74 -42.05 62.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.948 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -25.06 60.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.891 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.65 -57.28 5.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 71.15 112.474 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.941 HD13 HD22 ' A' ' 112' ' ' LEU . 4.4 mp -62.82 -53.46 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 63.44 111.154 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -52.19 -30.97 29.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.13 110.907 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -73.9 -34.73 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 72.4 110.848 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.5 -35.69 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.14 110.916 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.31 -51.69 28.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 73.45 110.939 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 mtt -51.66 -31.56 26.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.892 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.43 -28.57 30.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.895 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.96 -45.43 3.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.894 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.3 mp -113.31 75.12 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 72.42 111.119 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -8.76 24.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.724 2.283 . . . . 74.13 112.327 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.58 -51.92 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 72.54 110.868 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.42 144.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 73.45 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 -39.6 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.14 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -168.85 -175.99 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.41 111.08 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.65 147.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.43 111.126 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 61.43 110.9 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.78 0.241 . . . . 74.44 112.306 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.745 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.2 tm? -151.0 123.17 8.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.927 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -137.05 -177.36 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 61.05 111.146 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -54.24 -30.19 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 61.51 111.1 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.03 -61.01 2.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 72.52 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -56.77 -46.29 81.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 73.31 110.882 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HA ' HD21 ' A' ' 75' ' ' LEU . 6.8 p -49.96 -31.16 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.51 111.119 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -61.8 -39.83 93.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.908 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -63.92 -39.56 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 63.43 110.839 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -75.78 -42.49 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 70.52 111.136 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 98' ' ' VAL . 3.4 mp -71.35 -18.23 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 75.54 110.925 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.04 -27.58 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 60.11 110.857 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -76.44 -43.56 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.947 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 98' ' ' VAL . 10.4 p -82.46 -4.46 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 64.22 111.153 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.2 ttt-85 -60.62 -58.85 16.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 71.5 110.841 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.78 -7.29 20.7 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.692 2.262 . . . . 63.35 112.34 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -96.29 -64.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.898 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.725 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -53.48 -63.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 52.04 110.94 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 p -50.41 -31.19 14.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 63.44 111.15 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.83 -37.95 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 73.01 111.117 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.85 -36.83 80.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 53.04 110.842 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.12 -15.21 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 63.41 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.73 -128.1 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 55.34 112.535 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -170.79 142.37 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.878 0.37 . . . . 64.52 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.732 HG21 ' CG1' ' A' ' 87' ' ' VAL . 7.2 p -119.68 126.38 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.135 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.71 146.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.3 111.105 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 101' ' ' HIS . 11.1 tp -79.26 129.73 34.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.922 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.546 ' N ' HD12 ' A' ' 100' ' ' LEU . 33.4 t60 -93.37 -71.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 62.52 110.857 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.05 168.05 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 74.35 110.921 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.4 mt -123.47 109.06 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.31 111.098 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.64 -171.91 3.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 62.21 111.08 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.62 -91.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.51 112.489 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.34 22.75 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 61.31 110.858 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.543 HG11 ' OE1' ' A' ' 145' ' ' GLU . 21.5 t -145.15 150.22 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.31 111.13 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -114.96 127.51 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.144 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -89.08 101.45 14.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.828 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -109.41 152.62 25.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.928 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.434 ' O ' HD23 ' A' ' 112' ' ' LEU . 1.5 tttp -105.61 100.61 10.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.887 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.053 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -131.0 123.84 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 61.22 110.876 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -122.31 139.13 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.52 110.931 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 73.33 112.467 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.877 0.37 . . . . 74.13 110.845 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.68 -30.35 21.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.5 mm -86.82 -32.47 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 74.1 111.122 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -33.1 73.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 64.44 111.127 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.721 ' O ' HD12 ' A' ' 130' ' ' ILE . 41.4 pt -84.82 -26.76 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 65.35 111.126 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -51.0 -44.39 60.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 72.42 110.877 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -24.81 61.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 64.1 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.42 -52.12 28.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 52.33 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.053 HD13 HD13 ' A' ' 112' ' ' LEU . 3.8 mp -66.1 -55.52 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 72.35 111.12 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -52.24 -32.6 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 71.4 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -62.8 -41.34 99.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 61.13 110.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -79.07 -33.73 44.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -70.05 -56.72 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.4 110.889 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.6 tpp -56.56 -23.78 42.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 63.01 110.885 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.96 -45.28 78.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 63.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.627 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.7 mmtp -84.92 -46.41 11.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 54.14 110.907 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.39 76.84 2.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 74.25 111.125 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -9.7 26.74 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 74.3 112.354 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.9 -36.81 50.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.23 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 143' ' ' ALA . 16.3 t -75.37 151.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.14 111.159 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.53 -27.24 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 55.52 111.106 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.634 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.2 169.96 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 44.21 111.095 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.04 154.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.103 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.543 ' OE1' HG11 ' A' ' 107' ' ' VAL . 23.2 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 73.04 110.887 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.574 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.764 0.235 . . . . 74.45 112.311 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -141.42 123.68 15.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p -131.77 179.46 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 61.4 111.129 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.62 75.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 41.11 111.097 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.07 -47.82 7.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 53.43 112.471 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -65.68 -48.68 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 75.42 110.87 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.011 HG22 HD13 ' A' ' 84' ' ' LEU . 7.2 p -51.7 -31.03 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.152 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.44 -34.58 77.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.92 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -42.56 95.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 63.03 110.859 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.97 -42.05 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 65.43 111.148 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.011 HD13 HG22 ' A' ' 80' ' ' VAL . 4.9 mp -70.88 -18.76 62.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.23 110.943 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -52.12 -25.96 10.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.21 110.875 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -82.64 -43.55 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.54 110.927 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG22 HD23 ' A' ' 91' ' ' LEU . 8.8 p -82.75 1.36 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.13 111.12 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 92' ' ' THR . 20.6 ttt180 -68.14 -58.89 6.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.558 0.694 . . . . 74.24 110.858 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.0 Cg_endo -69.75 -8.29 23.23 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.664 2.242 . . . . 75.42 112.361 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -98.91 -12.78 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.936 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.854 HD11 HD12 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -101.15 -64.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 73.45 110.926 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 t -60.13 -19.49 53.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.1 111.139 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.25 -32.66 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.109 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.15 -24.67 19.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.874 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.26 -17.09 2.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 34.14 112.5 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 -140.46 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 62.13 112.499 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.5 -172.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 73.22 110.864 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.764 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.2 m -148.65 136.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 64.51 111.14 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.36 122.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.52 111.122 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG11 ' A' ' 80' ' ' VAL . 10.0 tp -76.73 120.94 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 64.03 110.919 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.441 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.4 t60 -93.41 -73.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 65.31 110.871 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -115.94 165.98 12.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.914 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 108' ' ' VAL . 10.7 mt -132.13 104.49 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.182 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.36 -169.5 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 71.32 111.088 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.89 -81.84 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 75.14 112.481 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 4.2 p-10 -91.77 13.53 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 75.53 110.874 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 20.0 t -145.18 151.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 71.45 111.162 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 103' ' ' ILE . 95.7 t -121.43 128.58 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.34 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.0 mpt_? -79.78 100.82 8.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 71.42 110.848 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.82 HD22 HD21 ' A' ' 84' ' ' LEU . 9.1 mt -109.03 127.7 54.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.0 110.926 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -83.48 101.79 11.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.919 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD22 HD13 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -126.58 159.2 34.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 55.22 110.917 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -143.25 133.39 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.919 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 63.23 112.487 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.905 0.383 . . . . 65.21 110.838 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -51.95 -30.48 24.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 73.21 110.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.02 -30.84 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.41 111.134 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 m -69.37 -34.55 74.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 75.33 111.165 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.854 HD12 HD11 ' A' ' 91' ' ' LEU . 27.8 pt -84.05 -27.8 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 55.0 111.123 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -51.89 -41.72 62.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 74.21 110.903 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -24.67 60.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 53.14 110.853 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.54 -56.04 5.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 55.44 112.461 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 87' ' ' VAL . 4.8 mp -65.03 -50.76 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 74.53 111.116 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.791 ' HB3' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.46 -31.55 23.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.34 110.917 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.41 -44.15 83.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.15 110.874 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -75.54 -36.45 60.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 71.33 110.866 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.439 HD11 ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.81 -29.16 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 71.33 110.914 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.2 ttm -76.97 -36.42 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 70.54 110.892 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -51.98 -47.4 64.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.4 mmtp -90.64 -48.5 7.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 75.1 110.89 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -112.93 76.34 2.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.66 0.743 . . . . 64.41 111.098 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.6 24.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 75.22 112.337 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.18 -27.49 69.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 62.45 110.86 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -88.92 144.59 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.2 111.098 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -80.4 -42.45 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.11 111.084 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.53 -177.43 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.22 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 131' ' ' GLU . 8.5 m -131.42 140.72 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 53.35 111.143 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 53.15 110.931 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.814 0.256 . . . . 72.32 112.361 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.685 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.63 136.85 26.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 75.22 110.918 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 75' ' ' LEU . 13.9 p -144.16 -178.25 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 70.24 111.148 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.629 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -60.97 -35.14 76.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.33 111.115 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.24 -47.33 7.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 72.13 112.485 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -65.71 -48.71 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 74.33 110.846 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.047 HG22 HD13 ' A' ' 84' ' ' LEU . 7.3 p -51.46 -31.15 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.24 111.121 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.05 -35.45 78.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.912 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.8 t -63.08 -42.75 99.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 72.42 110.846 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 134' ' ' LEU . 22.2 t -77.18 -41.74 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 72.41 111.143 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.047 HD13 HG22 ' A' ' 80' ' ' VAL . 2.7 mp -68.54 -19.0 64.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.955 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.77 -25.47 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.52 110.828 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -73.33 -47.71 40.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 63.22 110.909 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.76 HG23 HG11 ' A' ' 98' ' ' VAL . 3.3 m -82.23 -7.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 75.44 111.113 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.4 ttt180 -56.07 -58.82 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 74.23 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -21.18 33.76 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 74.02 112.355 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -81.41 -27.75 34.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 45.12 110.959 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -92.43 -49.5 6.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 64.43 110.933 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -62.5 -21.56 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 61.31 111.107 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -61.09 -53.83 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 65.14 111.067 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.07 -36.15 83.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 75.54 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.88 -30.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 63.25 112.482 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.85 -150.75 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 62.51 112.45 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -175.3 153.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 74.41 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -116.08 135.93 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.31 111.115 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.12 127.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 41.35 111.087 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 77' ' ' ALA . 13.9 tp -71.23 122.83 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.979 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -90.28 -48.29 7.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 54.11 110.871 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -160.6 172.52 17.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.913 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.527 HD11 HD21 ' A' ' 100' ' ' LEU . 12.1 mt -129.33 125.71 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.05 111.103 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.35 102.22 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 55.14 111.089 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.59 -125.09 28.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 52.24 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -77.48 -17.17 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 64.42 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.96 150.98 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 62.43 111.111 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 103' ' ' ILE . 56.4 t -125.2 137.36 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 73.44 111.097 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.1 mtt180 -93.88 101.82 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 62.53 110.834 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.735 HD22 HD21 ' A' ' 84' ' ' LEU . 3.6 mt -111.65 123.92 51.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 44.34 110.928 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 105.62 11.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 62.51 110.937 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -130.88 127.37 38.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 63.11 110.918 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 91' ' ' LEU . 30.5 tt0 -121.26 144.48 48.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.23 110.895 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 73.23 112.505 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 55.25 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.85 -30.21 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 71.32 110.885 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.85 -35.44 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.148 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -33.74 76.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.12 111.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.5 pt -81.92 -29.52 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.52 111.154 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.33 -45.57 62.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.893 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -24.91 63.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.885 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.24 -58.97 5.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 71.14 112.507 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -59.94 -54.93 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 73.44 111.129 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -51.9 -31.41 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 73.43 110.902 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -72.78 -35.69 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 65.41 110.869 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -76.08 -40.17 53.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.834 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.71 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.11 -30.26 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.963 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 22.6 mtt -69.67 -24.2 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 62.24 110.908 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -67.3 -48.51 67.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 138' ' ' ILE . 10.6 mmtt -84.03 -49.04 9.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 62.33 110.864 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.712 ' O ' HG12 ' A' ' 141' ' ' VAL . 5.4 mp -113.18 75.28 2.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 54.01 111.137 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -8.78 24.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.7 2.266 . . . . 44.4 112.346 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.12 -28.45 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.45 110.914 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -69.88 144.6 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 64.42 111.153 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 -39.65 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.24 111.09 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.7 171.83 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.2 111.084 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.79 151.94 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 60.33 111.125 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.7 0.762 . . . . 64.32 110.84 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.827 0.261 . . . . 71.52 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.52 HD21 ' CA ' ' A' ' 80' ' ' VAL . 3.0 tm? -93.45 130.82 39.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.872 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.457 ' N ' HD22 ' A' ' 75' ' ' LEU . 11.8 p -128.65 172.79 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 73.24 111.189 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -62.81 -27.01 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 52.21 111.079 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.78 -49.29 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 64.42 112.465 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -44.5 65.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 64.24 110.897 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.43 -31.43 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 75.04 111.119 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.93 -35.21 76.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.34 110.872 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -44.22 97.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 64.54 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 134' ' ' LEU . 25.3 t -77.21 -41.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.04 111.122 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -68.03 -19.4 64.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.912 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.21 -26.7 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 64.1 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -76.39 -44.0 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.903 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.727 ' CG2' HD23 ' A' ' 91' ' ' LEU . 10.8 p -81.5 -6.82 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.41 111.139 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.7 ttm180 -60.53 -58.8 16.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 63.53 110.885 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.79 -8.39 23.48 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.72 2.28 . . . . 73.2 112.354 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 3.8 t80 -94.63 -63.3 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.917 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -53.64 -49.05 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.891 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 88' ' ' ARG . 64.1 p -60.56 -28.53 68.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 65.43 111.137 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -56.88 -53.79 53.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 54.14 111.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.16 -24.96 65.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.0 6.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 75.22 112.455 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.09 -153.79 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 61.11 112.506 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -174.77 127.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 61.41 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.574 HG11 HG13 ' A' ' 87' ' ' VAL . 22.6 m -100.98 134.77 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 72.01 111.092 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.37 117.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.12 111.094 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD21 HD11 ' A' ' 103' ' ' ILE . 12.3 tp -63.03 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.32 110.946 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.47 ' N ' HD12 ' A' ' 100' ' ' LEU . 25.4 t60 -93.69 -74.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.54 110.853 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.36 171.36 9.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 61.22 110.915 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.565 HD11 HD21 ' A' ' 100' ' ' LEU . 37.0 mt -135.23 108.19 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 70.12 111.099 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.39 -172.05 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 65.1 111.119 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.39 -87.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 62.13 112.486 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.31 20.64 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 71.21 110.902 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.09 150.83 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.55 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.15 139.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.42 111.102 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mtp85 -99.4 101.05 12.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.876 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.5 mt -108.6 154.66 21.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.11 110.939 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -115.05 119.04 35.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.919 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -143.13 134.71 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 60.32 110.921 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.1 130.02 54.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.915 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.777 -0.725 . . . . 71.54 112.477 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.912 0.387 . . . . 74.52 110.841 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 pp -51.32 -30.67 19.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 64.15 110.929 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.72 -30.89 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -72.62 -34.64 67.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.42 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.74 HD12 HD11 ' A' ' 91' ' ' LEU . 26.7 pt -86.1 -30.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 63.03 111.145 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -50.85 -47.41 60.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.905 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -68.47 -24.77 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.33 110.869 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.78 -56.89 5.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 32.21 112.431 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.877 HD13 HD22 ' A' ' 112' ' ' LEU . 3.8 mp -62.9 -53.24 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 74.24 111.169 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -53.21 -31.78 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.12 110.891 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -68.43 -32.44 72.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.15 110.886 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -79.09 -46.0 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.852 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -61.52 -51.99 66.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 73.13 110.845 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 18.6 tpp -53.69 -39.4 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.88 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.1 -23.36 54.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.01 110.872 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -100.53 -37.88 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 62.33 110.867 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.83 80.23 2.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 71.12 111.124 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.7 2.267 . . . . 74.24 112.309 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.49 -26.79 62.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 143' ' ' ALA . 34.8 t -83.19 149.38 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.13 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.53 -30.08 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 63.23 111.148 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.46 -173.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.12 111.123 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.25 164.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 55.15 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.685 0.755 . . . . 73.41 110.853 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.86 0.275 . . . . 65.5 112.354 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.658 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -142.67 135.84 28.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 74.31 110.935 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.4 p -145.07 172.43 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 71.21 111.126 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.33 -30.37 18.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.14 111.131 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.3 -62.3 2.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 53.42 112.471 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -55.38 -47.83 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 73.24 110.863 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 8.1 p -50.64 -31.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.14 111.163 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.26 -37.55 83.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.866 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -42.7 99.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.5 t -77.1 -39.87 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 71.53 111.102 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 2.3 mp -70.63 -18.69 62.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 74.31 110.909 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.15 -25.88 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.888 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.03 -47.59 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.916 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 130' ' ' ILE . 3.6 m -82.64 -3.49 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.44 111.131 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.0 ttt180 -60.78 -58.74 17.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 73.32 110.872 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.2 Cg_endo -69.78 -10.92 29.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.65 2.234 . . . . 74.31 112.366 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.15 -32.55 14.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.943 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -85.94 -59.68 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 61.41 110.958 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' OD1' ' A' ' 97' ' ' ASP . 37.5 p -51.74 -39.39 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.31 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 51.4 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.69 -37.96 67.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 71.32 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.85 -38.57 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 63.04 112.525 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -73.76 -135.89 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 32.1 112.519 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' A' ' 92' ' ' THR . 10.0 t0 -174.9 175.99 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 61.33 110.825 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 112' ' ' LEU . 19.0 m -138.28 138.59 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 71.14 111.155 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.32 131.51 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 41.22 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.576 HD12 HG11 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -78.01 118.55 20.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.918 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -97.64 -64.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.865 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.43 165.08 16.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.34 110.882 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 108' ' ' VAL . 69.8 mt -138.5 113.36 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 72.13 111.137 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -90.56 -169.34 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.52 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.37 -90.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 65.41 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -85.98 4.94 35.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 75.52 110.867 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 19.6 t -133.39 151.19 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 53.03 111.145 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 103' ' ' ILE . 96.1 t -123.71 140.37 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 34.5 111.114 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 100.97 13.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 65.22 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.12 123.17 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 71.14 110.939 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -73.23 86.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 34.11 110.891 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -117.99 129.64 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.916 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -131.05 141.39 50.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 73.23 110.9 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.24 112.498 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.943 0.401 . . . . 72.13 110.861 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -54.34 -29.83 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.42 110.884 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.4 mm -85.11 -31.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 54.44 111.169 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.8 m -68.15 -34.36 76.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.124 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.717 ' CD1' HD11 ' A' ' 91' ' ' LEU . 24.5 pt -86.03 -30.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.13 111.135 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -52.64 -47.1 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 71.05 110.891 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -69.11 -24.88 64.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.885 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.25 -57.59 6.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.681 -0.771 . . . . 74.44 112.475 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -60.74 -55.31 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.34 . . . . 51.31 111.114 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HB3' HG22 ' A' ' 144' ' ' VAL . 22.5 pt-20 -51.68 -31.81 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 70.04 110.898 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -71.3 -36.77 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 64.21 110.908 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -79.03 -36.38 41.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.807 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.23 -33.54 71.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.44 110.925 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 3.2 mtm -63.91 -27.72 69.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.872 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.68 -58.55 8.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.881 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.719 ' HB2' HD12 ' A' ' 138' ' ' ILE . 4.3 mttm -77.62 -47.41 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.881 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.56 74.33 2.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.64 0.734 . . . . 73.21 111.114 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -14.31 35.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.623 2.215 . . . . 54.3 112.372 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -38.46 55.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.876 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.04 144.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 53.03 111.102 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.33 -53.66 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.128 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.13 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 71.31 111.1 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 131' ' ' GLU . 15.9 m -138.63 148.51 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 63.33 111.094 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.651 0.739 . . . . 64.33 110.867 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.609 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.795 0.248 . . . . 74.55 112.335 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 108' ' ' VAL . 5.1 tt -89.48 106.97 18.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.929 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 79' ' ' ASN . 6.6 t -135.58 166.04 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 74.14 111.144 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -27.39 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 74.54 111.086 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.16 -59.04 3.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 33.23 112.478 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.507 ' H ' HG23 ' A' ' 76' ' ' THR . 79.0 m-20 -62.23 -48.02 81.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 74.22 110.909 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.023 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.6 -30.99 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 61.03 111.143 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -61.79 -38.15 87.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 72.35 110.887 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -67.38 -37.85 83.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 52.15 110.868 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 134' ' ' LEU . 59.4 t -77.04 -39.41 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 73.32 111.147 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 80' ' ' VAL . 4.2 mp -71.1 -19.16 62.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.34 110.912 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.84 -26.89 10.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.87 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -76.35 -43.42 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.3 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG2' HD23 ' A' ' 91' ' ' LEU . 11.9 p -81.4 -7.35 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 73.32 111.086 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.7 ttm-85 -60.18 -58.79 16.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.603 0.716 . . . . 71.43 110.877 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.1 Cg_endo -69.83 -8.49 23.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.669 2.246 . . . . 74.44 112.32 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 5.5 t80 -94.55 -63.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.13 110.94 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -53.09 -54.77 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 62.33 110.891 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -51.48 -34.77 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.33 111.154 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -59.65 -37.18 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 54.25 111.06 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.89 -31.7 63.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.842 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.7 17.1 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 62.23 112.504 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.38 -135.96 8.84 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 53.41 112.477 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -179.16 136.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 74.04 110.851 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.8 m -110.13 129.45 65.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.33 111.141 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -167.8 129.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 42.2 111.098 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HA ' HD23 ' A' ' 110' ' ' LEU . 11.5 tp -71.78 119.65 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.32 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -76.96 -72.28 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.877 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.75 171.1 14.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.31 110.85 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.418 HD11 HD21 ' A' ' 100' ' ' LEU . 58.1 mt -125.91 121.35 59.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 54.33 111.101 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.24 -170.51 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 50.32 111.074 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.01 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 54.44 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -98.14 23.41 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 64.13 110.908 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.42 111.171 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.049 HG21 HD13 ' A' ' 75' ' ' LEU . 60.6 t -116.18 138.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.21 111.174 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 100' ' ' LEU . 24.1 mtp180 -101.02 101.05 11.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.872 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.1 mt -107.91 164.62 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 54.34 110.887 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.72 115.81 19.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 63.23 110.905 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -138.71 137.9 37.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.894 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.38 113.13 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.898 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.502 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.96 0.409 . . . . 44.21 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.67 -47.67 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.57 -31.2 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.13 111.122 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -61.66 -39.92 93.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.43 111.14 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 130' ' ' ILE . 30.1 pt -86.17 -29.99 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.12 111.135 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -50.75 -47.67 59.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 72.25 110.882 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.76 -24.71 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 60.15 110.839 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.15 -55.76 6.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.771 -0.728 . . . . 33.45 112.458 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 112' ' ' LEU . 4.0 mp -62.87 -54.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 73.21 111.134 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -52.88 -32.6 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 55.4 110.904 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.67 -32.74 74.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.868 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -78.88 -56.42 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.861 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.995 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -52.0 -35.65 47.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 51.2 110.893 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.1 mtt -62.78 -40.35 97.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 55.35 110.897 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.31 -20.07 57.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.14 110.913 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HZ2' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.67 -33.81 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 63.13 110.902 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.767 ' O ' HG12 ' A' ' 141' ' ' VAL . 11.5 mm -112.34 76.89 2.05 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 44.22 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -7.6 21.48 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.44 112.378 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.94 -29.53 35.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 63.32 110.879 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 138' ' ' ILE . 9.8 p -72.28 158.47 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.01 111.108 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -99.37 -47.29 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.147 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.24 -173.8 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 61.43 111.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.75 164.85 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 75.35 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 72.31 110.96 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.208 0 CA-C-O 120.843 0.268 . . . . 71.43 112.346 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.3 tm? -145.68 140.11 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 64.04 110.943 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.0 t -142.74 167.72 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 71.24 111.144 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.32 -28.35 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.34 111.07 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.88 -42.5 12.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.736 . . . . 60.0 112.472 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 76' ' ' THR . 1.9 m120 -72.65 -47.18 49.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.366 . . . . 63.54 110.91 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.831 HG22 HD13 ' A' ' 84' ' ' LEU . 9.5 p -50.78 -30.8 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 62.41 111.136 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.94 -37.08 83.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.912 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.71 -39.57 73.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.86 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.8 t -72.46 -44.74 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 61.53 111.097 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.831 HD13 HG22 ' A' ' 80' ' ' VAL . 6.5 mp -71.21 -18.97 62.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.93 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.8 -26.12 5.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.862 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -75.06 -45.46 41.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.892 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 130' ' ' ILE . 2.6 m -81.62 -7.06 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.03 111.157 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 17.7 ttt-85 -58.56 -58.8 16.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 71.32 110.885 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.7 -8.85 24.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.278 . . . . 72.1 112.353 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.1 -25.47 15.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 71.43 110.913 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.772 HD11 HD13 ' A' ' 126' ' ' ILE . 2.3 mm? -93.7 -57.32 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.34 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -53.11 -36.33 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 53.44 111.155 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.59 -28.74 70.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 111.088 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -76.81 -38.05 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 72.5 110.87 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.41 -39.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 73.4 112.495 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.48 -137.77 1.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 71.13 112.464 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -174.77 -175.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 74.52 110.825 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -137.94 138.96 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 71.35 111.121 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.42 123.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.23 111.13 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 109' ' ' ARG . 21.2 tp -66.12 133.59 51.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.967 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.408 ' N ' HD12 ' A' ' 100' ' ' LEU . 2.1 t60 -100.18 -63.53 1.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 62.32 110.823 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -144.75 163.87 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.894 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.406 HD11 HD21 ' A' ' 100' ' ' LEU . 54.8 mt -123.11 114.5 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.23 111.16 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.43 -172.32 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 62.1 111.147 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.63 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.714 -0.755 . . . . 74.14 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.99 25.06 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 55.12 110.9 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -144.69 151.01 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.34 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.42 128.96 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.33 111.127 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.7 mtt-85 -90.16 103.33 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.904 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.8 HD22 HD21 ' A' ' 84' ' ' LEU . 1.6 mt -112.82 133.67 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 60.15 110.896 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -86.07 91.76 8.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.895 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -119.44 131.33 55.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.51 110.877 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.512 ' O ' HD12 ' A' ' 91' ' ' LEU . 40.6 tt0 -127.84 127.01 42.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 62.04 110.895 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 75.12 112.468 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.907 0.384 . . . . 72.15 110.826 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -52.38 -30.12 27.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 62.15 110.935 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.97 -36.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.51 111.107 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -60.04 -34.02 72.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 72.12 111.137 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.772 HD13 HD11 ' A' ' 91' ' ' LEU . 49.9 pt -86.14 -26.83 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.106 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -51.07 -48.6 61.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.32 110.873 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -66.35 -24.7 66.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 65.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.13 -57.23 6.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.763 -0.732 . . . . 62.12 112.471 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.08 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -63.09 -54.54 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 75.5 111.132 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -31.74 25.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 55.02 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -69.27 -44.35 72.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.24 110.86 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -69.75 -39.98 76.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.852 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -70.21 -47.74 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 64.53 110.935 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.7 mmt -55.11 -26.49 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 63.31 110.89 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.4 -62.68 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.863 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.69 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.4 mttt -71.84 -47.27 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.885 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.24 75.06 2.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 54.11 111.103 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -11.06 30.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.65 2.233 . . . . 75.15 112.368 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -51.92 -43.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 54.32 110.878 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.99 148.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.118 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.42 -33.0 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 71.31 111.113 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -175.56 177.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.09 147.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 32.03 111.137 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.737 . . . . 62.5 110.868 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HG23 ' A' ' 138' ' ' ILE . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.849 0.27 . . . . 64.51 112.363 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 80' ' ' VAL . 3.3 tm? -144.95 120.14 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 62.11 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -134.51 -176.69 4.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 61.44 111.142 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.57 70.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 55.13 111.081 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.5 -52.28 4.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 71.44 112.474 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -61.22 -48.45 81.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 73.34 110.879 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 84' ' ' LEU . 5.8 p -51.79 -30.77 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 54.05 111.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.34 -33.58 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 72.41 110.947 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 t -63.93 -43.93 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 72.23 110.87 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 134' ' ' LEU . 48.4 t -76.5 -40.77 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.123 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 80' ' ' VAL . 3.1 mp -71.11 -18.97 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -51.26 -26.85 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 65.31 110.875 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -74.48 -42.23 59.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.51 110.921 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.848 HG11 HG13 ' A' ' 130' ' ' ILE . 33.7 m -81.96 -12.88 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.164 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.5 ttt85 -53.04 -58.59 11.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.587 0.708 . . . . 73.22 110.891 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.8 Cg_endo -69.77 -32.13 19.14 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 73.5 112.323 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -65.92 -57.7 7.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.955 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.8 mm? -58.05 -54.81 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 71.3 110.94 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.643 HG22 ' OD1' ' A' ' 97' ' ' ASP . 40.1 p -51.6 -30.57 21.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 54.55 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.96 -36.74 78.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 61.12 111.126 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.18 -38.03 61.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 63.54 110.89 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.76 -26.62 2.37 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 63.22 112.461 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.73 -136.84 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 64.42 112.492 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.643 ' OD1' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -179.39 -175.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 63.03 110.881 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.5 m -141.79 143.95 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.52 111.183 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.78 131.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.35 111.124 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HA ' HD13 ' A' ' 110' ' ' LEU . 25.0 tp -53.69 114.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 70.33 110.876 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -80.78 -49.98 10.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -168.41 167.9 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.42 110.889 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 100' ' ' LEU . 69.7 mt -127.97 105.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 74.14 111.141 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.32 -178.08 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.092 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.16 -75.88 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.747 . . . . 71.05 112.528 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -0.14 21.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 62.14 110.935 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 16.3 t -119.62 152.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.14 111.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 141' ' ' VAL . 19.6 t -113.78 142.85 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 52.44 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -115.13 100.42 8.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.899 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.2 mm? -100.69 146.29 27.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.895 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -102.29 124.05 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.892 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.956 HD13 HD13 ' A' ' 130' ' ' ILE . 6.4 mt -140.4 156.97 46.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 70.2 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -132.78 114.72 14.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 72.3 110.925 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 60.44 112.507 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.928 0.394 . . . . 74.43 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.97 -32.86 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.892 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.52 -31.02 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 65.42 111.12 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -40.65 97.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.161 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.6 pt -84.01 -30.91 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 65.44 111.066 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -52.0 -41.66 62.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.951 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -24.81 60.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 70.1 110.871 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.17 -54.81 7.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 53.33 112.549 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.956 HD13 HD13 ' A' ' 112' ' ' LEU . 3.3 mp -58.46 -50.92 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 72.24 111.106 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 144' ' ' VAL . 12.5 pt-20 -58.84 -34.73 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -76.68 -30.33 56.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -79.21 -34.32 43.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.858 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.686 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -57.08 5.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.972 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.4 ttm -50.89 -30.73 15.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 71.34 110.905 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -60.38 -37.56 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.948 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.724 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.0 mttm -91.7 -45.37 8.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 71.34 110.886 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.0 mp -113.41 73.74 2.0 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 74.23 111.117 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.87 36.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 74.22 112.347 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.71 -47.55 82.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 51.02 110.861 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.9 p -55.84 131.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.05 111.129 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.31 63.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 55.03 111.078 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.48 178.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 65.44 111.113 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 131' ' ' GLU . 2.1 p -139.85 134.47 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 72.32 111.129 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 64.14 110.92 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.858 0.274 . . . . 54.53 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.606 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.61 134.49 25.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.485 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.9 p -145.34 173.02 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.22 -30.52 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 51.12 111.094 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.08 -62.28 2.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 73.52 112.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -47.93 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 71.43 110.907 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 8.2 p -50.77 -30.88 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 55.15 111.112 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -61.63 -38.07 86.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.935 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -64.62 -40.39 95.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.4 110.846 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -76.49 -39.04 32.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 65.23 111.144 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 3.2 mp -71.06 -19.4 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 61.51 110.894 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.3 -26.83 20.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 75.03 110.857 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -75.32 -43.45 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.93 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.648 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.2 p -81.45 -9.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 45.11 111.09 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.8 ttt180 -56.67 -58.71 15.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 65.43 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -12.57 33.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.694 2.263 . . . . 73.01 112.302 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -92.14 -25.99 18.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 70.23 110.905 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 126' ' ' ILE . 1.6 mm? -101.0 -57.38 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.34 110.956 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 88' ' ' ARG . 29.9 p -52.33 -35.92 52.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.167 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.81 72.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 31.11 111.113 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.08 -37.98 69.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.15 110.89 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.45 -35.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.762 -0.732 . . . . 72.34 112.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -141.13 1.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.771 . . . . 75.15 112.47 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -170.19 -176.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 62.41 110.821 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 112' ' ' LEU . 18.8 m -141.93 138.43 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 53.11 111.104 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.74 137.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 52.24 111.083 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HA ' HD23 ' A' ' 110' ' ' LEU . 35.3 tp -76.28 135.53 39.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 60.43 110.951 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -103.5 -63.95 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 65.54 110.862 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.15 162.49 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.882 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 100' ' ' LEU . 58.2 mt -126.98 117.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 53.24 111.143 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -98.64 -169.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.41 111.125 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.94 -88.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 70.25 112.507 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 142' ' ' ALA . 9.6 p30 -102.55 13.45 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 62.13 110.877 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.54 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.9 t -131.33 139.03 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 74.35 111.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.63 134.81 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 65.41 111.072 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.95 101.09 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.3 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.6 mt -112.29 149.19 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 72.45 110.898 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -101.3 119.07 38.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.932 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 130' ' ' ILE . 7.6 mt -139.49 127.76 22.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.948 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -104.92 137.11 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 73.44 110.895 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 72.01 112.502 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.899 0.38 . . . . 75.34 110.812 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -31.08 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 74.42 110.936 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mm -88.07 -30.98 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 65.15 111.167 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 m -72.22 -33.3 67.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.33 111.163 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.779 HD12 HD11 ' A' ' 91' ' ' LEU . 25.4 pt -83.65 -30.91 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.164 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -51.8 -51.58 55.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.32 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.9 -24.93 66.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 64.04 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.6 -61.78 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -55.9 -54.73 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 63.22 111.147 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -52.53 -32.45 40.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 65.21 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -75.44 -32.43 60.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -76.34 -35.63 58.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.35 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.1 -48.12 58.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.23 110.914 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.96 -33.24 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 65.45 110.888 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.61 -55.25 23.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.9 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.637 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.4 OUTLIER -80.06 -45.83 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.899 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.642 HD13 ' CD2' ' A' ' 134' ' ' LEU . 5.2 mp -113.09 74.96 1.95 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.667 0.746 . . . . 73.42 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.86 33.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 61.13 112.333 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.76 -52.8 46.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 61.31 110.863 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.44 151.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.41 111.109 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' OD1' ' A' ' 106' ' ' ASN . . . -87.49 -45.75 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.37 -169.44 2.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.24 111.095 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.72 148.54 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 62.34 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.54 ' CG ' HG11 ' A' ' 107' ' ' VAL . 14.7 mm-40 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 64.35 110.896 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.808 0.253 . . . . 71.43 112.332 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.729 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.3 tm? -152.19 128.02 10.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 62.51 110.943 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.422 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.1 p -143.22 -178.15 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.42 111.167 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 54.13 111.089 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.4 -64.08 1.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 70.41 112.455 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.54 -46.73 73.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 74.12 110.846 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.989 HG22 HD13 ' A' ' 84' ' ' LEU . 5.9 p -51.24 -30.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 72.24 111.124 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.32 -35.62 77.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 71.23 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -42.3 73.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.52 110.881 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.769 HG11 ' HA ' ' A' ' 134' ' ' LEU . 29.4 t -71.47 -44.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 74.35 111.087 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 80' ' ' VAL . 5.7 mp -71.13 -19.43 62.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 60.22 110.904 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.19 -26.95 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.866 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -74.51 -41.38 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.895 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.649 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.8 p -83.02 -12.58 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 63.52 111.106 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 18.9 ttt180 -53.17 -58.75 11.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.709 . . . . 74.11 110.904 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -19.51 36.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 72.54 112.347 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -83.8 -24.13 31.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 62.02 110.898 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.4 mm? -101.04 -55.53 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.3 110.948 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.3 p -51.68 -39.35 58.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.0 111.112 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.68 69.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 71.33 111.116 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.17 -37.81 69.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.931 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.73 -28.0 1.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 74.21 112.484 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.86 -138.27 4.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 73.31 112.493 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -173.56 -175.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 64.22 110.838 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.463 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.8 m -141.09 141.33 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 72.32 111.136 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.4 132.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.21 111.094 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -69.27 117.19 10.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 63.25 110.933 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -80.8 -57.87 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.882 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -152.75 161.1 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.22 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.37 118.38 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 64.22 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.77 -177.08 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.32 111.131 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.39 -86.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 61.02 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -99.64 25.18 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 54.03 110.874 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 145' ' ' GLU . 22.0 t -145.26 149.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.103 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.78 115.77 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 61.11 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -82.7 101.19 10.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.2 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -112.11 150.88 30.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.11 110.946 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -106.29 117.23 33.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.33 110.908 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -132.04 139.28 48.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 70.21 110.934 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -122.06 119.24 30.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.968 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 64.41 112.476 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 54.34 110.851 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.95 -29.92 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.888 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.59 -42.66 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.097 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 m -53.37 -35.94 60.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.22 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.6 pt -85.94 -30.22 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 73.12 111.138 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -51.38 -41.93 61.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 63.41 110.915 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -25.59 61.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 72.53 110.839 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.71 -57.14 6.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 64.14 112.481 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 112' ' ' LEU . 4.3 mp -60.54 -54.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 62.22 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.87 -31.85 41.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.876 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -70.35 -48.28 57.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 65.34 110.847 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -63.34 -40.82 98.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.847 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.769 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.98 -45.9 66.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 62.01 110.933 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.7 mtt -59.53 -23.84 63.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.876 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -71.33 -52.53 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 72.31 110.878 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.702 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.7 mmpt? -75.22 -55.12 6.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 72.21 110.895 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.95 76.03 2.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.638 0.732 . . . . 53.44 111.17 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -8.85 24.65 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 62.1 112.329 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.08 -30.73 27.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 75.52 110.847 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -79.43 144.18 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 62.5 111.155 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.16 -53.1 7.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.056 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.5 -169.93 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 73.12 111.128 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.21 153.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 61.35 111.11 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 107' ' ' VAL . 13.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.13 110.909 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.78 0.242 . . . . 72.11 112.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.708 HD23 HD13 ' A' ' 138' ' ' ILE . 3.0 tm? -150.17 117.45 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 71.52 110.914 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 80' ' ' VAL . 16.5 p -135.48 179.7 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 73.32 111.098 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.16 -30.24 16.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 43.43 111.09 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.21 -63.25 2.08 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.738 . . . . 64.3 112.511 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -54.94 -47.23 74.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.02 110.865 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 84' ' ' LEU . 6.9 p -51.53 -31.14 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.143 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.44 -35.64 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 45.45 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -67.58 -40.22 84.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 53.21 110.883 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.7 t -75.91 -45.36 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mp -72.18 -18.27 61.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.94 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -50.48 -26.8 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.889 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.4 -42.81 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 63.2 110.931 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.756 HG21 HG13 ' A' ' 130' ' ' ILE . 11.1 p -80.85 -14.88 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 54.12 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.3 ttp85 -51.07 -58.65 9.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.583 0.706 . . . . 70.32 110.846 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.76 -26.53 27.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.256 . . . . 73.34 112.368 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -76.15 -22.11 55.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 64.2 110.956 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.641 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.2 mm? -100.58 -51.5 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 74.21 110.866 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.5 p -56.86 -30.75 64.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 55.45 111.155 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.66 -27.21 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 53.54 111.046 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.03 -38.0 19.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.869 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.74 -35.75 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 45.53 112.447 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.89 -144.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 52.51 112.463 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -177.34 168.81 2.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.384 . . . . 71.4 110.855 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 112' ' ' LEU . 22.8 m -125.23 135.62 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.2 111.167 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.17 125.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 14.54 111.098 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 103' ' ' ILE . 10.5 tp -75.68 117.65 17.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.52 110.972 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -83.77 -74.38 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 42.25 110.867 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -125.61 168.48 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.873 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 HD21 ' A' ' 100' ' ' LEU . 69.8 mt -130.22 123.28 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.0 111.172 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.36 -169.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.2 111.063 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.27 -87.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.482 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.43 -6.59 37.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 75.43 110.852 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 t -113.9 151.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.05 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 103' ' ' ILE . 73.3 t -119.98 133.28 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.095 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.58 102.65 15.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.858 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 100' ' ' LEU . 3.4 mt -108.44 151.08 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.91 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -104.28 90.31 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.939 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 130' ' ' ILE . 9.8 mt -120.45 129.62 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 72.32 110.902 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -129.86 159.09 37.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.51 110.909 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 31.11 112.507 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.862 0.363 . . . . 54.32 110.858 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 124' ' ' ILE . 1.4 pp -53.72 -28.01 31.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 74.03 110.89 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 123' ' ' LEU . 25.2 mm -81.18 -30.98 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 63.4 111.135 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -31.67 70.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 70.1 111.155 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 130' ' ' ILE . 32.6 pt -86.18 -28.39 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 62.33 111.073 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -52.89 -35.94 58.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.875 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -75.28 -26.25 58.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.34 110.92 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.27 -54.46 6.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.699 -0.762 . . . . 53.42 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 112' ' ' LEU . 4.4 mp -63.94 -44.6 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 73.55 111.16 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -64.69 -22.84 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.956 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -76.67 -51.33 11.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 72.12 110.832 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -73.41 -33.48 64.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.863 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 84' ' ' LEU . 14.3 tp -69.93 -47.5 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 70.01 110.95 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.4 ttm -68.9 -28.12 66.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.11 110.86 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -51.99 -53.83 36.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.3 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -70.56 -49.16 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.907 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.708 HD13 HD23 ' A' ' 75' ' ' LEU . 5.3 mp -112.99 76.16 2.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 75.11 111.184 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.72 24.33 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.728 2.285 . . . . 71.41 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -53.11 -28.72 26.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.03 110.887 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.0 p -81.45 144.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.1 111.117 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.58 -52.57 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 55.13 111.076 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.89 -173.18 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.32 111.086 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.35 163.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.45 111.13 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.618 0.723 . . . . 54.2 110.888 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.812 0.255 . . . . 62.13 112.303 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.688 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -152.82 128.2 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.34 110.908 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.469 ' N ' HD13 ' A' ' 75' ' ' LEU . 17.0 p -144.82 178.91 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 61.24 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.11 -30.3 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 51.31 111.073 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.97 -62.96 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 41.13 112.514 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -55.31 -47.56 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 73.5 110.947 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 134' ' ' LEU . 7.2 p -51.23 -31.12 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 55.04 111.183 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.01 -36.69 84.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 74.22 110.901 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -66.89 -40.66 87.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 64.11 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 27.4 t -74.96 -45.35 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.14 111.161 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.729 HD13 HG22 ' A' ' 80' ' ' VAL . 9.0 mp -71.86 -18.16 62.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 54.13 110.933 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.9 -26.98 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 63.12 110.849 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -74.61 -43.03 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.943 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.802 HG21 HG13 ' A' ' 130' ' ' ILE . 11.8 p -80.49 -14.73 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.45 111.142 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.2 ttm180 -51.6 -58.75 9.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 73.42 110.882 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.4 Cg_endo -69.74 -27.48 26.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 54.44 112.355 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -74.22 -25.01 59.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 70.44 110.92 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.626 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.4 mm? -98.77 -52.16 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 75.23 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -54.29 -32.5 56.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 73.24 111.132 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.77 71.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.51 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -79.7 -37.45 35.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.861 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.87 -42.66 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 11.4 112.48 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.11 -142.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 64.11 112.477 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -175.93 -177.39 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 65.32 110.858 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG12 ' CD2' ' A' ' 112' ' ' LEU . 33.3 m -138.6 132.96 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.129 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.27 123.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 73.24 111.104 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 80' ' ' VAL . 1.4 tt -71.5 116.0 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 54.4 110.896 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -75.88 -65.59 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 54.33 110.886 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.54 165.43 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.873 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.19 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.01 111.108 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.9 -176.44 3.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 62.23 111.094 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.47 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 73.24 112.461 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 4.8 p30 -96.28 25.46 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 42.24 110.869 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.494 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.7 t -144.98 150.06 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 62.13 111.121 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 141' ' ' VAL . 42.8 t -124.91 117.06 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.139 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 100' ' ' LEU . 36.5 mtt85 -82.33 100.93 10.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.3 110.836 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 134' ' ' LEU . 4.4 mt -105.22 146.52 29.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.932 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -105.78 103.1 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.682 ' CD2' HG12 ' A' ' 98' ' ' VAL . 3.9 mt -126.58 144.11 51.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 74.34 110.94 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -124.7 146.8 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.04 110.964 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 63.43 112.446 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 75.14 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.23 -30.23 26.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.915 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.23 -38.31 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.41 111.151 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -35.23 76.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 72.24 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 26.6 pt -85.89 -31.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 71.52 111.096 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.0 -45.19 71.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 45.41 110.86 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -73.01 -24.84 60.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 65.35 110.877 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.17 -60.28 3.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 34.1 112.477 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.802 HG13 HG21 ' A' ' 87' ' ' VAL . 2.9 mp -59.12 -50.06 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.748 0.309 . . . . 74.52 111.094 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -57.61 -25.63 60.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.854 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -80.04 -51.55 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.2 110.863 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -64.65 -36.32 83.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 52.41 110.89 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 80' ' ' VAL . 27.0 tp -70.14 -35.82 74.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.11 110.917 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.611 ' CE ' HG13 ' A' ' 144' ' ' VAL . 16.7 mtt -78.64 -29.56 45.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.21 110.893 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -51.91 -34.96 43.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.896 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 138' ' ' ILE . 17.2 mmtm -91.87 -37.6 12.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 65.32 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.688 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -127.34 75.12 77.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 62.22 111.103 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -8.19 22.98 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.671 2.248 . . . . 64.24 112.355 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -51.45 -30.7 20.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 72.31 110.875 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.3 p -76.28 144.01 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.12 111.127 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -77.24 -53.24 7.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -157.31 -175.68 5.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 71.43 111.124 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.611 HG13 ' CE ' ' A' ' 135' ' ' MET . 18.3 m -130.13 147.9 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 72.21 111.126 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.494 ' CG ' HG11 ' A' ' 107' ' ' VAL . 16.3 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 63.15 110.927 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.819 0.258 . . . . 73.34 112.34 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.719 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.27 111.17 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.951 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 p -119.98 -177.67 3.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.43 . . . . 73.25 111.124 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.89 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 70.43 111.067 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 -46.13 8.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.728 . . . . 52.45 112.473 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.96 -46.74 73.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.354 . . . . 73.14 110.866 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 7.8 p -54.1 -31.16 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.23 111.159 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.85 -23.81 67.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 t -71.91 -45.92 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.33 110.835 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.3 p -77.08 -34.64 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 72.33 111.102 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 3.5 mp -71.58 -19.82 62.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.952 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -53.65 -26.66 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.42 110.855 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.62 -42.97 57.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.35 110.94 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' HG ' ' A' ' 91' ' ' LEU . 13.9 p -80.69 -14.42 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.21 111.131 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 ttt180 -51.86 -58.63 10.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.714 . . . . 74.34 110.848 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.268 . . . . 75.42 112.336 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.34 -57.39 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 64.01 110.891 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 87' ' ' VAL . 10.6 mt -68.33 -44.27 75.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 55.33 110.925 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 88' ' ' ARG . 41.1 p -53.74 -29.01 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 73.11 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.48 67.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 45.3 111.107 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.31 -37.99 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.52 110.873 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.26 -15.2 3.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 53.42 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.19 -143.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 74.45 112.511 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -173.51 173.49 3.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.845 0.355 . . . . 61.21 110.844 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 84' ' ' LEU . 12.9 m -139.27 128.46 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.45 111.165 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.15 116.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.24 111.133 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -55.28 113.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.954 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -75.07 -65.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 65.2 110.865 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -141.76 166.15 25.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 55.1 mt -124.53 114.59 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.18 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.37 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 50.43 111.102 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.27 -91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 75.5 112.519 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -96.58 24.0 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 73.51 110.869 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.401 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.6 t -145.13 150.18 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.31 111.112 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.1 t -118.79 131.82 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.43 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -98.79 100.93 12.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 52.41 110.87 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -110.09 144.44 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 74.12 110.888 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -92.81 102.97 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 60.14 110.868 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 130' ' ' ILE . 9.1 mt -120.09 147.94 44.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 61.35 110.914 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.41 141.37 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 71.01 110.973 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 71.11 112.468 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.929 0.395 . . . . 53.24 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.88 -30.81 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 62.11 110.895 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mm -90.08 -30.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 54.32 111.168 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 m -64.67 -45.08 88.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 72.34 111.168 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 130' ' ' ILE . 47.5 pt -76.0 -26.65 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.51 111.082 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -51.56 -54.68 24.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.851 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -24.91 68.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 75.45 110.864 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.52 -60.33 4.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.524 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -56.56 -54.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 73.23 111.129 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.66 -32.38 41.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.45 110.915 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -77.9 -30.71 50.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.826 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -78.93 -33.59 45.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 72.13 110.898 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.789 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -69.41 -54.93 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 70.44 110.885 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -29.34 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.4 110.86 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.7 -26.1 55.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 64.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -44.22 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 55.44 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.719 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.05 75.84 2.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.621 0.724 . . . . 74.12 111.127 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.44 34.73 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 73.34 112.358 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.91 -39.45 59.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.864 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -73.09 144.44 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 54.34 111.16 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.54 -44.56 18.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.083 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.49 -171.99 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 41.33 111.092 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.3 154.0 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.116 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' CG ' HG11 ' A' ' 107' ' ' VAL . 46.5 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 64.55 110.897 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 120.837 0.265 . . . . 70.22 112.354 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.74 114.27 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.9 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -122.45 -177.13 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 63.53 111.128 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -61.87 -34.37 75.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 70.13 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.2 -46.44 8.18 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 74.13 112.483 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -67.3 -46.9 72.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 65.3 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.042 HG22 HD13 ' A' ' 84' ' ' LEU . 6.7 p -54.4 -31.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 75.24 111.121 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.88 -23.68 67.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 61.25 110.919 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -69.64 -47.26 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 73.52 110.852 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.1 p -77.21 -35.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 64.5 111.175 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.042 HD13 HG22 ' A' ' 80' ' ' VAL . 1.4 mp -71.72 -19.38 62.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.43 110.938 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.53 -26.71 8.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 75.3 110.858 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -74.44 -41.74 60.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 55.11 110.893 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.839 HG11 HG13 ' A' ' 130' ' ' ILE . 34.0 m -82.98 -11.42 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.144 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.4 ttt85 -54.38 -58.6 13.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 61.15 110.881 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.69 -31.75 20.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.684 2.256 . . . . 75.34 112.36 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.24 -57.99 5.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.7 mm? -56.66 -55.05 38.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 74.21 110.921 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.405 HG22 ' OD1' ' A' ' 97' ' ' ASP . 46.1 p -51.38 -41.84 60.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.21 111.186 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.66 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 51.1 111.104 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -82.86 -37.77 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.55 110.891 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 142.21 -17.04 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.765 -0.731 . . . . 60.43 112.473 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.31 -145.45 16.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 44.04 112.476 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 92' ' ' THR . 1.0 OUTLIER -167.12 -179.95 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 71.31 110.837 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.5 m -137.74 139.53 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.23 111.11 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.61 134.02 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.42 111.082 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -81.4 119.49 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 72.21 110.912 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -88.51 -71.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 72.44 110.83 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -124.63 168.79 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 55.32 110.866 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.642 HD11 HD21 ' A' ' 100' ' ' LEU . 62.2 mt -131.58 125.75 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.01 111.118 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.11 -176.05 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 62.15 111.095 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.51 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 74.13 112.511 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -98.01 25.32 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 72.43 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.547 HG11 ' CG ' ' A' ' 145' ' ' GLU . 25.8 t -145.78 149.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.122 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.2 t -119.63 135.56 59.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 64.3 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -94.97 101.0 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.03 110.889 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 84' ' ' LEU . 7.6 mt -110.59 126.16 54.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.879 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -79.62 101.64 8.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.91 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 130' ' ' ILE . 8.7 mt -123.34 129.69 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.934 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 91' ' ' LEU . 16.0 mt-30 -121.73 129.78 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.892 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 63.24 112.52 179.977 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.929 0.395 . . . . 63.01 110.873 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.78 -30.1 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 63.2 110.87 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.34 -32.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 73.42 111.07 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -74.36 -35.99 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.01 111.152 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.735 ' O ' HD12 ' A' ' 130' ' ' ILE . 19.2 pt -76.83 -29.06 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 71.13 111.109 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -51.2 -58.13 6.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.896 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -68.39 -24.3 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.85 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.53 -59.3 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 64.4 112.514 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 112' ' ' LEU . 2.6 mp -61.03 -54.93 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 75.44 111.102 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -50.56 -31.39 15.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -78.4 -37.15 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.42 110.883 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -72.92 -32.0 65.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 75.55 110.92 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.622 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -51.61 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.926 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.3 mtt -51.82 -31.16 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.54 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.44 -27.3 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -46.82 3.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 55.51 110.908 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.715 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -113.39 74.75 2.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 73.32 111.167 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -13.21 34.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 70.31 112.353 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.13 -33.84 58.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.832 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.2 p -74.59 144.42 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 65.12 111.095 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.44 18.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 61.45 111.1 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -166.32 -170.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 35.31 111.109 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.22 149.76 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.151 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.547 ' CG ' HG11 ' A' ' 107' ' ' VAL . 8.8 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 64.31 110.885 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.775 0.24 . . . . 62.34 112.347 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -147.41 139.91 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 70.3 110.957 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.2 t -148.45 169.87 19.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.52 111.161 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.38 -29.09 9.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.54 111.113 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.29 -55.08 4.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 72.35 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' HB2' HD22 ' A' ' 75' ' ' LEU . 18.5 m-20 -61.67 -47.56 84.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 64.11 110.837 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.647 HG23 HD13 ' A' ' 134' ' ' LEU . 8.8 p -53.16 -31.37 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 62.21 111.146 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.39 -30.67 71.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.857 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -39.93 63.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG13 ' HD3' ' A' ' 137' ' ' LYS . 26.0 t -75.76 -44.47 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 50.53 111.144 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.637 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mp -71.52 -18.6 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.919 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.34 -25.78 4.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.87 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -73.26 -45.28 56.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.23 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.727 HG23 HG11 ' A' ' 98' ' ' VAL . 2.0 m -81.13 -13.62 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.154 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 ttt180 -50.51 -58.67 9.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.61 0.719 . . . . 73.12 110.905 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.74 -35.11 13.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.746 2.297 . . . . 73.05 112.326 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -67.32 -25.45 66.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.93 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.82 -49.06 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.33 110.941 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 88' ' ' ARG . 76.2 p -61.73 -29.22 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 71.23 111.124 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.36 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 54.13 111.146 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.75 -38.01 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 53.31 110.899 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.22 -40.36 0.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 64.22 112.464 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.38 -148.53 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.779 -0.724 . . . . 65.45 112.448 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -178.28 -176.65 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 62.31 110.88 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.849 HG12 HD23 ' A' ' 112' ' ' LEU . 33.4 m -137.25 133.14 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.03 111.096 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.02 105.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 71.53 111.074 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 77' ' ' ALA . 10.9 tp -54.84 119.94 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.05 110.959 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -78.9 -54.49 6.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.888 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -162.91 172.58 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.859 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.13 121.03 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.132 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.28 95.63 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 74.32 111.093 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.4 -123.39 27.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 74.33 112.489 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.02 -17.58 58.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 71.5 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.96 150.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.12 111.148 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.65 123.66 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 52.44 111.069 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 74.32 110.861 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.3 mt -106.17 155.36 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 65.45 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -111.82 84.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.916 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 98' ' ' VAL . 3.8 mt -109.65 139.61 44.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 61.31 110.874 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -131.36 140.67 49.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.907 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 61.03 112.464 -179.96 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.949 0.404 . . . . 63.12 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.42 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 64.21 110.912 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.1 mt -80.47 -38.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.53 111.155 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -52.45 -39.76 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 71.41 111.099 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.479 ' O ' HD12 ' A' ' 130' ' ' ILE . 40.1 pt -86.36 -27.69 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 65.51 111.088 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -43.63 66.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.852 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -24.91 61.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.877 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.59 -57.75 5.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.01 112.53 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.707 ' CG1' HG21 ' A' ' 87' ' ' VAL . 4.4 mp -63.35 -53.3 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 72.1 111.164 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -52.02 -29.99 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.52 110.896 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -75.44 -50.66 15.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 72.01 110.887 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -63.66 -35.87 81.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 60.4 110.852 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.647 HD13 HG23 ' A' ' 80' ' ' VAL . 16.0 tp -70.25 -35.52 73.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.05 110.9 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 72.15 110.897 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.8 -38.27 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 62.1 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HD3' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -92.68 -32.02 14.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 60.14 110.895 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -129.99 76.56 77.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 70.21 111.124 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -8.64 24.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 72.12 112.365 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -56.2 -25.99 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.15 110.858 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.1 150.08 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 50.11 111.104 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.86 -51.12 5.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.51 111.043 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.78 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.34 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.2 153.21 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 72.35 111.145 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.622 0.725 . . . . 72.15 110.924 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HB2' HG23 ' A' ' 138' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.804 0.252 . . . . 62.34 112.368 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.725 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.06 139.81 29.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 75.43 110.924 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.643 ' N ' HD13 ' A' ' 75' ' ' LEU . 9.0 t -153.5 169.62 22.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 51.43 111.18 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.3 -29.56 10.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 75.41 111.098 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.44 -62.44 2.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 51.31 112.526 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -56.23 -48.22 76.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 65.24 110.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.986 HG22 HD13 ' A' ' 84' ' ' LEU . 8.9 p -51.22 -31.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 70.0 111.125 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.35 -36.67 82.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.868 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -63.81 -41.55 97.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 53.41 110.875 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.02 -42.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 62.42 111.127 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.986 HD13 HG22 ' A' ' 80' ' ' VAL . 4.8 mp -70.67 -18.85 62.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 65.4 110.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -51.58 -26.88 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.881 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -78.5 -43.89 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.89 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.836 HG22 HD23 ' A' ' 91' ' ' LEU . 8.2 p -82.38 -1.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.132 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 92' ' ' THR . 13.3 ttt180 -65.88 -58.79 10.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.706 . . . . 73.43 110.843 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.1 Cg_endo -69.72 -8.17 22.91 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.653 2.235 . . . . 64.42 112.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -12.61 20.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 71.02 110.899 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -101.21 -66.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 64.14 110.934 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.4 t -58.51 -20.1 43.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 50.13 111.116 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.23 -29.85 15.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 64.32 111.111 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.24 -31.64 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.12 110.889 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.22 -16.96 0.89 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 74.15 112.503 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.12 -138.89 2.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 63.14 112.518 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 179.85 -175.96 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 41.44 110.921 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.673 ' HB ' HD23 ' A' ' 84' ' ' LEU . 27.9 m -141.17 127.06 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.24 111.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.69 133.42 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.4 111.16 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HA ' HD23 ' A' ' 110' ' ' LEU . 17.9 tp -81.34 112.91 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 70.25 110.913 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -74.56 -73.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.896 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.62 171.14 13.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.12 110.901 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 HD21 ' A' ' 100' ' ' LEU . 56.6 mt -129.74 110.82 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.41 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.33 179.73 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 73.45 111.085 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 74.31 112.473 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -96.77 23.56 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 63.13 110.946 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -145.54 149.4 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -123.07 133.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.123 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 100' ' ' LEU . 8.5 mtt-85 -96.86 100.84 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.854 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 100' ' ' LEU . 31.3 mt -107.64 130.56 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.884 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -82.99 118.63 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.916 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.061 HD13 HD13 ' A' ' 130' ' ' ILE . 7.3 mt -142.19 123.69 14.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 62.34 110.928 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -111.79 115.29 28.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 62.25 110.957 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 54.34 112.48 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.86 0.362 . . . . 44.01 110.881 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.11 -29.9 23.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.128 -0.487 . . . . 55.25 110.903 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.1 mm -87.1 -39.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 71.34 111.099 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -57.78 -34.01 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.33 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.834 HD12 HD11 ' A' ' 91' ' ' LEU . 27.9 pt -86.13 -29.91 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 64.34 111.136 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -49.87 -58.31 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.88 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -24.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.06 -50.05 19.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 34.25 112.452 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.061 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -68.51 -55.6 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 71.43 111.127 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.4 -32.05 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 71.05 110.849 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.94 -40.89 95.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.905 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -72.29 -37.34 69.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.891 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -65.02 -38.89 92.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 73.05 110.926 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.4 ttm -67.9 -25.46 65.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.24 110.86 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.84 -59.4 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 138' ' ' ILE . 9.3 mmtm -73.24 -51.2 18.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.865 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.86 76.15 2.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 71.23 111.137 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.8 33.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.254 . . . . 64.22 112.331 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.83 -36.18 47.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.86 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.13 144.1 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.3 111.13 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.75 -51.45 8.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.35 111.064 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.84 -170.16 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.066 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.0 144.06 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.15 111.168 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 73.51 110.909 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.849 0.271 . . . . 72.41 112.36 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 108' ' ' VAL . 5.2 tt -94.54 106.61 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.23 110.914 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -129.76 175.66 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 63.14 111.123 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -63.7 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.08 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.96 -43.76 10.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 62.1 112.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -71.83 -47.43 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 74.52 110.893 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.015 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.61 -31.13 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 64.12 111.144 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.25 -39.9 92.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.844 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -41.1 95.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 45.23 110.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 134' ' ' LEU . 74.3 t -77.28 -39.57 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 61.2 111.122 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.015 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -69.87 -19.43 63.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.931 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -52.35 -27.08 14.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.853 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -76.85 -43.65 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.35 110.896 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.697 ' CG2' HD23 ' A' ' 91' ' ' LEU . 8.6 p -82.34 -4.51 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 75.43 111.153 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.3 ttp85 -61.26 -58.72 16.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 74.42 110.892 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.78 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 71.44 112.353 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.23 -46.95 6.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 72.45 110.914 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.697 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -73.38 -43.56 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.963 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -65.63 -23.16 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 73.13 111.19 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.68 -51.99 62.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.091 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -63.7 -29.25 70.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.843 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.47 19.21 3.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 74.02 112.467 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.58 -135.91 8.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.708 -0.758 . . . . 75.1 112.497 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -179.37 139.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 73.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.713 HG12 HD23 ' A' ' 112' ' ' LEU . 33.3 m -115.54 133.04 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.34 111.108 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.89 138.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 54.53 111.092 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 77' ' ' ALA . 11.8 tp -79.81 126.71 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 65.22 110.892 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.473 ' N ' HD12 ' A' ' 100' ' ' LEU . 85.1 t60 -88.36 -71.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.871 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -134.58 174.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.4 110.922 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 100' ' ' LEU . 53.5 mt -132.35 110.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.4 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.9 -170.21 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.132 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.55 -89.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 71.14 112.467 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -95.12 21.04 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 52.44 110.886 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.26 150.28 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.1 111.141 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.028 HG21 HD13 ' A' ' 75' ' ' LEU . 92.4 t -114.46 139.83 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.12 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.27 100.87 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.43 110.848 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 100' ' ' LEU . 1.1 mt -105.92 178.17 4.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.922 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -134.01 120.25 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 63.55 110.909 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 130' ' ' ILE . 4.0 mt -138.25 143.15 39.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 64.01 110.945 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -118.99 106.71 12.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 65.42 110.916 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.461 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.894 0.378 . . . . 75.23 110.837 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.86 -31.72 29.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.928 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 HH11 ' A' ' 128' ' ' ARG . 40.8 mm -79.49 -38.07 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.094 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.85 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.14 111.145 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.8 pt -86.09 -26.97 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 73.4 111.116 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -50.68 54.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 72.2 110.902 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.506 HH11 HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -71.0 -24.83 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.23 110.858 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.66 -51.91 18.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 31.43 112.463 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.953 HD13 HD13 ' A' ' 112' ' ' LEU . 2.8 mp -64.06 -56.41 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.728 0.299 . . . . 60.43 111.13 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.49 -33.32 44.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.933 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -63.51 -33.54 75.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 75.22 110.859 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -77.02 -56.57 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.2 110.894 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.95 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -53.8 -47.32 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 53.51 110.914 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 32.7 ttm -55.15 -39.43 69.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 65.23 110.879 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.37 -19.38 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.04 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 -33.13 9.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.13 110.932 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 141' ' ' VAL . 9.9 mm -111.49 78.8 2.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 71.13 111.132 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -8.13 22.82 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.242 . . . . 45.54 112.324 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -33.89 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 74.04 110.895 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.4 p -74.43 155.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.31 111.149 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.41 -45.11 8.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 62.13 111.115 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.12 -169.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.36 160.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 64.31 111.121 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.758 . . . . 74.14 110.887 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.789 0.328 . . . . 64.14 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.56 -110.32 4.0 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 61.34 112.486 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.9 159.31 64.55 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.623 0.725 . . . . 72.43 110.911 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo -69.75 -29.99 23.03 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.696 2.264 . . . . 73.21 112.337 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.718 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.3 122.39 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.973 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 80' ' ' VAL . 17.7 p -132.04 172.07 12.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 63.42 111.13 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.56 -30.21 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 53.1 111.089 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.62 -61.24 2.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 70.01 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 73.12 110.894 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.077 HG22 HD13 ' A' ' 84' ' ' LEU . 8.0 p -54.11 -31.23 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 71.23 111.156 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.88 -24.13 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -74.06 -44.28 54.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.856 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.5 p -77.02 -34.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.24 111.16 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.077 HD13 HG22 ' A' ' 80' ' ' VAL . 3.7 mp -71.61 -20.11 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 75.53 110.898 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.15 -26.6 28.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.836 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -74.03 -42.51 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 65.35 110.918 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' HD23 ' A' ' 91' ' ' LEU . 9.2 p -82.23 -13.87 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 62.03 111.165 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.8 ttt180 -51.45 -58.67 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.583 0.706 . . . . 72.1 110.835 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -8.32 23.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.246 . . . . 62.55 112.353 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -98.47 -19.27 17.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 74.11 110.922 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.25 -40.21 7.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.34 110.905 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 96' ' ' GLY . 44.1 p -69.94 -16.21 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 64.53 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -54.88 24.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 55.32 111.066 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -131.54 40.14 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.02 110.879 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -149.87 -63.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 61.24 112.476 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' THR . . . 152.61 -71.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 74.4 112.464 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.54 168.93 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 60.13 110.896 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.566 ' CG2' HD23 ' A' ' 84' ' ' LEU . 27.8 m -123.02 166.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.17 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.35 141.7 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 60.31 111.093 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.727 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -86.85 115.32 24.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.982 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.13 -73.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.87 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -131.76 169.08 16.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 71.53 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.727 HD11 HD21 ' A' ' 100' ' ' LEU . 12.9 mt -129.34 110.52 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 52.04 111.15 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.47 -173.96 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 72.1 111.117 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.34 -89.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.728 -0.749 . . . . 74.55 112.501 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -95.43 23.73 5.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 74.13 110.891 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.93 150.55 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 60.22 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.67 129.61 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.32 111.126 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 100' ' ' LEU . 9.6 mtp85 -89.46 103.39 16.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.839 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD22 HD21 ' A' ' 84' ' ' LEU . 3.7 mt -116.35 142.84 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.31 110.944 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.35 104.76 16.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 62.23 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 130' ' ' ILE . 9.5 mt -113.54 128.98 56.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 73.34 110.913 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 87.66 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.935 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.3 -72.21 0.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 64.34 112.522 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.92 132.0 41.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 74.34 111.11 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.4 t -73.6 101.54 3.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 73.14 110.893 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.49 -166.21 37.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 51.22 112.502 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -92.45 -28.66 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 73.41 110.869 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.7 t -124.08 72.63 55.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.594 0.711 . . . . 75.34 110.876 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 132.97 24.49 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.263 . . . . 65.45 112.346 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.2 p -110.12 -33.49 6.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 63.14 110.848 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 t -61.72 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.11 110.877 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -51.84 -49.78 62.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 72.31 110.922 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -70.2 -32.57 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 73.44 111.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.4 m -66.87 -39.65 87.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.164 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' HD12 ' A' ' 130' ' ' ILE . 24.5 pt -86.08 -26.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 64.14 111.144 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -51.17 -48.09 61.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.23 110.942 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.56 -25.0 65.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 71.12 110.817 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.95 -60.28 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 54.5 112.462 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 112' ' ' LEU . 3.1 mp -56.2 -53.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 41.22 111.159 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.26 -32.3 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -76.38 -30.5 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -79.09 -33.8 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.856 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.02 -52.68 22.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.925 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -30.11 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.52 110.886 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.6 -27.01 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.01 110.863 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -113.29 -45.65 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 55.12 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.12 75.71 2.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 74.1 111.132 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -11.77 31.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 72.42 112.358 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -51.99 -30.69 26.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 64.13 110.85 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.79 149.26 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.02 111.122 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.34 -36.16 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 61.11 111.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.46 -175.31 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.11 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.31 153.91 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 70.05 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -136.37 160.23 67.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.646 0.736 . . . . 74.13 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 71.13 112.333 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 148' ' ' THR . 14.9 p -95.72 -24.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.142 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.519 HG23 HG13 ' A' ' 147' ' ' VAL . 46.7 p -137.33 -177.48 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.165 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.11 82.18 8.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.88 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -139.93 26.57 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.88 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -104.65 -44.22 4.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 72.52 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.0 t -110.51 73.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 61.23 111.195 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 45.31 112.462 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.8 mtp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.786 0.327 . . . . 74.41 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.28 97.94 0.25 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 71.2 112.505 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -121.83 160.55 46.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.632 0.729 . . . . 71.43 110.879 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo -69.82 -37.62 8.78 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.689 2.259 . . . . 72.33 112.349 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.702 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -133.42 131.13 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 73.34 110.932 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 79' ' ' ASN . 1.8 t -129.31 160.91 31.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.53 111.149 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.89 -27.85 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 45.43 111.133 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.69 -39.13 22.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 60.12 112.48 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.597 ' H ' HG23 ' A' ' 76' ' ' THR . 3.1 m120 -76.43 -46.89 25.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 72.5 110.907 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -50.58 -31.36 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.23 111.105 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -45.06 91.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.54 110.949 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -61.88 -36.21 80.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.44 110.845 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 134' ' ' LEU . 33.6 t -77.28 -39.98 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 45.53 111.14 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 80' ' ' VAL . 4.5 mp -71.08 -19.03 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.912 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -26.84 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.02 110.878 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -75.22 -42.97 54.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 73.1 110.874 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.644 ' CG2' HD23 ' A' ' 91' ' ' LEU . 15.0 p -81.01 -11.8 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.133 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 14.1 ttt180 -54.79 -58.67 13.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.588 0.709 . . . . 73.31 110.881 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.83 -16.06 37.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.226 . . . . 64.31 112.343 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -88.2 -23.91 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.54 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.794 HD11 HD12 ' A' ' 126' ' ' ILE . 1.4 mm? -101.1 -53.23 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.32 110.913 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 88' ' ' ARG . 73.2 p -52.73 -42.44 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.148 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.97 67.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 52.44 111.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -76.24 -38.08 56.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 74.55 110.813 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.0 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 61.11 112.524 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.96 -131.18 1.98 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.21 112.506 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -179.33 -176.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 72.52 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.4 m -131.4 140.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.41 111.118 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.96 137.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.24 111.098 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 109' ' ' ARG . 38.1 tp -78.69 137.01 37.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 72.02 110.896 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -103.14 -45.67 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.12 110.894 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -171.9 168.09 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.906 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.19 119.63 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 72.11 111.104 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.28 88.68 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.072 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.73 -120.75 18.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 42.12 112.469 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -76.09 -18.22 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 75.23 110.915 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.46 151.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 74.41 111.123 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.61 136.58 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.01 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.609 ' O ' HD12 ' A' ' 100' ' ' LEU . 27.2 mtp85 -96.86 101.37 12.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 54.32 110.855 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD22 HD21 ' A' ' 84' ' ' LEU . 7.1 mt -117.67 130.63 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -81.35 105.65 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 60.53 110.912 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.041 HD13 HD13 ' A' ' 130' ' ' ILE . 10.1 mt -125.15 127.48 46.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 65.12 110.883 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -146.27 127.55 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 74.14 110.935 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.21 -22.59 12.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 40.23 112.51 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -178.4 145.49 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 55.52 111.131 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.41 -75.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 42.2 110.912 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.6 -167.63 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.743 -0.741 . . . . 74.14 112.519 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 m -98.02 -26.31 14.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 71.2 110.859 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.8 t -166.11 68.67 1.13 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.714 . . . . 51.54 110.863 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.69 67.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 54.42 112.376 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 t -115.93 -21.92 9.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 64.43 110.833 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.5 m -55.57 -25.96 40.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 53.54 110.872 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 tp -51.68 -35.6 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 74.3 110.949 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.612 HD11 ' O ' ' A' ' 151' ' ' GLU . 45.7 mm -88.75 -31.06 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.158 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -65.18 -34.36 78.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.101 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 91' ' ' LEU . 27.4 pt -84.8 -30.38 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.21 111.152 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -51.47 -49.88 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.14 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.5 -25.14 66.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 71.31 110.868 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.82 -54.0 10.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 44.12 112.503 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.041 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -61.35 -55.02 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 72.05 111.138 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.42 -32.61 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 50.4 110.885 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.08 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.1 110.835 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -61.31 -42.5 98.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 64.25 110.855 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.715 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.24 -31.97 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 42.02 110.944 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 19.1 mtt -67.42 -29.82 69.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.832 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.07 -53.2 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.02 110.907 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -81.89 -45.71 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 75.35 110.901 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.78 76.47 2.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 62.11 111.172 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -15.81 37.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 63.4 112.346 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -52.43 -46.08 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 65.32 110.877 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -52.29 144.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.161 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.85 -35.32 12.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 55.2 111.08 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -171.92 179.66 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 54.14 111.11 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.83 144.39 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.41 111.149 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.17 159.91 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 72.15 110.905 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -170.87 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.704 2.27 . . . . 71.32 112.298 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 148' ' ' THR . 28.0 m -91.26 -32.25 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 54.12 111.12 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.585 HG23 HG23 ' A' ' 147' ' ' VAL . 45.1 p -104.86 22.2 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 64.24 111.146 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 51.9 30.29 7.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.851 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -99.3 97.42 8.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.01 110.876 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.612 ' O ' HD11 ' A' ' 124' ' ' ILE . 12.1 pt-20 -120.88 -46.62 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.33 110.905 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 150.0 23.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 72.34 111.181 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 72.41 112.488 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.3 mtm . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.834 0.349 . . . . 72.42 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.07 -146.28 16.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 63.34 112.514 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -86.43 160.73 50.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 72.34 110.907 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.55 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.8 Cg_endo -69.75 -29.85 23.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 61.42 112.343 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -144.6 136.69 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.898 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.544 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.9 t -140.68 167.35 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.31 111.155 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -28.7 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 75.42 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.54 -45.8 9.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 73.3 112.462 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 76' ' ' THR . 9.2 m-20 -69.71 -48.16 60.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 72.41 110.888 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.0 -31.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 55.3 111.153 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.85 -36.1 78.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 65.22 110.914 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -44.4 87.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.23 110.88 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 134' ' ' LEU . 66.3 t -72.8 -43.63 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 71.4 111.146 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 5.2 mp -71.09 -18.87 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.893 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.93 -26.18 5.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 54.54 110.901 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -74.96 -46.43 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.966 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 130' ' ' ILE . 2.8 m -82.31 -3.5 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.21 111.135 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.5 ttp85 -61.91 -58.77 15.94 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 64.13 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.3 Cg_endo -69.75 -14.68 36.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 51.22 112.352 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 2.7 m-85 -87.03 -55.81 3.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 74.55 110.886 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 126' ' ' ILE . 3.5 mm? -56.3 -55.64 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.44 110.901 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.59 -34.0 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -54.0 -27.25 30.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 74.33 111.124 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.47 -38.03 20.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.13 110.833 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.82 -23.27 1.8 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 71.23 112.472 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.03 -142.05 7.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 43.45 112.44 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -171.94 -176.26 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 51.13 110.885 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.65 HG11 HG23 ' A' ' 87' ' ' VAL . 19.1 m -137.44 138.18 45.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 72.52 111.104 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.88 136.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 54.14 111.128 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 77' ' ' ALA . 12.8 tp -83.05 112.96 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 71.15 110.888 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -77.71 -66.39 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.828 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -138.55 173.35 11.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.92 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 100' ' ' LEU . 58.0 mt -130.25 112.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 63.34 111.133 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.84 -169.57 2.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 34.41 111.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.99 -89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 63.33 112.491 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -95.27 23.12 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 64.05 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 t -146.11 148.62 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.4 111.122 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.87 127.29 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.12 111.11 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 100' ' ' LEU . 21.3 mtt-85 -82.53 100.97 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 72.45 110.901 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 80' ' ' VAL . 7.0 mt -116.43 127.37 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 53.03 110.906 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -86.55 100.17 12.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 71.11 110.911 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.941 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -128.0 129.73 47.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 73.1 110.948 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 91' ' ' LEU . 15.7 tt0 -133.1 141.18 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 70.34 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.24 -161.77 10.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 74.41 112.486 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.56 144.88 47.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 73.54 111.083 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.1 t -59.31 147.13 37.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 53.02 110.895 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -179.85 -98.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.764 -0.731 . . . . 74.05 112.498 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 p -58.03 -58.02 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 71.43 110.887 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.25 160.57 25.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.562 0.696 . . . . 73.23 110.856 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.16 37.65 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.699 2.266 . . . . 75.31 112.314 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 m -130.64 88.03 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 33.31 110.891 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.92 -31.53 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.863 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.9 tp -51.98 -41.12 61.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.935 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.82 -36.72 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.097 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -56.84 -38.01 72.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.02 111.116 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 91' ' ' LEU . 25.2 pt -84.77 -31.21 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.122 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -51.74 -42.05 62.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.948 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -25.06 60.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.891 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.65 -57.28 5.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 71.15 112.474 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.941 HD13 HD22 ' A' ' 112' ' ' LEU . 4.4 mp -62.82 -53.46 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 63.44 111.154 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -52.19 -30.97 29.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.13 110.907 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -73.9 -34.73 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 72.4 110.848 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.5 -35.69 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.14 110.916 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.31 -51.69 28.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 73.45 110.939 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 mtt -51.66 -31.56 26.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.892 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.43 -28.57 30.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.895 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.96 -45.43 3.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.894 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.3 mp -113.31 75.12 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 72.42 111.119 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -8.76 24.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.724 2.283 . . . . 74.13 112.327 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.58 -51.92 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 72.54 110.868 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.42 144.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 73.45 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 -39.6 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.14 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -168.85 -175.99 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.41 111.08 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.65 147.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.43 111.126 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -131.42 160.25 68.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 61.43 110.9 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -170.84 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 64.41 112.353 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.57 -25.74 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 64.11 111.118 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.0 p -85.25 -174.34 5.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.2 111.147 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -53.72 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 72.13 110.89 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -140.26 -175.31 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 53.23 110.867 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.3 160.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 72.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -87.75 153.53 21.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 71.5 111.143 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 51.44 112.49 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 mtp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.782 0.325 . . . . 53.35 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.83 -107.73 2.62 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 74.02 112.52 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.527 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -91.71 160.52 36.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 73.12 110.899 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.7 Cg_endo -69.75 -27.72 26.19 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.662 2.242 . . . . 74.44 112.306 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.745 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.2 tm? -151.0 123.17 8.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.927 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -137.05 -177.36 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 61.05 111.146 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -54.24 -30.19 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 61.51 111.1 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.03 -61.01 2.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 72.52 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -56.77 -46.29 81.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 73.31 110.882 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HA ' HD21 ' A' ' 75' ' ' LEU . 6.8 p -49.96 -31.16 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.51 111.119 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -61.8 -39.83 93.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.908 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -63.92 -39.56 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 63.43 110.839 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -75.78 -42.49 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 70.52 111.136 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 98' ' ' VAL . 3.4 mp -71.35 -18.23 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 75.54 110.925 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.04 -27.58 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 60.11 110.857 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -76.44 -43.56 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.947 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 98' ' ' VAL . 10.4 p -82.46 -4.46 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 64.22 111.153 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.2 ttt-85 -60.62 -58.85 16.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 71.5 110.841 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.78 -7.29 20.7 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.692 2.262 . . . . 63.35 112.34 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -96.29 -64.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.898 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.725 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -53.48 -63.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 52.04 110.94 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 p -50.41 -31.19 14.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 63.44 111.15 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.83 -37.95 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 73.01 111.117 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.85 -36.83 80.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 53.04 110.842 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.12 -15.21 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 63.41 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.73 -128.1 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 55.34 112.535 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -170.79 142.37 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.878 0.37 . . . . 64.52 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.732 HG21 ' CG1' ' A' ' 87' ' ' VAL . 7.2 p -119.68 126.38 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.135 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.71 146.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.3 111.105 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 101' ' ' HIS . 11.1 tp -79.26 129.73 34.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.922 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.546 ' N ' HD12 ' A' ' 100' ' ' LEU . 11.6 t-80 -93.37 -71.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 62.52 110.857 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.05 168.05 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 74.35 110.921 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.4 mt -123.47 109.06 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.31 111.098 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.64 -171.91 3.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 62.21 111.08 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.62 -91.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.51 112.489 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.34 22.75 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 61.31 110.858 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.543 HG11 ' OE1' ' A' ' 145' ' ' GLU . 21.5 t -145.15 150.22 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.31 111.13 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -114.96 127.51 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.144 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -89.08 101.45 14.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.828 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -109.41 152.62 25.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.928 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.434 ' O ' HD23 ' A' ' 112' ' ' LEU . 1.5 tttp -105.61 100.61 10.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.887 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.053 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -131.0 123.84 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 61.22 110.876 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -122.31 139.13 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.52 110.931 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -66.09 2.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 73.33 112.467 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 61.09 33.45 19.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 70.44 111.077 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.7 p -55.23 -30.21 59.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 54.51 110.893 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.57 -72.33 0.42 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 71.31 112.482 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 p -53.46 -71.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 54.34 110.825 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.7 m -144.56 160.63 47.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.635 0.731 . . . . 75.03 110.822 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 123' ' ' LEU . 53.5 Cg_endo -69.75 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 73.03 112.35 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.4 ' C ' HD23 ' A' ' 123' ' ' LEU . 4.7 p -120.6 -32.55 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.35 110.888 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -19.07 64.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 74.13 110.845 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 120' ' ' PRO . 2.6 pt? -51.68 -30.35 21.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.928 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.5 mm -86.82 -32.47 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 74.1 111.122 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -33.1 73.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 64.44 111.127 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.721 ' O ' HD12 ' A' ' 130' ' ' ILE . 41.4 pt -84.82 -26.76 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 65.35 111.126 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -51.0 -44.39 60.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 72.42 110.877 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -24.81 61.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 64.1 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.42 -52.12 28.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 52.33 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.053 HD13 HD13 ' A' ' 112' ' ' LEU . 3.8 mp -66.1 -55.52 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 72.35 111.12 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -52.24 -32.6 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 71.4 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -62.8 -41.34 99.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 61.13 110.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -79.07 -33.73 44.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -70.05 -56.72 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.4 110.889 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.6 tpp -56.56 -23.78 42.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 63.01 110.885 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.96 -45.28 78.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 63.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.627 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.7 mmtp -84.92 -46.41 11.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 54.14 110.907 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.39 76.84 2.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 74.25 111.125 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -9.7 26.74 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 74.3 112.354 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.9 -36.81 50.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.23 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 143' ' ' ALA . 16.3 t -75.37 151.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.14 111.159 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.53 -27.24 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 55.52 111.106 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.634 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.2 169.96 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 44.21 111.095 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.04 154.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.103 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.543 ' OE1' HG11 ' A' ' 107' ' ' VAL . 23.2 mt-10 -132.27 160.22 68.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 73.04 110.887 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -172.41 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.599 2.199 . . . . 54.42 112.382 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 148' ' ' THR . 14.6 p -86.87 -28.87 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 74.23 111.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 147' ' ' VAL . 1.8 p -156.81 177.59 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 64.4 111.146 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.03 87.8 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 64.45 110.859 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -119.67 -33.7 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.21 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -51.99 119.51 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 75.02 110.838 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -99.58 -29.95 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 71.12 111.12 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 53.54 112.467 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.3 mtm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.841 0.353 . . . . 72.15 110.873 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.97 -24.4 2.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 75.3 112.488 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -104.68 160.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.613 0.721 . . . . 73.44 110.915 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.574 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.78 -29.76 23.25 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.693 2.262 . . . . 74.45 112.311 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -141.42 123.68 15.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p -131.77 179.46 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 61.4 111.129 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.62 75.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 41.11 111.097 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.07 -47.82 7.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 53.43 112.471 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -65.68 -48.68 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 75.42 110.87 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.011 HG22 HD13 ' A' ' 84' ' ' LEU . 7.2 p -51.7 -31.03 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.152 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.44 -34.58 77.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.92 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -42.56 95.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 63.03 110.859 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.97 -42.05 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 65.43 111.148 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.011 HD13 HG22 ' A' ' 80' ' ' VAL . 4.9 mp -70.88 -18.76 62.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.23 110.943 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -52.12 -25.96 10.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.21 110.875 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -82.64 -43.55 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.54 110.927 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG22 HD23 ' A' ' 91' ' ' LEU . 8.8 p -82.75 1.36 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.13 111.12 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 92' ' ' THR . 20.6 ttt180 -68.14 -58.89 6.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.558 0.694 . . . . 74.24 110.858 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.0 Cg_endo -69.75 -8.29 23.23 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.664 2.242 . . . . 75.42 112.361 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -98.91 -12.78 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.936 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.854 HD11 HD12 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -101.15 -64.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 73.45 110.926 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 t -60.13 -19.49 53.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.1 111.139 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.25 -32.66 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.109 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.15 -24.67 19.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.874 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.26 -17.09 2.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 34.14 112.5 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 -140.46 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 62.13 112.499 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.5 -172.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 73.22 110.864 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.764 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.2 m -148.65 136.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 64.51 111.14 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.36 122.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.52 111.122 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG11 ' A' ' 80' ' ' VAL . 10.0 tp -76.73 120.94 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 64.03 110.919 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.441 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.4 t60 -93.41 -73.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 65.31 110.871 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -115.94 165.98 12.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.914 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 108' ' ' VAL . 10.7 mt -132.13 104.49 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.182 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.36 -169.5 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 71.32 111.088 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.89 -81.84 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 75.14 112.481 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 4.2 p-10 -91.77 13.53 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 75.53 110.874 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 20.0 t -145.18 151.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 71.45 111.162 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 103' ' ' ILE . 95.7 t -121.43 128.58 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.34 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.0 mpt_? -79.78 100.82 8.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 71.42 110.848 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.82 HD22 HD21 ' A' ' 84' ' ' LEU . 9.1 mt -109.03 127.7 54.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.0 110.926 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -83.48 101.79 11.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.919 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD22 HD13 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -126.58 159.2 34.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 55.22 110.917 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -143.25 133.39 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.919 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.36 19.49 4.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 63.23 112.487 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 110.22 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.815 0.34 . . . . 71.12 111.095 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.3 t -175.93 117.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 42.31 110.883 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.12 -151.2 21.42 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 73.43 112.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 t -94.86 20.21 9.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 73.43 110.852 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.5 p -123.73 73.42 53.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 75.43 110.908 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -12.46 32.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.6 2.2 . . . . 73.34 112.37 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 57.5 p -94.05 40.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.849 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -80.76 -25.97 37.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 65.21 110.838 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD11 ' O ' ' A' ' 150' ' ' LYS . 2.7 pt? -51.95 -30.48 24.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 73.21 110.871 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.02 -30.84 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.41 111.134 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 m -69.37 -34.55 74.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 75.33 111.165 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.854 HD12 HD11 ' A' ' 91' ' ' LEU . 27.8 pt -84.05 -27.8 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 55.0 111.123 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -51.89 -41.72 62.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 74.21 110.903 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -24.67 60.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 53.14 110.853 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.54 -56.04 5.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 55.44 112.461 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 87' ' ' VAL . 4.8 mp -65.03 -50.76 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 74.53 111.116 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.791 ' HB3' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.46 -31.55 23.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.34 110.917 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.41 -44.15 83.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.15 110.874 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -75.54 -36.45 60.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 71.33 110.866 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.439 HD11 ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.81 -29.16 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 71.33 110.914 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.2 ttm -76.97 -36.42 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 70.54 110.892 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -51.98 -47.4 64.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.4 mmtp -90.64 -48.5 7.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 75.1 110.89 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -112.93 76.34 2.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.66 0.743 . . . . 64.41 111.098 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.6 24.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 75.22 112.337 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.18 -27.49 69.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 62.45 110.86 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -88.92 144.59 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.2 111.098 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -80.4 -42.45 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.11 111.084 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.53 -177.43 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.22 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 131' ' ' GLU . 8.5 m -131.42 140.72 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 53.35 111.143 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -128.86 159.72 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 53.15 110.931 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.653 2.235 . . . . 75.42 112.388 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.45 -28.8 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.158 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.2 p -140.4 173.36 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 52.22 111.148 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.76 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.23 110.903 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.489 ' O ' HD11 ' A' ' 123' ' ' LEU . 22.3 mmtp 51.54 30.09 6.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 62.23 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.82 -54.44 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.868 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -109.2 139.17 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.41 111.158 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 63.0 112.492 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.9 mtp . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.856 0.36 . . . . 63.42 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.97 -28.17 1.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 30.1 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -109.11 160.58 26.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 75.21 110.847 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.8 Cg_endo -69.81 -28.69 24.72 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.239 . . . . 72.32 112.361 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.685 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.63 136.85 26.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 75.22 110.918 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 75' ' ' LEU . 13.9 p -144.16 -178.25 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 70.24 111.148 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.629 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -60.97 -35.14 76.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.33 111.115 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.24 -47.33 7.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 72.13 112.485 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -65.71 -48.71 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 74.33 110.846 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.047 HG22 HD13 ' A' ' 84' ' ' LEU . 7.3 p -51.46 -31.15 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.24 111.121 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.05 -35.45 78.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.912 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.8 t -63.08 -42.75 99.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 72.42 110.846 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 134' ' ' LEU . 22.2 t -77.18 -41.74 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 72.41 111.143 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.047 HD13 HG22 ' A' ' 80' ' ' VAL . 2.7 mp -68.54 -19.0 64.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.955 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.77 -25.47 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.52 110.828 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -73.33 -47.71 40.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 63.22 110.909 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.76 HG23 HG11 ' A' ' 98' ' ' VAL . 3.3 m -82.23 -7.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 75.44 111.113 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.4 ttt180 -56.07 -58.82 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 74.23 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -21.18 33.76 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 74.02 112.355 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -81.41 -27.75 34.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 45.12 110.959 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -92.43 -49.5 6.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 64.43 110.933 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -62.5 -21.56 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 61.31 111.107 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -61.09 -53.83 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 65.14 111.067 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.07 -36.15 83.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 75.54 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.88 -30.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 63.25 112.482 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.85 -150.75 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 62.51 112.45 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -175.3 153.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 74.41 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -116.08 135.93 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.31 111.115 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.12 127.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 41.35 111.087 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 77' ' ' ALA . 13.9 tp -71.23 122.83 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.979 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -90.28 -48.29 7.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 54.11 110.871 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -160.6 172.52 17.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.913 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.527 HD11 HD21 ' A' ' 100' ' ' LEU . 12.1 mt -129.33 125.71 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.05 111.103 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.35 102.22 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 55.14 111.089 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.59 -125.09 28.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 52.24 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -77.48 -17.17 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 64.42 110.859 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.96 150.98 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 62.43 111.111 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 103' ' ' ILE . 56.4 t -125.2 137.36 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 73.44 111.097 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.1 mtt180 -93.88 101.82 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 62.53 110.834 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.735 HD22 HD21 ' A' ' 84' ' ' LEU . 3.6 mt -111.65 123.92 51.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 44.34 110.928 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 105.62 11.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 62.51 110.937 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -130.88 127.37 38.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 63.11 110.918 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 91' ' ' LEU . 30.5 tt0 -121.26 144.48 48.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.23 110.895 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.53 -146.83 18.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 73.23 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.94 150.83 47.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 74.21 111.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.04 136.54 48.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 74.4 110.876 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.47 -169.96 41.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 73.4 112.517 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.44 -25.37 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 33.24 110.845 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.8 p -119.53 73.59 16.07 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.589 0.709 . . . . 74.34 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.576 ' O ' HD23 ' A' ' 123' ' ' LEU . 53.5 Cg_endo -69.84 104.87 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.662 2.242 . . . . 70.35 112.339 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -108.92 -23.13 11.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 50.44 110.817 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.0 -24.39 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 55.25 110.846 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 120' ' ' PRO . 1.7 pp -51.85 -30.21 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 71.32 110.885 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.85 -35.44 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.148 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -33.74 76.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.12 111.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.5 pt -81.92 -29.52 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.52 111.154 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.33 -45.57 62.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.893 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -24.91 63.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.885 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.24 -58.97 5.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 71.14 112.507 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -59.94 -54.93 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 73.44 111.129 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -51.9 -31.41 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 73.43 110.902 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -72.78 -35.69 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 65.41 110.869 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -76.08 -40.17 53.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.834 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.71 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.11 -30.26 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.963 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 22.6 mtt -69.67 -24.2 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 62.24 110.908 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -67.3 -48.51 67.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 138' ' ' ILE . 10.6 mmtt -84.03 -49.04 9.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 62.33 110.864 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.712 ' O ' HG12 ' A' ' 141' ' ' VAL . 5.4 mp -113.18 75.28 2.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 54.01 111.137 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -8.78 24.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.7 2.266 . . . . 44.4 112.346 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.12 -28.45 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.45 110.914 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -69.88 144.6 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 64.42 111.153 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 -39.65 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.24 111.09 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.7 171.83 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.2 111.084 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.79 151.94 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 60.33 111.125 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -132.32 160.08 69.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.7 0.762 . . . . 64.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 174.51 9.41 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.717 2.278 . . . . 72.02 112.301 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.48 -24.36 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 72.41 111.144 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.8 p -98.52 -172.04 2.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 74.12 111.132 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.97 -67.78 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.53 110.832 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -136.54 -170.86 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.52 110.935 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -52.19 -32.72 37.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 71.22 110.88 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.0 t -113.03 26.67 10.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 54.41 111.166 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.743 . . . . 73.2 112.471 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.811 0.338 . . . . 53.21 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.04 -28.52 8.34 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 64.53 112.537 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.579 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -95.02 160.74 30.28 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 74.34 110.915 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.8 Cg_endo -69.75 -45.73 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.726 2.284 . . . . 71.52 112.344 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.52 HD21 ' CA ' ' A' ' 80' ' ' VAL . 3.0 tm? -93.45 130.82 39.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.872 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.457 ' N ' HD22 ' A' ' 75' ' ' LEU . 11.8 p -128.65 172.79 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 73.24 111.189 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -62.81 -27.01 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 52.21 111.079 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.78 -49.29 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 64.42 112.465 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -44.5 65.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 64.24 110.897 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.43 -31.43 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 75.04 111.119 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.93 -35.21 76.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.34 110.872 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -44.22 97.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 64.54 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 134' ' ' LEU . 25.3 t -77.21 -41.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.04 111.122 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -68.03 -19.4 64.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.912 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.21 -26.7 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 64.1 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -76.39 -44.0 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.903 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.727 ' CG2' HD23 ' A' ' 91' ' ' LEU . 10.8 p -81.5 -6.82 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.41 111.139 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.7 ttm180 -60.53 -58.8 16.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 63.53 110.885 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.79 -8.39 23.48 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.72 2.28 . . . . 73.2 112.354 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 3.8 t80 -94.63 -63.3 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.917 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -53.64 -49.05 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.891 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 88' ' ' ARG . 64.1 p -60.56 -28.53 68.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 65.43 111.137 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -56.88 -53.79 53.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 54.14 111.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.16 -24.96 65.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.0 6.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 75.22 112.455 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.09 -153.79 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 61.11 112.506 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -174.77 127.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 61.41 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.574 HG11 HG13 ' A' ' 87' ' ' VAL . 22.6 m -100.98 134.77 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 72.01 111.092 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.37 117.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.12 111.094 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD21 HD11 ' A' ' 103' ' ' ILE . 12.3 tp -63.03 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.32 110.946 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' N ' HD12 ' A' ' 100' ' ' LEU . 25.4 t60 -93.69 -74.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.54 110.853 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.36 171.36 9.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 61.22 110.915 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.577 ' CG2' HD22 ' A' ' 73' ' ' LEU . 37.0 mt -135.23 108.19 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 70.12 111.099 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.39 -172.05 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 65.1 111.119 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.39 -87.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 62.13 112.486 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.31 20.64 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 71.21 110.902 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.09 150.83 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.55 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.15 139.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.42 111.102 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mtp85 -99.4 101.05 12.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.876 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.5 mt -108.6 154.66 21.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.11 110.939 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.713 ' HG3' HG21 ' A' ' 147' ' ' VAL . 8.3 tttp -115.05 119.04 35.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.919 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -143.13 134.71 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 60.32 110.921 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.1 130.02 54.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.915 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.0 90.94 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.777 -0.725 . . . . 71.54 112.477 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.11 -59.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 71.41 111.118 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.0 m -66.9 118.84 10.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 63.23 110.873 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.21 -144.37 11.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.672 -0.775 . . . . 75.41 112.426 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -73.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 64.31 110.845 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.85 160.64 25.61 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 121.639 0.733 . . . . 72.01 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -17.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 71.4 112.355 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p -113.19 60.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.851 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.82 -19.23 60.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.52 110.841 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 pp -51.32 -30.67 19.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 64.15 110.929 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.72 -30.89 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -72.62 -34.64 67.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.42 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.74 HD12 HD11 ' A' ' 91' ' ' LEU . 26.7 pt -86.1 -30.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 63.03 111.145 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -50.85 -47.41 60.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.905 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -68.47 -24.77 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.33 110.869 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.78 -56.89 5.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 32.21 112.431 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.877 HD13 HD22 ' A' ' 112' ' ' LEU . 3.8 mp -62.9 -53.24 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 74.24 111.169 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -53.21 -31.78 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.12 110.891 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -68.43 -32.44 72.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.15 110.886 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -79.09 -46.0 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.852 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -61.52 -51.99 66.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 73.13 110.845 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 18.6 tpp -53.69 -39.4 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.88 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.1 -23.36 54.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.01 110.872 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -100.53 -37.88 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 62.33 110.867 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.83 80.23 2.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 71.12 111.124 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.7 2.267 . . . . 74.24 112.309 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.49 -26.79 62.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 143' ' ' ALA . 34.8 t -83.19 149.38 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.13 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.53 -30.08 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 63.23 111.148 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.46 -173.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.12 111.123 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.25 164.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 55.15 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -144.69 160.13 48.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.685 0.755 . . . . 73.41 110.853 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.83 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.249 . . . . 72.13 112.334 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.767 HG23 HG23 ' A' ' 148' ' ' THR . 12.8 m -104.15 -28.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.13 111.181 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.767 HG23 HG23 ' A' ' 147' ' ' VAL . 20.5 p -117.01 -26.16 6.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 73.11 111.138 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.32 48.26 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 61.54 110.88 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -127.98 76.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.911 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.4 148.51 51.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 70.03 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.3 p -115.99 152.23 33.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.138 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 44.43 112.504 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.84 0.353 . . . . 42.1 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.61 143.82 4.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 72.21 112.476 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt 61.04 159.55 0.11 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.6 0.714 . . . . 62.01 110.941 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -30.65 21.76 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 65.5 112.354 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.658 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -142.67 135.84 28.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 74.31 110.935 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.4 p -145.07 172.43 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 71.21 111.126 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.33 -30.37 18.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.14 111.131 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.3 -62.3 2.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 53.42 112.471 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -55.38 -47.83 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 73.24 110.863 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 8.1 p -50.64 -31.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.14 111.163 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.26 -37.55 83.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.866 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -42.7 99.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.5 t -77.1 -39.87 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 71.53 111.102 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 2.3 mp -70.63 -18.69 62.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 74.31 110.909 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.15 -25.88 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.888 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.03 -47.59 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.916 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 130' ' ' ILE . 3.6 m -82.64 -3.49 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.44 111.131 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.0 ttt180 -60.78 -58.74 17.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 73.32 110.872 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.2 Cg_endo -69.78 -10.92 29.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.65 2.234 . . . . 74.31 112.366 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.15 -32.55 14.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.943 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -85.94 -59.68 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 61.41 110.958 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' OD1' ' A' ' 97' ' ' ASP . 37.5 p -51.74 -39.39 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.31 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 51.4 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.69 -37.96 67.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 71.32 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.85 -38.57 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 63.04 112.525 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -73.76 -135.89 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 32.1 112.519 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' A' ' 92' ' ' THR . 10.0 t0 -174.9 175.99 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 61.33 110.825 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 112' ' ' LEU . 19.0 m -138.28 138.59 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 71.14 111.155 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.32 131.51 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 41.22 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.576 HD12 HG11 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -78.01 118.55 20.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.918 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -97.64 -64.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.865 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.43 165.08 16.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.34 110.882 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 108' ' ' VAL . 69.8 mt -138.5 113.36 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 72.13 111.137 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -90.56 -169.34 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.52 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.37 -90.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 65.41 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -85.98 4.94 35.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 75.52 110.867 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 19.6 t -133.39 151.19 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 53.03 111.145 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 103' ' ' ILE . 96.1 t -123.71 140.37 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 34.5 111.114 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 100.97 13.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 65.22 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.12 123.17 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 71.14 110.939 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.666 ' HG3' HG21 ' A' ' 147' ' ' VAL . 8.9 ttpt -73.23 86.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 34.11 110.891 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -117.99 129.64 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.916 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -131.05 141.39 50.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 73.23 110.9 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.69 173.32 14.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.24 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.01 154.89 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 74.31 111.115 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 10.3 m -130.96 147.66 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.03 110.899 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 136.25 -97.85 0.28 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 62.45 112.489 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -79.58 -26.79 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 63.14 110.848 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.6 p -131.43 70.78 81.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.618 0.723 . . . . 75.1 110.89 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -174.5 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.661 2.241 . . . . 72.05 112.303 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.7 p 56.49 28.43 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 72.04 110.848 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -69.38 -28.14 65.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.861 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -54.34 -29.83 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.42 110.884 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.4 mm -85.11 -31.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 54.44 111.169 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.8 m -68.15 -34.36 76.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.124 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.717 ' CD1' HD11 ' A' ' 91' ' ' LEU . 24.5 pt -86.03 -30.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.13 111.135 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -52.64 -47.1 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 71.05 110.891 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -69.11 -24.88 64.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.885 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.25 -57.59 6.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.681 -0.771 . . . . 74.44 112.475 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -60.74 -55.31 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.34 . . . . 51.31 111.114 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HB3' HG22 ' A' ' 144' ' ' VAL . 22.5 pt-20 -51.68 -31.81 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 70.04 110.898 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -71.3 -36.77 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 64.21 110.908 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -79.03 -36.38 41.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.807 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.23 -33.54 71.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.44 110.925 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 3.2 mtm -63.91 -27.72 69.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.872 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.68 -58.55 8.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.881 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.719 ' HB2' HD12 ' A' ' 138' ' ' ILE . 4.3 mttm -77.62 -47.41 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.881 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.56 74.33 2.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.64 0.734 . . . . 73.21 111.114 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -14.31 35.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.623 2.215 . . . . 54.3 112.372 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -38.46 55.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.876 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.04 144.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 53.03 111.102 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.33 -53.66 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.128 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.13 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 71.31 111.1 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 131' ' ' GLU . 15.9 m -138.63 148.51 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 63.33 111.094 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.04 159.71 60.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.651 0.739 . . . . 64.33 110.867 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -177.51 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.667 2.245 . . . . 72.22 112.339 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.666 HG21 ' HG3' ' A' ' 111' ' ' LYS . 31.0 m -101.22 25.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 51.32 111.087 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.3 t -155.42 -179.91 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 73.24 111.108 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.46 159.52 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.23 110.836 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -55.2 175.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.04 110.922 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.91 -72.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.891 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.8 p -103.25 133.15 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.4 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.698 -0.763 . . . . 61.51 112.47 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ttm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.82 0.343 . . . . 71.43 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.31 -156.18 18.49 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 61.04 112.502 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.529 HD22 HG21 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -136.42 160.47 66.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 72.21 110.877 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.609 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.8 -47.84 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.712 2.275 . . . . 74.55 112.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 108' ' ' VAL . 5.1 tt -89.48 106.97 18.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.929 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 79' ' ' ASN . 6.6 t -135.58 166.04 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 74.14 111.144 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -27.39 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 74.54 111.086 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.16 -59.04 3.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 33.23 112.478 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.507 ' H ' HG23 ' A' ' 76' ' ' THR . 79.0 m-20 -62.23 -48.02 81.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 74.22 110.909 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.023 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.6 -30.99 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 61.03 111.143 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -61.79 -38.15 87.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 72.35 110.887 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -67.38 -37.85 83.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 52.15 110.868 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 134' ' ' LEU . 59.4 t -77.04 -39.41 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 73.32 111.147 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 80' ' ' VAL . 4.2 mp -71.1 -19.16 62.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.34 110.912 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.84 -26.89 10.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.87 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -76.35 -43.42 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.3 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG2' HD23 ' A' ' 91' ' ' LEU . 11.9 p -81.4 -7.35 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 73.32 111.086 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.7 ttm-85 -60.18 -58.79 16.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.603 0.716 . . . . 71.43 110.877 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.1 Cg_endo -69.83 -8.49 23.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.669 2.246 . . . . 74.44 112.32 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 5.5 t80 -94.55 -63.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.13 110.94 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -53.09 -54.77 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 62.33 110.891 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -51.48 -34.77 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.33 111.154 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -59.65 -37.18 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 54.25 111.06 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.89 -31.7 63.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.842 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.7 17.1 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 62.23 112.504 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.38 -135.96 8.84 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 53.41 112.477 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -179.16 136.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 74.04 110.851 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.8 m -110.13 129.45 65.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.33 111.141 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -167.8 129.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 42.2 111.098 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HA ' HD23 ' A' ' 110' ' ' LEU . 11.5 tp -71.78 119.65 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.32 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -76.96 -72.28 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.877 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.75 171.1 14.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.31 110.85 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.529 HG21 HD22 ' A' ' 73' ' ' LEU . 58.1 mt -125.91 121.35 59.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 54.33 111.101 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.24 -170.51 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 50.32 111.074 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.01 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 54.44 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -98.14 23.41 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 64.13 110.908 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.42 111.171 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.049 HG21 HD13 ' A' ' 75' ' ' LEU . 60.6 t -116.18 138.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.21 111.174 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 100' ' ' LEU . 24.1 mtp180 -101.02 101.05 11.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.872 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.1 mt -107.91 164.62 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 54.34 110.887 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.472 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -126.72 115.81 19.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 63.23 110.905 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -138.71 137.9 37.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.894 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.38 113.13 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.898 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.29 -48.62 0.64 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.77 128.56 37.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.32 . . . . 60.32 111.101 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.0 t -100.24 -50.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 52.03 110.873 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.43 -85.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 71.12 112.501 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.2 p -75.67 -28.51 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 61.13 110.879 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.18 160.65 3.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 72.31 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 64.25 112.358 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 p -71.88 80.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 54.41 110.828 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -26.11 58.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 44.21 110.907 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.67 -47.67 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.57 -31.2 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.13 111.122 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -61.66 -39.92 93.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.43 111.14 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 130' ' ' ILE . 30.1 pt -86.17 -29.99 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.12 111.135 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -50.75 -47.67 59.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 72.25 110.882 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.76 -24.71 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 60.15 110.839 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.15 -55.76 6.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.771 -0.728 . . . . 33.45 112.458 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 112' ' ' LEU . 4.0 mp -62.87 -54.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 73.21 111.134 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -52.88 -32.6 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 55.4 110.904 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.67 -32.74 74.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.868 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -78.88 -56.42 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.861 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.995 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -52.0 -35.65 47.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 51.2 110.893 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.1 mtt -62.78 -40.35 97.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 55.35 110.897 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.31 -20.07 57.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.14 110.913 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HZ2' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.67 -33.81 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 63.13 110.902 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.767 ' O ' HG12 ' A' ' 141' ' ' VAL . 11.5 mm -112.34 76.89 2.05 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 44.22 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -7.6 21.48 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.44 112.378 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.94 -29.53 35.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 63.32 110.879 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 138' ' ' ILE . 9.8 p -72.28 158.47 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.01 111.108 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -99.37 -47.29 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.147 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.24 -173.8 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 61.43 111.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.75 164.85 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 75.35 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -147.96 160.38 37.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 72.31 110.96 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -171.01 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.744 2.296 . . . . 71.15 112.312 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 111' ' ' LYS . 9.3 p -108.54 -25.02 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.44 111.127 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 147' ' ' VAL . 22.6 p -119.59 24.89 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 72.51 111.141 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 55.18 35.6 25.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 63.13 110.836 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -98.43 68.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.44 110.853 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.26 -25.79 14.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 73.34 110.88 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 p 49.87 42.65 24.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.34 111.131 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 71.21 112.486 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.8 0.334 . . . . 73.33 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.32 -146.77 5.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.782 -0.723 . . . . 51.32 112.517 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt 61.04 159.68 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.596 0.712 . . . . 64.33 110.943 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.71 -29.28 24.35 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.678 2.252 . . . . 71.43 112.346 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.3 tm? -145.68 140.11 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 64.04 110.943 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.0 t -142.74 167.72 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 71.24 111.144 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.32 -28.35 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.34 111.07 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.88 -42.5 12.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.736 . . . . 60.0 112.472 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 76' ' ' THR . 1.9 m120 -72.65 -47.18 49.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.366 . . . . 63.54 110.91 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.831 HG22 HD13 ' A' ' 84' ' ' LEU . 9.5 p -50.78 -30.8 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 62.41 111.136 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.94 -37.08 83.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.912 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.71 -39.57 73.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.86 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.8 t -72.46 -44.74 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 61.53 111.097 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.831 HD13 HG22 ' A' ' 80' ' ' VAL . 6.5 mp -71.21 -18.97 62.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.93 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.8 -26.12 5.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.862 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -75.06 -45.46 41.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.892 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 130' ' ' ILE . 2.6 m -81.62 -7.06 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.03 111.157 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 17.7 ttt-85 -58.56 -58.8 16.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 71.32 110.885 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.7 -8.85 24.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.278 . . . . 72.1 112.353 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.1 -25.47 15.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 71.43 110.913 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.772 HD11 HD13 ' A' ' 126' ' ' ILE . 2.3 mm? -93.7 -57.32 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.34 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -53.11 -36.33 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 53.44 111.155 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.59 -28.74 70.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 111.088 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -76.81 -38.05 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 72.5 110.87 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.41 -39.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 73.4 112.495 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.48 -137.77 1.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 71.13 112.464 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -174.77 -175.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 74.52 110.825 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -137.94 138.96 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 71.35 111.121 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.42 123.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.23 111.13 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 109' ' ' ARG . 21.2 tp -66.12 133.59 51.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.967 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.408 ' N ' HD12 ' A' ' 100' ' ' LEU . 2.1 t60 -100.18 -63.53 1.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 62.32 110.823 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -144.75 163.87 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.894 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.406 HD11 HD21 ' A' ' 100' ' ' LEU . 54.8 mt -123.11 114.5 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.23 111.16 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.43 -172.32 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 62.1 111.147 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.63 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.714 -0.755 . . . . 74.14 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.99 25.06 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 55.12 110.9 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -144.69 151.01 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.34 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.42 128.96 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.33 111.127 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.7 mtt-85 -90.16 103.33 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.904 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.8 HD22 HD21 ' A' ' 84' ' ' LEU . 1.6 mt -112.82 133.67 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 60.15 110.896 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG3' HG11 ' A' ' 147' ' ' VAL . 61.8 tttt -86.07 91.76 8.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.895 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -119.44 131.33 55.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.51 110.877 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.512 ' O ' HD12 ' A' ' 91' ' ' LEU . 40.6 tt0 -127.84 127.01 42.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 62.04 110.895 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -83.46 -61.76 1.86 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 75.12 112.468 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.36 139.77 18.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 60.31 111.116 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.5 t -72.62 139.59 47.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 73.11 110.879 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.68 168.97 32.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.22 112.472 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -67.11 -26.72 66.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 54.02 110.847 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.3 t -115.17 73.31 3.45 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.64 0.733 . . . . 72.41 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.652 2.235 . . . . 64.52 112.352 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.5 p -115.98 -26.5 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.845 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.52 -28.84 33.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.499 . . . . 72.15 110.826 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -52.38 -30.12 27.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 62.15 110.935 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.97 -36.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.51 111.107 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -60.04 -34.02 72.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 72.12 111.137 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.772 HD13 HD11 ' A' ' 91' ' ' LEU . 49.9 pt -86.14 -26.83 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.106 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -51.07 -48.6 61.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.32 110.873 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -66.35 -24.7 66.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 65.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.13 -57.23 6.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.763 -0.732 . . . . 62.12 112.471 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.08 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -63.09 -54.54 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 75.5 111.132 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -31.74 25.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 55.02 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -69.27 -44.35 72.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.24 110.86 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -69.75 -39.98 76.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.852 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -70.21 -47.74 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 64.53 110.935 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.7 mmt -55.11 -26.49 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 63.31 110.89 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.4 -62.68 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.863 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.69 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.4 mttt -71.84 -47.27 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.885 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.24 75.06 2.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 54.11 111.103 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -11.06 30.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.65 2.233 . . . . 75.15 112.368 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -51.92 -43.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 54.32 110.878 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.99 148.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.118 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.42 -33.0 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 71.31 111.113 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -175.56 177.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.09 147.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 32.03 111.137 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -131.92 159.84 70.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.737 . . . . 62.5 110.868 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.83 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.701 2.267 . . . . 75.22 112.359 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.73 HG23 ' H ' ' A' ' 149' ' ' ASP . 19.5 m -65.61 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 53.11 111.141 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.43 -32.7 27.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 50.23 111.112 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.73 ' H ' HG23 ' A' ' 147' ' ' VAL . 1.6 m-20 -64.86 -173.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.799 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -115.73 -177.52 3.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 74.02 110.945 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -52.15 -32.69 36.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 74.34 110.845 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.7 p -112.18 100.37 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.15 111.168 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 70.41 112.486 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.869 0.366 . . . . 73.43 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.31 -27.13 1.99 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.721 . . . . 41.42 112.507 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -108.59 160.67 26.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.621 0.724 . . . . 74.52 110.878 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.557 ' HD2' HD23 ' A' ' 73' ' ' LEU . 54.0 Cg_endo -69.8 -30.29 22.33 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.63 2.22 . . . . 64.51 112.363 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 80' ' ' VAL . 3.3 tm? -144.95 120.14 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 62.11 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -134.51 -176.69 4.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 61.44 111.142 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.57 70.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 55.13 111.081 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.5 -52.28 4.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 71.44 112.474 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -61.22 -48.45 81.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 73.34 110.879 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 84' ' ' LEU . 5.8 p -51.79 -30.77 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 54.05 111.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.34 -33.58 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 72.41 110.947 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 t -63.93 -43.93 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 72.23 110.87 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 134' ' ' LEU . 48.4 t -76.5 -40.77 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.123 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 80' ' ' VAL . 3.1 mp -71.11 -18.97 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -51.26 -26.85 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 65.31 110.875 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -74.48 -42.23 59.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.51 110.921 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.848 HG11 HG13 ' A' ' 130' ' ' ILE . 33.7 m -81.96 -12.88 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.164 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.5 ttt85 -53.04 -58.59 11.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.587 0.708 . . . . 73.22 110.891 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.8 Cg_endo -69.77 -32.13 19.14 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 73.5 112.323 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -65.92 -57.7 7.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.955 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.8 mm? -58.05 -54.81 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 71.3 110.94 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.643 HG22 ' OD1' ' A' ' 97' ' ' ASP . 40.1 p -51.6 -30.57 21.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 54.55 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.96 -36.74 78.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 61.12 111.126 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.18 -38.03 61.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 63.54 110.89 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.76 -26.62 2.37 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 63.22 112.461 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.73 -136.84 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 64.42 112.492 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.643 ' OD1' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -179.39 -175.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 63.03 110.881 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.5 m -141.79 143.95 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.52 111.183 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.78 131.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.35 111.124 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HA ' HD13 ' A' ' 110' ' ' LEU . 25.0 tp -53.69 114.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 70.33 110.876 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.568 ' CG ' HG11 ' A' ' 147' ' ' VAL . 11.1 t60 -80.78 -49.98 10.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.835 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -168.41 167.9 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.42 110.889 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 100' ' ' LEU . 69.7 mt -127.97 105.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 74.14 111.141 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.32 -178.08 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.092 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.16 -75.88 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.747 . . . . 71.05 112.528 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -0.14 21.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 62.14 110.935 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 16.3 t -119.62 152.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.14 111.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 141' ' ' VAL . 19.6 t -113.78 142.85 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 52.44 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -115.13 100.42 8.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.899 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.2 mm? -100.69 146.29 27.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.895 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HG3' HG21 ' A' ' 147' ' ' VAL . 11.7 tttt -102.29 124.05 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.892 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.956 HD13 HD13 ' A' ' 130' ' ' ILE . 6.4 mt -140.4 156.97 46.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 70.2 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -132.78 114.72 14.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 72.3 110.925 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.97 -51.39 0.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 60.44 112.507 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.06 103.07 14.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.761 0.315 . . . . 74.15 111.131 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -75.95 -28.62 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.865 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 172.66 -90.07 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.31 112.487 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -63.67 -32.96 74.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.348 . . . . 73.23 110.839 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.61 160.68 2.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 73.1 110.841 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.694 2.262 . . . . 62.35 112.386 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -80.19 59.12 3.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 73.41 110.905 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -71.32 -26.16 62.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 74.43 110.846 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.97 -32.86 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.892 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.52 -31.02 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 65.42 111.12 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -40.65 97.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.161 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.6 pt -84.01 -30.91 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 65.44 111.066 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -52.0 -41.66 62.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.951 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -24.81 60.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 70.1 110.871 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.17 -54.81 7.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 53.33 112.549 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.956 HD13 HD13 ' A' ' 112' ' ' LEU . 3.3 mp -58.46 -50.92 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 72.24 111.106 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 144' ' ' VAL . 12.5 pt-20 -58.84 -34.73 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -76.68 -30.33 56.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -79.21 -34.32 43.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.858 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.686 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -57.08 5.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.972 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.4 ttm -50.89 -30.73 15.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 71.34 110.905 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -60.38 -37.56 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.948 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.724 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.0 mttm -91.7 -45.37 8.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 71.34 110.886 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.0 mp -113.41 73.74 2.0 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 74.23 111.117 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.87 36.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 74.22 112.347 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.71 -47.55 82.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 51.02 110.861 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.9 p -55.84 131.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.05 111.129 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.31 63.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 55.03 111.078 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.48 178.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 65.44 111.113 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 131' ' ' GLU . 2.1 p -139.85 134.47 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 72.32 111.129 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -121.38 160.06 47.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 64.14 110.92 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.67 0.34 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.665 2.243 . . . . 63.32 112.336 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 110' ' ' LEU . 20.0 m -112.8 25.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 64.33 111.141 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.1 t -161.51 164.28 29.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 72.21 111.117 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -59.69 176.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 74.11 110.899 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -63.46 -174.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 75.34 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -53.55 -29.4 36.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 75.12 110.912 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 29.5 p -127.92 -40.62 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 63.41 111.127 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 35.12 112.493 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 mtm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.829 0.347 . . . . 42.02 110.892 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.51 -157.21 53.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.776 -0.726 . . . . 71.21 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.0 mt 60.96 159.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.25 110.936 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.71 -30.78 21.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 54.53 112.367 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.606 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.61 134.49 25.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.485 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.9 p -145.34 173.02 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.22 -30.52 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 51.12 111.094 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.08 -62.28 2.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 73.52 112.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -47.93 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 71.43 110.907 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 8.2 p -50.77 -30.88 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 55.15 111.112 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -61.63 -38.07 86.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.935 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -64.62 -40.39 95.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.4 110.846 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -76.49 -39.04 32.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 65.23 111.144 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 3.2 mp -71.06 -19.4 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 61.51 110.894 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.3 -26.83 20.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 75.03 110.857 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -75.32 -43.45 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.93 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.648 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.2 p -81.45 -9.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 45.11 111.09 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.8 ttt180 -56.67 -58.71 15.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 65.43 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -12.57 33.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.694 2.263 . . . . 73.01 112.302 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -92.14 -25.99 18.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 70.23 110.905 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 126' ' ' ILE . 1.6 mm? -101.0 -57.38 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.34 110.956 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 88' ' ' ARG . 29.9 p -52.33 -35.92 52.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.167 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.81 72.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 31.11 111.113 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.08 -37.98 69.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.15 110.89 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.45 -35.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.762 -0.732 . . . . 72.34 112.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -141.13 1.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.771 . . . . 75.15 112.47 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -170.19 -176.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 62.41 110.821 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 112' ' ' LEU . 18.8 m -141.93 138.43 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 53.11 111.104 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.74 137.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 52.24 111.083 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HA ' HD23 ' A' ' 110' ' ' LEU . 35.3 tp -76.28 135.53 39.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 60.43 110.951 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -103.5 -63.95 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 65.54 110.862 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.15 162.49 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.882 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 100' ' ' LEU . 58.2 mt -126.98 117.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 53.24 111.143 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -98.64 -169.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.41 111.125 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.94 -88.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 70.25 112.507 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 142' ' ' ALA . 9.6 p30 -102.55 13.45 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 62.13 110.877 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.54 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.9 t -131.33 139.03 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 74.35 111.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.63 134.81 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 65.41 111.072 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.95 101.09 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.3 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.6 mt -112.29 149.19 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 72.45 110.898 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -101.3 119.07 38.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.932 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 130' ' ' ILE . 7.6 mt -139.49 127.76 22.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.948 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 115' ' ' ALA . 31.0 tp60 -104.92 137.11 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 73.44 110.895 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.22 -36.22 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 72.01 112.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB3' HE22 ' A' ' 113' ' ' GLN . . . -57.11 144.35 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.805 0.336 . . . . 70.25 111.079 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.5 p -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.65 -40.66 0.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 73.34 112.432 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 t -94.71 20.15 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 65.33 110.881 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.7 t 54.37 68.53 2.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 72.01 110.888 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -15.78 37.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.642 2.228 . . . . 73.34 112.364 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.22 30.96 15.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 63.34 110.895 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -80.23 -24.98 39.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.812 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -31.08 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 74.42 110.936 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mm -88.07 -30.98 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 65.15 111.167 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 m -72.22 -33.3 67.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.33 111.163 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.779 HD12 HD11 ' A' ' 91' ' ' LEU . 25.4 pt -83.65 -30.91 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.164 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -51.8 -51.58 55.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.32 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.9 -24.93 66.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 64.04 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.6 -61.78 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -55.9 -54.73 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 63.22 111.147 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -52.53 -32.45 40.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 65.21 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -75.44 -32.43 60.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -76.34 -35.63 58.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.35 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.1 -48.12 58.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.23 110.914 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.96 -33.24 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 65.45 110.888 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.61 -55.25 23.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.9 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.637 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.4 OUTLIER -80.06 -45.83 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.899 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.642 HD13 ' CD2' ' A' ' 134' ' ' LEU . 5.2 mp -113.09 74.96 1.95 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.667 0.746 . . . . 73.42 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.86 33.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 61.13 112.333 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.76 -52.8 46.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 61.31 110.863 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.44 151.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.41 111.109 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' OD1' ' A' ' 106' ' ' ASN . . . -87.49 -45.75 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.37 -169.44 2.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.24 111.095 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.72 148.54 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 62.34 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.54 ' CG ' HG11 ' A' ' 107' ' ' VAL . 14.7 mm-40 -120.49 95.67 49.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 64.35 110.896 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 145' ' ' GLU . 53.2 Cg_endo -69.85 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 75.54 112.322 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.15 46.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 60.32 111.149 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.6 t -159.03 129.17 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 70.51 111.138 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.86 -46.25 4.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 63.41 110.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -79.11 176.59 9.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 60.44 110.916 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -102.09 -54.16 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 75.22 110.909 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.0 t -132.92 152.21 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 61.41 111.157 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 64.34 112.496 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.824 0.345 . . . . 74.31 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.8 -92.03 1.02 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 73.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.529 HD12 HG22 ' A' ' 76' ' ' THR . 2.3 mt -103.33 155.04 37.27 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.572 0.701 . . . . 71.13 110.923 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -23.13 31.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.706 2.271 . . . . 71.43 112.332 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.729 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.3 tm? -152.19 128.02 10.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 62.51 110.943 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 HD12 ' A' ' 73' ' ' LEU . 18.1 p -143.22 -178.15 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.42 111.167 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 54.13 111.089 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.4 -64.08 1.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 70.41 112.455 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.54 -46.73 73.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 74.12 110.846 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.989 HG22 HD13 ' A' ' 84' ' ' LEU . 5.9 p -51.24 -30.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 72.24 111.124 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.32 -35.62 77.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 71.23 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -42.3 73.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.52 110.881 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.769 HG11 ' HA ' ' A' ' 134' ' ' LEU . 29.4 t -71.47 -44.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 74.35 111.087 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 80' ' ' VAL . 5.7 mp -71.13 -19.43 62.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 60.22 110.904 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.19 -26.95 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.866 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -74.51 -41.38 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.895 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.649 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.8 p -83.02 -12.58 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 63.52 111.106 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 18.9 ttt180 -53.17 -58.75 11.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.709 . . . . 74.11 110.904 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -19.51 36.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 72.54 112.347 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -83.8 -24.13 31.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 62.02 110.898 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.4 mm? -101.04 -55.53 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.3 110.948 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.3 p -51.68 -39.35 58.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.0 111.112 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.68 69.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 71.33 111.116 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 115' ' ' ALA . 9.5 t0 -72.17 -37.81 69.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.931 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.73 -28.0 1.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 74.21 112.484 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.86 -138.27 4.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 73.31 112.493 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -173.56 -175.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 64.22 110.838 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.463 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.8 m -141.09 141.33 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 72.32 111.136 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.4 132.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.21 111.094 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -69.27 117.19 10.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 63.25 110.933 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -80.8 -57.87 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.882 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -152.75 161.1 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.22 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.37 118.38 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 64.22 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.77 -177.08 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.32 111.131 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.39 -86.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 61.02 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -99.64 25.18 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 54.03 110.874 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 145' ' ' GLU . 22.0 t -145.26 149.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.103 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.78 115.77 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 61.11 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -82.7 101.19 10.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.2 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -112.11 150.88 30.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.11 110.946 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -106.29 117.23 33.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.33 110.908 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -132.04 139.28 48.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 70.21 110.934 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -122.06 119.24 30.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.968 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.28 118.61 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 64.41 112.476 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' A' ' 94' ' ' ASP . . . -59.73 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.738 0.304 . . . . 54.01 111.085 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 p -52.25 -39.11 59.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 52.45 110.885 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 52.23 -161.01 2.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 55.42 112.468 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -97.67 -27.1 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 74.42 110.891 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.1 m -93.68 160.53 32.56 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.607 0.718 . . . . 71.35 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -33.05 17.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.248 . . . . 75.25 112.301 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 p -122.21 88.12 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.845 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.48 -37.88 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 54.34 110.851 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 149' ' ' ASP . 2.6 pt? -51.95 -29.92 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.888 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.59 -42.66 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.097 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 m -53.37 -35.94 60.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.22 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.6 pt -85.94 -30.22 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 73.12 111.138 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -51.38 -41.93 61.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 63.41 110.915 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -25.59 61.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 72.53 110.839 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.71 -57.14 6.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 64.14 112.481 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 112' ' ' LEU . 4.3 mp -60.54 -54.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 62.22 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.87 -31.85 41.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.876 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -70.35 -48.28 57.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 65.34 110.847 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -63.34 -40.82 98.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.847 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.769 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.98 -45.9 66.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 62.01 110.933 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.7 mtt -59.53 -23.84 63.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.876 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -71.33 -52.53 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 72.31 110.878 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.702 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.7 mmpt? -75.22 -55.12 6.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 72.21 110.895 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.95 76.03 2.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.638 0.732 . . . . 53.44 111.17 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -8.85 24.65 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 62.1 112.329 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.08 -30.73 27.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 75.52 110.847 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -79.43 144.18 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 62.5 111.155 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.16 -53.1 7.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.056 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.5 -169.93 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 73.12 111.128 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.21 153.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 61.35 111.11 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 107' ' ' VAL . 13.1 mm-40 -119.73 95.61 49.26 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.13 110.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 115.22 3.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.741 2.294 . . . . 43.21 112.318 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.29 148.47 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 74.51 111.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 m 59.1 34.87 23.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.45 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 123' ' ' LEU . 26.6 p30 -84.53 57.17 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.3 110.861 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -88.68 101.69 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.14 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -66.91 -68.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.3 110.866 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 145.21 45.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 71.25 111.133 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.746 -0.74 . . . . 54.45 112.491 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.0 ptm . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.805 0.336 . . . . 74.53 110.849 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.43 26.01 6.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.796 -0.716 . . . . 74.45 112.516 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.6 159.25 55.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 75.54 110.921 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -21.77 32.81 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.641 2.227 . . . . 72.11 112.337 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.708 HD23 HD13 ' A' ' 138' ' ' ILE . 3.0 tm? -150.17 117.45 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 71.52 110.914 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 80' ' ' VAL . 16.5 p -135.48 179.7 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 73.32 111.098 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.16 -30.24 16.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 43.43 111.09 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.21 -63.25 2.08 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.738 . . . . 64.3 112.511 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -54.94 -47.23 74.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.02 110.865 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 84' ' ' LEU . 6.9 p -51.53 -31.14 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.143 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.44 -35.64 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 45.45 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -67.58 -40.22 84.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 53.21 110.883 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.7 t -75.91 -45.36 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mp -72.18 -18.27 61.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.94 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -50.48 -26.8 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.889 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.4 -42.81 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 63.2 110.931 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.756 HG21 HG13 ' A' ' 130' ' ' ILE . 11.1 p -80.85 -14.88 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 54.12 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.3 ttp85 -51.07 -58.65 9.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.583 0.706 . . . . 70.32 110.846 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.76 -26.53 27.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.256 . . . . 73.34 112.368 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -76.15 -22.11 55.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 64.2 110.956 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.641 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.2 mm? -100.58 -51.5 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 74.21 110.866 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.5 p -56.86 -30.75 64.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 55.45 111.155 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.66 -27.21 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 53.54 111.046 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.03 -38.0 19.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.869 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.74 -35.75 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 45.53 112.447 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.89 -144.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 52.51 112.463 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -177.34 168.81 2.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.384 . . . . 71.4 110.855 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 112' ' ' LEU . 22.8 m -125.23 135.62 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.2 111.167 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.17 125.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 14.54 111.098 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 103' ' ' ILE . 10.5 tp -75.68 117.65 17.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.52 110.972 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -83.77 -74.38 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 42.25 110.867 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -125.61 168.48 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.873 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 HD21 ' A' ' 100' ' ' LEU . 69.8 mt -130.22 123.28 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.0 111.172 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.36 -169.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.2 111.063 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.27 -87.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.482 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.43 -6.59 37.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 75.43 110.852 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 t -113.9 151.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.05 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 103' ' ' ILE . 73.3 t -119.98 133.28 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.095 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.58 102.65 15.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.858 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 100' ' ' LEU . 3.4 mt -108.44 151.08 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.22 110.91 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.76 ' HG3' HG11 ' A' ' 147' ' ' VAL . 3.4 ttmm -104.28 90.31 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.939 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 130' ' ' ILE . 9.8 mt -120.45 129.62 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 72.32 110.902 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -129.86 159.09 37.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.51 110.909 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.72 -89.87 1.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 31.11 112.507 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.95 -175.57 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.779 0.323 . . . . 54.43 111.065 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -134.33 122.62 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 44.45 110.916 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -171.55 -149.42 6.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 61.14 112.521 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -62.16 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.355 . . . . 72.14 110.849 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.0 t -126.65 68.33 68.78 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.607 0.718 . . . . 51.35 110.923 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 80.04 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 63.43 112.347 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -95.85 26.71 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.874 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m -78.48 -24.13 46.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 54.32 110.858 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 124' ' ' ILE . 1.4 pp -53.72 -28.01 31.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 74.03 110.89 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 123' ' ' LEU . 25.2 mm -81.18 -30.98 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 63.4 111.135 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -31.67 70.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 70.1 111.155 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 130' ' ' ILE . 32.6 pt -86.18 -28.39 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 62.33 111.073 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -52.89 -35.94 58.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.875 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -75.28 -26.25 58.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.34 110.92 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.27 -54.46 6.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.699 -0.762 . . . . 53.42 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 112' ' ' LEU . 4.4 mp -63.94 -44.6 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 73.55 111.16 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -64.69 -22.84 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.956 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -76.67 -51.33 11.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 72.12 110.832 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -73.41 -33.48 64.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.863 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 84' ' ' LEU . 14.3 tp -69.93 -47.5 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 70.01 110.95 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.4 ttm -68.9 -28.12 66.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.11 110.86 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -51.99 -53.83 36.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.3 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -70.56 -49.16 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.907 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.708 HD13 HD23 ' A' ' 75' ' ' LEU . 5.3 mp -112.99 76.16 2.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 75.11 111.184 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.72 24.33 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.728 2.285 . . . . 71.41 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -53.11 -28.72 26.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.03 110.887 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.0 p -81.45 144.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.1 111.117 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.58 -52.57 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 55.13 111.076 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.89 -173.18 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.32 111.086 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.35 163.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.45 111.13 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.69 160.07 54.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.618 0.723 . . . . 54.2 110.888 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -172.23 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 65.43 112.295 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.76 HG11 ' HG3' ' A' ' 111' ' ' LYS . 17.6 m -82.39 -172.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.03 111.114 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.37 85.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 63.32 111.14 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -174.35 -170.84 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 73.24 110.877 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -125.51 133.78 52.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.875 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.73 170.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 72.41 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.5 t -117.09 -25.11 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 75.23 111.084 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 71.31 112.499 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttm . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.855 0.36 . . . . 72.12 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.11 -169.19 31.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.781 -0.723 . . . . 43.44 112.542 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.05 159.71 0.11 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 74.22 110.942 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.21 27.71 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.712 2.275 . . . . 62.13 112.303 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.688 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -152.82 128.2 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.34 110.908 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.469 ' N ' HD13 ' A' ' 75' ' ' LEU . 17.0 p -144.82 178.91 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 61.24 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.11 -30.3 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 51.31 111.073 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.97 -62.96 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 41.13 112.514 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -55.31 -47.56 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 73.5 110.947 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 134' ' ' LEU . 7.2 p -51.23 -31.12 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 55.04 111.183 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.01 -36.69 84.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 74.22 110.901 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -66.89 -40.66 87.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 64.11 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 27.4 t -74.96 -45.35 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.14 111.161 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.729 HD13 HG22 ' A' ' 80' ' ' VAL . 9.0 mp -71.86 -18.16 62.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 54.13 110.933 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.9 -26.98 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 63.12 110.849 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -74.61 -43.03 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.943 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.802 HG21 HG13 ' A' ' 130' ' ' ILE . 11.8 p -80.49 -14.73 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.45 111.142 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.2 ttm180 -51.6 -58.75 9.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 73.42 110.882 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.4 Cg_endo -69.74 -27.48 26.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 54.44 112.355 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -74.22 -25.01 59.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 70.44 110.92 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.626 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.4 mm? -98.77 -52.16 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 75.23 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -54.29 -32.5 56.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 73.24 111.132 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.77 71.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.51 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -79.7 -37.45 35.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.861 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.87 -42.66 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 11.4 112.48 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.11 -142.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 64.11 112.477 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -175.93 -177.39 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 65.32 110.858 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG12 ' CD2' ' A' ' 112' ' ' LEU . 33.3 m -138.6 132.96 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.129 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.27 123.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 73.24 111.104 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 80' ' ' VAL . 1.4 tt -71.5 116.0 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 54.4 110.896 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -75.88 -65.59 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 54.33 110.886 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.54 165.43 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.873 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.19 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.01 111.108 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.9 -176.44 3.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 62.23 111.094 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.47 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 73.24 112.461 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 4.8 p30 -96.28 25.46 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 42.24 110.869 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.494 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.7 t -144.98 150.06 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 62.13 111.121 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 141' ' ' VAL . 42.8 t -124.91 117.06 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.139 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 100' ' ' LEU . 36.5 mtt85 -82.33 100.93 10.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.3 110.836 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 134' ' ' LEU . 4.4 mt -105.22 146.52 29.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.932 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.42 ' HA ' HG13 ' A' ' 147' ' ' VAL . 3.4 ttmm -105.78 103.1 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.878 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.682 ' CD2' HG12 ' A' ' 98' ' ' VAL . 3.9 mt -126.58 144.11 51.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 74.34 110.94 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -124.7 146.8 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.04 110.964 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.81 -107.62 3.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 63.43 112.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -170.52 174.25 5.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 71.14 111.082 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 19.0 m -145.9 120.66 9.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.916 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.31 -77.59 0.32 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 65.23 112.463 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -93.59 -38.53 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 53.13 110.88 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 t -114.88 73.05 2.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.641 0.734 . . . . 60.42 110.916 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 157.17 61.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.631 2.221 . . . . 71.52 112.336 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 m 53.66 28.21 7.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 70.54 110.868 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 p -72.43 -26.44 61.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.83 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.23 -30.23 26.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.915 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.23 -38.31 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.41 111.151 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -35.23 76.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 72.24 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 26.6 pt -85.89 -31.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 71.52 111.096 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.0 -45.19 71.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 45.41 110.86 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -73.01 -24.84 60.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 65.35 110.877 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.17 -60.28 3.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 34.1 112.477 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.802 HG13 HG21 ' A' ' 87' ' ' VAL . 2.9 mp -59.12 -50.06 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.748 0.309 . . . . 74.52 111.094 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -57.61 -25.63 60.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.854 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -80.04 -51.55 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.2 110.863 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -64.65 -36.32 83.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 52.41 110.89 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 80' ' ' VAL . 27.0 tp -70.14 -35.82 74.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.11 110.917 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.611 ' CE ' HG13 ' A' ' 144' ' ' VAL . 16.7 mtt -78.64 -29.56 45.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.21 110.893 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -51.91 -34.96 43.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.896 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 138' ' ' ILE . 17.2 mmtm -91.87 -37.6 12.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 65.32 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.688 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -127.34 75.12 77.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 62.22 111.103 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -8.19 22.98 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.671 2.248 . . . . 64.24 112.355 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -51.45 -30.7 20.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 72.31 110.875 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.3 p -76.28 144.01 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.12 111.127 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -77.24 -53.24 7.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -157.31 -175.68 5.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 71.43 111.124 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.611 HG13 ' CE ' ' A' ' 135' ' ' MET . 18.3 m -130.13 147.9 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 72.21 111.126 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.494 ' CG ' HG11 ' A' ' 107' ' ' VAL . 16.3 mm-40 -112.65 95.66 33.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 63.15 110.927 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 145' ' ' GLU . 54.0 Cg_endo -69.72 169.26 19.28 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 73.12 112.394 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG13 ' HA ' ' A' ' 111' ' ' LYS . 7.0 m -54.86 138.03 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.24 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.1 p -75.11 133.66 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 71.23 111.125 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -176.6 179.99 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 62.01 110.871 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -92.79 118.9 31.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 71.04 110.923 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -98.66 26.41 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 70.3 110.893 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 t -110.91 -26.99 9.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 52.24 111.122 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 70.11 112.475 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.815 0.34 . . . . 74.44 110.825 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.01 19.92 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 42.41 112.507 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.91 160.69 39.7 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.605 0.717 . . . . 74.43 110.919 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo -69.79 -30.1 22.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.665 2.244 . . . . 73.34 112.34 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.719 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.27 111.17 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.951 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 p -119.98 -177.67 3.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.43 . . . . 73.25 111.124 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.89 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 70.43 111.067 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 -46.13 8.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.728 . . . . 52.45 112.473 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.96 -46.74 73.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.354 . . . . 73.14 110.866 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 7.8 p -54.1 -31.16 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.23 111.159 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.85 -23.81 67.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 t -71.91 -45.92 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.33 110.835 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.3 p -77.08 -34.64 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 72.33 111.102 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 3.5 mp -71.58 -19.82 62.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.952 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -53.65 -26.66 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.42 110.855 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.62 -42.97 57.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.35 110.94 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' HG ' ' A' ' 91' ' ' LEU . 13.9 p -80.69 -14.42 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.21 111.131 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 ttt180 -51.86 -58.63 10.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.714 . . . . 74.34 110.848 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.268 . . . . 75.42 112.336 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.34 -57.39 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 64.01 110.891 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 87' ' ' VAL . 10.6 mt -68.33 -44.27 75.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 55.33 110.925 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 88' ' ' ARG . 41.1 p -53.74 -29.01 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 73.11 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.48 67.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 45.3 111.107 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.31 -37.99 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.52 110.873 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.26 -15.2 3.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 53.42 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.19 -143.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 74.45 112.511 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -173.51 173.49 3.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.845 0.355 . . . . 61.21 110.844 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 84' ' ' LEU . 12.9 m -139.27 128.46 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.45 111.165 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.15 116.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.24 111.133 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -55.28 113.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.954 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -75.07 -65.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 65.2 110.865 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -141.76 166.15 25.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 55.1 mt -124.53 114.59 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.18 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.37 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 50.43 111.102 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.27 -91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 75.5 112.519 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -96.58 24.0 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 73.51 110.869 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.401 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.6 t -145.13 150.18 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.31 111.112 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.1 t -118.79 131.82 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.43 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -98.79 100.93 12.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 52.41 110.87 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -110.09 144.44 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 74.12 110.888 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -92.81 102.97 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 60.14 110.868 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 130' ' ' ILE . 9.1 mt -120.09 147.94 44.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 61.35 110.914 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.41 141.37 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 71.01 110.973 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.93 29.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 71.11 112.468 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.43 113.37 23.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 70.52 111.132 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.4 t -125.46 70.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.42 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.56 -77.01 0.56 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.02 112.492 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 p -98.08 -26.47 14.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 74.04 110.829 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.8 t 54.37 67.96 3.03 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.708 . . . . 64.31 110.891 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 78.11 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.643 2.229 . . . . 53.35 112.366 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 p 46.17 36.18 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.43 110.836 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.08 -41.71 70.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 53.24 110.916 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD12 ' HB ' ' A' ' 148' ' ' THR . 2.6 pt? -51.88 -30.81 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 62.11 110.895 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mm -90.08 -30.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 54.32 111.168 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 m -64.67 -45.08 88.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 72.34 111.168 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 130' ' ' ILE . 47.5 pt -76.0 -26.65 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.51 111.082 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -51.56 -54.68 24.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.851 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -24.91 68.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 75.45 110.864 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.52 -60.33 4.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.524 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -56.56 -54.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 73.23 111.129 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.66 -32.38 41.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.45 110.915 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -77.9 -30.71 50.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.826 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -78.93 -33.59 45.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 72.13 110.898 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.789 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -69.41 -54.93 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 70.44 110.885 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -29.34 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.4 110.86 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.7 -26.1 55.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 64.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -44.22 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 55.44 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.719 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.05 75.84 2.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.621 0.724 . . . . 74.12 111.127 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.44 34.73 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 73.34 112.358 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.91 -39.45 59.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.864 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -73.09 144.44 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 54.34 111.16 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.54 -44.56 18.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.083 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.49 -171.99 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 41.33 111.092 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.3 154.0 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.116 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' CG ' HG11 ' A' ' 107' ' ' VAL . 46.5 mt-10 -134.3 95.66 16.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 64.55 110.897 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 158.78 55.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 51.42 112.352 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 m -51.58 -31.25 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 74.13 111.109 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 123' ' ' LEU . 44.4 p -79.32 119.63 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.13 111.202 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -89.65 -61.5 1.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 64.01 110.844 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 170.48 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 62.52 110.903 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -77.85 159.12 29.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.43 110.9 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 p -113.16 130.58 56.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 75.44 111.179 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 70.11 112.466 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.4 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.851 0.358 . . . . 73.42 110.851 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.85 -28.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.21 112.474 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.14 160.66 82.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.621 0.724 . . . . 60.44 110.89 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo -69.73 -29.91 23.24 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.645 2.23 . . . . 70.22 112.354 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.74 114.27 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.9 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -122.45 -177.13 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 63.53 111.128 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -61.87 -34.37 75.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 70.13 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.2 -46.44 8.18 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 74.13 112.483 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -67.3 -46.9 72.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 65.3 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.042 HG22 HD13 ' A' ' 84' ' ' LEU . 6.7 p -54.4 -31.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 75.24 111.121 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.88 -23.68 67.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 61.25 110.919 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -69.64 -47.26 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 73.52 110.852 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.1 p -77.21 -35.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 64.5 111.175 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.042 HD13 HG22 ' A' ' 80' ' ' VAL . 1.4 mp -71.72 -19.38 62.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.43 110.938 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.53 -26.71 8.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 75.3 110.858 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -74.44 -41.74 60.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 55.11 110.893 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.839 HG11 HG13 ' A' ' 130' ' ' ILE . 34.0 m -82.98 -11.42 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.144 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.4 ttt85 -54.38 -58.6 13.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 61.15 110.881 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.69 -31.75 20.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.684 2.256 . . . . 75.34 112.36 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.24 -57.99 5.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.7 mm? -56.66 -55.05 38.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 74.21 110.921 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.405 HG22 ' OD1' ' A' ' 97' ' ' ASP . 46.1 p -51.38 -41.84 60.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.21 111.186 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.66 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 51.1 111.104 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -82.86 -37.77 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.55 110.891 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 142.21 -17.04 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.765 -0.731 . . . . 60.43 112.473 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.31 -145.45 16.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 44.04 112.476 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 92' ' ' THR . 1.0 OUTLIER -167.12 -179.95 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 71.31 110.837 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.5 m -137.74 139.53 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.23 111.11 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.61 134.02 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.42 111.082 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -81.4 119.49 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 72.21 110.912 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -88.51 -71.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 72.44 110.83 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -124.63 168.79 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 55.32 110.866 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.642 HD11 HD21 ' A' ' 100' ' ' LEU . 62.2 mt -131.58 125.75 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.01 111.118 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.11 -176.05 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 62.15 111.095 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.51 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 74.13 112.511 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -98.01 25.32 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 72.43 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.547 HG11 ' CG ' ' A' ' 145' ' ' GLU . 25.8 t -145.78 149.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.122 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.2 t -119.63 135.56 59.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 64.3 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -94.97 101.0 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.03 110.889 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 84' ' ' LEU . 7.6 mt -110.59 126.16 54.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 44.23 110.879 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -79.62 101.64 8.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.91 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 130' ' ' ILE . 8.7 mt -123.34 129.69 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.934 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 91' ' ' LEU . 16.0 mt-30 -121.73 129.78 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.892 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -83.23 -113.22 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 63.24 112.52 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -173.94 -179.19 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 72.31 111.133 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 78.7 m -142.06 112.56 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 60.44 110.911 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 170.02 -94.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 51.21 112.494 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.5 t -97.95 -25.94 14.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 64.12 110.84 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -113.99 73.12 2.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 73.21 110.875 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 164.57 34.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.688 2.258 . . . . 71.52 112.322 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m 52.43 32.31 11.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.24 110.847 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -41.85 96.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 63.01 110.873 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.78 -30.1 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 63.2 110.87 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.34 -32.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 73.42 111.07 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -74.36 -35.99 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.01 111.152 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.735 ' O ' HD12 ' A' ' 130' ' ' ILE . 19.2 pt -76.83 -29.06 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 71.13 111.109 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -51.2 -58.13 6.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.896 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -68.39 -24.3 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.85 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.53 -59.3 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 64.4 112.514 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 112' ' ' LEU . 2.6 mp -61.03 -54.93 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 75.44 111.102 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -50.56 -31.39 15.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -78.4 -37.15 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.42 110.883 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -72.92 -32.0 65.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 75.55 110.92 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.622 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -51.61 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.926 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.3 mtt -51.82 -31.16 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.54 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.44 -27.3 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -46.82 3.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 55.51 110.908 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.715 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -113.39 74.75 2.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 73.32 111.167 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -13.21 34.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 70.31 112.353 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.13 -33.84 58.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.832 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.2 p -74.59 144.42 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 65.12 111.095 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.44 18.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 61.45 111.1 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -166.32 -170.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 35.31 111.109 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.22 149.76 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.151 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.547 ' CG ' HG11 ' A' ' 107' ' ' VAL . 8.8 mm-40 -116.14 95.7 45.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 64.31 110.885 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 179.26 3.83 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 64.05 112.378 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.24 129.06 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 73.41 111.111 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.8 t -63.69 135.24 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 72.53 111.135 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -174.4 162.82 3.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.873 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.34 141.68 57.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.923 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.38 -32.63 20.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.9 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -76.3 138.66 40.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 74.1 111.139 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 63.34 112.444 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.9 mtm . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.817 0.341 . . . . 62.1 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.65 -27.05 17.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 45.03 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp 62.88 160.66 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 71.24 110.925 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.26 25.4 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.688 2.259 . . . . 62.34 112.347 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -147.41 139.91 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 70.3 110.957 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.2 t -148.45 169.87 19.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.52 111.161 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.38 -29.09 9.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.54 111.113 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.29 -55.08 4.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 72.35 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' HB2' HD22 ' A' ' 75' ' ' LEU . 18.5 m-20 -61.67 -47.56 84.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 64.11 110.837 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.647 HG23 HD13 ' A' ' 134' ' ' LEU . 8.8 p -53.16 -31.37 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 62.21 111.146 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.39 -30.67 71.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.857 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -39.93 63.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG13 ' HD3' ' A' ' 137' ' ' LYS . 26.0 t -75.76 -44.47 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 50.53 111.144 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.637 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mp -71.52 -18.6 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.919 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.34 -25.78 4.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.87 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -73.26 -45.28 56.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.23 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.727 HG23 HG11 ' A' ' 98' ' ' VAL . 2.0 m -81.13 -13.62 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.154 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 ttt180 -50.51 -58.67 9.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.61 0.719 . . . . 73.12 110.905 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.74 -35.11 13.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.746 2.297 . . . . 73.05 112.326 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -67.32 -25.45 66.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.93 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.82 -49.06 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.33 110.941 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 88' ' ' ARG . 76.2 p -61.73 -29.22 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 71.23 111.124 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.36 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 54.13 111.146 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.75 -38.01 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 53.31 110.899 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.22 -40.36 0.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 64.22 112.464 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.38 -148.53 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.779 -0.724 . . . . 65.45 112.448 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -178.28 -176.65 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 62.31 110.88 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.849 HG12 HD23 ' A' ' 112' ' ' LEU . 33.4 m -137.25 133.14 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.03 111.096 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.02 105.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 71.53 111.074 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 77' ' ' ALA . 10.9 tp -54.84 119.94 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.05 110.959 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -78.9 -54.49 6.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.888 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -162.91 172.58 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.859 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.13 121.03 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.132 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.28 95.63 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 74.32 111.093 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.4 -123.39 27.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 74.33 112.489 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.02 -17.58 58.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 71.5 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.96 150.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.12 111.148 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.65 123.66 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 52.44 111.069 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 74.32 110.861 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.3 mt -106.17 155.36 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 65.45 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.429 ' HE2' HG21 ' A' ' 147' ' ' VAL . 6.0 mttt -111.82 84.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.916 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 98' ' ' VAL . 3.8 mt -109.65 139.61 44.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 61.31 110.874 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -131.36 140.67 49.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.907 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.68 -69.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 61.03 112.464 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.43 177.18 10.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 71.23 111.093 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.88 154.73 45.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 42.45 110.892 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.74 -160.45 29.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.751 . . . . 61.51 112.515 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.87 0.367 . . . . 42.01 110.876 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.1 t -143.26 70.47 18.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.595 0.712 . . . . 73.24 110.883 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.689 2.259 . . . . 64.21 112.319 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 m 61.6 26.51 16.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.71 -23.62 39.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 63.12 110.891 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.42 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 64.21 110.912 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.1 mt -80.47 -38.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.53 111.155 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -52.45 -39.76 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 71.41 111.099 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.479 ' O ' HD12 ' A' ' 130' ' ' ILE . 40.1 pt -86.36 -27.69 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 65.51 111.088 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -43.63 66.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.852 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -24.91 61.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.877 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.59 -57.75 5.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.01 112.53 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.707 ' CG1' HG21 ' A' ' 87' ' ' VAL . 4.4 mp -63.35 -53.3 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 72.1 111.164 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -52.02 -29.99 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.52 110.896 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -75.44 -50.66 15.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 72.01 110.887 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -63.66 -35.87 81.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 60.4 110.852 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.647 HD13 HG23 ' A' ' 80' ' ' VAL . 16.0 tp -70.25 -35.52 73.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.05 110.9 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 72.15 110.897 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.8 -38.27 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 62.1 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HD3' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -92.68 -32.02 14.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 60.14 110.895 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -129.99 76.56 77.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 70.21 111.124 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -8.64 24.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 72.12 112.365 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -56.2 -25.99 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.15 110.858 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.1 150.08 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 50.11 111.104 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.86 -51.12 5.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.51 111.043 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.78 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.34 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.2 153.21 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 72.35 111.145 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -132.64 160.25 69.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.622 0.725 . . . . 72.15 110.924 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -170.88 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 74.12 112.334 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.429 HG21 ' HE2' ' A' ' 111' ' ' LYS . 7.0 p -90.81 -24.91 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 64.31 111.146 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.83 166.86 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 64.0 111.115 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -64.84 120.69 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 71.13 110.866 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -146.61 -48.45 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.22 110.899 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.04 -30.01 23.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 64.12 110.899 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 t -63.5 -35.92 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 71.52 111.129 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 51.22 112.468 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.9 ttm . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.798 0.332 . . . . 75.41 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.07 -107.16 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.712 -0.756 . . . . 53.43 112.499 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -105.02 160.31 26.41 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.588 0.709 . . . . 72.34 110.922 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HD2' HD23 ' A' ' 73' ' ' LEU . 54.1 Cg_endo -69.79 -26.16 27.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.642 2.228 . . . . 62.34 112.368 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.725 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.06 139.81 29.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 75.43 110.924 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.643 ' N ' HD13 ' A' ' 75' ' ' LEU . 9.0 t -153.5 169.62 22.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 51.43 111.18 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.3 -29.56 10.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 75.41 111.098 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.44 -62.44 2.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 51.31 112.526 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -56.23 -48.22 76.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 65.24 110.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.986 HG22 HD13 ' A' ' 84' ' ' LEU . 8.9 p -51.22 -31.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 70.0 111.125 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.35 -36.67 82.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.868 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -63.81 -41.55 97.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 53.41 110.875 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.02 -42.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 62.42 111.127 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.986 HD13 HG22 ' A' ' 80' ' ' VAL . 4.8 mp -70.67 -18.85 62.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 65.4 110.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -51.58 -26.88 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.881 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -78.5 -43.89 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.89 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.836 HG22 HD23 ' A' ' 91' ' ' LEU . 8.2 p -82.38 -1.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.132 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 92' ' ' THR . 13.3 ttt180 -65.88 -58.79 10.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.706 . . . . 73.43 110.843 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.1 Cg_endo -69.72 -8.17 22.91 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.653 2.235 . . . . 64.42 112.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -12.61 20.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 71.02 110.899 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -101.21 -66.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 64.14 110.934 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.4 t -58.51 -20.1 43.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 50.13 111.116 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.23 -29.85 15.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 64.32 111.111 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.24 -31.64 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.12 110.889 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.22 -16.96 0.89 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 74.15 112.503 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.12 -138.89 2.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 63.14 112.518 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 179.85 -175.96 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 41.44 110.921 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.673 ' HB ' HD23 ' A' ' 84' ' ' LEU . 27.9 m -141.17 127.06 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.24 111.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.69 133.42 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.4 111.16 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HA ' HD23 ' A' ' 110' ' ' LEU . 17.9 tp -81.34 112.91 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 70.25 110.913 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -74.56 -73.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.896 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.62 171.14 13.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.12 110.901 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 HD21 ' A' ' 100' ' ' LEU . 56.6 mt -129.74 110.82 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.41 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.33 179.73 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 73.45 111.085 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 74.31 112.473 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -96.77 23.56 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 63.13 110.946 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -145.54 149.4 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -123.07 133.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.32 111.123 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 100' ' ' LEU . 8.5 mtt-85 -96.86 100.84 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.23 110.854 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 100' ' ' LEU . 31.3 mt -107.64 130.56 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.884 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -82.99 118.63 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.916 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.061 HD13 HD13 ' A' ' 130' ' ' ILE . 7.3 mt -142.19 123.69 14.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 62.34 110.928 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -111.79 115.29 28.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 62.25 110.957 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.69 -162.76 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 54.34 112.48 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.32 -75.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 60.34 111.108 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.15 -177.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 72.01 110.888 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.89 9.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 53.33 112.45 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.7 t -53.16 -28.87 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 71.14 110.871 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.5 p -144.07 156.54 58.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.59 0.709 . . . . 75.24 110.897 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 93.51 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 62.44 112.337 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.5 m -130.1 -39.9 1.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 63.33 110.869 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.38 -45.3 65.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 44.01 110.881 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.11 -29.9 23.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.128 -0.487 . . . . 55.25 110.903 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.1 mm -87.1 -39.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 71.34 111.099 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -57.78 -34.01 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.33 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.834 HD12 HD11 ' A' ' 91' ' ' LEU . 27.9 pt -86.13 -29.91 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 64.34 111.136 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -49.87 -58.31 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.88 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -24.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.06 -50.05 19.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 34.25 112.452 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.061 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -68.51 -55.6 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 71.43 111.127 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.4 -32.05 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 71.05 110.849 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.94 -40.89 95.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.905 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -72.29 -37.34 69.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.891 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -65.02 -38.89 92.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 73.05 110.926 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.4 ttm -67.9 -25.46 65.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.24 110.86 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.84 -59.4 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 138' ' ' ILE . 9.3 mmtm -73.24 -51.2 18.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.865 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.86 76.15 2.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 71.23 111.137 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.8 33.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.254 . . . . 64.22 112.331 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.83 -36.18 47.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.86 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.13 144.1 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.3 111.13 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.75 -51.45 8.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.35 111.064 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.84 -170.16 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.066 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.0 144.06 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.15 111.168 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -123.88 95.65 43.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 73.51 110.909 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -175.35 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 63.33 112.393 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.22 120.46 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 71.05 111.13 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 t -51.71 133.93 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 60.13 111.141 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -157.1 173.98 16.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.848 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -75.37 82.48 2.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.45 110.935 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.58 164.15 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.55 110.863 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 p -126.27 153.03 45.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 73.45 111.139 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 73.04 112.515 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.1 ttm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.819 0.342 . . . . 73.54 110.874 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.19 163.34 23.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 64.53 112.511 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 mt -78.51 159.21 75.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 74.04 110.914 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo -69.76 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.704 2.269 . . . . 72.41 112.36 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 108' ' ' VAL . 5.2 tt -94.54 106.61 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.23 110.914 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -129.76 175.66 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 63.14 111.123 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -63.7 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.08 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.96 -43.76 10.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 62.1 112.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -71.83 -47.43 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 74.52 110.893 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.015 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.61 -31.13 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 64.12 111.144 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.25 -39.9 92.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.844 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -41.1 95.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 45.23 110.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 134' ' ' LEU . 74.3 t -77.28 -39.57 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 61.2 111.122 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.015 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -69.87 -19.43 63.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.931 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -52.35 -27.08 14.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.853 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -76.85 -43.65 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.35 110.896 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.697 ' CG2' HD23 ' A' ' 91' ' ' LEU . 8.6 p -82.34 -4.51 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 75.43 111.153 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.3 ttp85 -61.26 -58.72 16.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 74.42 110.892 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.78 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 71.44 112.353 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.23 -46.95 6.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 72.45 110.914 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.697 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -73.38 -43.56 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.963 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -65.63 -23.16 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 73.13 111.19 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.68 -51.99 62.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.091 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -63.7 -29.25 70.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.843 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.47 19.21 3.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 74.02 112.467 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.58 -135.91 8.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.708 -0.758 . . . . 75.1 112.497 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -179.37 139.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 73.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.713 HG12 HD23 ' A' ' 112' ' ' LEU . 33.3 m -115.54 133.04 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.34 111.108 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.89 138.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 54.53 111.092 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 77' ' ' ALA . 11.8 tp -79.81 126.71 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 65.22 110.892 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.473 ' N ' HD12 ' A' ' 100' ' ' LEU . 85.1 t60 -88.36 -71.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.871 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -134.58 174.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.4 110.922 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 100' ' ' LEU . 53.5 mt -132.35 110.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.4 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.9 -170.21 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.132 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.55 -89.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 71.14 112.467 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -95.12 21.04 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 52.44 110.886 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.26 150.28 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.1 111.141 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.028 HG21 HD13 ' A' ' 75' ' ' LEU . 92.4 t -114.46 139.83 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.12 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.27 100.87 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.43 110.848 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 100' ' ' LEU . 1.1 mt -105.92 178.17 4.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.922 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -134.01 120.25 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 63.55 110.909 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 130' ' ' ILE . 4.0 mt -138.25 143.15 39.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 64.01 110.945 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -118.99 106.71 12.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 65.42 110.916 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -115.8 83.58 0.34 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.461 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.77 117.96 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 72.25 111.069 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.06 -47.41 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 64.31 110.85 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.6 -69.02 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 43.4 112.473 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 t -75.82 -26.58 57.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 74.12 110.875 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.7 t -118.73 73.36 11.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.616 0.722 . . . . 71.22 110.892 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -16.92 37.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.657 2.238 . . . . 52.43 112.336 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.8 m -96.83 31.88 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 61.41 110.883 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.6 m -79.41 -25.74 42.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 75.23 110.837 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.86 -31.72 29.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.928 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 HH11 ' A' ' 128' ' ' ARG . 40.8 mm -79.49 -38.07 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.094 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.85 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.14 111.145 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.8 pt -86.09 -26.97 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 73.4 111.116 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -50.68 54.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 72.2 110.902 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.506 HH11 HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -71.0 -24.83 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.23 110.858 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.66 -51.91 18.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 31.43 112.463 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.953 HD13 HD13 ' A' ' 112' ' ' LEU . 2.8 mp -64.06 -56.41 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.728 0.299 . . . . 60.43 111.13 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.49 -33.32 44.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.933 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -63.51 -33.54 75.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 75.22 110.859 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -77.02 -56.57 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.2 110.894 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.95 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -53.8 -47.32 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 53.51 110.914 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 32.7 ttm -55.15 -39.43 69.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 65.23 110.879 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.37 -19.38 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.04 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 -33.13 9.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.13 110.932 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 141' ' ' VAL . 9.9 mm -111.49 78.8 2.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 71.13 111.132 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -8.13 22.82 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.242 . . . . 45.54 112.324 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -33.89 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 74.04 110.895 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.4 p -74.43 155.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.31 111.149 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.41 -45.11 8.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 62.13 111.115 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.12 -169.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.36 160.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 64.31 111.121 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 146' ' ' PRO . 9.9 mm-40 -146.61 95.65 4.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.758 . . . . 74.14 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 145' ' ' GLU . 53.9 Cg_endo -69.77 179.21 3.86 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.613 2.208 . . . . 75.51 112.362 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.04 126.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 44.33 111.121 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 4.4 t -170.56 160.9 7.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 75.52 111.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.9 -50.12 6.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.21 110.864 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -124.31 149.89 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.924 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -157.41 129.45 7.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.918 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -163.5 135.59 5.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.51 111.173 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 63.51 112.528 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.83 0.262 . . . . 73.209999999999994 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.718 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.3 122.39 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.973 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 80' ' ' VAL . 17.7 p -132.04 172.07 12.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 63.420000000000002 111.13 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.56 -30.21 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 53.100000000000001 111.089 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.62 -61.24 2.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 70.010000000000005 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 73.120000000000005 110.894 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.077 HG22 HD13 ' A' ' 84' ' ' LEU . 8.0 p -54.11 -31.23 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 111.156 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.88 -24.13 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -74.06 -44.28 54.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.856 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.5 p -77.02 -34.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 111.16 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.077 HD13 HG22 ' A' ' 80' ' ' VAL . 3.7 mp -71.61 -20.11 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 75.530000000000001 110.898 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.15 -26.6 28.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.836 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -74.03 -42.51 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 65.349999999999994 110.918 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' HD23 ' A' ' 91' ' ' LEU . 9.2 p -82.23 -13.87 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 62.030000000000001 111.165 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.8 ttt180 -51.45 -58.67 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.583 0.706 . . . . 72.099999999999994 110.835 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -8.32 23.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.246 . . . . 62.549999999999997 112.353 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -98.47 -19.27 17.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 74.109999999999999 110.922 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.25 -40.21 7.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.340000000000003 110.905 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 96' ' ' GLY . 44.1 p -69.94 -16.21 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 64.530000000000001 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -54.88 24.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 55.32 111.066 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -131.54 40.14 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 110.879 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -149.87 -63.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 61.240000000000002 112.476 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' THR . . . 152.61 -71.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 74.400000000000006 112.464 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.54 168.93 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 60.130000000000003 110.896 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.566 ' CG2' HD23 ' A' ' 84' ' ' LEU . 27.8 m -123.02 166.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 111.17 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.35 141.7 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 60.310000000000002 111.093 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.727 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -86.85 115.32 24.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.982 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.13 -73.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.87 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -131.76 169.08 16.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.727 HD11 HD21 ' A' ' 100' ' ' LEU . 12.9 mt -129.34 110.52 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 52.039999999999999 111.15 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.47 -173.96 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 72.099999999999994 111.117 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.34 -89.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.728 -0.749 . . . . 74.549999999999997 112.501 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.43 23.73 5.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 74.129999999999995 110.891 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.93 150.55 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 60.219999999999999 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.67 129.61 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.126 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 100' ' ' LEU . 9.6 mtp85 -89.46 103.39 16.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.839 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.405 HD22 HD21 ' A' ' 84' ' ' LEU . 3.7 mt -116.35 142.84 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.944 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.35 104.76 16.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 62.229999999999997 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 130' ' ' ILE . 9.5 mt -113.54 128.98 56.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 73.340000000000003 110.913 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 87.66 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 110.935 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 64.340000000000003 112.522 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.894 0.378 . . . . 72.109999999999999 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -51.84 -49.78 62.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 72.310000000000002 110.922 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -70.2 -32.57 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.4 m -66.87 -39.65 87.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.164 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' HD12 ' A' ' 130' ' ' ILE . 24.5 pt -86.08 -26.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 64.140000000000001 111.144 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -51.17 -48.09 61.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.230000000000004 110.942 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.56 -25.0 65.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 71.120000000000005 110.817 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.95 -60.28 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 54.5 112.462 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 112' ' ' LEU . 3.1 mp -56.2 -53.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 41.219999999999999 111.159 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.26 -32.3 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -76.38 -30.5 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -79.09 -33.8 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 110.856 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.02 -52.68 22.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.925 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -30.11 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.519999999999996 110.886 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.6 -27.01 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.863 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -113.29 -45.65 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 55.119999999999997 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.12 75.71 2.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 74.099999999999994 111.132 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -11.77 31.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 72.420000000000002 112.358 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -51.99 -30.69 26.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 64.129999999999995 110.85 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.79 149.26 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.019999999999996 111.122 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.34 -36.16 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 61.109999999999999 111.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.46 -175.31 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.109999999999999 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.31 153.91 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 70.049999999999997 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.891 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.828 0.262 . . . . 72.329999999999998 112.349 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.702 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -133.42 131.13 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 73.340000000000003 110.932 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 79' ' ' ASN . 1.8 t -129.31 160.91 31.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 111.149 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.89 -27.85 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 45.43 111.133 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.69 -39.13 22.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 60.119999999999997 112.48 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.597 ' H ' HG23 ' A' ' 76' ' ' THR . 1.5 m-80 -76.43 -46.89 25.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 72.5 110.907 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -50.58 -31.36 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.105 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -45.06 91.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 110.949 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -61.88 -36.21 80.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.439999999999998 110.845 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 134' ' ' LEU . 33.6 t -77.28 -39.98 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 45.530000000000001 111.14 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 80' ' ' VAL . 4.5 mp -71.08 -19.03 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.912 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -26.84 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.019999999999996 110.878 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -75.22 -42.97 54.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 73.099999999999994 110.874 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.644 ' CG2' HD23 ' A' ' 91' ' ' LEU . 15.0 p -81.01 -11.8 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.230000000000004 111.133 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 14.1 ttt180 -54.79 -58.67 13.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.588 0.709 . . . . 73.310000000000002 110.881 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.83 -16.06 37.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.226 . . . . 64.310000000000002 112.343 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -88.2 -23.91 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.539999999999999 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.794 HD11 HD12 ' A' ' 126' ' ' ILE . 1.4 mm? -101.1 -53.23 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.319999999999993 110.913 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 88' ' ' ARG . 73.2 p -52.73 -42.44 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.148 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.97 67.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 52.439999999999998 111.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -76.24 -38.08 56.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 110.813 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.0 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 61.109999999999999 112.524 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.96 -131.18 1.98 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.209999999999994 112.506 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -179.33 -176.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 72.519999999999996 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.4 m -131.4 140.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 111.118 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.96 137.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 111.098 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 109' ' ' ARG . 38.1 tp -78.69 137.01 37.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 72.019999999999996 110.896 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -103.14 -45.67 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 110.894 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -171.9 168.09 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.906 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.19 119.63 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 72.109999999999999 111.104 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.28 88.68 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 111.072 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.73 -120.75 18.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 42.119999999999997 112.469 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -76.09 -18.22 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 75.230000000000004 110.915 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.46 151.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.123 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.61 136.58 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.609 ' O ' HD12 ' A' ' 100' ' ' LEU . 27.2 mtp85 -96.86 101.37 12.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 54.32 110.855 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD22 HD21 ' A' ' 84' ' ' LEU . 7.1 mt -117.67 130.63 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 71.510000000000005 110.902 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -81.35 105.65 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 60.530000000000001 110.912 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.041 HD13 HD13 ' A' ' 130' ' ' ILE . 10.1 mt -125.15 127.48 46.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 65.120000000000005 110.883 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -146.27 127.55 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 110.935 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 40.229999999999997 112.51 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.919 0.39 . . . . 53.539999999999999 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 tp -51.68 -35.6 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 74.299999999999997 110.949 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.7 mm -88.75 -31.06 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.158 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -65.18 -34.36 78.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 111.101 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 91' ' ' LEU . 27.4 pt -84.8 -30.38 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.209999999999994 111.152 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -51.47 -49.88 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.140000000000001 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.5 -25.14 66.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.868 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.82 -54.0 10.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 44.119999999999997 112.503 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.041 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -61.35 -55.02 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 72.049999999999997 111.138 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.42 -32.61 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 50.399999999999999 110.885 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.08 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 110.835 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -61.31 -42.5 98.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 64.25 110.855 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.715 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.24 -31.97 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 42.020000000000003 110.944 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 19.1 mtt -67.42 -29.82 69.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.832 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.07 -53.2 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.019999999999996 110.907 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -81.89 -45.71 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 75.349999999999994 110.901 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.78 76.47 2.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 62.109999999999999 111.172 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -15.81 37.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 63.399999999999999 112.346 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -52.43 -46.08 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 65.319999999999993 110.877 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -52.29 144.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.161 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.85 -35.32 12.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 55.200000000000003 111.08 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -171.92 179.66 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 54.140000000000001 111.11 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.83 144.39 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.409999999999997 111.149 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 72.150000000000006 110.905 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.835 0.264 . . . . 61.420000000000002 112.343 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -144.6 136.69 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.898 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.544 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.9 t -140.68 167.35 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.155 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -28.7 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 75.420000000000002 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.54 -45.8 9.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 73.299999999999997 112.462 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 76' ' ' THR . 9.2 m-20 -69.71 -48.16 60.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 72.409999999999997 110.888 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.0 -31.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 55.299999999999997 111.153 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.85 -36.1 78.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 65.219999999999999 110.914 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -44.4 87.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.230000000000004 110.88 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 134' ' ' LEU . 66.3 t -72.8 -43.63 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 71.400000000000006 111.146 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 5.2 mp -71.09 -18.87 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.010000000000005 110.893 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.93 -26.18 5.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 54.539999999999999 110.901 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -74.96 -46.43 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 63.340000000000003 110.966 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 130' ' ' ILE . 2.8 m -82.31 -3.5 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.135 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.5 ttp85 -61.91 -58.77 15.94 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 64.129999999999995 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.3 Cg_endo -69.75 -14.68 36.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 51.219999999999999 112.352 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 2.7 m-85 -87.03 -55.81 3.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.886 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 126' ' ' ILE . 3.5 mm? -56.3 -55.64 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.439999999999998 110.901 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.59 -34.0 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -54.0 -27.25 30.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.124 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.47 -38.03 20.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.129999999999995 110.833 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.82 -23.27 1.8 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 71.230000000000004 112.472 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.03 -142.05 7.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 43.450000000000003 112.44 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -171.94 -176.26 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 51.130000000000003 110.885 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.65 HG11 HG23 ' A' ' 87' ' ' VAL . 19.1 m -137.44 138.18 45.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 111.104 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.88 136.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 54.140000000000001 111.128 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 77' ' ' ALA . 12.8 tp -83.05 112.96 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 71.150000000000006 110.888 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -77.71 -66.39 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.828 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -138.55 173.35 11.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.92 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 100' ' ' LEU . 58.0 mt -130.25 112.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 63.340000000000003 111.133 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.84 -169.57 2.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 34.409999999999997 111.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.99 -89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 63.329999999999998 112.491 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.27 23.12 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 64.049999999999997 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 t -146.11 148.62 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.400000000000006 111.122 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.87 127.29 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 111.11 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 100' ' ' LEU . 21.3 mtt-85 -82.53 100.97 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 72.450000000000003 110.901 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 80' ' ' VAL . 7.0 mt -116.43 127.37 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 53.030000000000001 110.906 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -86.55 100.17 12.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 71.109999999999999 110.911 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.941 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -128.0 129.73 47.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 73.099999999999994 110.948 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 91' ' ' LEU . 15.7 tt0 -133.1 141.18 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 70.340000000000003 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 74.409999999999997 112.486 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.927 0.394 . . . . 63.409999999999997 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.9 tp -51.98 -41.12 61.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.935 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.82 -36.72 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.097 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -56.84 -38.01 72.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.116 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 91' ' ' LEU . 25.2 pt -84.77 -31.21 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 111.122 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -51.74 -42.05 62.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.948 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -25.06 60.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 110.891 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.65 -57.28 5.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 71.150000000000006 112.474 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.941 HD13 HD22 ' A' ' 112' ' ' LEU . 4.4 mp -62.82 -53.46 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 63.439999999999998 111.154 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -52.19 -30.97 29.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.129999999999995 110.907 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -73.9 -34.73 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 72.400000000000006 110.848 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.5 -35.69 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.140000000000001 110.916 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.31 -51.69 28.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 73.450000000000003 110.939 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 mtt -51.66 -31.56 26.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.892 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.43 -28.57 30.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.895 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.96 -45.43 3.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.894 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.3 mp -113.31 75.12 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 72.420000000000002 111.119 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -8.76 24.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.724 2.283 . . . . 74.129999999999995 112.327 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.58 -51.92 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.42 144.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 73.450000000000003 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 -39.6 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -168.85 -175.99 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 111.08 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.65 147.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.126 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 61.43 110.9 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.78 0.241 . . . . 74.439999999999998 112.306 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.745 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.2 tm? -151.0 123.17 8.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 110.927 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -137.05 -177.36 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 61.049999999999997 111.146 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -54.24 -30.19 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 61.509999999999998 111.1 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.03 -61.01 2.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 72.519999999999996 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -56.77 -46.29 81.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 73.310000000000002 110.882 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HA ' HD21 ' A' ' 75' ' ' LEU . 6.8 p -49.96 -31.16 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 111.119 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -61.8 -39.83 93.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 110.908 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -63.92 -39.56 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 63.43 110.839 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -75.78 -42.49 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 70.519999999999996 111.136 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 98' ' ' VAL . 3.4 mp -71.35 -18.23 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 75.540000000000006 110.925 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.04 -27.58 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 60.109999999999999 110.857 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -76.44 -43.56 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.947 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 98' ' ' VAL . 10.4 p -82.46 -4.46 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 64.219999999999999 111.153 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.2 ttt-85 -60.62 -58.85 16.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 71.5 110.841 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.78 -7.29 20.7 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.692 2.262 . . . . 63.350000000000001 112.34 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -96.29 -64.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.898 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.725 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -53.48 -63.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 52.039999999999999 110.94 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 p -50.41 -31.19 14.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 63.439999999999998 111.15 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.83 -37.95 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 73.010000000000005 111.117 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.85 -36.83 80.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 53.039999999999999 110.842 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.12 -15.21 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 63.409999999999997 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.73 -128.1 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 55.340000000000003 112.535 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -170.79 142.37 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.878 0.37 . . . . 64.519999999999996 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.732 HG21 ' CG1' ' A' ' 87' ' ' VAL . 7.2 p -119.68 126.38 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.135 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.71 146.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 111.105 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 101' ' ' HIS . 11.1 tp -79.26 129.73 34.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 110.922 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.546 ' N ' HD12 ' A' ' 100' ' ' LEU . 33.4 t60 -93.37 -71.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 110.857 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.05 168.05 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.921 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.4 mt -123.47 109.06 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.310000000000002 111.098 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.64 -171.91 3.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 62.210000000000001 111.08 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.62 -91.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.510000000000005 112.489 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.34 22.75 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 61.310000000000002 110.858 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.543 HG11 ' OE1' ' A' ' 145' ' ' GLU . 21.5 t -145.15 150.22 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 111.13 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -114.96 127.51 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.144 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -89.08 101.45 14.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.828 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -109.41 152.62 25.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.928 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.434 ' O ' HD23 ' A' ' 112' ' ' LEU . 1.5 tttp -105.61 100.61 10.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.887 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.053 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -131.0 123.84 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 61.219999999999999 110.876 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -122.31 139.13 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.519999999999996 110.931 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.467 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.877 0.37 . . . . 74.129999999999995 110.845 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.68 -30.35 21.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 71.420000000000002 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.5 mm -86.82 -32.47 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 74.099999999999994 111.122 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -33.1 73.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 111.127 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.721 ' O ' HD12 ' A' ' 130' ' ' ILE . 41.4 pt -84.82 -26.76 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 65.349999999999994 111.126 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -51.0 -44.39 60.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 110.877 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -24.81 61.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 64.099999999999994 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.42 -52.12 28.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 52.329999999999998 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.053 HD13 HD13 ' A' ' 112' ' ' LEU . 3.8 mp -66.1 -55.52 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 72.349999999999994 111.12 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -52.24 -32.6 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -62.8 -41.34 99.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 61.130000000000003 110.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -79.07 -33.73 44.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 73.439999999999998 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -70.05 -56.72 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 110.889 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.6 tpp -56.56 -23.78 42.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 63.009999999999998 110.885 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.96 -45.28 78.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 63.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.627 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.7 mmtp -84.92 -46.41 11.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 54.140000000000001 110.907 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.39 76.84 2.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 74.25 111.125 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -9.7 26.74 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 74.299999999999997 112.354 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.9 -36.81 50.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 143' ' ' ALA . 16.3 t -75.37 151.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 111.159 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.53 -27.24 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 55.520000000000003 111.106 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.634 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.2 169.96 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 44.210000000000001 111.095 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.04 154.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.103 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.543 ' OE1' HG11 ' A' ' 107' ' ' VAL . 23.2 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 73.040000000000006 110.887 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.574 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.764 0.235 . . . . 74.450000000000003 112.311 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -141.42 123.68 15.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p -131.77 179.46 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 61.399999999999999 111.129 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.62 75.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 41.109999999999999 111.097 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.07 -47.82 7.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 53.43 112.471 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -65.68 -48.68 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 75.420000000000002 110.87 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.011 HG22 HD13 ' A' ' 84' ' ' LEU . 7.2 p -51.7 -31.03 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.152 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.44 -34.58 77.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 110.92 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -42.56 95.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 63.030000000000001 110.859 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.97 -42.05 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 111.148 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.011 HD13 HG22 ' A' ' 80' ' ' VAL . 4.9 mp -70.88 -18.76 62.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.230000000000004 110.943 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -52.12 -25.96 10.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.210000000000001 110.875 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -82.64 -43.55 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.927 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG22 HD23 ' A' ' 91' ' ' LEU . 8.8 p -82.75 1.36 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.12 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 92' ' ' THR . 20.6 ttt180 -68.14 -58.89 6.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 110.858 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.0 Cg_endo -69.75 -8.29 23.23 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.664 2.242 . . . . 75.420000000000002 112.361 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -98.91 -12.78 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.936 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.854 HD11 HD12 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -101.15 -64.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 73.450000000000003 110.926 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 t -60.13 -19.49 53.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.099999999999994 111.139 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.25 -32.66 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.109 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.15 -24.67 19.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 110.874 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.26 -17.09 2.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 34.140000000000001 112.5 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 -140.46 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 62.130000000000003 112.499 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.5 -172.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 110.864 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.764 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.2 m -148.65 136.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 64.510000000000005 111.14 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.36 122.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.519999999999996 111.122 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG11 ' A' ' 80' ' ' VAL . 10.0 tp -76.73 120.94 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 64.030000000000001 110.919 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.441 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.4 t60 -93.41 -73.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 110.871 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -115.94 165.98 12.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.914 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 108' ' ' VAL . 10.7 mt -132.13 104.49 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 111.182 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.36 -169.5 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 111.088 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.89 -81.84 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 75.140000000000001 112.481 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 4.2 p-10 -91.77 13.53 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 75.530000000000001 110.874 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 20.0 t -145.18 151.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 71.450000000000003 111.162 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 103' ' ' ILE . 95.7 t -121.43 128.58 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.340000000000003 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.0 mpt_? -79.78 100.82 8.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 71.420000000000002 110.848 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.82 HD22 HD21 ' A' ' 84' ' ' LEU . 9.1 mt -109.03 127.7 54.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.0 110.926 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -83.48 101.79 11.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.230000000000004 110.919 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD22 HD13 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -126.58 159.2 34.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 55.219999999999999 110.917 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -143.25 133.39 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 110.919 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 63.229999999999997 112.487 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.905 0.383 . . . . 65.209999999999994 110.838 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -51.95 -30.48 24.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 73.209999999999994 110.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.02 -30.84 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.409999999999997 111.134 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 m -69.37 -34.55 74.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 111.165 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.854 HD12 HD11 ' A' ' 91' ' ' LEU . 27.8 pt -84.05 -27.8 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 55.0 111.123 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -51.89 -41.72 62.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 110.903 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -24.67 60.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 53.140000000000001 110.853 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.54 -56.04 5.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 55.439999999999998 112.461 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 87' ' ' VAL . 4.8 mp -65.03 -50.76 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 74.530000000000001 111.116 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.791 ' HB3' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.46 -31.55 23.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.340000000000003 110.917 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.41 -44.15 83.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.150000000000006 110.874 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -75.54 -36.45 60.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 110.866 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.439 HD11 ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.81 -29.16 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 71.329999999999998 110.914 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.2 ttm -76.97 -36.42 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 70.540000000000006 110.892 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -51.98 -47.4 64.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.4 mmtp -90.64 -48.5 7.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 75.099999999999994 110.89 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -112.93 76.34 2.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.66 0.743 . . . . 64.409999999999997 111.098 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.6 24.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 75.219999999999999 112.337 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.18 -27.49 69.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 62.450000000000003 110.86 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -88.92 144.59 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.200000000000003 111.098 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -80.4 -42.45 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.084 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.53 -177.43 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.219999999999999 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 131' ' ' GLU . 8.5 m -131.42 140.72 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 53.350000000000001 111.143 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 53.149999999999999 110.931 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.814 0.256 . . . . 72.319999999999993 112.361 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.685 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.63 136.85 26.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.918 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 75' ' ' LEU . 13.9 p -144.16 -178.25 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 70.239999999999995 111.148 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.629 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -60.97 -35.14 76.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 111.115 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.24 -47.33 7.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 72.129999999999995 112.485 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -65.71 -48.71 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 74.329999999999998 110.846 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.047 HG22 HD13 ' A' ' 84' ' ' LEU . 7.3 p -51.46 -31.15 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 111.121 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.05 -35.45 78.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.912 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.8 t -63.08 -42.75 99.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 72.420000000000002 110.846 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 134' ' ' LEU . 22.2 t -77.18 -41.74 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.143 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.047 HD13 HG22 ' A' ' 80' ' ' VAL . 2.7 mp -68.54 -19.0 64.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.955 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.77 -25.47 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.519999999999996 110.828 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -73.33 -47.71 40.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 63.219999999999999 110.909 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.76 HG23 HG11 ' A' ' 98' ' ' VAL . 3.3 m -82.23 -7.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 111.113 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.4 ttt180 -56.07 -58.82 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 74.230000000000004 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -21.18 33.76 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 74.019999999999996 112.355 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -81.41 -27.75 34.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 45.119999999999997 110.959 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -92.43 -49.5 6.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 64.430000000000007 110.933 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -62.5 -21.56 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 61.310000000000002 111.107 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -61.09 -53.83 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 65.140000000000001 111.067 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.07 -36.15 83.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 75.540000000000006 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.88 -30.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 63.25 112.482 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.85 -150.75 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.45 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -175.3 153.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 74.409999999999997 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -116.08 135.93 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 111.115 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.12 127.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 41.350000000000001 111.087 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 77' ' ' ALA . 13.9 tp -71.23 122.83 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 110.979 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -90.28 -48.29 7.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 54.109999999999999 110.871 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -160.6 172.52 17.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 110.913 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.527 HD11 HD21 ' A' ' 100' ' ' LEU . 12.1 mt -129.33 125.71 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.049999999999997 111.103 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.35 102.22 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 55.140000000000001 111.089 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.59 -125.09 28.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 52.240000000000002 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.503 HD22 ' HB3' ' A' ' 142' ' ' ALA . 1.8 p-10 -77.48 -17.17 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 64.420000000000002 110.859 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.96 150.98 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 62.43 111.111 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 103' ' ' ILE . 56.4 t -125.2 137.36 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 73.439999999999998 111.097 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.1 mtt180 -93.88 101.82 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 62.530000000000001 110.834 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.735 HD22 HD21 ' A' ' 84' ' ' LEU . 3.6 mt -111.65 123.92 51.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 44.340000000000003 110.928 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 105.62 11.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 62.509999999999998 110.937 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -130.88 127.37 38.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 63.109999999999999 110.918 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 91' ' ' LEU . 30.5 tt0 -121.26 144.48 48.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.895 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 73.230000000000004 112.505 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 55.25 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.85 -30.21 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 71.319999999999993 110.885 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.85 -35.44 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 111.148 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -33.74 76.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 111.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.5 pt -81.92 -29.52 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.519999999999996 111.154 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.33 -45.57 62.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.893 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -24.91 63.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 73.519999999999996 110.885 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.24 -58.97 5.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 71.140000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -59.94 -54.93 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.129 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -51.9 -31.41 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 110.902 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -72.78 -35.69 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 65.409999999999997 110.869 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -76.08 -40.17 53.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.834 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.71 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.11 -30.26 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 64.439999999999998 110.963 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 22.6 mtt -69.67 -24.2 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 110.908 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -67.3 -48.51 67.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.519999999999996 110.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 138' ' ' ILE . 10.6 mmtt -84.03 -49.04 9.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.864 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.712 ' O ' HG12 ' A' ' 141' ' ' VAL . 5.4 mp -113.18 75.28 2.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 54.009999999999998 111.137 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -8.78 24.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.7 2.266 . . . . 44.399999999999999 112.346 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.12 -28.45 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.450000000000003 110.914 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -69.88 144.6 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 64.420000000000002 111.153 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.503 ' HB3' HD22 ' A' ' 106' ' ' ASN . . . -89.06 -39.65 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 111.09 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.7 171.83 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.200000000000003 111.084 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.79 151.94 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 60.329999999999998 111.125 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.7 0.762 . . . . 64.319999999999993 110.84 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.827 0.261 . . . . 71.519999999999996 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.52 HD21 ' CA ' ' A' ' 80' ' ' VAL . 3.0 tm? -93.45 130.82 39.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.872 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.457 ' N ' HD22 ' A' ' 75' ' ' LEU . 11.8 p -128.65 172.79 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 73.239999999999995 111.189 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -62.81 -27.01 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 52.210000000000001 111.079 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.78 -49.29 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 64.420000000000002 112.465 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -44.5 65.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 64.239999999999995 110.897 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.43 -31.43 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 75.040000000000006 111.119 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.93 -35.21 76.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.340000000000003 110.872 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -44.22 97.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 64.540000000000006 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 134' ' ' LEU . 25.3 t -77.21 -41.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.040000000000006 111.122 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -68.03 -19.4 64.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.912 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.21 -26.7 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 64.099999999999994 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -76.39 -44.0 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.040000000000006 110.903 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.727 ' CG2' HD23 ' A' ' 91' ' ' LEU . 10.8 p -81.5 -6.82 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.409999999999997 111.139 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.7 ttm180 -60.53 -58.8 16.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 63.530000000000001 110.885 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.79 -8.39 23.48 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.72 2.28 . . . . 73.200000000000003 112.354 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 3.8 t80 -94.63 -63.3 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.917 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -53.64 -49.05 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.891 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 88' ' ' ARG . 64.1 p -60.56 -28.53 68.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 65.430000000000007 111.137 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -56.88 -53.79 53.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 111.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.16 -24.96 65.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.0 6.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 75.219999999999999 112.455 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.09 -153.79 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 61.109999999999999 112.506 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -174.77 127.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 61.409999999999997 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.574 HG11 HG13 ' A' ' 87' ' ' VAL . 22.6 m -100.98 134.77 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 72.010000000000005 111.092 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.37 117.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 111.094 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD21 HD11 ' A' ' 103' ' ' ILE . 12.3 tp -63.03 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.946 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.47 ' N ' HD12 ' A' ' 100' ' ' LEU . 25.4 t60 -93.69 -74.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.540000000000006 110.853 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.36 171.36 9.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 61.219999999999999 110.915 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.565 HD11 HD21 ' A' ' 100' ' ' LEU . 37.0 mt -135.23 108.19 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.099 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.39 -172.05 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 65.099999999999994 111.119 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.39 -87.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 62.130000000000003 112.486 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -94.31 20.64 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 71.209999999999994 110.902 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.09 150.83 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.549999999999997 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.15 139.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.102 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mtp85 -99.4 101.05 12.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.876 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.5 mt -108.6 154.66 21.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.109999999999999 110.939 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -115.05 119.04 35.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -143.13 134.71 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 60.32 110.921 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.1 130.02 54.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.915 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.477 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.912 0.387 . . . . 74.519999999999996 110.841 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 pp -51.32 -30.67 19.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 64.150000000000006 110.929 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.72 -30.89 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.115 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -72.62 -34.64 67.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.74 HD12 HD11 ' A' ' 91' ' ' LEU . 26.7 pt -86.1 -30.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 63.030000000000001 111.145 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -50.85 -47.41 60.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 110.905 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -68.47 -24.77 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.869 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.78 -56.89 5.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 32.210000000000001 112.431 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.877 HD13 HD22 ' A' ' 112' ' ' LEU . 3.8 mp -62.9 -53.24 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 74.239999999999995 111.169 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -53.21 -31.78 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 110.891 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -68.43 -32.44 72.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.149999999999999 110.886 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -79.09 -46.0 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 110.852 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -61.52 -51.99 66.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 110.845 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 18.6 tpp -53.69 -39.4 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.88 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.1 -23.36 54.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 110.872 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -100.53 -37.88 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 62.329999999999998 110.867 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.83 80.23 2.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.124 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.7 2.267 . . . . 74.239999999999995 112.309 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.49 -26.79 62.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.434 . . . . 74.319999999999993 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 143' ' ' ALA . 34.8 t -83.19 149.38 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.13 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.53 -30.08 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.148 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.46 -173.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 111.123 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.25 164.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 55.149999999999999 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.685 0.755 . . . . 73.409999999999997 110.853 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.86 0.275 . . . . 65.5 112.354 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.658 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -142.67 135.84 28.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.935 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.4 p -145.07 172.43 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 71.209999999999994 111.126 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.33 -30.37 18.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.140000000000001 111.131 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.3 -62.3 2.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 53.420000000000002 112.471 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -55.38 -47.83 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 73.239999999999995 110.863 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 8.1 p -50.64 -31.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 111.163 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.26 -37.55 83.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 73.140000000000001 110.866 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -42.7 99.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.5 t -77.1 -39.87 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 71.530000000000001 111.102 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 2.3 mp -70.63 -18.69 62.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 74.310000000000002 110.909 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.15 -25.88 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.888 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.03 -47.59 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 110.916 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 130' ' ' ILE . 3.6 m -82.64 -3.49 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 111.131 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.0 ttt180 -60.78 -58.74 17.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 73.319999999999993 110.872 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.2 Cg_endo -69.78 -10.92 29.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.65 2.234 . . . . 74.310000000000002 112.366 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.15 -32.55 14.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.943 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -85.94 -59.68 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 61.409999999999997 110.958 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' OD1' ' A' ' 97' ' ' ASP . 37.5 p -51.74 -39.39 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.310000000000002 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 51.399999999999999 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.69 -37.96 67.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 71.319999999999993 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.85 -38.57 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 63.039999999999999 112.525 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -73.76 -135.89 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 32.100000000000001 112.519 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' A' ' 92' ' ' THR . 10.0 t0 -174.9 175.99 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 61.329999999999998 110.825 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 112' ' ' LEU . 19.0 m -138.28 138.59 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 71.140000000000001 111.155 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.32 131.51 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 41.219999999999999 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.576 HD12 HG11 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -78.01 118.55 20.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.918 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -97.64 -64.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 72.209999999999994 110.865 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.43 165.08 16.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 110.882 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 108' ' ' VAL . 69.8 mt -138.5 113.36 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 111.137 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -90.56 -169.34 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.37 -90.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 65.409999999999997 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -85.98 4.94 35.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 75.519999999999996 110.867 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 19.6 t -133.39 151.19 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.145 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 103' ' ' ILE . 96.1 t -123.71 140.37 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 34.5 111.114 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 100.97 13.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 65.219999999999999 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.12 123.17 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 71.140000000000001 110.939 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -73.23 86.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 34.109999999999999 110.891 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -117.99 129.64 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 110.916 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -131.05 141.39 50.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 73.230000000000004 110.9 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.240000000000002 112.498 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.943 0.401 . . . . 72.129999999999995 110.861 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -54.34 -29.83 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.420000000000002 110.884 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.4 mm -85.11 -31.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 54.439999999999998 111.169 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.8 m -68.15 -34.36 76.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.420000000000002 111.124 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.717 ' CD1' HD11 ' A' ' 91' ' ' LEU . 24.5 pt -86.03 -30.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 111.135 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -52.64 -47.1 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 71.049999999999997 110.891 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -69.11 -24.88 64.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 75.099999999999994 110.885 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.25 -57.59 6.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.681 -0.771 . . . . 74.439999999999998 112.475 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -60.74 -55.31 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.34 . . . . 51.310000000000002 111.114 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HB3' HG22 ' A' ' 144' ' ' VAL . 22.5 pt-20 -51.68 -31.81 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 70.040000000000006 110.898 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -71.3 -36.77 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 64.209999999999994 110.908 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -79.03 -36.38 41.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 61.240000000000002 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.807 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.23 -33.54 71.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.439999999999998 110.925 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 3.2 mtm -63.91 -27.72 69.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 75.420000000000002 110.872 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.68 -58.55 8.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 71.230000000000004 110.881 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.719 ' HB2' HD12 ' A' ' 138' ' ' ILE . 4.3 mttm -77.62 -47.41 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 73.549999999999997 110.881 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.56 74.33 2.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.64 0.734 . . . . 73.209999999999994 111.114 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -14.31 35.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.623 2.215 . . . . 54.299999999999997 112.372 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -38.46 55.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.876 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.04 144.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 53.030000000000001 111.102 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.33 -53.66 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.128 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.13 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.1 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 131' ' ' GLU . 15.9 m -138.63 148.51 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 63.329999999999998 111.094 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.651 0.739 . . . . 64.329999999999998 110.867 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.609 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.795 0.248 . . . . 74.549999999999997 112.335 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 108' ' ' VAL . 5.1 tt -89.48 106.97 18.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.929 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 79' ' ' ASN . 6.6 t -135.58 166.04 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 74.140000000000001 111.144 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -27.39 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 111.086 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.16 -59.04 3.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 33.229999999999997 112.478 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.507 ' H ' HG23 ' A' ' 76' ' ' THR . 79.0 m-20 -62.23 -48.02 81.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 74.219999999999999 110.909 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.023 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.6 -30.99 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 61.030000000000001 111.143 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -61.79 -38.15 87.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 72.349999999999994 110.887 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -67.38 -37.85 83.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 52.149999999999999 110.868 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 134' ' ' LEU . 59.4 t -77.04 -39.41 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 111.147 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 80' ' ' VAL . 4.2 mp -71.1 -19.16 62.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.340000000000003 110.912 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.84 -26.89 10.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.87 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -76.35 -43.42 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG2' HD23 ' A' ' 91' ' ' LEU . 11.9 p -81.4 -7.35 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 73.319999999999993 111.086 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.7 ttm-85 -60.18 -58.79 16.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.603 0.716 . . . . 71.430000000000007 110.877 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.1 Cg_endo -69.83 -8.49 23.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.669 2.246 . . . . 74.439999999999998 112.32 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 5.5 t80 -94.55 -63.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 110.94 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -53.09 -54.77 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 62.329999999999998 110.891 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -51.48 -34.77 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.329999999999998 111.154 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -59.65 -37.18 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 54.25 111.06 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.89 -31.7 63.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.842 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.7 17.1 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 62.229999999999997 112.504 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.38 -135.96 8.84 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 53.409999999999997 112.477 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -179.16 136.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 74.040000000000006 110.851 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.8 m -110.13 129.45 65.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.141 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -167.8 129.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 42.200000000000003 111.098 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HA ' HD23 ' A' ' 110' ' ' LEU . 11.5 tp -71.78 119.65 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -76.96 -72.28 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 72.010000000000005 110.877 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.75 171.1 14.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.85 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.418 HD11 HD21 ' A' ' 100' ' ' LEU . 58.1 mt -125.91 121.35 59.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 54.329999999999998 111.101 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.24 -170.51 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 50.32 111.074 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.01 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 54.439999999999998 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 23.41 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 64.129999999999995 110.908 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.171 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.049 HG21 HD13 ' A' ' 75' ' ' LEU . 60.6 t -116.18 138.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.174 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 100' ' ' LEU . 24.1 mtp180 -101.02 101.05 11.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.872 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.1 mt -107.91 164.62 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 54.340000000000003 110.887 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.72 115.81 19.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 63.229999999999997 110.905 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -138.71 137.9 37.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.894 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.38 113.13 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.340000000000003 110.898 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 72.420000000000002 112.502 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.96 0.409 . . . . 44.210000000000001 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.67 -47.67 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 73.219999999999999 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.57 -31.2 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.129999999999995 111.122 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -61.66 -39.92 93.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.14 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 130' ' ' ILE . 30.1 pt -86.17 -29.99 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 111.135 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -50.75 -47.67 59.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 72.25 110.882 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.76 -24.71 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 60.149999999999999 110.839 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.15 -55.76 6.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.771 -0.728 . . . . 33.450000000000003 112.458 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 112' ' ' LEU . 4.0 mp -62.87 -54.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 111.134 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -52.88 -32.6 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 55.399999999999999 110.904 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.67 -32.74 74.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.868 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -78.88 -56.42 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.995 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -52.0 -35.65 47.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 51.200000000000003 110.893 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.1 mtt -62.78 -40.35 97.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 55.350000000000001 110.897 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.31 -20.07 57.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HZ2' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.67 -33.81 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 63.130000000000003 110.902 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.767 ' O ' HG12 ' A' ' 141' ' ' VAL . 11.5 mm -112.34 76.89 2.05 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 44.219999999999999 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -7.6 21.48 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.439999999999998 112.378 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.94 -29.53 35.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 63.32 110.879 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 138' ' ' ILE . 9.8 p -72.28 158.47 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.010000000000005 111.108 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -99.37 -47.29 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.147 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.24 -173.8 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 61.43 111.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.75 164.85 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 72.310000000000002 110.96 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.208 0 CA-C-O 120.843 0.268 . . . . 71.430000000000007 112.346 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.3 tm? -145.68 140.11 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 64.040000000000006 110.943 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.0 t -142.74 167.72 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 71.239999999999995 111.144 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.32 -28.35 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.07 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.88 -42.5 12.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.736 . . . . 60.0 112.472 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 76' ' ' THR . 1.9 m120 -72.65 -47.18 49.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.366 . . . . 63.539999999999999 110.91 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.831 HG22 HD13 ' A' ' 84' ' ' LEU . 9.5 p -50.78 -30.8 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 62.409999999999997 111.136 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.94 -37.08 83.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.912 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.71 -39.57 73.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 73.450000000000003 110.86 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.8 t -72.46 -44.74 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 61.530000000000001 111.097 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.831 HD13 HG22 ' A' ' 80' ' ' VAL . 6.5 mp -71.21 -18.97 62.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.93 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.8 -26.12 5.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.862 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -75.06 -45.46 41.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.892 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 130' ' ' ILE . 2.6 m -81.62 -7.06 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.030000000000001 111.157 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 17.7 ttt-85 -58.56 -58.8 16.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 71.319999999999993 110.885 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.7 -8.85 24.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.278 . . . . 72.099999999999994 112.353 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.1 -25.47 15.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.913 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.772 HD11 HD13 ' A' ' 126' ' ' ILE . 2.3 mm? -93.7 -57.32 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -53.11 -36.33 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 53.439999999999998 111.155 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.59 -28.74 70.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 111.088 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -76.81 -38.05 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 72.5 110.87 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.41 -39.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 73.400000000000006 112.495 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.48 -137.77 1.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 71.129999999999995 112.464 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -174.77 -175.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 74.519999999999996 110.825 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -137.94 138.96 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 71.349999999999994 111.121 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.42 123.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 111.13 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 109' ' ' ARG . 21.2 tp -66.12 133.59 51.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.967 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.408 ' N ' HD12 ' A' ' 100' ' ' LEU . 2.1 t60 -100.18 -63.53 1.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 62.32 110.823 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -144.75 163.87 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.894 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.406 HD11 HD21 ' A' ' 100' ' ' LEU . 54.8 mt -123.11 114.5 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 111.16 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.43 -172.32 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 62.100000000000001 111.147 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.63 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.99 25.06 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 55.119999999999997 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -144.69 151.01 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.42 128.96 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 111.127 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.7 mtt-85 -90.16 103.33 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.904 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.8 HD22 HD21 ' A' ' 84' ' ' LEU . 1.6 mt -112.82 133.67 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 60.149999999999999 110.896 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -86.07 91.76 8.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.895 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -119.44 131.33 55.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.510000000000005 110.877 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.512 ' O ' HD12 ' A' ' 91' ' ' LEU . 40.6 tt0 -127.84 127.01 42.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 62.039999999999999 110.895 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 75.120000000000005 112.468 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.907 0.384 . . . . 72.150000000000006 110.826 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -52.38 -30.12 27.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 62.149999999999999 110.935 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.97 -36.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 111.107 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -60.04 -34.02 72.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 72.120000000000005 111.137 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.772 HD13 HD11 ' A' ' 91' ' ' LEU . 49.9 pt -86.14 -26.83 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 111.106 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -51.07 -48.6 61.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.32 110.873 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -66.35 -24.7 66.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 65.310000000000002 110.858 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.13 -57.23 6.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.763 -0.732 . . . . 62.119999999999997 112.471 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.08 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -63.09 -54.54 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 75.5 111.132 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -31.74 25.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 55.020000000000003 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -69.27 -44.35 72.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 110.86 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -69.75 -39.98 76.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 110.852 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -70.21 -47.74 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 64.530000000000001 110.935 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.7 mmt -55.11 -26.49 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 63.310000000000002 110.89 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.4 -62.68 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.863 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.69 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.4 mttt -71.84 -47.27 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.885 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.24 75.06 2.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 54.109999999999999 111.103 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -11.06 30.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.65 2.233 . . . . 75.150000000000006 112.368 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -51.92 -43.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 54.32 110.878 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.99 148.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 111.118 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.42 -33.0 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 71.310000000000002 111.113 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -175.56 177.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.09 147.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 32.030000000000001 111.137 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.737 . . . . 62.5 110.868 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HG23 ' A' ' 138' ' ' ILE . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.849 0.27 . . . . 64.510000000000005 112.363 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 80' ' ' VAL . 3.3 tm? -144.95 120.14 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 62.109999999999999 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -134.51 -176.69 4.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 61.439999999999998 111.142 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.57 70.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 55.130000000000003 111.081 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.5 -52.28 4.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 71.439999999999998 112.474 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -61.22 -48.45 81.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 73.340000000000003 110.879 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 84' ' ' LEU . 5.8 p -51.79 -30.77 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 54.049999999999997 111.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.34 -33.58 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 72.409999999999997 110.947 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 t -63.93 -43.93 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 72.230000000000004 110.87 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 134' ' ' LEU . 48.4 t -76.5 -40.77 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 111.123 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 80' ' ' VAL . 3.1 mp -71.11 -18.97 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -51.26 -26.85 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 65.310000000000002 110.875 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -74.48 -42.23 59.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.510000000000005 110.921 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.848 HG11 HG13 ' A' ' 130' ' ' ILE . 33.7 m -81.96 -12.88 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.164 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.5 ttt85 -53.04 -58.59 11.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.587 0.708 . . . . 73.219999999999999 110.891 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.8 Cg_endo -69.77 -32.13 19.14 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 73.5 112.323 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -65.92 -57.7 7.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.955 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.8 mm? -58.05 -54.81 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 71.299999999999997 110.94 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.643 HG22 ' OD1' ' A' ' 97' ' ' ASP . 40.1 p -51.6 -30.57 21.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 54.549999999999997 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.96 -36.74 78.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.126 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.18 -38.03 61.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 63.539999999999999 110.89 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.76 -26.62 2.37 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 63.219999999999999 112.461 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.73 -136.84 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.492 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.643 ' OD1' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -179.39 -175.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 63.030000000000001 110.881 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.5 m -141.79 143.95 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.519999999999996 111.183 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.78 131.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.124 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HA ' HD13 ' A' ' 110' ' ' LEU . 25.0 tp -53.69 114.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 70.329999999999998 110.876 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -80.78 -49.98 10.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -168.41 167.9 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.889 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 100' ' ' LEU . 69.7 mt -127.97 105.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 74.140000000000001 111.141 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.32 -178.08 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 111.092 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.16 -75.88 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.747 . . . . 71.049999999999997 112.528 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -0.14 21.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 62.140000000000001 110.935 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 16.3 t -119.62 152.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 111.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 141' ' ' VAL . 19.6 t -113.78 142.85 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 52.439999999999998 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -115.13 100.42 8.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.899 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.2 mm? -100.69 146.29 27.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.895 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -102.29 124.05 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 75.340000000000003 110.892 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.956 HD13 HD13 ' A' ' 130' ' ' ILE . 6.4 mt -140.4 156.97 46.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 70.200000000000003 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -132.78 114.72 14.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 72.299999999999997 110.925 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 60.439999999999998 112.507 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.928 0.394 . . . . 74.430000000000007 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.97 -32.86 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 74.200000000000003 110.892 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.52 -31.02 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 65.420000000000002 111.12 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -40.65 97.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.161 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.6 pt -84.01 -30.91 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 65.439999999999998 111.066 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -52.0 -41.66 62.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.951 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -24.81 60.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 70.099999999999994 110.871 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.17 -54.81 7.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 53.329999999999998 112.549 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.956 HD13 HD13 ' A' ' 112' ' ' LEU . 3.3 mp -58.46 -50.92 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 72.239999999999995 111.106 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 144' ' ' VAL . 12.5 pt-20 -58.84 -34.73 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -76.68 -30.33 56.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -79.21 -34.32 43.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.549999999999997 110.858 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.686 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -57.08 5.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.972 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.4 ttm -50.89 -30.73 15.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 71.340000000000003 110.905 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -60.38 -37.56 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.948 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.724 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.0 mttm -91.7 -45.37 8.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 71.340000000000003 110.886 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.0 mp -113.41 73.74 2.0 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 74.230000000000004 111.117 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.87 36.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 74.219999999999999 112.347 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.71 -47.55 82.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 51.020000000000003 110.861 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.9 p -55.84 131.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.049999999999997 111.129 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.31 63.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 55.030000000000001 111.078 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.48 178.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 65.439999999999998 111.113 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 131' ' ' GLU . 2.1 p -139.85 134.47 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.129 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 64.140000000000001 110.92 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.858 0.274 . . . . 54.530000000000001 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.606 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.61 134.49 25.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 72.409999999999997 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.485 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.9 p -145.34 173.02 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.219999999999999 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.22 -30.52 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 51.119999999999997 111.094 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.08 -62.28 2.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 73.519999999999996 112.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -47.93 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 71.430000000000007 110.907 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 8.2 p -50.77 -30.88 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 55.149999999999999 111.112 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -61.63 -38.07 86.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.935 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -64.62 -40.39 95.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.400000000000006 110.846 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -76.49 -39.04 32.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 111.144 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 3.2 mp -71.06 -19.4 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 61.509999999999998 110.894 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.3 -26.83 20.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 75.030000000000001 110.857 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -75.32 -43.45 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.93 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.648 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.2 p -81.45 -9.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 45.109999999999999 111.09 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.8 ttt180 -56.67 -58.71 15.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 65.430000000000007 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -12.57 33.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.694 2.263 . . . . 73.010000000000005 112.302 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -92.14 -25.99 18.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 110.905 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 126' ' ' ILE . 1.6 mm? -101.0 -57.38 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.956 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 88' ' ' ARG . 29.9 p -52.33 -35.92 52.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 111.167 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.81 72.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 31.109999999999999 111.113 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.08 -37.98 69.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 110.89 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.45 -35.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.762 -0.732 . . . . 72.340000000000003 112.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -141.13 1.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.771 . . . . 75.150000000000006 112.47 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -170.19 -176.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 62.409999999999997 110.821 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 112' ' ' LEU . 18.8 m -141.93 138.43 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 53.109999999999999 111.104 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.74 137.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 52.240000000000002 111.083 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HA ' HD23 ' A' ' 110' ' ' LEU . 35.3 tp -76.28 135.53 39.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 60.43 110.951 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -103.5 -63.95 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 65.540000000000006 110.862 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.15 162.49 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.882 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 100' ' ' LEU . 58.2 mt -126.98 117.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 53.240000000000002 111.143 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -98.64 -169.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.125 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.94 -88.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 70.25 112.507 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 142' ' ' ALA . 9.6 p30 -102.55 13.45 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 62.130000000000003 110.877 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.54 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.9 t -131.33 139.03 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.63 134.81 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 65.409999999999997 111.072 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.95 101.09 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.299999999999997 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.6 mt -112.29 149.19 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 72.450000000000003 110.898 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -101.3 119.07 38.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.420000000000002 110.932 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 130' ' ' ILE . 7.6 mt -139.49 127.76 22.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.948 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -104.92 137.11 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 73.439999999999998 110.895 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 72.010000000000005 112.502 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.899 0.38 . . . . 75.340000000000003 110.812 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -31.08 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 74.420000000000002 110.936 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mm -88.07 -30.98 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 65.150000000000006 111.167 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 m -72.22 -33.3 67.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 111.163 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.779 HD12 HD11 ' A' ' 91' ' ' LEU . 25.4 pt -83.65 -30.91 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.164 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -51.8 -51.58 55.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.319999999999993 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.9 -24.93 66.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 64.040000000000006 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.6 -61.78 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 62.240000000000002 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -55.9 -54.73 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 63.219999999999999 111.147 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -52.53 -32.45 40.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 65.209999999999994 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -75.44 -32.43 60.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -76.34 -35.63 58.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.349999999999994 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.1 -48.12 58.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 110.914 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.96 -33.24 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.888 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.61 -55.25 23.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.9 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.637 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.4 OUTLIER -80.06 -45.83 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.899 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.642 HD13 ' CD2' ' A' ' 134' ' ' LEU . 5.2 mp -113.09 74.96 1.95 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.667 0.746 . . . . 73.420000000000002 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.86 33.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 61.130000000000003 112.333 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.76 -52.8 46.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 61.310000000000002 110.863 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.44 151.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 111.109 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' OD1' ' A' ' 106' ' ' ASN . . . -87.49 -45.75 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.37 -169.44 2.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.095 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.72 148.54 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 62.340000000000003 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.54 ' CG ' HG11 ' A' ' 107' ' ' VAL . 14.7 mm-40 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 64.349999999999994 110.896 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.808 0.253 . . . . 71.430000000000007 112.332 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.729 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.3 tm? -152.19 128.02 10.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 62.509999999999998 110.943 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.422 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.1 p -143.22 -178.15 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 111.167 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 54.130000000000003 111.089 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.4 -64.08 1.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 70.409999999999997 112.455 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.54 -46.73 73.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 74.120000000000005 110.846 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.989 HG22 HD13 ' A' ' 84' ' ' LEU . 5.9 p -51.24 -30.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 111.124 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.32 -35.62 77.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -42.3 73.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.520000000000003 110.881 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.769 HG11 ' HA ' ' A' ' 134' ' ' LEU . 29.4 t -71.47 -44.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 74.349999999999994 111.087 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 80' ' ' VAL . 5.7 mp -71.13 -19.43 62.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 60.219999999999999 110.904 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.19 -26.95 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.866 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -74.51 -41.38 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 60.340000000000003 110.895 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.649 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.8 p -83.02 -12.58 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 63.520000000000003 111.106 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 18.9 ttt180 -53.17 -58.75 11.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.709 . . . . 74.109999999999999 110.904 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -19.51 36.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 72.540000000000006 112.347 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -83.8 -24.13 31.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 62.020000000000003 110.898 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.4 mm? -101.04 -55.53 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.299999999999997 110.948 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.3 p -51.68 -39.35 58.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.0 111.112 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.68 69.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 71.329999999999998 111.116 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -72.17 -37.81 69.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.120000000000005 110.931 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.73 -28.0 1.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 74.209999999999994 112.484 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.86 -138.27 4.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 73.310000000000002 112.493 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -173.56 -175.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 64.219999999999999 110.838 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.463 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.8 m -141.09 141.33 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 72.319999999999993 111.136 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.4 132.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.209999999999994 111.094 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -69.27 117.19 10.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 63.25 110.933 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -80.8 -57.87 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.882 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -152.75 161.1 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.219999999999999 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.37 118.38 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.77 -177.08 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.131 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.39 -86.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 61.020000000000003 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.64 25.18 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 54.030000000000001 110.874 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 145' ' ' GLU . 22.0 t -145.26 149.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.103 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.78 115.77 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 61.109999999999999 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -82.7 101.19 10.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.200000000000003 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -112.11 150.88 30.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.109999999999999 110.946 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -106.29 117.23 33.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 110.908 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -132.04 139.28 48.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 70.209999999999994 110.934 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -122.06 119.24 30.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.968 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 64.409999999999997 112.476 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 54.340000000000003 110.851 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.95 -29.92 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.209999999999994 110.888 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.59 -42.66 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 111.097 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 m -53.37 -35.94 60.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.6 pt -85.94 -30.22 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 73.120000000000005 111.138 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -51.38 -41.93 61.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 110.915 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -25.59 61.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 110.839 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.71 -57.14 6.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 64.140000000000001 112.481 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 112' ' ' LEU . 4.3 mp -60.54 -54.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 62.219999999999999 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.87 -31.85 41.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -70.35 -48.28 57.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 110.847 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -63.34 -40.82 98.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.847 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.769 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.98 -45.9 66.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 62.009999999999998 110.933 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.7 mtt -59.53 -23.84 63.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.230000000000004 110.876 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -71.33 -52.53 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.878 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.702 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.7 mmpt? -75.22 -55.12 6.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 72.209999999999994 110.895 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.95 76.03 2.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.638 0.732 . . . . 53.439999999999998 111.17 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -8.85 24.65 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 62.100000000000001 112.329 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.08 -30.73 27.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 75.519999999999996 110.847 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -79.43 144.18 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 62.5 111.155 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.16 -53.1 7.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.056 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.5 -169.93 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 73.120000000000005 111.128 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.21 153.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 61.350000000000001 111.11 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 107' ' ' VAL . 13.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.129999999999995 110.909 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.78 0.242 . . . . 72.109999999999999 112.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.708 HD23 HD13 ' A' ' 138' ' ' ILE . 3.0 tm? -150.17 117.45 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 71.519999999999996 110.914 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 80' ' ' VAL . 16.5 p -135.48 179.7 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 111.098 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.16 -30.24 16.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 43.43 111.09 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.21 -63.25 2.08 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.738 . . . . 64.299999999999997 112.511 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -54.94 -47.23 74.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.019999999999996 110.865 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 84' ' ' LEU . 6.9 p -51.53 -31.14 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.040000000000006 111.143 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.44 -35.64 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 45.450000000000003 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -67.58 -40.22 84.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 53.210000000000001 110.883 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.7 t -75.91 -45.36 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 111.136 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mp -72.18 -18.27 61.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.420000000000002 110.94 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -50.48 -26.8 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 110.889 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.4 -42.81 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 63.200000000000003 110.931 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.756 HG21 HG13 ' A' ' 130' ' ' ILE . 11.1 p -80.85 -14.88 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 54.119999999999997 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.3 ttp85 -51.07 -58.65 9.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.583 0.706 . . . . 70.319999999999993 110.846 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.76 -26.53 27.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.256 . . . . 73.340000000000003 112.368 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -76.15 -22.11 55.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 64.200000000000003 110.956 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.641 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.2 mm? -100.58 -51.5 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 74.209999999999994 110.866 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.5 p -56.86 -30.75 64.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 55.450000000000003 111.155 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.66 -27.21 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 53.539999999999999 111.046 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.03 -38.0 19.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.869 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.74 -35.75 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 45.530000000000001 112.447 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.89 -144.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 52.509999999999998 112.463 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -177.34 168.81 2.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.384 . . . . 71.400000000000006 110.855 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 112' ' ' LEU . 22.8 m -125.23 135.62 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.167 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.17 125.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 14.539999999999999 111.098 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 103' ' ' ILE . 10.5 tp -75.68 117.65 17.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.519999999999996 110.972 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -83.77 -74.38 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 42.25 110.867 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -125.61 168.48 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 65.409999999999997 110.873 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 HD21 ' A' ' 100' ' ' LEU . 69.8 mt -130.22 123.28 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.0 111.172 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.36 -169.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.200000000000003 111.063 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.27 -87.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 62.109999999999999 112.482 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.43 -6.59 37.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 75.430000000000007 110.852 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 t -113.9 151.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 103' ' ' ILE . 73.3 t -119.98 133.28 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.095 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.58 102.65 15.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.858 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 100' ' ' LEU . 3.4 mt -108.44 151.08 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.91 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -104.28 90.31 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.939 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 130' ' ' ILE . 9.8 mt -120.45 129.62 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 72.319999999999993 110.902 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -129.86 159.09 37.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.509999999999998 110.909 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 31.109999999999999 112.507 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.862 0.363 . . . . 54.32 110.858 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 124' ' ' ILE . 1.4 pp -53.72 -28.01 31.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 110.89 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 123' ' ' LEU . 25.2 mm -81.18 -30.98 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 63.399999999999999 111.135 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -31.67 70.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 70.099999999999994 111.155 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 130' ' ' ILE . 32.6 pt -86.18 -28.39 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 62.329999999999998 111.073 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -52.89 -35.94 58.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.875 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -75.28 -26.25 58.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.92 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.27 -54.46 6.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.699 -0.762 . . . . 53.420000000000002 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 112' ' ' LEU . 4.4 mp -63.94 -44.6 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 73.549999999999997 111.16 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -64.69 -22.84 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.956 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -76.67 -51.33 11.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 72.120000000000005 110.832 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -73.41 -33.48 64.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.863 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 84' ' ' LEU . 14.3 tp -69.93 -47.5 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 70.010000000000005 110.95 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.4 ttm -68.9 -28.12 66.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.109999999999999 110.86 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -51.99 -53.83 36.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -70.56 -49.16 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.907 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.708 HD13 HD23 ' A' ' 75' ' ' LEU . 5.3 mp -112.99 76.16 2.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 75.109999999999999 111.184 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.72 24.33 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.728 2.285 . . . . 71.409999999999997 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -53.11 -28.72 26.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 110.887 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.0 p -81.45 144.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 111.117 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.58 -52.57 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 55.130000000000003 111.076 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.89 -173.18 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 111.086 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.35 163.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 111.13 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.618 0.723 . . . . 54.200000000000003 110.888 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.209 0 CA-C-O 120.812 0.255 . . . . 62.130000000000003 112.303 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.688 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -152.82 128.2 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.340000000000003 110.908 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.469 ' N ' HD13 ' A' ' 75' ' ' LEU . 17.0 p -144.82 178.91 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 61.240000000000002 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.11 -30.3 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 51.310000000000002 111.073 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.97 -62.96 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 41.130000000000003 112.514 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -55.31 -47.56 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 73.5 110.947 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 134' ' ' LEU . 7.2 p -51.23 -31.12 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 55.039999999999999 111.183 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.01 -36.69 84.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 74.219999999999999 110.901 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -66.89 -40.66 87.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 64.109999999999999 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 27.4 t -74.96 -45.35 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.140000000000001 111.161 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.729 HD13 HG22 ' A' ' 80' ' ' VAL . 9.0 mp -71.86 -18.16 62.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 54.130000000000003 110.933 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.9 -26.98 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 110.849 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -74.61 -43.03 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.943 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.802 HG21 HG13 ' A' ' 130' ' ' ILE . 11.8 p -80.49 -14.73 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.450000000000003 111.142 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.2 ttm180 -51.6 -58.75 9.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 73.420000000000002 110.882 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.4 Cg_endo -69.74 -27.48 26.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 54.439999999999998 112.355 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -74.22 -25.01 59.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 70.439999999999998 110.92 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.626 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.4 mm? -98.77 -52.16 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 75.230000000000004 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -54.29 -32.5 56.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 111.132 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.77 71.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.510000000000005 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -79.7 -37.45 35.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.861 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.87 -42.66 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 11.4 112.48 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.11 -142.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 64.109999999999999 112.477 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -175.93 -177.39 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 65.319999999999993 110.858 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG12 ' CD2' ' A' ' 112' ' ' LEU . 33.3 m -138.6 132.96 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 111.129 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.27 123.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 73.239999999999995 111.104 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 80' ' ' VAL . 1.4 tt -71.5 116.0 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 54.399999999999999 110.896 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -75.88 -65.59 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 54.329999999999998 110.886 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.54 165.43 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 72.439999999999998 110.873 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.19 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.010000000000005 111.108 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.9 -176.44 3.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 62.229999999999997 111.094 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.47 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.461 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -96.28 25.46 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 42.240000000000002 110.869 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.494 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.7 t -144.98 150.06 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 62.130000000000003 111.121 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 141' ' ' VAL . 42.8 t -124.91 117.06 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 111.139 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 100' ' ' LEU . 36.5 mtt85 -82.33 100.93 10.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.836 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 134' ' ' LEU . 4.4 mt -105.22 146.52 29.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.932 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -105.78 103.1 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.682 ' CD2' HG12 ' A' ' 98' ' ' VAL . 3.9 mt -126.58 144.11 51.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.94 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -124.7 146.8 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 110.964 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 63.43 112.446 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 75.140000000000001 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.23 -30.23 26.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.915 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.23 -38.31 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 111.151 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -35.23 76.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 72.239999999999995 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 26.6 pt -85.89 -31.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 71.519999999999996 111.096 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.0 -45.19 71.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 45.409999999999997 110.86 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -73.01 -24.84 60.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 65.349999999999994 110.877 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.17 -60.28 3.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 34.100000000000001 112.477 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.802 HG13 HG21 ' A' ' 87' ' ' VAL . 2.9 mp -59.12 -50.06 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.748 0.309 . . . . 74.519999999999996 111.094 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -57.61 -25.63 60.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.854 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -80.04 -51.55 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.200000000000003 110.863 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -64.65 -36.32 83.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 52.409999999999997 110.89 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 80' ' ' VAL . 27.0 tp -70.14 -35.82 74.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.109999999999999 110.917 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.611 ' CE ' HG13 ' A' ' 144' ' ' VAL . 16.7 mtt -78.64 -29.56 45.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.209999999999994 110.893 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -51.91 -34.96 43.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.896 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 138' ' ' ILE . 17.2 mmtm -91.87 -37.6 12.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 65.319999999999993 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.688 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -127.34 75.12 77.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 62.219999999999999 111.103 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -8.19 22.98 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.671 2.248 . . . . 64.239999999999995 112.355 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -51.45 -30.7 20.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 110.875 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.3 p -76.28 144.01 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.120000000000005 111.127 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -77.24 -53.24 7.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -157.31 -175.68 5.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 111.124 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.611 HG13 ' CE ' ' A' ' 135' ' ' MET . 18.3 m -130.13 147.9 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 111.126 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.494 ' CG ' HG11 ' A' ' 107' ' ' VAL . 16.3 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 63.149999999999999 110.927 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.819 0.258 . . . . 73.340000000000003 112.34 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.719 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.27 111.17 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 72.239999999999995 110.951 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 p -119.98 -177.67 3.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.43 . . . . 73.25 111.124 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.89 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 70.430000000000007 111.067 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 -46.13 8.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.728 . . . . 52.450000000000003 112.473 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.96 -46.74 73.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.354 . . . . 73.140000000000001 110.866 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 7.8 p -54.1 -31.16 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 111.159 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.85 -23.81 67.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 t -71.91 -45.92 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 110.835 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.3 p -77.08 -34.64 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 72.329999999999998 111.102 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 3.5 mp -71.58 -19.82 62.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.952 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -53.65 -26.66 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.420000000000002 110.855 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.62 -42.97 57.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 110.94 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' HG ' ' A' ' 91' ' ' LEU . 13.9 p -80.69 -14.42 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.210000000000001 111.131 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 ttt180 -51.86 -58.63 10.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.714 . . . . 74.340000000000003 110.848 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.268 . . . . 75.420000000000002 112.336 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.34 -57.39 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 64.010000000000005 110.891 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 87' ' ' VAL . 10.6 mt -68.33 -44.27 75.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 55.329999999999998 110.925 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 88' ' ' ARG . 41.1 p -53.74 -29.01 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.48 67.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 45.299999999999997 111.107 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.31 -37.99 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.520000000000003 110.873 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.26 -15.2 3.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 53.420000000000002 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.19 -143.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 74.450000000000003 112.511 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -173.51 173.49 3.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.845 0.355 . . . . 61.210000000000001 110.844 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 84' ' ' LEU . 12.9 m -139.27 128.46 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.165 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.15 116.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 111.133 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -55.28 113.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.954 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -75.07 -65.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 65.200000000000003 110.865 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -141.76 166.15 25.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 71.329999999999998 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 55.1 mt -124.53 114.59 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.18 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.37 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 50.43 111.102 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.27 -91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 75.5 112.519 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.58 24.0 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 73.510000000000005 110.869 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.401 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.6 t -145.13 150.18 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.112 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.1 t -118.79 131.82 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -98.79 100.93 12.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 52.409999999999997 110.87 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -110.09 144.44 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 110.888 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -92.81 102.97 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 60.140000000000001 110.868 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 130' ' ' ILE . 9.1 mt -120.09 147.94 44.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 61.350000000000001 110.914 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.41 141.37 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 71.010000000000005 110.973 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 71.109999999999999 112.468 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.929 0.395 . . . . 53.240000000000002 110.916 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.88 -30.81 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 62.109999999999999 110.895 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mm -90.08 -30.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 54.32 111.168 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 m -64.67 -45.08 88.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 111.168 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 130' ' ' ILE . 47.5 pt -76.0 -26.65 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.510000000000005 111.082 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -51.56 -54.68 24.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 110.851 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -24.91 68.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 75.450000000000003 110.864 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.52 -60.33 4.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.524 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -56.56 -54.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 73.230000000000004 111.129 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.66 -32.38 41.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.915 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -77.9 -30.71 50.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.826 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -78.93 -33.59 45.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.898 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.789 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -69.41 -54.93 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 70.439999999999998 110.885 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -29.34 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.86 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.7 -26.1 55.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 64.109999999999999 110.905 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -44.22 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 55.439999999999998 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.719 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.05 75.84 2.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 111.127 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.44 34.73 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 73.340000000000003 112.358 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.91 -39.45 59.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 110.864 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -73.09 144.44 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 54.340000000000003 111.16 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.54 -44.56 18.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.230000000000004 111.083 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.49 -171.99 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 41.329999999999998 111.092 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.3 154.0 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.130000000000003 111.116 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' CG ' HG11 ' A' ' 107' ' ' VAL . 46.5 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 64.549999999999997 110.897 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 120.837 0.265 . . . . 70.219999999999999 112.354 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.74 114.27 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.9 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -122.45 -177.13 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 63.530000000000001 111.128 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -61.87 -34.37 75.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 70.129999999999995 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.2 -46.44 8.18 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 74.129999999999995 112.483 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -67.3 -46.9 72.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 65.299999999999997 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.042 HG22 HD13 ' A' ' 84' ' ' LEU . 6.7 p -54.4 -31.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 111.121 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.88 -23.68 67.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 61.25 110.919 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -69.64 -47.26 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 73.519999999999996 110.852 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.1 p -77.21 -35.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 64.5 111.175 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.042 HD13 HG22 ' A' ' 80' ' ' VAL . 1.4 mp -71.72 -19.38 62.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.938 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.53 -26.71 8.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.858 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -74.44 -41.74 60.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 55.109999999999999 110.893 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.839 HG11 HG13 ' A' ' 130' ' ' ILE . 34.0 m -82.98 -11.42 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.144 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.4 ttt85 -54.38 -58.6 13.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 61.149999999999999 110.881 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.69 -31.75 20.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.684 2.256 . . . . 75.340000000000003 112.36 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.24 -57.99 5.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.7 mm? -56.66 -55.05 38.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.921 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.405 HG22 ' OD1' ' A' ' 97' ' ' ASP . 46.1 p -51.38 -41.84 60.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.209999999999994 111.186 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.66 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 51.100000000000001 111.104 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -82.86 -37.77 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.549999999999997 110.891 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 142.21 -17.04 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.765 -0.731 . . . . 60.43 112.473 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.31 -145.45 16.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 44.039999999999999 112.476 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 92' ' ' THR . 1.0 OUTLIER -167.12 -179.95 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 71.310000000000002 110.837 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.5 m -137.74 139.53 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 111.11 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.61 134.02 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 111.082 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -81.4 119.49 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 72.209999999999994 110.912 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -88.51 -71.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.83 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -124.63 168.79 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 55.32 110.866 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.642 HD11 HD21 ' A' ' 100' ' ' LEU . 62.2 mt -131.58 125.75 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 111.118 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.11 -176.05 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 62.149999999999999 111.095 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.51 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 74.129999999999995 112.511 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.01 25.32 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 72.430000000000007 110.882 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.547 HG11 ' CG ' ' A' ' 145' ' ' GLU . 25.8 t -145.78 149.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 111.122 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.2 t -119.63 135.56 59.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 64.299999999999997 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -94.97 101.0 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.030000000000001 110.889 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 84' ' ' LEU . 7.6 mt -110.59 126.16 54.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 44.229999999999997 110.879 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -79.62 101.64 8.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 72.109999999999999 110.91 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 130' ' ' ILE . 8.7 mt -123.34 129.69 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.230000000000004 110.934 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 91' ' ' LEU . 16.0 mt-30 -121.73 129.78 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.892 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 63.240000000000002 112.52 179.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.929 0.395 . . . . 63.009999999999998 110.873 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.78 -30.1 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 63.200000000000003 110.87 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.34 -32.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.07 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -74.36 -35.99 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 111.152 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.735 ' O ' HD12 ' A' ' 130' ' ' ILE . 19.2 pt -76.83 -29.06 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 71.129999999999995 111.109 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -51.2 -58.13 6.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 64.129999999999995 110.896 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -68.39 -24.3 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.85 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.53 -59.3 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 64.400000000000006 112.514 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 112' ' ' LEU . 2.6 mp -61.03 -54.93 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 75.439999999999998 111.102 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -50.56 -31.39 15.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -78.4 -37.15 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.420000000000002 110.883 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -72.92 -32.0 65.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 75.549999999999997 110.92 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.622 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -51.61 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.926 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.3 mtt -51.82 -31.16 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.44 -27.3 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -46.82 3.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 55.509999999999998 110.908 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.715 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -113.39 74.75 2.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 73.319999999999993 111.167 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -13.21 34.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 70.310000000000002 112.353 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.13 -33.84 58.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.832 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.2 p -74.59 144.42 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 65.120000000000005 111.095 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.44 18.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 61.450000000000003 111.1 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -166.32 -170.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 35.310000000000002 111.109 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.22 149.76 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.151 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.547 ' CG ' HG11 ' A' ' 107' ' ' VAL . 8.8 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 64.310000000000002 110.885 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.775 0.24 . . . . 62.340000000000003 112.347 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -147.41 139.91 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 70.299999999999997 110.957 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.2 t -148.45 169.87 19.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.519999999999996 111.161 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.38 -29.09 9.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 111.113 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.29 -55.08 4.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 72.349999999999994 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' HB2' HD22 ' A' ' 75' ' ' LEU . 18.5 m-20 -61.67 -47.56 84.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 64.109999999999999 110.837 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.647 HG23 HD13 ' A' ' 134' ' ' LEU . 8.8 p -53.16 -31.37 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 62.210000000000001 111.146 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.39 -30.67 71.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.857 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -39.93 63.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG13 ' HD3' ' A' ' 137' ' ' LYS . 26.0 t -75.76 -44.47 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 50.530000000000001 111.144 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.637 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mp -71.52 -18.6 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.919 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.34 -25.78 4.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.87 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -73.26 -45.28 56.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.727 HG23 HG11 ' A' ' 98' ' ' VAL . 2.0 m -81.13 -13.62 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 65.129999999999995 111.154 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 ttt180 -50.51 -58.67 9.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.61 0.719 . . . . 73.120000000000005 110.905 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.74 -35.11 13.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.746 2.297 . . . . 73.049999999999997 112.326 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -67.32 -25.45 66.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.93 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.82 -49.06 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.329999999999998 110.941 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 88' ' ' ARG . 76.2 p -61.73 -29.22 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 111.124 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.36 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 54.130000000000003 111.146 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.75 -38.01 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 53.310000000000002 110.899 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.22 -40.36 0.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 64.219999999999999 112.464 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.38 -148.53 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.779 -0.724 . . . . 65.450000000000003 112.448 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -178.28 -176.65 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 62.310000000000002 110.88 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.849 HG12 HD23 ' A' ' 112' ' ' LEU . 33.4 m -137.25 133.14 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 111.096 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.02 105.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 71.530000000000001 111.074 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 77' ' ' ALA . 10.9 tp -54.84 119.94 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.049999999999997 110.959 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -78.9 -54.49 6.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 110.888 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -162.91 172.58 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.859 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.13 121.03 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 111.132 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.28 95.63 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 74.319999999999993 111.093 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.4 -123.39 27.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 74.329999999999998 112.489 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.02 -17.58 58.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 71.5 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.96 150.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 111.148 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.65 123.66 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 52.439999999999998 111.069 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 110.861 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.3 mt -106.17 155.36 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 65.450000000000003 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -111.82 84.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.916 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 98' ' ' VAL . 3.8 mt -109.65 139.61 44.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 61.310000000000002 110.874 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -131.36 140.67 49.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 110.907 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 61.030000000000001 112.464 -179.96 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.949 0.404 . . . . 63.119999999999997 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.42 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 64.209999999999994 110.912 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.1 mt -80.47 -38.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.530000000000001 111.155 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -52.45 -39.76 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 71.409999999999997 111.099 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.479 ' O ' HD12 ' A' ' 130' ' ' ILE . 40.1 pt -86.36 -27.69 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 65.510000000000005 111.088 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -43.63 66.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.852 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -24.91 61.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.877 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.59 -57.75 5.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.010000000000005 112.53 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.707 ' CG1' HG21 ' A' ' 87' ' ' VAL . 4.4 mp -63.35 -53.3 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 72.099999999999994 111.164 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -52.02 -29.99 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.520000000000003 110.896 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -75.44 -50.66 15.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 72.010000000000005 110.887 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -63.66 -35.87 81.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 60.399999999999999 110.852 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.647 HD13 HG23 ' A' ' 80' ' ' VAL . 16.0 tp -70.25 -35.52 73.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.049999999999997 110.9 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.897 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.8 -38.27 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 62.100000000000001 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HD3' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -92.68 -32.02 14.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 60.140000000000001 110.895 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -129.99 76.56 77.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 70.209999999999994 111.124 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -8.64 24.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 72.120000000000005 112.365 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -56.2 -25.99 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.150000000000006 110.858 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.1 150.08 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 50.109999999999999 111.104 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.86 -51.12 5.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.510000000000005 111.043 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.78 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.340000000000003 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.2 153.21 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 72.349999999999994 111.145 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.622 0.725 . . . . 72.150000000000006 110.924 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HB2' HG23 ' A' ' 138' ' ' ILE . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 120.804 0.252 . . . . 62.340000000000003 112.368 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.725 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.06 139.81 29.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 75.430000000000007 110.924 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.643 ' N ' HD13 ' A' ' 75' ' ' LEU . 9.0 t -153.5 169.62 22.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 51.43 111.18 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.3 -29.56 10.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.098 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.44 -62.44 2.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 51.310000000000002 112.526 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -56.23 -48.22 76.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 65.239999999999995 110.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.986 HG22 HD13 ' A' ' 84' ' ' LEU . 8.9 p -51.22 -31.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 70.0 111.125 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.35 -36.67 82.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.868 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -63.81 -41.55 97.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 53.409999999999997 110.875 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.02 -42.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 62.420000000000002 111.127 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.986 HD13 HG22 ' A' ' 80' ' ' VAL . 4.8 mp -70.67 -18.85 62.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 65.400000000000006 110.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -51.58 -26.88 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.881 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -78.5 -43.89 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.89 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.836 HG22 HD23 ' A' ' 91' ' ' LEU . 8.2 p -82.38 -1.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.132 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 92' ' ' THR . 13.3 ttt180 -65.88 -58.79 10.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.706 . . . . 73.430000000000007 110.843 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.1 Cg_endo -69.72 -8.17 22.91 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.653 2.235 . . . . 64.420000000000002 112.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -12.61 20.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.899 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -101.21 -66.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 64.140000000000001 110.934 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.4 t -58.51 -20.1 43.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 50.130000000000003 111.116 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.23 -29.85 15.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 64.319999999999993 111.111 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.24 -31.64 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 110.889 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.22 -16.96 0.89 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 74.150000000000006 112.503 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.12 -138.89 2.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 63.140000000000001 112.518 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 179.85 -175.96 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 41.439999999999998 110.921 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.673 ' HB ' HD23 ' A' ' 84' ' ' LEU . 27.9 m -141.17 127.06 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 111.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.69 133.42 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.399999999999999 111.16 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HA ' HD23 ' A' ' 110' ' ' LEU . 17.9 tp -81.34 112.91 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 70.25 110.913 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -74.56 -73.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.896 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.62 171.14 13.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 110.901 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 HD21 ' A' ' 100' ' ' LEU . 56.6 mt -129.74 110.82 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.409999999999997 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.33 179.73 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.085 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.473 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.77 23.56 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 63.130000000000003 110.946 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -145.54 149.4 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.430000000000007 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -123.07 133.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.123 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 100' ' ' LEU . 8.5 mtt-85 -96.86 100.84 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 110.854 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 100' ' ' LEU . 31.3 mt -107.64 130.56 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.884 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -82.99 118.63 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.916 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.061 HD13 HD13 ' A' ' 130' ' ' ILE . 7.3 mt -142.19 123.69 14.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 110.928 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -111.79 115.29 28.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 62.25 110.957 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 54.340000000000003 112.48 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.86 0.362 . . . . 44.009999999999998 110.881 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.11 -29.9 23.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.128 -0.487 . . . . 55.25 110.903 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.1 mm -87.1 -39.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 71.340000000000003 111.099 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -57.78 -34.01 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.329999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.834 HD12 HD11 ' A' ' 91' ' ' LEU . 27.9 pt -86.13 -29.91 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 64.340000000000003 111.136 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -49.87 -58.31 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.88 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -24.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.06 -50.05 19.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 34.25 112.452 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.061 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -68.51 -55.6 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 71.430000000000007 111.127 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.4 -32.05 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 71.049999999999997 110.849 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.94 -40.89 95.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.905 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -72.29 -37.34 69.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.891 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -65.02 -38.89 92.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 73.049999999999997 110.926 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.4 ttm -67.9 -25.46 65.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.239999999999995 110.86 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.84 -59.4 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 138' ' ' ILE . 9.3 mmtm -73.24 -51.2 18.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.865 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.86 76.15 2.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 71.230000000000004 111.137 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.8 33.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.254 . . . . 64.219999999999999 112.331 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.83 -36.18 47.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 64.329999999999998 110.86 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.13 144.1 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.299999999999997 111.13 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.75 -51.45 8.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.349999999999994 111.064 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.84 -170.16 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 111.066 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.0 144.06 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 111.168 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 73.510000000000005 110.909 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.849 0.271 . . . . 72.409999999999997 112.36 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 108' ' ' VAL . 5.2 tt -94.54 106.61 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 110.914 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -129.76 175.66 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 63.140000000000001 111.123 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -63.7 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.08 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.96 -43.76 10.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 62.100000000000001 112.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -71.83 -47.43 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 74.519999999999996 110.893 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.015 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.61 -31.13 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 111.144 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.25 -39.9 92.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.844 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -41.1 95.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 45.229999999999997 110.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 134' ' ' LEU . 74.3 t -77.28 -39.57 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 111.122 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.015 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -69.87 -19.43 63.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.931 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -52.35 -27.08 14.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.129999999999995 110.853 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -76.85 -43.65 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.896 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.697 ' CG2' HD23 ' A' ' 91' ' ' LEU . 8.6 p -82.34 -4.51 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.153 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.3 ttp85 -61.26 -58.72 16.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 74.420000000000002 110.892 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.78 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 71.439999999999998 112.353 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.23 -46.95 6.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 72.450000000000003 110.914 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.697 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -73.38 -43.56 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 73.219999999999999 110.963 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -65.63 -23.16 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.19 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.68 -51.99 62.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 111.091 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -63.7 -29.25 70.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.843 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.47 19.21 3.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 74.019999999999996 112.467 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.58 -135.91 8.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.708 -0.758 . . . . 75.099999999999994 112.497 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -179.37 139.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 73.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.713 HG12 HD23 ' A' ' 112' ' ' LEU . 33.3 m -115.54 133.04 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 111.108 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.89 138.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 54.530000000000001 111.092 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 77' ' ' ALA . 11.8 tp -79.81 126.71 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 65.219999999999999 110.892 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.473 ' N ' HD12 ' A' ' 100' ' ' LEU . 85.1 t60 -88.36 -71.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.871 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -134.58 174.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.400000000000006 110.922 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 100' ' ' LEU . 53.5 mt -132.35 110.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.9 -170.21 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 111.132 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.55 -89.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 71.140000000000001 112.467 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.12 21.04 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 52.439999999999998 110.886 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.26 150.28 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.099999999999994 111.141 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.028 HG21 HD13 ' A' ' 75' ' ' LEU . 92.4 t -114.46 139.83 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.120000000000005 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.27 100.87 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.430000000000007 110.848 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 100' ' ' LEU . 1.1 mt -105.92 178.17 4.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.922 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -134.01 120.25 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 63.549999999999997 110.909 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 130' ' ' ILE . 4.0 mt -138.25 143.15 39.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 64.010000000000005 110.945 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -118.99 106.71 12.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.916 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 72.340000000000003 112.461 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.894 0.378 . . . . 75.230000000000004 110.837 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.86 -31.72 29.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.519999999999996 110.928 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 HH11 ' A' ' 128' ' ' ARG . 40.8 mm -79.49 -38.07 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.094 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.85 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.145 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.8 pt -86.09 -26.97 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 73.400000000000006 111.116 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -50.68 54.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 72.200000000000003 110.902 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.506 HH11 HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -71.0 -24.83 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 110.858 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.66 -51.91 18.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 31.43 112.463 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.953 HD13 HD13 ' A' ' 112' ' ' LEU . 2.8 mp -64.06 -56.41 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.728 0.299 . . . . 60.43 111.13 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.49 -33.32 44.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.933 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -63.51 -33.54 75.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 75.219999999999999 110.859 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -77.02 -56.57 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.200000000000003 110.894 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.95 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -53.8 -47.32 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 53.509999999999998 110.914 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 32.7 ttm -55.15 -39.43 69.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 65.230000000000004 110.879 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.37 -19.38 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.040000000000006 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 -33.13 9.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.129999999999995 110.932 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 141' ' ' VAL . 9.9 mm -111.49 78.8 2.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 71.129999999999995 111.132 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -8.13 22.82 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.242 . . . . 45.539999999999999 112.324 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -33.89 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 74.040000000000006 110.895 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.4 p -74.43 155.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 111.149 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.41 -45.11 8.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 62.130000000000003 111.115 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.12 -169.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.36 160.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 111.121 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.758 . . . . 74.140000000000001 110.887 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.1 ptm . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.789 0.328 . . . . 64.140000000000001 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.56 -110.32 4.0 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 61.340000000000003 112.486 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.9 159.31 64.55 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.623 0.725 . . . . 72.430000000000007 110.911 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.497 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo -69.75 -29.99 23.03 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.696 2.264 . . . . 73.209999999999994 112.337 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.718 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.3 122.39 12.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.973 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 80' ' ' VAL . 17.7 p -132.04 172.07 12.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 63.420000000000002 111.13 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.56 -30.21 19.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 53.100000000000001 111.089 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.62 -61.24 2.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 70.010000000000005 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.877 0.37 . . . . 73.120000000000005 110.894 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.077 HG22 HD13 ' A' ' 84' ' ' LEU . 8.0 p -54.11 -31.23 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 111.156 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -62.88 -24.13 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -74.06 -44.28 54.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.856 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.5 p -77.02 -34.45 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 111.16 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.077 HD13 HG22 ' A' ' 80' ' ' VAL . 3.7 mp -71.61 -20.11 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 75.530000000000001 110.898 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -54.15 -26.6 28.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.836 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -74.03 -42.51 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 65.349999999999994 110.918 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' CG2' HD23 ' A' ' 91' ' ' LEU . 9.2 p -82.23 -13.87 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 62.030000000000001 111.165 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.8 ttt180 -51.45 -58.67 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.583 0.706 . . . . 72.099999999999994 110.835 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -8.32 23.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.246 . . . . 62.549999999999997 112.353 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -98.47 -19.27 17.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 74.109999999999999 110.922 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.25 -40.21 7.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 52.340000000000003 110.905 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 96' ' ' GLY . 44.1 p -69.94 -16.21 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 64.530000000000001 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -54.88 24.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 55.32 111.066 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -131.54 40.14 3.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 110.879 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -149.87 -63.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 61.240000000000002 112.476 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' HG22 ' A' ' 92' ' ' THR . . . 152.61 -71.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 74.400000000000006 112.464 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.54 168.93 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.823 0.344 . . . . 60.130000000000003 110.896 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.566 ' CG2' HD23 ' A' ' 84' ' ' LEU . 27.8 m -123.02 166.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 111.17 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.35 141.7 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 60.310000000000002 111.093 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.727 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -86.85 115.32 24.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.982 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -77.13 -73.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.87 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -131.76 169.08 16.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.727 HD11 HD21 ' A' ' 100' ' ' LEU . 12.9 mt -129.34 110.52 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 52.039999999999999 111.15 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.47 -173.96 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 72.099999999999994 111.117 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.34 -89.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.728 -0.749 . . . . 74.549999999999997 112.501 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -95.43 23.73 5.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.863 0.363 . . . . 74.129999999999995 110.891 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.93 150.55 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 60.219999999999999 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.67 129.61 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 111.126 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' HD12 ' A' ' 100' ' ' LEU . 9.6 mtp85 -89.46 103.39 16.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.340000000000003 110.839 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.405 HD22 HD21 ' A' ' 84' ' ' LEU . 3.7 mt -116.35 142.84 46.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.944 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.35 104.76 16.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 62.229999999999997 110.893 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 130' ' ' ILE . 9.5 mt -113.54 128.98 56.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 73.340000000000003 110.913 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.44 87.66 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 110.935 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.3 -72.21 0.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 64.340000000000003 112.522 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.92 132.0 41.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 74.340000000000003 111.11 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.4 t -73.6 101.54 3.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 110.893 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.49 -166.21 37.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 51.219999999999999 112.502 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -92.45 -28.66 16.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 73.409999999999997 110.869 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.7 t -124.08 72.63 55.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.594 0.711 . . . . 75.340000000000003 110.876 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 132.97 24.49 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.263 . . . . 65.450000000000003 112.346 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 96.2 p -110.12 -33.49 6.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 63.140000000000001 110.848 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 t -61.72 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.109999999999999 110.877 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -51.84 -49.78 62.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 72.310000000000002 110.922 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -70.2 -32.57 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.4 m -66.87 -39.65 87.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.164 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.753 ' O ' HD12 ' A' ' 130' ' ' ILE . 24.5 pt -86.08 -26.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 64.140000000000001 111.144 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -51.17 -48.09 61.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.230000000000004 110.942 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -67.56 -25.0 65.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 71.120000000000005 110.817 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.95 -60.28 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 54.5 112.462 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 112' ' ' LEU . 3.1 mp -56.2 -53.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.757 0.313 . . . . 41.219999999999999 111.159 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -54.26 -32.3 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -76.38 -30.5 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -79.09 -33.8 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 110.856 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.72 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.02 -52.68 22.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.925 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.93 -30.11 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.519999999999996 110.886 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.6 -27.01 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.863 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -113.29 -45.65 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 55.119999999999997 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.12 75.71 2.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.627 0.727 . . . . 74.099999999999994 111.132 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -11.77 31.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 72.420000000000002 112.358 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -51.99 -30.69 26.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 64.129999999999995 110.85 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.7 t -80.79 149.26 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.019999999999996 111.122 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.34 -36.16 13.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 61.109999999999999 111.123 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.46 -175.31 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.109999999999999 111.077 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.31 153.91 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 70.049999999999997 111.147 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -136.37 160.23 67.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.661 2.24 . . . . 71.129999999999995 112.333 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 148' ' ' THR . 14.9 p -95.72 -24.76 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 64.109999999999999 111.142 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.519 HG23 HG13 ' A' ' 147' ' ' VAL . 46.7 p -137.33 -177.48 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 111.165 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.11 82.18 8.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 75.340000000000003 110.88 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -139.93 26.57 2.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 74.049999999999997 110.88 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -104.65 -44.22 4.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 72.519999999999996 110.892 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.0 t -110.51 73.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 61.229999999999997 111.195 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 45.310000000000002 112.462 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.8 mtp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.786 0.327 . . . . 74.409999999999997 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.28 97.94 0.25 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 71.200000000000003 112.505 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -121.83 160.55 46.37 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.632 0.729 . . . . 71.430000000000007 110.879 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo -69.82 -37.62 8.78 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.689 2.259 . . . . 72.329999999999998 112.349 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.702 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -133.42 131.13 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 73.340000000000003 110.932 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 79' ' ' ASN . 1.8 t -129.31 160.91 31.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 111.149 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.89 -27.85 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 45.43 111.133 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.69 -39.13 22.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 60.119999999999997 112.48 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.597 ' H ' HG23 ' A' ' 76' ' ' THR . 1.5 m-80 -76.43 -46.89 25.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 72.5 110.907 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -50.58 -31.36 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 111.105 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.9 -45.06 91.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 110.949 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -61.88 -36.21 80.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.439999999999998 110.845 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.715 HG11 ' HA ' ' A' ' 134' ' ' LEU . 33.6 t -77.28 -39.98 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 45.530000000000001 111.14 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 80' ' ' VAL . 4.5 mp -71.08 -19.03 62.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.912 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -26.84 9.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.019999999999996 110.878 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -75.22 -42.97 54.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 73.099999999999994 110.874 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.644 ' CG2' HD23 ' A' ' 91' ' ' LEU . 15.0 p -81.01 -11.8 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.230000000000004 111.133 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 14.1 ttt180 -54.79 -58.67 13.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.588 0.709 . . . . 73.310000000000002 110.881 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.83 -16.06 37.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.226 . . . . 64.310000000000002 112.343 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -88.2 -23.91 23.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 63.539999999999999 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.794 HD11 HD12 ' A' ' 126' ' ' ILE . 1.4 mm? -101.1 -53.23 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.319999999999993 110.913 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 88' ' ' ARG . 73.2 p -52.73 -42.44 64.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.148 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.97 67.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 52.439999999999998 111.067 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -76.24 -38.08 56.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 74.549999999999997 110.813 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.0 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 61.109999999999999 112.524 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.96 -131.18 1.98 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.209999999999994 112.506 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -179.33 -176.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 72.519999999999996 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.545 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.4 m -131.4 140.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 111.118 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -171.96 137.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 111.098 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 109' ' ' ARG . 38.1 tp -78.69 137.01 37.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 72.019999999999996 110.896 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -103.14 -45.67 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 110.894 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -171.9 168.09 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.906 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.19 119.63 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 72.109999999999999 111.104 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.28 88.68 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 111.072 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.73 -120.75 18.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 42.119999999999997 112.469 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -76.09 -18.22 59.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 75.230000000000004 110.915 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.46 151.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.123 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.61 136.58 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.609 ' O ' HD12 ' A' ' 100' ' ' LEU . 27.2 mtp85 -96.86 101.37 12.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 54.32 110.855 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD22 HD21 ' A' ' 84' ' ' LEU . 7.1 mt -117.67 130.63 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 71.510000000000005 110.902 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -81.35 105.65 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 60.530000000000001 110.912 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.041 HD13 HD13 ' A' ' 130' ' ' ILE . 10.1 mt -125.15 127.48 46.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 65.120000000000005 110.883 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -146.27 127.55 14.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 110.935 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.21 -22.59 12.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 40.229999999999997 112.51 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -178.4 145.49 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 55.520000000000003 111.131 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.41 -75.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 42.200000000000003 110.912 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 51.6 -167.63 0.67 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.743 -0.741 . . . . 74.140000000000001 112.519 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.1 m -98.02 -26.31 14.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 71.200000000000003 110.859 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.8 t -166.11 68.67 1.13 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.714 . . . . 51.539999999999999 110.863 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 154.69 67.29 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.658 2.239 . . . . 54.420000000000002 112.376 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.2 t -115.93 -21.92 9.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 64.430000000000007 110.833 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.5 m -55.57 -25.96 40.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 53.539999999999999 110.872 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 tp -51.68 -35.6 43.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 74.299999999999997 110.949 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.612 HD11 ' O ' ' A' ' 151' ' ' GLU . 45.7 mm -88.75 -31.06 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.158 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 m -65.18 -34.36 78.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 111.101 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 91' ' ' LEU . 27.4 pt -84.8 -30.38 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.209999999999994 111.152 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -51.47 -49.88 60.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.140000000000001 110.888 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -66.5 -25.14 66.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.868 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.82 -54.0 10.51 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.758 -0.734 . . . . 44.119999999999997 112.503 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.041 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -61.35 -55.02 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 72.049999999999997 111.138 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -52.42 -32.61 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 50.399999999999999 110.885 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.08 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 110.835 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -61.31 -42.5 98.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 64.25 110.855 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.715 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.24 -31.97 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 42.020000000000003 110.944 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 19.1 mtt -67.42 -29.82 69.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.832 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.07 -53.2 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.019999999999996 110.907 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -81.89 -45.71 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 75.349999999999994 110.901 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.702 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.78 76.47 2.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.612 0.72 . . . . 62.109999999999999 111.172 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -15.81 37.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 63.399999999999999 112.346 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -52.43 -46.08 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 65.319999999999993 110.877 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -52.29 144.57 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.161 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.85 -35.32 12.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 55.200000000000003 111.08 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -171.92 179.66 2.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 54.140000000000001 111.11 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.83 144.39 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.409999999999997 111.149 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.17 159.91 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 72.150000000000006 110.905 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -170.87 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.704 2.27 . . . . 71.319999999999993 112.298 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 148' ' ' THR . 28.0 m -91.26 -32.25 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 54.119999999999997 111.12 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.585 HG23 HG23 ' A' ' 147' ' ' VAL . 45.1 p -104.86 22.2 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 64.239999999999995 111.146 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 51.9 30.29 7.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.851 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -99.3 97.42 8.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 110.876 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.612 ' O ' HD11 ' A' ' 124' ' ' ILE . 12.1 pt-20 -120.88 -46.62 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.329999999999998 110.905 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 150.0 23.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 72.340000000000003 111.181 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 72.409999999999997 112.488 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.3 mtm . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.834 0.349 . . . . 72.420000000000002 110.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.07 -146.28 16.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 63.340000000000003 112.514 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -86.43 160.73 50.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.625 0.726 . . . . 72.340000000000003 110.907 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.55 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.8 Cg_endo -69.75 -29.85 23.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 61.420000000000002 112.343 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -144.6 136.69 26.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.898 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.544 ' N ' HD13 ' A' ' 75' ' ' LEU . 7.9 t -140.68 167.35 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.155 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -28.7 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 75.420000000000002 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.54 -45.8 9.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 73.299999999999997 112.462 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 76' ' ' THR . 9.2 m-20 -69.71 -48.16 60.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.85 0.357 . . . . 72.409999999999997 110.888 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.0 -31.17 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 55.299999999999997 111.153 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -60.85 -36.1 78.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 65.219999999999999 110.914 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -44.4 87.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.230000000000004 110.88 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 134' ' ' LEU . 66.3 t -72.8 -43.63 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 71.400000000000006 111.146 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 5.2 mp -71.09 -18.87 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.010000000000005 110.893 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.93 -26.18 5.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 54.539999999999999 110.901 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -74.96 -46.43 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 63.340000000000003 110.966 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 130' ' ' ILE . 2.8 m -82.31 -3.5 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 111.135 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 6.5 ttp85 -61.91 -58.77 15.94 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.623 0.725 . . . . 64.129999999999995 110.875 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.3 Cg_endo -69.75 -14.68 36.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.693 2.262 . . . . 51.219999999999999 112.352 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 2.7 m-85 -87.03 -55.81 3.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 110.886 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 126' ' ' ILE . 3.5 mm? -56.3 -55.64 30.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 72.439999999999998 110.901 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.3 p -51.59 -34.0 35.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -54.0 -27.25 30.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.124 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.47 -38.03 20.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.129999999999995 110.833 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.82 -23.27 1.8 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 71.230000000000004 112.472 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.03 -142.05 7.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 43.450000000000003 112.44 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -171.94 -176.26 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 51.130000000000003 110.885 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.65 HG11 HG23 ' A' ' 87' ' ' VAL . 19.1 m -137.44 138.18 45.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 111.104 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.88 136.04 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 54.140000000000001 111.128 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 77' ' ' ALA . 12.8 tp -83.05 112.96 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 71.150000000000006 110.888 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -77.71 -66.39 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.828 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -138.55 173.35 11.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.92 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 HD21 ' A' ' 100' ' ' LEU . 58.0 mt -130.25 112.12 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 63.340000000000003 111.133 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.84 -169.57 2.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 34.409999999999997 111.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -57.99 -89.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 63.329999999999998 112.491 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.27 23.12 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 64.049999999999997 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 t -146.11 148.62 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.400000000000006 111.122 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.87 127.29 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 111.11 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 100' ' ' LEU . 21.3 mtt-85 -82.53 100.97 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 72.450000000000003 110.901 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 80' ' ' VAL . 7.0 mt -116.43 127.37 54.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 53.030000000000001 110.906 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -86.55 100.17 12.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 71.109999999999999 110.911 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.941 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -128.0 129.73 47.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 73.099999999999994 110.948 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' O ' HD12 ' A' ' 91' ' ' LEU . 15.7 tt0 -133.1 141.18 48.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 70.340000000000003 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.24 -161.77 10.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 74.409999999999997 112.486 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.56 144.88 47.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.322 . . . . 73.540000000000006 111.083 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.1 t -59.31 147.13 37.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 53.020000000000003 110.895 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -179.85 -98.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.764 -0.731 . . . . 74.049999999999997 112.498 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 p -58.03 -58.02 10.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 110.887 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.6 m -106.25 160.57 25.75 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.562 0.696 . . . . 73.230000000000004 110.856 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.16 37.65 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.699 2.266 . . . . 75.310000000000002 112.314 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 m -130.64 88.03 2.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 33.310000000000002 110.891 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.92 -31.53 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 63.409999999999997 110.863 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.9 tp -51.98 -41.12 61.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.935 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.82 -36.72 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.097 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -56.84 -38.01 72.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.116 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 91' ' ' LEU . 25.2 pt -84.77 -31.21 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 111.122 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -51.74 -42.05 62.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.948 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -25.06 60.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 110.891 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.65 -57.28 5.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 71.150000000000006 112.474 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.941 HD13 HD22 ' A' ' 112' ' ' LEU . 4.4 mp -62.82 -53.46 46.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.848 0.356 . . . . 63.439999999999998 111.154 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -52.19 -30.97 29.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.129999999999995 110.907 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -73.9 -34.73 64.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 72.400000000000006 110.848 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -74.5 -35.69 63.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.140000000000001 110.916 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.31 -51.69 28.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 73.450000000000003 110.939 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 14.2 mtt -51.66 -31.56 26.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.892 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.43 -28.57 30.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.895 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.96 -45.43 3.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.894 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.3 mp -113.31 75.12 2.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 72.420000000000002 111.119 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -8.76 24.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.724 2.283 . . . . 74.129999999999995 112.327 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -51.58 -51.92 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.42 144.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 73.450000000000003 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.35 -39.6 22.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.140000000000001 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -168.85 -175.99 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 111.08 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.65 147.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.430000000000007 111.126 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -131.42 160.25 68.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 61.43 110.9 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -170.84 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 64.409999999999997 112.353 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.57 -25.74 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 64.109999999999999 111.118 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.0 p -85.25 -174.34 5.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 72.200000000000003 111.147 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -53.72 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.89 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -140.26 -175.31 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 53.229999999999997 110.867 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.3 160.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 72.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -87.75 153.53 21.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 71.5 111.143 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 51.439999999999998 112.49 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.6 mtp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.782 0.325 . . . . 53.350000000000001 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.83 -107.73 2.62 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 74.019999999999996 112.52 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.527 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -91.71 160.52 36.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 73.120000000000005 110.899 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.7 Cg_endo -69.75 -27.72 26.19 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.662 2.242 . . . . 74.439999999999998 112.306 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.745 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.2 tm? -151.0 123.17 8.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 110.927 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.5 p -137.05 -177.36 4.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 61.049999999999997 111.146 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -54.24 -30.19 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 61.509999999999998 111.1 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.03 -61.01 2.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.758 -0.734 . . . . 72.519999999999996 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -56.77 -46.29 81.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 73.310000000000002 110.882 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HA ' HD21 ' A' ' 75' ' ' LEU . 6.8 p -49.96 -31.16 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 111.119 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -61.8 -39.83 93.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 110.908 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -63.92 -39.56 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 63.43 110.839 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -75.78 -42.49 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 70.519999999999996 111.136 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 98' ' ' VAL . 3.4 mp -71.35 -18.23 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 75.540000000000006 110.925 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -50.04 -27.58 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 60.109999999999999 110.857 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -76.44 -43.56 39.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.947 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 98' ' ' VAL . 10.4 p -82.46 -4.46 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 64.219999999999999 111.153 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.2 ttt-85 -60.62 -58.85 16.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.629 0.728 . . . . 71.5 110.841 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.78 -7.29 20.7 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.692 2.262 . . . . 63.350000000000001 112.34 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -96.29 -64.57 1.04 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.898 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.725 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -53.48 -63.24 1.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 52.039999999999999 110.94 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 p -50.41 -31.19 14.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 63.439999999999998 111.15 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.83 -37.95 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 73.010000000000005 111.117 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -60.85 -36.83 80.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 53.039999999999999 110.842 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 136.12 -15.21 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 63.409999999999997 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.73 -128.1 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 55.340000000000003 112.535 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -170.79 142.37 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.878 0.37 . . . . 64.519999999999996 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.732 HG21 ' CG1' ' A' ' 87' ' ' VAL . 7.2 p -119.68 126.38 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.135 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.71 146.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 111.105 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 101' ' ' HIS . 11.1 tp -79.26 129.73 34.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 110.922 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.546 ' N ' HD12 ' A' ' 100' ' ' LEU . 33.4 t60 -93.37 -71.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 110.857 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.05 168.05 20.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.921 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.4 mt -123.47 109.06 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 62.310000000000002 111.098 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.64 -171.91 3.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 62.210000000000001 111.08 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.62 -91.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.510000000000005 112.489 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -96.34 22.75 7.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 61.310000000000002 110.858 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.543 HG11 ' OE1' ' A' ' 145' ' ' GLU . 21.5 t -145.15 150.22 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 111.13 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -114.96 127.51 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.144 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -89.08 101.45 14.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.828 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -109.41 152.62 25.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.928 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.434 ' O ' HD23 ' A' ' 112' ' ' LEU . 1.5 tttp -105.61 100.61 10.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.887 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.053 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -131.0 123.84 29.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 61.219999999999999 110.876 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -122.31 139.13 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.519999999999996 110.931 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -66.09 2.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 73.329999999999998 112.467 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 61.09 33.45 19.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 70.439999999999998 111.077 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.7 p -55.23 -30.21 59.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 54.509999999999998 110.893 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.57 -72.33 0.42 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 71.310000000000002 112.482 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.2 p -53.46 -71.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 54.340000000000003 110.825 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.7 m -144.56 160.63 47.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.635 0.731 . . . . 75.030000000000001 110.822 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 123' ' ' LEU . 53.5 Cg_endo -69.75 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.677 2.251 . . . . 73.030000000000001 112.35 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.4 ' C ' HD23 ' A' ' 123' ' ' LEU . 4.7 p -120.6 -32.55 4.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.888 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.05 -19.07 64.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 74.129999999999995 110.845 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 120' ' ' PRO . 2.6 pt? -51.68 -30.35 21.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 71.420000000000002 110.928 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.5 mm -86.82 -32.47 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 74.099999999999994 111.122 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.12 -33.1 73.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 111.127 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.721 ' O ' HD12 ' A' ' 130' ' ' ILE . 41.4 pt -84.82 -26.76 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 65.349999999999994 111.126 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -51.0 -44.39 60.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 110.877 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -24.81 61.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 64.099999999999994 110.875 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.42 -52.12 28.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.742 . . . . 52.329999999999998 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.053 HD13 HD13 ' A' ' 112' ' ' LEU . 3.8 mp -66.1 -55.52 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 72.349999999999994 111.12 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -52.24 -32.6 37.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -62.8 -41.34 99.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 61.130000000000003 110.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -79.07 -33.73 44.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 73.439999999999998 110.874 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.7 OUTLIER -70.05 -56.72 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 110.889 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 7.6 tpp -56.56 -23.78 42.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 63.009999999999998 110.885 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.96 -45.28 78.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 63.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.627 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.7 mmtp -84.92 -46.41 11.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 54.140000000000001 110.907 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.39 76.84 2.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.662 0.744 . . . . 74.25 111.125 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -9.7 26.74 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 74.299999999999997 112.354 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.9 -36.81 50.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 143' ' ' ALA . 16.3 t -75.37 151.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 111.159 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.53 -27.24 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 55.520000000000003 111.106 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.634 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.2 169.96 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 44.210000000000001 111.095 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.04 154.33 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.103 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.543 ' OE1' HG11 ' A' ' 107' ' ' VAL . 23.2 mt-10 -132.27 160.22 68.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 73.040000000000006 110.887 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -172.41 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.599 2.199 . . . . 54.420000000000002 112.382 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.493 HG23 ' CD2' ' A' ' 101' ' ' HIS . 14.6 p -86.87 -28.87 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 74.230000000000004 111.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 147' ' ' VAL . 1.8 p -156.81 177.59 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 64.400000000000006 111.146 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.03 87.8 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 64.450000000000003 110.859 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -119.67 -33.7 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.209999999999994 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -51.99 119.51 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 75.019999999999996 110.838 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -99.58 -29.95 12.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 71.120000000000005 111.12 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 53.539999999999999 112.467 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.3 mtm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.841 0.353 . . . . 72.150000000000006 110.873 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.97 -24.4 2.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 75.299999999999997 112.488 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -104.68 160.64 25.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.613 0.721 . . . . 73.439999999999998 110.915 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.574 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.78 -29.76 23.25 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.693 2.262 . . . . 74.450000000000003 112.311 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -141.42 123.68 15.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p -131.77 179.46 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 61.399999999999999 111.129 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.62 75.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 41.109999999999999 111.097 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.07 -47.82 7.34 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 53.43 112.471 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -65.68 -48.68 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.862 0.363 . . . . 75.420000000000002 110.87 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.011 HG22 HD13 ' A' ' 84' ' ' LEU . 7.2 p -51.7 -31.03 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.152 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -62.44 -34.58 77.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 110.92 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.5 -42.56 95.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 63.030000000000001 110.859 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.97 -42.05 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 111.148 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.011 HD13 HG22 ' A' ' 80' ' ' VAL . 4.9 mp -70.88 -18.76 62.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.230000000000004 110.943 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -52.12 -25.96 10.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 61.210000000000001 110.875 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -82.64 -43.55 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.927 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG22 HD23 ' A' ' 91' ' ' LEU . 8.8 p -82.75 1.36 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.12 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.725 ' O ' HG22 ' A' ' 92' ' ' THR . 20.6 ttt180 -68.14 -58.89 6.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.558 0.694 . . . . 74.239999999999995 110.858 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.676 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.0 Cg_endo -69.75 -8.29 23.23 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.664 2.242 . . . . 75.420000000000002 112.361 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -98.91 -12.78 20.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.936 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.854 HD11 HD12 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -101.15 -64.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 73.450000000000003 110.926 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.7 t -60.13 -19.49 53.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.099999999999994 111.139 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.25 -32.66 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.109 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.15 -24.67 19.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.209999999999994 110.874 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.26 -17.09 2.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 34.140000000000001 112.5 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 -140.46 1.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 62.130000000000003 112.499 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.5 -172.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 73.219999999999999 110.864 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.764 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.2 m -148.65 136.82 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 64.510000000000005 111.14 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.36 122.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.519999999999996 111.122 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HG11 ' A' ' 80' ' ' VAL . 10.0 tp -76.73 120.94 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 64.030000000000001 110.919 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.441 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.4 t60 -93.41 -73.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 110.871 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -115.94 165.98 12.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.914 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 108' ' ' VAL . 10.7 mt -132.13 104.49 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 111.182 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.36 -169.5 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 111.088 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.89 -81.84 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 75.140000000000001 112.481 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 4.2 p-10 -91.77 13.53 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 75.530000000000001 110.874 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 20.0 t -145.18 151.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 71.450000000000003 111.162 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 103' ' ' ILE . 95.7 t -121.43 128.58 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 64.340000000000003 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 3.0 mpt_? -79.78 100.82 8.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 71.420000000000002 110.848 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.82 HD22 HD21 ' A' ' 84' ' ' LEU . 9.1 mt -109.03 127.7 54.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.0 110.926 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -83.48 101.79 11.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.230000000000004 110.919 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD22 HD13 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -126.58 159.2 34.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 55.219999999999999 110.917 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -143.25 133.39 24.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 110.919 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.36 19.49 4.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 63.229999999999997 112.487 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 110.22 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.815 0.34 . . . . 71.120000000000005 111.095 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.3 t -175.93 117.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 42.310000000000002 110.883 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.12 -151.2 21.42 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 t -94.86 20.21 9.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 73.430000000000007 110.852 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.5 p -123.73 73.42 53.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 75.430000000000007 110.908 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -12.46 32.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.6 2.2 . . . . 73.340000000000003 112.37 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 57.5 p -94.05 40.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.849 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -80.76 -25.97 37.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 65.209999999999994 110.838 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD11 ' O ' ' A' ' 150' ' ' LYS . 2.7 pt? -51.95 -30.48 24.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 73.209999999999994 110.871 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.02 -30.84 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.409999999999997 111.134 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 m -69.37 -34.55 74.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 111.165 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.854 HD12 HD11 ' A' ' 91' ' ' LEU . 27.8 pt -84.05 -27.8 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 55.0 111.123 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -51.89 -41.72 62.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 110.903 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -24.67 60.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 53.140000000000001 110.853 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.54 -56.04 5.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 55.439999999999998 112.461 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 87' ' ' VAL . 4.8 mp -65.03 -50.76 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 74.530000000000001 111.116 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.791 ' HB3' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.46 -31.55 23.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 65.340000000000003 110.917 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -66.41 -44.15 83.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.150000000000006 110.874 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -75.54 -36.45 60.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 110.866 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.439 HD11 ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -59.81 -29.16 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 71.329999999999998 110.914 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.2 ttm -76.97 -36.42 56.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 70.540000000000006 110.892 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -51.98 -47.4 64.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 110.9 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.4 mmtp -90.64 -48.5 7.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 75.099999999999994 110.89 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -112.93 76.34 2.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.66 0.743 . . . . 64.409999999999997 111.098 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.6 24.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 75.219999999999999 112.337 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.18 -27.49 69.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 62.450000000000003 110.86 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -88.92 144.59 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.200000000000003 111.098 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -80.4 -42.45 22.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.084 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.53 -177.43 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 72.219999999999999 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 131' ' ' GLU . 8.5 m -131.42 140.72 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 53.350000000000001 111.143 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -128.86 159.72 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 53.149999999999999 110.931 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -171.03 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.653 2.235 . . . . 75.420000000000002 112.388 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.45 -28.8 10.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.158 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.2 p -140.4 173.36 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 52.219999999999999 111.148 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.76 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.903 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.489 ' O ' HD11 ' A' ' 123' ' ' LEU . 22.3 mmtp 51.54 30.09 6.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 62.229999999999997 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.82 -54.44 6.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.439999999999998 110.868 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -109.2 139.17 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 72.409999999999997 111.158 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 63.0 112.492 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.9 mtp . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.856 0.36 . . . . 63.420000000000002 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.97 -28.17 1.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 30.100000000000001 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -109.11 160.58 26.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 75.209999999999994 110.847 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.8 Cg_endo -69.81 -28.69 24.72 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.239 . . . . 72.319999999999993 112.361 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.685 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.63 136.85 26.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.918 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.546 ' N ' HD13 ' A' ' 75' ' ' LEU . 13.9 p -144.16 -178.25 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 70.239999999999995 111.148 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.629 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -60.97 -35.14 76.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 111.115 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.24 -47.33 7.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 72.129999999999995 112.485 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -65.71 -48.71 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 74.329999999999998 110.846 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.047 HG22 HD13 ' A' ' 84' ' ' LEU . 7.3 p -51.46 -31.15 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 111.121 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -62.05 -35.45 78.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.912 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.8 t -63.08 -42.75 99.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 72.420000000000002 110.846 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 134' ' ' LEU . 22.2 t -77.18 -41.74 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 111.143 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.047 HD13 HG22 ' A' ' 80' ' ' VAL . 2.7 mp -68.54 -19.0 64.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.955 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -51.77 -25.47 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.519999999999996 110.828 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -73.33 -47.71 40.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 63.219999999999999 110.909 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.76 HG23 HG11 ' A' ' 98' ' ' VAL . 3.3 m -82.23 -7.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 111.113 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 20.4 ttt180 -56.07 -58.82 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 74.230000000000004 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -21.18 33.76 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 74.019999999999996 112.355 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -81.41 -27.75 34.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 45.119999999999997 110.959 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -92.43 -49.5 6.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 64.430000000000007 110.933 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.5 p -62.5 -21.56 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 61.310000000000002 111.107 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -61.09 -53.83 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 65.140000000000001 111.067 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -64.07 -36.15 83.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 75.540000000000006 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.88 -30.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 63.25 112.482 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.85 -150.75 0.11 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.45 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -175.3 153.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.842 0.353 . . . . 74.409999999999997 110.886 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -116.08 135.93 54.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 111.115 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.12 127.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 41.350000000000001 111.087 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 77' ' ' ALA . 13.9 tp -71.23 122.83 20.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 110.979 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -90.28 -48.29 7.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 54.109999999999999 110.871 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -160.6 172.52 17.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 110.913 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.527 HD11 HD21 ' A' ' 100' ' ' LEU . 12.1 mt -129.33 125.71 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.049999999999997 111.103 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.35 102.22 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 55.140000000000001 111.089 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.59 -125.09 28.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 52.240000000000002 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.503 HD22 ' HB3' ' A' ' 142' ' ' ALA . 1.8 p-10 -77.48 -17.17 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 64.420000000000002 110.859 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.6 t -95.96 150.98 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 62.43 111.111 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 103' ' ' ILE . 56.4 t -125.2 137.36 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 73.439999999999998 111.097 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.1 mtt180 -93.88 101.82 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 62.530000000000001 110.834 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.735 HD22 HD21 ' A' ' 84' ' ' LEU . 3.6 mt -111.65 123.92 51.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 44.340000000000003 110.928 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 105.62 11.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 62.509999999999998 110.937 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -130.88 127.37 38.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 63.109999999999999 110.918 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.496 ' O ' HD12 ' A' ' 91' ' ' LEU . 30.5 tt0 -121.26 144.48 48.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.895 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.53 -146.83 18.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 73.230000000000004 112.505 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.94 150.83 47.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 74.209999999999994 111.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.04 136.54 48.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 74.400000000000006 110.876 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.47 -169.96 41.9 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 73.400000000000006 112.517 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.44 -25.37 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 33.240000000000002 110.845 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.8 p -119.53 73.59 16.07 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.589 0.709 . . . . 74.340000000000003 110.867 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.576 ' O ' HD23 ' A' ' 123' ' ' LEU . 53.5 Cg_endo -69.84 104.87 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.662 2.242 . . . . 70.349999999999994 112.339 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -108.92 -23.13 11.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 50.439999999999998 110.817 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.0 -24.39 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 55.25 110.846 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 120' ' ' PRO . 1.7 pp -51.85 -30.21 22.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 71.319999999999993 110.885 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.85 -35.44 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 111.148 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -33.74 76.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 111.106 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.5 pt -81.92 -29.52 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 72.519999999999996 111.154 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -51.33 -45.57 62.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.893 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -24.91 63.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 73.519999999999996 110.885 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.24 -58.97 5.23 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 71.140000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -59.94 -54.93 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.129 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -51.9 -31.41 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 110.902 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -72.78 -35.69 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 65.409999999999997 110.869 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.7 mtp85 -76.08 -40.17 53.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.834 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.71 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.11 -30.26 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 64.439999999999998 110.963 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 22.6 mtt -69.67 -24.2 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 110.908 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -67.3 -48.51 67.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.519999999999996 110.94 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 138' ' ' ILE . 10.6 mmtt -84.03 -49.04 9.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.864 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.712 ' O ' HG12 ' A' ' 141' ' ' VAL . 5.4 mp -113.18 75.28 2.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 54.009999999999998 111.137 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -8.78 24.47 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.7 2.266 . . . . 44.399999999999999 112.346 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.12 -28.45 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 74.450000000000003 110.914 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.5 p -69.88 144.6 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 64.420000000000002 111.153 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.503 ' HB3' HD22 ' A' ' 106' ' ' ASN . . . -89.06 -39.65 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 111.09 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.7 171.83 3.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.200000000000003 111.084 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.79 151.94 34.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 60.329999999999998 111.125 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -132.32 160.08 69.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.7 0.762 . . . . 64.319999999999993 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 174.51 9.41 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.717 2.278 . . . . 72.019999999999996 112.301 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -72.48 -24.36 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 111.144 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.8 p -98.52 -172.04 2.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 111.132 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.97 -67.78 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.530000000000001 110.832 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -136.54 -170.86 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.519999999999996 110.935 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -52.19 -32.72 37.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 71.219999999999999 110.88 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.0 t -113.03 26.67 10.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 54.409999999999997 111.166 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.743 . . . . 73.200000000000003 112.471 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.811 0.338 . . . . 53.210000000000001 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.04 -28.52 8.34 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 64.530000000000001 112.537 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.579 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -95.02 160.74 30.28 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 74.340000000000003 110.915 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HD2' HD23 ' A' ' 73' ' ' LEU . 53.8 Cg_endo -69.75 -45.73 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.726 2.284 . . . . 71.519999999999996 112.344 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.52 HD21 ' CA ' ' A' ' 80' ' ' VAL . 3.0 tm? -93.45 130.82 39.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.872 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.457 ' N ' HD22 ' A' ' 75' ' ' LEU . 11.8 p -128.65 172.79 10.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 73.239999999999995 111.189 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -62.81 -27.01 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 52.210000000000001 111.079 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.78 -49.29 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 64.420000000000002 112.465 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -44.5 65.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 64.239999999999995 110.897 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HD13 ' A' ' 84' ' ' LEU . 9.8 p -51.43 -31.43 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 75.040000000000006 111.119 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -60.93 -35.21 76.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.340000000000003 110.872 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -44.22 97.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 64.540000000000006 110.856 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 134' ' ' LEU . 25.3 t -77.21 -41.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 71.040000000000006 111.122 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -68.03 -19.4 64.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.912 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -53.21 -26.7 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 64.099999999999994 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -76.39 -44.0 38.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.040000000000006 110.903 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.727 ' CG2' HD23 ' A' ' 91' ' ' LEU . 10.8 p -81.5 -6.82 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.409999999999997 111.139 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.7 ttm180 -60.53 -58.8 16.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 63.530000000000001 110.885 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.79 -8.39 23.48 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.72 2.28 . . . . 73.200000000000003 112.354 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 3.8 t80 -94.63 -63.3 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.917 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.74 HD11 HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -53.64 -49.05 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.891 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 88' ' ' ARG . 64.1 p -60.56 -28.53 68.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 65.430000000000007 111.137 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -56.88 -53.79 53.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 111.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -68.16 -24.96 65.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.0 6.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 75.219999999999999 112.455 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.09 -153.79 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 61.109999999999999 112.506 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -174.77 127.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 61.409999999999997 110.867 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.574 HG11 HG13 ' A' ' 87' ' ' VAL . 22.6 m -100.98 134.77 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 72.010000000000005 111.092 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.37 117.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 111.094 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD21 HD11 ' A' ' 103' ' ' ILE . 12.3 tp -63.03 126.97 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.946 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' N ' HD12 ' A' ' 100' ' ' LEU . 25.4 t60 -93.69 -74.09 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.540000000000006 110.853 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -124.36 171.36 9.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 61.219999999999999 110.915 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.577 ' CG2' HD22 ' A' ' 73' ' ' LEU . 37.0 mt -135.23 108.19 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 70.120000000000005 111.099 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.39 -172.05 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 65.099999999999994 111.119 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.39 -87.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 62.130000000000003 112.486 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -94.31 20.64 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 71.209999999999994 110.902 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.09 150.83 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.549999999999997 111.138 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.15 139.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 75.420000000000002 111.102 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mtp85 -99.4 101.05 12.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 110.876 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.5 mt -108.6 154.66 21.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 53.109999999999999 110.939 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.713 ' HG3' HG21 ' A' ' 147' ' ' VAL . 8.3 tttp -115.05 119.04 35.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 110.919 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -143.13 134.71 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 60.32 110.921 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.1 130.02 54.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.915 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.0 90.94 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.477 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.11 -59.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 71.409999999999997 111.118 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.0 m -66.9 118.84 10.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 63.229999999999997 110.873 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.21 -144.37 11.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.672 -0.775 . . . . 75.409999999999997 112.426 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -73.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 64.310000000000002 110.845 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.85 160.64 25.61 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 121.639 0.733 . . . . 72.010000000000005 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -17.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 71.400000000000006 112.355 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p -113.19 60.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 110.851 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.82 -19.23 60.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.519999999999996 110.841 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 pp -51.32 -30.67 19.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 64.150000000000006 110.929 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.72 -30.89 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 111.115 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.2 m -72.62 -34.64 67.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.74 HD12 HD11 ' A' ' 91' ' ' LEU . 26.7 pt -86.1 -30.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 63.030000000000001 111.145 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -50.85 -47.41 60.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 110.905 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -68.47 -24.77 64.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.869 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.78 -56.89 5.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 32.210000000000001 112.431 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.877 HD13 HD22 ' A' ' 112' ' ' LEU . 3.8 mp -62.9 -53.24 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 74.239999999999995 111.169 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -53.21 -31.78 44.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 110.891 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -68.43 -32.44 72.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.149999999999999 110.886 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -79.09 -46.0 18.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 110.852 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -61.52 -51.99 66.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 110.845 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 18.6 tpp -53.69 -39.4 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.88 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.1 -23.36 54.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 110.872 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -100.53 -37.88 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 62.329999999999998 110.867 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.83 80.23 2.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.124 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.7 2.267 . . . . 74.239999999999995 112.309 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.49 -26.79 62.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.434 . . . . 74.319999999999993 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 143' ' ' ALA . 34.8 t -83.19 149.38 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.13 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.53 -30.08 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.148 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.572 ' H ' HG12 ' A' ' 141' ' ' VAL . . . -178.46 -173.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 111.123 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.25 164.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 55.149999999999999 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -144.69 160.13 48.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.685 0.755 . . . . 73.409999999999997 110.853 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.83 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.249 . . . . 72.129999999999995 112.334 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.767 HG23 HG23 ' A' ' 148' ' ' THR . 12.8 m -104.15 -28.84 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.130000000000003 111.181 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.767 HG23 HG23 ' A' ' 147' ' ' VAL . 20.5 p -117.01 -26.16 6.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 111.138 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.32 48.26 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 61.539999999999999 110.88 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -127.98 76.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.911 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.4 148.51 51.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 70.030000000000001 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.3 p -115.99 152.23 33.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.138 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 44.43 112.504 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.84 0.353 . . . . 42.100000000000001 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.61 143.82 4.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 72.209999999999994 112.476 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt 61.04 159.55 0.11 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.6 0.714 . . . . 62.009999999999998 110.941 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -30.65 21.76 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 65.5 112.354 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.658 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -142.67 135.84 28.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.935 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.4 p -145.07 172.43 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 71.209999999999994 111.126 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.33 -30.37 18.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.140000000000001 111.131 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.3 -62.3 2.21 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 53.420000000000002 112.471 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -55.38 -47.83 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.858 0.361 . . . . 73.239999999999995 110.863 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 8.1 p -50.64 -31.04 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 111.163 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.26 -37.55 83.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 73.140000000000001 110.866 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -42.7 99.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.89 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.5 t -77.1 -39.87 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 71.530000000000001 111.102 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 2.3 mp -70.63 -18.69 62.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 74.310000000000002 110.909 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.15 -25.88 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.888 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.03 -47.59 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 110.916 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 130' ' ' ILE . 3.6 m -82.64 -3.49 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 111.131 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 4.0 ttt180 -60.78 -58.74 17.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 73.319999999999993 110.872 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.2 Cg_endo -69.78 -10.92 29.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.65 2.234 . . . . 74.310000000000002 112.366 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.15 -32.55 14.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 63.32 110.943 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.717 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.1 mm? -85.94 -59.68 2.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 61.409999999999997 110.958 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' OD1' ' A' ' 97' ' ' ASP . 37.5 p -51.74 -39.39 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.310000000000002 111.139 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.51 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 51.399999999999999 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.69 -37.96 67.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 71.319999999999993 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.85 -38.57 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 63.039999999999999 112.525 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -73.76 -135.89 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 32.100000000000001 112.519 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' A' ' 92' ' ' THR . 10.0 t0 -174.9 175.99 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.359 . . . . 61.329999999999998 110.825 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 112' ' ' LEU . 19.0 m -138.28 138.59 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 71.140000000000001 111.155 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -178.32 131.51 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 41.219999999999999 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.576 HD12 HG11 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -78.01 118.55 20.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 63.25 110.918 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -97.64 -64.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 72.209999999999994 110.865 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -121.43 165.08 16.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 110.882 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 108' ' ' VAL . 69.8 mt -138.5 113.36 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 111.137 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -90.56 -169.34 2.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 111.094 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.37 -90.2 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 65.409999999999997 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -85.98 4.94 35.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 75.519999999999996 110.867 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 19.6 t -133.39 151.19 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.145 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 103' ' ' ILE . 96.1 t -123.71 140.37 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 34.5 111.114 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 100.97 13.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 65.219999999999999 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.12 123.17 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 71.140000000000001 110.939 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.666 ' HG3' HG21 ' A' ' 147' ' ' VAL . 8.9 ttpt -73.23 86.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 34.109999999999999 110.891 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 130' ' ' ILE . 6.6 mt -117.99 129.64 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 110.916 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -131.05 141.39 50.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 73.230000000000004 110.9 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.69 173.32 14.92 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 63.240000000000002 112.498 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.01 154.89 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 74.310000000000002 111.115 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 10.3 m -130.96 147.66 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.030000000000001 110.899 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 136.25 -97.85 0.28 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 62.450000000000003 112.489 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -79.58 -26.79 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 63.140000000000001 110.848 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.6 p -131.43 70.78 81.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.618 0.723 . . . . 75.099999999999994 110.89 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -174.5 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.661 2.241 . . . . 72.049999999999997 112.303 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.7 p 56.49 28.43 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 72.040000000000006 110.848 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.7 m -69.38 -28.14 65.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.861 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -54.34 -29.83 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 62.420000000000002 110.884 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.4 mm -85.11 -31.34 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 54.439999999999998 111.169 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.8 m -68.15 -34.36 76.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.420000000000002 111.124 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.717 ' CD1' HD11 ' A' ' 91' ' ' LEU . 24.5 pt -86.03 -30.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 111.135 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -52.64 -47.1 67.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 71.049999999999997 110.891 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -69.11 -24.88 64.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 75.099999999999994 110.885 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.25 -57.59 6.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.681 -0.771 . . . . 74.439999999999998 112.475 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -60.74 -55.31 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.815 0.34 . . . . 51.310000000000002 111.114 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HB3' HG22 ' A' ' 144' ' ' VAL . 22.5 pt-20 -51.68 -31.81 27.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 70.040000000000006 110.898 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -71.3 -36.77 71.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 64.209999999999994 110.908 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -79.03 -36.38 41.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 61.240000000000002 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.807 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -70.23 -33.54 71.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.439999999999998 110.925 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 3.2 mtm -63.91 -27.72 69.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 75.420000000000002 110.872 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.68 -58.55 8.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.253 -0.431 . . . . 71.230000000000004 110.881 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.719 ' HB2' HD12 ' A' ' 138' ' ' ILE . 4.3 mttm -77.62 -47.41 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 73.549999999999997 110.881 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.56 74.33 2.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.64 0.734 . . . . 73.209999999999994 111.114 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -14.31 35.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.623 2.215 . . . . 54.299999999999997 112.372 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -38.46 55.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.876 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.04 144.1 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 53.030000000000001 111.102 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.33 -53.66 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.128 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.13 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.1 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 131' ' ' GLU . 15.9 m -138.63 148.51 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 63.329999999999998 111.094 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.04 159.71 60.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.651 0.739 . . . . 64.329999999999998 110.867 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -177.51 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.667 2.245 . . . . 72.219999999999999 112.339 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.666 HG21 ' HG3' ' A' ' 111' ' ' LYS . 31.0 m -101.22 25.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 51.32 111.087 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.3 t -155.42 -179.91 8.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 111.108 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.46 159.52 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 110.836 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -55.2 175.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.922 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.91 -72.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.891 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.8 p -103.25 133.15 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.400000000000006 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.698 -0.763 . . . . 61.509999999999998 112.47 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.4 ttm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.82 0.343 . . . . 71.430000000000007 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.31 -156.18 18.49 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.722 . . . . 61.039999999999999 112.502 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.529 HD22 HG21 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -136.42 160.47 66.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 72.209999999999994 110.877 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.609 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.8 -47.84 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.712 2.275 . . . . 74.549999999999997 112.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 108' ' ' VAL . 5.1 tt -89.48 106.97 18.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.929 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 79' ' ' ASN . 6.6 t -135.58 166.04 24.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 74.140000000000001 111.144 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.88 -27.39 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 111.086 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.16 -59.04 3.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 33.229999999999997 112.478 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.507 ' H ' HG23 ' A' ' 76' ' ' THR . 79.0 m-20 -62.23 -48.02 81.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 74.219999999999999 110.909 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.023 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.6 -30.99 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 61.030000000000001 111.143 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -61.79 -38.15 87.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 72.349999999999994 110.887 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 t -67.38 -37.85 83.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 52.149999999999999 110.868 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.767 HG11 ' HA ' ' A' ' 134' ' ' LEU . 59.4 t -77.04 -39.41 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 111.147 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 80' ' ' VAL . 4.2 mp -71.1 -19.16 62.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.340000000000003 110.912 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.84 -26.89 10.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.87 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -76.35 -43.42 41.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.732 ' CG2' HD23 ' A' ' 91' ' ' LEU . 11.9 p -81.4 -7.35 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 73.319999999999993 111.086 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.7 ttm-85 -60.18 -58.79 16.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.603 0.716 . . . . 71.430000000000007 110.877 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.1 Cg_endo -69.83 -8.49 23.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.669 2.246 . . . . 74.439999999999998 112.32 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 5.5 t80 -94.55 -63.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 110.94 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -53.09 -54.77 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 62.329999999999998 110.891 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -51.48 -34.77 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.329999999999998 111.154 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 90' ' ' TYR . . . -59.65 -37.18 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 54.25 111.06 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.89 -31.7 63.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.842 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.7 17.1 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 62.229999999999997 112.504 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.38 -135.96 8.84 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 53.409999999999997 112.477 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -179.16 136.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 74.040000000000006 110.851 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.8 m -110.13 129.45 65.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.141 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -167.8 129.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 42.200000000000003 111.098 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HA ' HD23 ' A' ' 110' ' ' LEU . 11.5 tp -71.78 119.65 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.319999999999993 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 147' ' ' VAL . 84.5 t60 -76.96 -72.28 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 72.010000000000005 110.877 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.75 171.1 14.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.85 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.529 HG21 HD22 ' A' ' 73' ' ' LEU . 58.1 mt -125.91 121.35 59.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 54.329999999999998 111.101 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.24 -170.51 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 50.32 111.074 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -55.01 -90.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 54.439999999999998 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 23.41 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 64.129999999999995 110.908 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.15 150.26 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.171 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.049 HG21 HD13 ' A' ' 75' ' ' LEU . 60.6 t -116.18 138.1 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.174 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 100' ' ' LEU . 24.1 mtp180 -101.02 101.05 11.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.872 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.1 mt -107.91 164.62 12.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 54.340000000000003 110.887 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.472 ' HG3' HG11 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -126.72 115.81 19.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 63.229999999999997 110.905 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.826 HD22 HD13 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -138.71 137.9 37.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.894 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.38 113.13 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.340000000000003 110.898 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.29 -48.62 0.64 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 72.420000000000002 112.502 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.77 128.56 37.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.32 . . . . 60.32 111.101 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 9.0 t -100.24 -50.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 52.030000000000001 110.873 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -174.43 -85.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 71.120000000000005 112.501 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.2 p -75.67 -28.51 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 61.130000000000003 110.879 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.18 160.65 3.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 72.310000000000002 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 64.25 112.358 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.1 p -71.88 80.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 54.409999999999997 110.828 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.31 -26.11 58.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 44.210000000000001 110.907 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 tp -51.67 -47.67 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 73.219999999999999 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.57 -31.2 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.129999999999995 111.122 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -61.66 -39.92 93.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.14 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 130' ' ' ILE . 30.1 pt -86.17 -29.99 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 111.135 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -50.75 -47.67 59.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 72.25 110.882 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.76 -24.71 65.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 60.149999999999999 110.839 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.15 -55.76 6.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.771 -0.728 . . . . 33.450000000000003 112.458 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.826 HD13 HD22 ' A' ' 112' ' ' LEU . 4.0 mp -62.87 -54.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 111.134 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -52.88 -32.6 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 55.399999999999999 110.904 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.67 -32.74 74.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.868 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -78.88 -56.42 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.995 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -52.0 -35.65 47.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 51.200000000000003 110.893 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.1 mtt -62.78 -40.35 97.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 55.350000000000001 110.897 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.31 -20.07 57.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.140000000000001 110.913 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HZ2' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.67 -33.81 9.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 63.130000000000003 110.902 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.767 ' O ' HG12 ' A' ' 141' ' ' VAL . 11.5 mm -112.34 76.89 2.05 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 44.219999999999999 111.079 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -7.6 21.48 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.671 2.247 . . . . 75.439999999999998 112.378 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.94 -29.53 35.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 63.32 110.879 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 138' ' ' ILE . 9.8 p -72.28 158.47 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.010000000000005 111.108 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 141' ' ' VAL . . . -99.37 -47.29 5.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.147 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.24 -173.8 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 61.43 111.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.75 164.85 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.139 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -147.96 160.38 37.89 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.6 0.714 . . . . 72.310000000000002 110.96 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -171.01 0.43 Allowed 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.744 2.296 . . . . 71.150000000000006 112.312 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.491 HG23 ' CD2' ' A' ' 101' ' ' HIS . 9.3 p -108.54 -25.02 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 111.127 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.457 HG23 HG13 ' A' ' 147' ' ' VAL . 22.6 p -119.59 24.89 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 72.510000000000005 111.141 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 55.18 35.6 25.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 63.130000000000003 110.836 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -98.43 68.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.853 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.26 -25.79 14.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 110.88 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 p 49.87 42.65 24.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 111.131 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 71.209999999999994 112.486 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.8 0.334 . . . . 73.329999999999998 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -138.32 -146.77 5.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.782 -0.723 . . . . 51.32 112.517 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.1 mt 61.04 159.68 0.11 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.596 0.712 . . . . 64.329999999999998 110.943 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.71 -29.28 24.35 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.678 2.252 . . . . 71.430000000000007 112.346 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.3 tm? -145.68 140.11 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 64.040000000000006 110.943 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.647 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.0 t -142.74 167.72 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 71.239999999999995 111.144 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.32 -28.35 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.07 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.88 -42.5 12.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.736 . . . . 60.0 112.472 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' H ' HG23 ' A' ' 76' ' ' THR . 1.9 m120 -72.65 -47.18 49.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.366 . . . . 63.539999999999999 110.91 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.831 HG22 HD13 ' A' ' 84' ' ' LEU . 9.5 p -50.78 -30.8 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 62.409999999999997 111.136 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.94 -37.08 83.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.912 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.71 -39.57 73.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 73.450000000000003 110.86 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.8 t -72.46 -44.74 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 61.530000000000001 111.097 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.831 HD13 HG22 ' A' ' 80' ' ' VAL . 6.5 mp -71.21 -18.97 62.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.93 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -50.8 -26.12 5.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.862 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -75.06 -45.46 41.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.892 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 130' ' ' ILE . 2.6 m -81.62 -7.06 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 74.030000000000001 111.157 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 17.7 ttt-85 -58.56 -58.8 16.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 71.319999999999993 110.885 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.7 -8.85 24.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.716 2.278 . . . . 72.099999999999994 112.353 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.1 -25.47 15.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.913 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.772 HD11 HD13 ' A' ' 126' ' ' ILE . 2.3 mm? -93.7 -57.32 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -53.11 -36.33 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 53.439999999999998 111.155 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.59 -28.74 70.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 111.088 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -76.81 -38.05 54.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 72.5 110.87 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.41 -39.41 0.8 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 73.400000000000006 112.495 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.48 -137.77 1.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.753 . . . . 71.129999999999995 112.464 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -174.77 -175.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 74.519999999999996 110.825 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 87' ' ' VAL . 18.7 m -137.94 138.96 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 71.349999999999994 111.121 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.42 123.32 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 111.13 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 109' ' ' ARG . 21.2 tp -66.12 133.59 51.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.967 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.408 ' N ' HD12 ' A' ' 100' ' ' LEU . 2.1 t60 -100.18 -63.53 1.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 62.32 110.823 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -144.75 163.87 32.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.894 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.406 HD11 HD21 ' A' ' 100' ' ' LEU . 54.8 mt -123.11 114.5 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 111.16 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.43 -172.32 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 62.100000000000001 111.147 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.63 -87.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.99 25.06 8.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.372 . . . . 55.119999999999997 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -144.69 151.01 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 111.108 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.42 128.96 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 111.127 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.7 mtt-85 -90.16 103.33 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.904 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.8 HD22 HD21 ' A' ' 84' ' ' LEU . 1.6 mt -112.82 133.67 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 60.149999999999999 110.896 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG3' HG11 ' A' ' 147' ' ' VAL . 61.8 tttt -86.07 91.76 8.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.895 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 130' ' ' ILE . 9.9 mt -119.44 131.33 55.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.510000000000005 110.877 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.512 ' O ' HD12 ' A' ' 91' ' ' LEU . 40.6 tt0 -127.84 127.01 42.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 62.039999999999999 110.895 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -83.46 -61.76 1.86 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.739 -0.743 . . . . 75.120000000000005 112.468 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.36 139.77 18.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 60.310000000000002 111.116 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.5 t -72.62 139.59 47.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.879 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.68 168.97 32.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.219999999999999 112.472 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -67.11 -26.72 66.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 54.020000000000003 110.847 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.3 t -115.17 73.31 3.45 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.64 0.733 . . . . 72.409999999999997 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 90.54 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.652 2.235 . . . . 64.519999999999996 112.352 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.5 p -115.98 -26.5 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.845 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.52 -28.84 33.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.499 . . . . 72.150000000000006 110.826 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pp -52.38 -30.12 27.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 62.149999999999999 110.935 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.97 -36.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 111.107 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -60.04 -34.02 72.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 72.120000000000005 111.137 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.772 HD13 HD11 ' A' ' 91' ' ' LEU . 49.9 pt -86.14 -26.83 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 111.106 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -51.07 -48.6 61.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.32 110.873 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -66.35 -24.7 66.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 65.310000000000002 110.858 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.13 -57.23 6.34 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.763 -0.732 . . . . 62.119999999999997 112.471 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.08 HD13 HD13 ' A' ' 112' ' ' LEU . 4.2 mp -63.09 -54.54 32.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 75.5 111.132 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -31.74 25.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 55.020000000000003 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -69.27 -44.35 72.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 110.86 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -69.75 -39.98 76.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 110.852 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -70.21 -47.74 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 64.530000000000001 110.935 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 8.7 mmt -55.11 -26.49 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 63.310000000000002 110.89 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.4 -62.68 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.863 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.69 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.4 mttt -71.84 -47.27 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.885 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.69 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.2 mp -113.24 75.06 2.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 54.109999999999999 111.103 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -11.06 30.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.65 2.233 . . . . 75.150000000000006 112.368 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -51.92 -43.84 63.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 54.32 110.878 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.99 148.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 111.118 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.42 -33.0 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 71.310000000000002 111.113 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -175.56 177.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.09 147.35 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 32.030000000000001 111.137 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -131.92 159.84 70.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.649 0.737 . . . . 62.5 110.868 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.83 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.701 2.267 . . . . 75.219999999999999 112.359 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.73 HG23 ' H ' ' A' ' 149' ' ' ASP . 19.5 m -65.61 -173.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 53.109999999999999 111.141 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.43 -32.7 27.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 50.229999999999997 111.112 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.73 ' H ' HG23 ' A' ' 147' ' ' VAL . 1.6 m-20 -64.86 -173.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 110.799 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -115.73 -177.52 3.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 74.019999999999996 110.945 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -52.15 -32.69 36.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 74.340000000000003 110.845 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.7 p -112.18 100.37 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.150000000000006 111.168 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.742 -0.742 . . . . 70.409999999999997 112.486 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.869 0.366 . . . . 73.430000000000007 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.31 -27.13 1.99 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.721 . . . . 41.420000000000002 112.507 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -108.59 160.67 26.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.621 0.724 . . . . 74.519999999999996 110.878 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.557 ' HD2' HD23 ' A' ' 73' ' ' LEU . 54.0 Cg_endo -69.8 -30.29 22.33 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.63 2.22 . . . . 64.510000000000005 112.363 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' HA ' ' A' ' 80' ' ' VAL . 3.3 tm? -144.95 120.14 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 62.109999999999999 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -134.51 -176.69 4.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.183 -0.462 . . . . 61.439999999999998 111.142 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.57 70.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 55.130000000000003 111.081 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.5 -52.28 4.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.714 -0.755 . . . . 71.439999999999998 112.474 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -61.22 -48.45 81.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 73.340000000000003 110.879 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 84' ' ' LEU . 5.8 p -51.79 -30.77 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 54.049999999999997 111.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -62.34 -33.58 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 72.409999999999997 110.947 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 t -63.93 -43.93 94.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 72.230000000000004 110.87 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 134' ' ' LEU . 48.4 t -76.5 -40.77 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 111.123 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 80' ' ' VAL . 3.1 mp -71.11 -18.97 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -51.26 -26.85 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 65.310000000000002 110.875 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -74.48 -42.23 59.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.510000000000005 110.921 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.848 HG11 HG13 ' A' ' 130' ' ' ILE . 33.7 m -81.96 -12.88 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.164 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.5 ttt85 -53.04 -58.59 11.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.587 0.708 . . . . 73.219999999999999 110.891 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.8 Cg_endo -69.77 -32.13 19.14 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 73.5 112.323 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -65.92 -57.7 7.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.955 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.8 mm? -58.05 -54.81 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 71.299999999999997 110.94 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.643 HG22 ' OD1' ' A' ' 97' ' ' ASP . 40.1 p -51.6 -30.57 21.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 54.549999999999997 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.96 -36.74 78.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.126 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.18 -38.03 61.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 63.539999999999999 110.89 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.76 -26.62 2.37 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 63.219999999999999 112.461 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.73 -136.84 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.492 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.643 ' OD1' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -179.39 -175.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.861 0.362 . . . . 63.030000000000001 110.881 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG12 ' CD2' ' A' ' 112' ' ' LEU . 17.5 m -141.79 143.95 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.519999999999996 111.183 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.78 131.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.349999999999994 111.124 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HA ' HD13 ' A' ' 110' ' ' LEU . 25.0 tp -53.69 114.93 1.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 70.329999999999998 110.876 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.568 ' CG ' HG11 ' A' ' 147' ' ' VAL . 11.1 t60 -80.78 -49.98 10.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.439999999999998 110.835 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -168.41 167.9 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.889 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 100' ' ' LEU . 69.7 mt -127.97 105.07 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 74.140000000000001 111.141 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -77.32 -178.08 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 111.092 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.16 -75.88 0.2 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.747 . . . . 71.049999999999997 112.528 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.07 -0.14 21.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 62.140000000000001 110.935 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 104' ' ' ALA . 16.3 t -119.62 152.74 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 111.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 141' ' ' VAL . 19.6 t -113.78 142.85 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 52.439999999999998 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -115.13 100.42 8.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.899 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.679 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.2 mm? -100.69 146.29 27.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.895 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HG3' HG21 ' A' ' 147' ' ' VAL . 11.7 tttt -102.29 124.05 47.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 75.340000000000003 110.892 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.956 HD13 HD13 ' A' ' 130' ' ' ILE . 6.4 mt -140.4 156.97 46.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 70.200000000000003 110.905 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -132.78 114.72 14.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 72.299999999999997 110.925 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.97 -51.39 0.48 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 60.439999999999998 112.507 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.06 103.07 14.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.761 0.315 . . . . 74.150000000000006 111.131 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.4 p -75.95 -28.62 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 75.129999999999995 110.865 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 172.66 -90.07 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.310000000000002 112.487 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -63.67 -32.96 74.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.832 0.348 . . . . 73.230000000000004 110.839 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.61 160.68 2.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 73.099999999999994 110.841 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.694 2.262 . . . . 62.350000000000001 112.386 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -80.19 59.12 3.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 73.409999999999997 110.905 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.3 m -71.32 -26.16 62.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 74.430000000000007 110.846 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.97 -32.86 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 74.200000000000003 110.892 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.52 -31.02 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 65.420000000000002 111.12 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -63.7 -40.65 97.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.161 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.6 pt -84.01 -30.91 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 65.439999999999998 111.066 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -52.0 -41.66 62.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.951 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -24.81 60.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 70.099999999999994 110.871 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.17 -54.81 7.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 53.329999999999998 112.549 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.956 HD13 HD13 ' A' ' 112' ' ' LEU . 3.3 mp -58.46 -50.92 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 72.239999999999995 111.106 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.532 ' HB2' HG13 ' A' ' 144' ' ' VAL . 12.5 pt-20 -58.84 -34.73 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -76.68 -30.33 56.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 110.853 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -79.21 -34.32 43.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.549999999999997 110.858 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.686 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -57.08 5.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.972 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 4.4 ttm -50.89 -30.73 15.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 71.340000000000003 110.905 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -60.38 -37.56 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.948 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.724 ' HB2' HD12 ' A' ' 138' ' ' ILE . 6.0 mttm -91.7 -45.37 8.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 71.340000000000003 110.886 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.0 mp -113.41 73.74 2.0 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 74.230000000000004 111.117 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.87 36.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 74.219999999999999 112.347 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.71 -47.55 82.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 51.020000000000003 110.861 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.9 p -55.84 131.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.049999999999997 111.129 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.31 63.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 55.030000000000001 111.078 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -178.48 178.9 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 65.439999999999998 111.113 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 131' ' ' GLU . 2.1 p -139.85 134.47 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 111.129 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -121.38 160.06 47.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.628 0.728 . . . . 64.140000000000001 110.92 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.67 0.34 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.665 2.243 . . . . 63.32 112.336 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 110' ' ' LEU . 20.0 m -112.8 25.51 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 64.329999999999998 111.141 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.1 t -161.51 164.28 29.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 72.209999999999994 111.117 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -59.69 176.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.899 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -63.46 -174.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -53.55 -29.4 36.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 75.120000000000005 110.912 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 29.5 p -127.92 -40.62 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 111.127 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 35.119999999999997 112.493 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 mtm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.829 0.347 . . . . 42.020000000000003 110.892 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.51 -157.21 53.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.776 -0.726 . . . . 71.209999999999994 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.0 mt 60.96 159.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.626 0.727 . . . . 75.25 110.936 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.9 Cg_endo -69.71 -30.78 21.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 54.530000000000001 112.367 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.606 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.61 134.49 25.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 72.409999999999997 110.885 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.485 ' N ' HD13 ' A' ' 75' ' ' LEU . 18.9 p -145.34 173.02 12.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.219999999999999 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.22 -30.52 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 51.119999999999997 111.094 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.08 -62.28 2.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 73.519999999999996 112.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -47.93 75.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 71.430000000000007 110.907 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.017 HG22 HD13 ' A' ' 84' ' ' LEU . 8.2 p -50.77 -30.88 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 55.149999999999999 111.112 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -61.63 -38.07 86.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.935 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -64.62 -40.39 95.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.400000000000006 110.846 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.6 t -76.49 -39.04 32.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 65.230000000000004 111.144 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.017 HD13 HG22 ' A' ' 80' ' ' VAL . 3.2 mp -71.06 -19.4 62.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 61.509999999999998 110.894 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.3 -26.83 20.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 75.030000000000001 110.857 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -75.32 -43.45 50.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.93 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.648 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.2 p -81.45 -9.77 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 45.109999999999999 111.09 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.8 ttt180 -56.67 -58.71 15.48 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 65.430000000000007 110.855 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.2 Cg_endo -69.78 -12.57 33.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.694 2.263 . . . . 73.010000000000005 112.302 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -92.14 -25.99 18.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 110.905 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD11 HD12 ' A' ' 126' ' ' ILE . 1.6 mm? -101.0 -57.38 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 110.956 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 88' ' ' ARG . 29.9 p -52.33 -35.92 52.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 111.167 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.81 72.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 31.109999999999999 111.113 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.08 -37.98 69.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.150000000000006 110.89 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.45 -35.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.762 -0.732 . . . . 72.340000000000003 112.524 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -141.13 1.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.771 . . . . 75.150000000000006 112.47 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -170.19 -176.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.888 0.375 . . . . 62.409999999999997 110.821 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.606 HG12 ' CD2' ' A' ' 112' ' ' LEU . 18.8 m -141.93 138.43 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 53.109999999999999 111.104 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.74 137.3 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 52.240000000000002 111.083 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HA ' HD23 ' A' ' 110' ' ' LEU . 35.3 tp -76.28 135.53 39.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 60.43 110.951 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -103.5 -63.95 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 65.540000000000006 110.862 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -140.15 162.49 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.882 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 100' ' ' LEU . 58.2 mt -126.98 117.8 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 53.240000000000002 111.143 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -98.64 -169.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.125 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.94 -88.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.718 -0.753 . . . . 70.25 112.507 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 142' ' ' ALA . 9.6 p30 -102.55 13.45 34.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 62.130000000000003 110.877 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.54 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.9 t -131.33 139.03 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.63 134.81 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 65.409999999999997 111.072 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.95 101.09 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.299999999999997 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.6 mt -112.29 149.19 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 72.450000000000003 110.898 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -101.3 119.07 38.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 73.420000000000002 110.932 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 130' ' ' ILE . 7.6 mt -139.49 127.76 22.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.948 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.429 HE22 ' HB3' ' A' ' 115' ' ' ALA . 31.0 tp60 -104.92 137.11 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 73.439999999999998 110.895 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.22 -36.22 0.43 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 72.010000000000005 112.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.429 ' HB3' HE22 ' A' ' 113' ' ' GLN . . . -57.11 144.35 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.805 0.336 . . . . 70.25 111.079 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.5 p -118.23 -32.18 4.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 162.65 -40.66 0.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 73.340000000000003 112.432 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 t -94.71 20.15 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 65.329999999999998 110.881 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.7 t 54.37 68.53 2.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.628 0.728 . . . . 72.010000000000005 110.888 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -15.78 37.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.642 2.228 . . . . 73.340000000000003 112.364 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.22 30.96 15.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 63.340000000000003 110.895 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -80.23 -24.98 39.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 75.340000000000003 110.812 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -31.08 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 74.420000000000002 110.936 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mm -88.07 -30.98 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 65.150000000000006 111.167 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.4 m -72.22 -33.3 67.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 111.163 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.779 HD12 HD11 ' A' ' 91' ' ' LEU . 25.4 pt -83.65 -30.91 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.164 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -51.8 -51.58 55.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 72.319999999999993 110.878 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.9 -24.93 66.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 64.040000000000006 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.6 -61.78 3.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 62.240000000000002 112.48 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 112' ' ' LEU . 2.9 mp -55.9 -54.73 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 63.219999999999999 111.147 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -52.53 -32.45 40.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 65.209999999999994 110.888 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -75.44 -32.43 60.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -76.34 -35.63 58.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 72.349999999999994 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -70.1 -48.12 58.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 110.914 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.96 -33.24 36.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.888 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.61 -55.25 23.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.9 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.637 ' HB2' HD12 ' A' ' 138' ' ' ILE . 0.4 OUTLIER -80.06 -45.83 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.899 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.642 HD13 ' CD2' ' A' ' 134' ' ' LEU . 5.2 mp -113.09 74.96 1.95 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.667 0.746 . . . . 73.420000000000002 111.163 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.86 33.79 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 61.130000000000003 112.333 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.76 -52.8 46.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 61.310000000000002 110.863 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.44 151.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 111.109 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB3' ' OD1' ' A' ' 106' ' ' ASN . . . -87.49 -45.75 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 111.13 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.37 -169.44 2.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.095 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.72 148.54 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 62.340000000000003 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.54 ' CG ' HG11 ' A' ' 107' ' ' VAL . 14.7 mm-40 -120.49 95.67 49.01 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.646 0.736 . . . . 64.349999999999994 110.896 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 145' ' ' GLU . 53.2 Cg_endo -69.85 -172.94 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 75.540000000000006 112.322 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.15 46.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 60.32 111.149 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.6 t -159.03 129.17 5.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 70.510000000000005 111.138 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -104.86 -46.25 4.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 110.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -79.11 176.59 9.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 60.439999999999998 110.916 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -102.09 -54.16 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 75.219999999999999 110.909 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.0 t -132.92 152.21 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 61.409999999999997 111.157 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 64.340000000000003 112.496 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 mtp . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.824 0.345 . . . . 74.310000000000002 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.8 -92.03 1.02 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 73.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.529 HD12 HG22 ' A' ' 76' ' ' THR . 2.3 mt -103.33 155.04 37.27 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 110.923 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -23.13 31.4 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.706 2.271 . . . . 71.430000000000007 112.332 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.729 ' HG ' HD21 ' A' ' 134' ' ' LEU . 3.3 tm? -152.19 128.02 10.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 62.509999999999998 110.943 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 HD12 ' A' ' 73' ' ' LEU . 18.1 p -143.22 -178.15 5.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 111.167 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 54.130000000000003 111.089 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.4 -64.08 1.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 70.409999999999997 112.455 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -54.54 -46.73 73.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.844 0.354 . . . . 74.120000000000005 110.846 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.989 HG22 HD13 ' A' ' 84' ' ' LEU . 5.9 p -51.24 -30.63 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 111.124 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.32 -35.62 77.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -42.3 73.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.520000000000003 110.881 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.769 HG11 ' HA ' ' A' ' 134' ' ' LEU . 29.4 t -71.47 -44.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 74.349999999999994 111.087 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.989 HD13 HG22 ' A' ' 80' ' ' VAL . 5.7 mp -71.13 -19.43 62.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 60.219999999999999 110.904 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.19 -26.95 12.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.866 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -74.51 -41.38 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 60.340000000000003 110.895 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.649 ' CG2' HD23 ' A' ' 91' ' ' LEU . 13.8 p -83.02 -12.58 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 63.520000000000003 111.106 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 18.9 ttt180 -53.17 -58.75 11.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.709 . . . . 74.109999999999999 110.904 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.9 Cg_endo -69.74 -19.51 36.13 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 72.540000000000006 112.347 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -83.8 -24.13 31.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 62.020000000000003 110.898 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 126' ' ' ILE . 1.4 mm? -101.04 -55.53 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.299999999999997 110.948 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.3 p -51.68 -39.35 58.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.0 111.112 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.68 69.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 71.329999999999998 111.116 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' CG ' ' HB3' ' A' ' 115' ' ' ALA . 9.5 t0 -72.17 -37.81 69.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.120000000000005 110.931 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.73 -28.0 1.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 74.209999999999994 112.484 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -84.86 -138.27 4.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 73.310000000000002 112.493 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -173.56 -175.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 64.219999999999999 110.838 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.463 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.8 m -141.09 141.33 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 72.319999999999993 111.136 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.4 132.35 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.209999999999994 111.094 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.707 HD12 HG11 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -69.27 117.19 10.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 63.25 110.933 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -80.8 -57.87 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.882 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -152.75 161.1 43.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.219999999999999 110.921 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.37 118.38 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 111.135 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.77 -177.08 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.131 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.39 -86.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 61.020000000000003 112.489 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.64 25.18 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 54.030000000000001 110.874 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' CG ' ' A' ' 145' ' ' GLU . 22.0 t -145.26 149.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.103 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.78 115.77 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 61.109999999999999 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -82.7 101.19 10.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.200000000000003 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -112.11 150.88 30.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.109999999999999 110.946 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -106.29 117.23 33.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 110.908 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.821 HD22 HD13 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -132.04 139.28 48.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 70.209999999999994 110.934 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -122.06 119.24 30.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.968 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.28 118.61 5.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 64.409999999999997 112.476 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' A' ' 94' ' ' ASP . . . -59.73 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.738 0.304 . . . . 54.009999999999998 111.085 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 8.5 p -52.25 -39.11 59.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 52.450000000000003 110.885 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 52.23 -161.01 2.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 55.420000000000002 112.468 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.3 m -97.67 -27.1 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.891 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.1 m -93.68 160.53 32.56 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.607 0.718 . . . . 71.349999999999994 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -33.05 17.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.671 2.248 . . . . 75.25 112.301 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 p -122.21 88.12 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 75.239999999999995 110.845 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.48 -37.88 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 54.340000000000003 110.851 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 149' ' ' ASP . 2.6 pt? -51.95 -29.92 22.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.209999999999994 110.888 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.59 -42.66 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 111.097 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 m -53.37 -35.94 60.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 91' ' ' LEU . 25.6 pt -85.94 -30.22 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 73.120000000000005 111.138 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -51.38 -41.93 61.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 110.915 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -25.59 61.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 110.839 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.71 -57.14 6.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 64.140000000000001 112.481 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.821 HD13 HD22 ' A' ' 112' ' ' LEU . 4.3 mp -60.54 -54.86 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 62.219999999999999 111.133 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.87 -31.85 41.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.876 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -70.35 -48.28 57.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 110.847 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -63.34 -40.82 98.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.847 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.769 ' HA ' HG11 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.98 -45.9 66.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 62.009999999999998 110.933 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 28.7 mtt -59.53 -23.84 63.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.230000000000004 110.876 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -71.33 -52.53 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.878 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.702 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.7 mmpt? -75.22 -55.12 6.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 72.209999999999994 110.895 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 137' ' ' LYS . 5.3 mp -112.95 76.03 2.14 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.638 0.732 . . . . 53.439999999999998 111.17 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -8.85 24.65 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 62.100000000000001 112.329 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -52.08 -30.73 27.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 75.519999999999996 110.847 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -79.43 144.18 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 62.5 111.155 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.16 -53.1 7.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.056 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.5 -169.93 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 73.120000000000005 111.128 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.21 153.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 61.350000000000001 111.11 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' CG ' HG11 ' A' ' 107' ' ' VAL . 13.1 mm-40 -119.73 95.61 49.26 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.129999999999995 110.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 115.22 3.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.741 2.294 . . . . 43.210000000000001 112.318 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.8 t -63.29 148.47 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 74.510000000000005 111.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 m 59.1 34.87 23.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.450000000000003 111.171 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.64 ' HA ' HD12 ' A' ' 123' ' ' LEU . 26.6 p30 -84.53 57.17 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.861 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -88.68 101.69 14.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.140000000000001 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -66.91 -68.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.299999999999997 110.866 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.8 t -136.09 145.21 45.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 71.25 111.133 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.746 -0.74 . . . . 54.450000000000003 112.491 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.0 ptm . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.805 0.336 . . . . 74.530000000000001 110.849 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.43 26.01 6.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.796 -0.716 . . . . 74.450000000000003 112.516 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.6 159.25 55.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 75.540000000000006 110.921 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -21.77 32.81 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.641 2.227 . . . . 72.109999999999999 112.337 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.708 HD23 HD13 ' A' ' 138' ' ' ILE . 3.0 tm? -150.17 117.45 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 71.519999999999996 110.914 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' HG12 ' A' ' 80' ' ' VAL . 16.5 p -135.48 179.7 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 111.098 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -51.16 -30.24 16.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 43.43 111.09 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.21 -63.25 2.08 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.738 . . . . 64.299999999999997 112.511 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -54.94 -47.23 74.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.019999999999996 110.865 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 84' ' ' LEU . 6.9 p -51.53 -31.14 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.040000000000006 111.143 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -64.44 -35.64 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 45.450000000000003 110.909 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 t -67.58 -40.22 84.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 53.210000000000001 110.883 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 21.7 t -75.91 -45.36 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 111.136 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mp -72.18 -18.27 61.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.420000000000002 110.94 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -50.48 -26.8 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 110.889 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -74.4 -42.81 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 63.200000000000003 110.931 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.756 HG21 HG13 ' A' ' 130' ' ' ILE . 11.1 p -80.85 -14.88 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 54.119999999999997 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.3 ttp85 -51.07 -58.65 9.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.583 0.706 . . . . 70.319999999999993 110.846 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.76 -26.53 27.5 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.683 2.256 . . . . 73.340000000000003 112.368 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -76.15 -22.11 55.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 64.200000000000003 110.956 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.641 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.2 mm? -100.58 -51.5 3.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 74.209999999999994 110.866 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.5 p -56.86 -30.75 64.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 55.450000000000003 111.155 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.66 -27.21 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 53.539999999999999 111.046 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -85.03 -38.0 19.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.869 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.74 -35.75 0.92 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 45.530000000000001 112.447 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.89 -144.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 52.509999999999998 112.463 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -177.34 168.81 2.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.384 . . . . 71.400000000000006 110.855 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 112' ' ' LEU . 22.8 m -125.23 135.62 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.167 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -176.17 125.89 0.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 14.539999999999999 111.098 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.702 HD21 HD11 ' A' ' 103' ' ' ILE . 10.5 tp -75.68 117.65 17.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 70.519999999999996 110.972 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -83.77 -74.38 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 42.25 110.867 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -125.61 168.48 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 65.409999999999997 110.873 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.702 HD11 HD21 ' A' ' 100' ' ' LEU . 69.8 mt -130.22 123.28 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.0 111.172 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.36 -169.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.200000000000003 111.063 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.27 -87.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 62.109999999999999 112.482 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -96.43 -6.59 37.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.874 0.369 . . . . 75.430000000000007 110.852 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 t -113.9 151.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 103' ' ' ILE . 73.3 t -119.98 133.28 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.095 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -88.58 102.65 15.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.858 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 100' ' ' LEU . 3.4 mt -108.44 151.08 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.91 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.76 ' HG3' HG11 ' A' ' 147' ' ' VAL . 3.4 ttmm -104.28 90.31 3.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 72.319999999999993 110.939 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 130' ' ' ILE . 9.8 mt -120.45 129.62 53.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 72.319999999999993 110.902 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -129.86 159.09 37.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.509999999999998 110.909 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.72 -89.87 1.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 31.109999999999999 112.507 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.95 -175.57 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.779 0.323 . . . . 54.43 111.065 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -134.33 122.62 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 44.450000000000003 110.916 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -171.55 -149.42 6.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 61.140000000000001 112.521 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.5 m -64.0 -62.16 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.355 . . . . 72.140000000000001 110.849 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.0 t -126.65 68.33 68.78 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.607 0.718 . . . . 51.350000000000001 110.923 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 80.04 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.255 . . . . 63.43 112.347 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -95.85 26.71 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 72.420000000000002 110.874 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m -78.48 -24.13 46.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 54.32 110.858 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.413 ' CD1' HD13 ' A' ' 124' ' ' ILE . 1.4 pp -53.72 -28.01 31.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 74.030000000000001 110.89 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 123' ' ' LEU . 25.2 mm -81.18 -30.98 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 63.399999999999999 111.135 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.03 -31.67 70.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 70.099999999999994 111.155 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 130' ' ' ILE . 32.6 pt -86.18 -28.39 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 62.329999999999998 111.073 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -52.89 -35.94 58.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.875 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -75.28 -26.25 58.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.92 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.27 -54.46 6.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.699 -0.762 . . . . 53.420000000000002 112.499 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 112' ' ' LEU . 4.4 mp -63.94 -44.6 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 73.549999999999997 111.16 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -64.69 -22.84 67.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.956 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -76.67 -51.33 11.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 72.120000000000005 110.832 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -73.41 -33.48 64.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.863 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 84' ' ' LEU . 14.3 tp -69.93 -47.5 62.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 70.010000000000005 110.95 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.4 ttm -68.9 -28.12 66.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.109999999999999 110.86 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -51.99 -53.83 36.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -70.56 -49.16 50.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.907 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.708 HD13 HD23 ' A' ' 75' ' ' LEU . 5.3 mp -112.99 76.16 2.2 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 75.109999999999999 111.184 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -8.72 24.33 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.728 2.285 . . . . 71.409999999999997 112.335 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -53.11 -28.72 26.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 110.887 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.0 p -81.45 144.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 111.117 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.58 -52.57 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 55.130000000000003 111.076 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.89 -173.18 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.319999999999993 111.086 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.35 163.37 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 111.13 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.69 160.07 54.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.618 0.723 . . . . 54.200000000000003 110.888 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -172.23 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.677 2.251 . . . . 65.430000000000007 112.295 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.76 HG11 ' HG3' ' A' ' 111' ' ' LYS . 17.6 m -82.39 -172.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 111.114 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.37 85.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 63.32 111.14 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -174.35 -170.84 0.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.877 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -125.51 133.78 52.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.875 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.73 170.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.5 t -117.09 -25.11 7.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 75.230000000000004 111.084 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 71.310000000000002 112.499 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttm . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.855 0.36 . . . . 72.120000000000005 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.11 -169.19 31.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.781 -0.723 . . . . 43.439999999999998 112.542 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 61.05 159.71 0.11 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 74.219999999999999 110.942 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -26.21 27.71 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.712 2.275 . . . . 62.130000000000003 112.303 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.688 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.2 tm? -152.82 128.2 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.340000000000003 110.908 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.469 ' N ' HD13 ' A' ' 75' ' ' LEU . 17.0 p -144.82 178.91 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 61.240000000000002 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.11 -30.3 15.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 51.310000000000002 111.073 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.97 -62.96 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 41.130000000000003 112.514 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -55.31 -47.56 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 73.5 110.947 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.732 HG23 ' CD1' ' A' ' 134' ' ' LEU . 7.2 p -51.23 -31.12 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 55.039999999999999 111.183 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -64.01 -36.69 84.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 74.219999999999999 110.901 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -66.89 -40.66 87.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 64.109999999999999 110.848 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 134' ' ' LEU . 27.4 t -74.96 -45.35 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.140000000000001 111.161 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.729 HD13 HG22 ' A' ' 80' ' ' VAL . 9.0 mp -71.86 -18.16 62.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 54.130000000000003 110.933 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -49.9 -26.98 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 110.849 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -74.61 -43.03 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.943 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.802 HG21 HG13 ' A' ' 130' ' ' ILE . 11.8 p -80.49 -14.73 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.450000000000003 111.142 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 13.2 ttm180 -51.6 -58.75 9.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 73.420000000000002 110.882 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.4 Cg_endo -69.74 -27.48 26.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 54.439999999999998 112.355 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -74.22 -25.01 59.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 70.439999999999998 110.92 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.626 HD23 ' CG2' ' A' ' 87' ' ' VAL . 1.4 mm? -98.77 -52.16 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 75.230000000000004 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -54.29 -32.5 56.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 111.132 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.51 -30.77 71.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.510000000000005 111.1 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -79.7 -37.45 35.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.861 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.87 -42.66 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 11.4 112.48 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.11 -142.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 64.109999999999999 112.477 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -175.93 -177.39 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 65.319999999999993 110.858 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG12 ' CD2' ' A' ' 112' ' ' LEU . 33.3 m -138.6 132.96 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 111.129 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.27 123.99 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 73.239999999999995 111.104 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD12 HG11 ' A' ' 80' ' ' VAL . 1.4 tt -71.5 116.0 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 54.399999999999999 110.896 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -75.88 -65.59 0.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 54.329999999999998 110.886 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -139.54 165.43 27.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 72.439999999999998 110.873 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.8 mt -127.19 123.62 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.010000000000005 111.108 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.9 -176.44 3.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 62.229999999999997 111.094 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.47 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.461 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -96.28 25.46 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.888 0.375 . . . . 42.240000000000002 110.869 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.494 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.7 t -144.98 150.06 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 62.130000000000003 111.121 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 141' ' ' VAL . 42.8 t -124.91 117.06 49.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 111.139 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 100' ' ' LEU . 36.5 mtt85 -82.33 100.93 10.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.836 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 134' ' ' LEU . 4.4 mt -105.22 146.52 29.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.932 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.42 ' HA ' HG13 ' A' ' 147' ' ' VAL . 3.4 ttmm -105.78 103.1 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.878 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.682 ' CD2' HG12 ' A' ' 98' ' ' VAL . 3.9 mt -126.58 144.11 51.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.94 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -124.7 146.8 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 110.964 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.81 -107.62 3.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 63.43 112.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -170.52 174.25 5.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 71.140000000000001 111.082 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 19.0 m -145.9 120.66 9.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 63.210000000000001 110.916 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.31 -77.59 0.32 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 65.230000000000004 112.463 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.7 m -93.59 -38.53 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 53.130000000000003 110.88 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 t -114.88 73.05 2.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.641 0.734 . . . . 60.420000000000002 110.916 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 157.17 61.29 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.631 2.221 . . . . 71.519999999999996 112.336 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 m 53.66 28.21 7.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 70.540000000000006 110.868 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.4 p -72.43 -26.44 61.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 75.140000000000001 110.83 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.23 -30.23 26.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.915 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.23 -38.31 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 111.151 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -35.23 76.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 72.239999999999995 111.124 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 130' ' ' ILE . 26.6 pt -85.89 -31.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 71.519999999999996 111.096 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.0 -45.19 71.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 45.409999999999997 110.86 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -73.01 -24.84 60.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 65.349999999999994 110.877 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.17 -60.28 3.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 34.100000000000001 112.477 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.802 HG13 HG21 ' A' ' 87' ' ' VAL . 2.9 mp -59.12 -50.06 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.748 0.309 . . . . 74.519999999999996 111.094 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -57.61 -25.63 60.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.854 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -80.04 -51.55 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.200000000000003 110.863 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -64.65 -36.32 83.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 52.409999999999997 110.89 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.732 ' CD1' HG23 ' A' ' 80' ' ' VAL . 27.0 tp -70.14 -35.82 74.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.109999999999999 110.917 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.611 ' CE ' HG13 ' A' ' 144' ' ' VAL . 16.7 mtt -78.64 -29.56 45.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.209999999999994 110.893 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -51.91 -34.96 43.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.896 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 138' ' ' ILE . 17.2 mmtm -91.87 -37.6 12.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 65.319999999999993 110.852 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.688 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -127.34 75.12 77.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.582 0.706 . . . . 62.219999999999999 111.103 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -8.19 22.98 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.671 2.248 . . . . 64.239999999999995 112.355 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -51.45 -30.7 20.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 110.875 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.3 p -76.28 144.01 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.120000000000005 111.127 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 106' ' ' ASN . . . -77.24 -53.24 7.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.25 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -157.31 -175.68 5.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 111.124 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.611 HG13 ' CE ' ' A' ' 135' ' ' MET . 18.3 m -130.13 147.9 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 111.126 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.494 ' CG ' HG11 ' A' ' 107' ' ' VAL . 16.3 mm-40 -112.65 95.66 33.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 63.149999999999999 110.927 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 145' ' ' GLU . 54.0 Cg_endo -69.72 169.26 19.28 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 73.120000000000005 112.394 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG13 ' HA ' ' A' ' 111' ' ' LYS . 7.0 m -54.86 138.03 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.239999999999995 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.1 p -75.11 133.66 41.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 111.125 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -176.6 179.99 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 62.009999999999998 110.871 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -92.79 118.9 31.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.923 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -98.66 26.41 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 70.299999999999997 110.893 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.4 t -110.91 -26.99 9.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 52.240000000000002 111.122 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 70.109999999999999 112.475 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.7 ptm . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.815 0.34 . . . . 74.439999999999998 110.825 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.01 19.92 36.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 42.409999999999997 112.507 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.91 160.69 39.7 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.605 0.717 . . . . 74.430000000000007 110.919 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo -69.79 -30.1 22.67 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.665 2.244 . . . . 73.340000000000003 112.34 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.719 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.27 111.17 6.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 72.239999999999995 110.951 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 p -119.98 -177.67 3.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.43 . . . . 73.25 111.124 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.89 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 70.430000000000007 111.067 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.69 -46.13 8.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.728 . . . . 52.450000000000003 112.473 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.96 -46.74 73.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.354 . . . . 73.140000000000001 110.866 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.05 HG22 HD13 ' A' ' 84' ' ' LEU . 7.8 p -54.1 -31.16 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 111.159 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.85 -23.81 67.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.875 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 t -71.91 -45.92 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 110.835 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.3 p -77.08 -34.64 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 72.329999999999998 111.102 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.05 HD13 HG22 ' A' ' 80' ' ' VAL . 3.5 mp -71.58 -19.82 62.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.952 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -53.65 -26.66 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.420000000000002 110.855 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.62 -42.97 57.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 110.94 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' HG ' ' A' ' 91' ' ' LEU . 13.9 p -80.69 -14.42 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.210000000000001 111.131 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 ttt180 -51.86 -58.63 10.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.714 . . . . 74.340000000000003 110.848 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.0 Cg_endo -69.75 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.701 2.268 . . . . 75.420000000000002 112.336 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.34 -57.39 3.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 64.010000000000005 110.891 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.687 ' HG ' HG22 ' A' ' 87' ' ' VAL . 10.6 mt -68.33 -44.27 75.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 55.329999999999998 110.925 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 88' ' ' ARG . 41.1 p -53.74 -29.01 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 111.117 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.48 67.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 45.299999999999997 111.107 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -97.31 -37.99 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.520000000000003 110.873 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.26 -15.2 3.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 53.420000000000002 112.489 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.19 -143.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 74.450000000000003 112.511 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -173.51 173.49 3.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.845 0.355 . . . . 61.210000000000001 110.844 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 84' ' ' LEU . 12.9 m -139.27 128.46 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.165 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -173.15 116.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 111.133 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -55.28 113.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.954 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -75.07 -65.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 65.200000000000003 110.865 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -141.76 166.15 25.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 71.329999999999998 110.887 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 55.1 mt -124.53 114.59 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.18 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.37 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 50.43 111.102 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.27 -91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 75.5 112.519 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.58 24.0 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.354 . . . . 73.510000000000005 110.869 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.401 HG11 ' CG ' ' A' ' 145' ' ' GLU . 21.6 t -145.13 150.18 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.112 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.1 t -118.79 131.82 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -98.79 100.93 12.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 52.409999999999997 110.87 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -110.09 144.44 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 110.888 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -92.81 102.97 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 60.140000000000001 110.868 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 130' ' ' ILE . 9.1 mt -120.09 147.94 44.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 61.350000000000001 110.914 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -143.41 141.37 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 71.010000000000005 110.973 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.93 29.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 71.109999999999999 112.468 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.43 113.37 23.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.796 0.331 . . . . 70.519999999999996 111.132 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.4 t -125.46 70.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.56 -77.01 0.56 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.019999999999996 112.492 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 p -98.08 -26.47 14.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 74.040000000000006 110.829 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.8 t 54.37 67.96 3.03 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.708 . . . . 64.310000000000002 110.891 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 78.11 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.643 2.229 . . . . 53.350000000000001 112.366 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 p 46.17 36.18 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.43 110.836 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.08 -41.71 70.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 53.240000000000002 110.916 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD12 ' HB ' ' A' ' 148' ' ' THR . 2.6 pt? -51.88 -30.81 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 62.109999999999999 110.895 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mm -90.08 -30.86 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 54.32 111.168 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.0 m -64.67 -45.08 88.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 111.168 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.747 ' O ' HD12 ' A' ' 130' ' ' ILE . 47.5 pt -76.0 -26.65 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.510000000000005 111.082 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -51.56 -54.68 24.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 110.851 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -24.91 68.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 75.450000000000003 110.864 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.52 -60.33 4.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 73.209999999999994 112.524 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -56.56 -54.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.76 0.314 . . . . 73.230000000000004 111.129 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -52.66 -32.38 41.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.915 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -77.9 -30.71 50.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.826 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -78.93 -33.59 45.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.898 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.789 ' HA ' HG21 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -69.41 -54.93 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 70.439999999999998 110.885 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -29.34 22.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.86 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.7 -26.1 55.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 64.109999999999999 110.905 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -44.22 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 55.439999999999998 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.719 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -113.05 75.84 2.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 111.127 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -13.44 34.73 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 73.340000000000003 112.358 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.91 -39.45 59.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 110.864 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.4 p -73.09 144.44 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 54.340000000000003 111.16 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.54 -44.56 18.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.230000000000004 111.083 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -163.49 -171.99 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 41.329999999999998 111.092 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.3 154.0 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 62.130000000000003 111.116 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' CG ' HG11 ' A' ' 107' ' ' VAL . 46.5 mt-10 -134.3 95.66 16.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 64.549999999999997 110.897 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 158.78 55.78 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 51.420000000000002 112.352 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.9 m -51.58 -31.25 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 111.109 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 123' ' ' LEU . 44.4 p -79.32 119.63 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 111.202 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -89.65 -61.5 1.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 64.010000000000005 110.844 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 170.48 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 62.520000000000003 110.903 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -77.85 159.12 29.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.430000000000007 110.9 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 p -113.16 130.58 56.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 75.439999999999998 111.179 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 70.109999999999999 112.466 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.4 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.851 0.358 . . . . 73.420000000000002 110.851 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.85 -28.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 71.209999999999994 112.474 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.14 160.66 82.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.621 0.724 . . . . 60.439999999999998 110.89 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.8 Cg_endo -69.73 -29.91 23.24 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.645 2.23 . . . . 70.219999999999999 112.354 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.3 tm? -143.74 114.27 7.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.9 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -122.45 -177.13 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 63.530000000000001 111.128 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -61.87 -34.37 75.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 70.129999999999995 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.2 -46.44 8.18 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 74.129999999999995 112.483 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -67.3 -46.9 72.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 65.299999999999997 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.042 HG22 HD13 ' A' ' 84' ' ' LEU . 6.7 p -54.4 -31.12 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 111.121 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -62.88 -23.68 67.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 61.25 110.919 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -69.64 -47.26 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 73.519999999999996 110.852 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 134' ' ' LEU . 7.1 p -77.21 -35.43 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 64.5 111.175 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.042 HD13 HG22 ' A' ' 80' ' ' VAL . 1.4 mp -71.72 -19.38 62.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.938 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.53 -26.71 8.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.858 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -74.44 -41.74 60.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 55.109999999999999 110.893 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.839 HG11 HG13 ' A' ' 130' ' ' ILE . 34.0 m -82.98 -11.42 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.144 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 8.4 ttt85 -54.38 -58.6 13.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.572 0.701 . . . . 61.149999999999999 110.881 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 54.1 Cg_endo -69.69 -31.75 20.21 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.684 2.256 . . . . 75.340000000000003 112.36 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -67.24 -57.99 5.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD11 ' CD1' ' A' ' 126' ' ' ILE . 3.7 mm? -56.66 -55.05 38.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.921 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.405 HG22 ' OD1' ' A' ' 97' ' ' ASP . 46.1 p -51.38 -41.84 60.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 71.209999999999994 111.186 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.75 -28.66 23.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 51.100000000000001 111.104 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -82.86 -37.77 23.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.549999999999997 110.891 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 142.21 -17.04 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.765 -0.731 . . . . 60.43 112.473 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.31 -145.45 16.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 44.039999999999999 112.476 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 92' ' ' THR . 1.0 OUTLIER -167.12 -179.95 4.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 71.310000000000002 110.837 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 84' ' ' LEU . 18.5 m -137.74 139.53 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 111.11 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.61 134.02 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 111.082 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 103' ' ' ILE . 10.6 tp -81.4 119.49 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 72.209999999999994 110.912 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -88.51 -71.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 110.83 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -124.63 168.79 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 55.32 110.866 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.642 HD11 HD21 ' A' ' 100' ' ' LEU . 62.2 mt -131.58 125.75 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 111.118 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.11 -176.05 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 62.149999999999999 111.095 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.51 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 74.129999999999995 112.511 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.01 25.32 6.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 72.430000000000007 110.882 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.547 HG11 ' CG ' ' A' ' 145' ' ' GLU . 25.8 t -145.78 149.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 111.122 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.2 t -119.63 135.56 59.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 64.299999999999997 111.127 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -94.97 101.0 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.030000000000001 110.889 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 84' ' ' LEU . 7.6 mt -110.59 126.16 54.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 44.229999999999997 110.879 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -79.62 101.64 8.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 72.109999999999999 110.91 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 130' ' ' ILE . 8.7 mt -123.34 129.69 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.230000000000004 110.934 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 91' ' ' LEU . 16.0 mt-30 -121.73 129.78 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.892 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -83.23 -113.22 0.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 63.240000000000002 112.52 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -173.94 -179.19 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 72.310000000000002 111.133 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 78.7 m -142.06 112.56 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 60.439999999999998 110.911 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 170.02 -94.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 51.210000000000001 112.494 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.5 t -97.95 -25.94 14.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 64.120000000000005 110.84 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -113.99 73.12 2.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 73.209999999999994 110.875 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 164.57 34.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.688 2.258 . . . . 71.519999999999996 112.322 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m 52.43 32.31 11.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 63.240000000000002 110.847 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -41.85 96.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 63.009999999999998 110.873 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.78 -30.1 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 63.200000000000003 110.87 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.34 -32.75 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.07 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -74.36 -35.99 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 111.152 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.735 ' O ' HD12 ' A' ' 130' ' ' ILE . 19.2 pt -76.83 -29.06 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 71.129999999999995 111.109 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -51.2 -58.13 6.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 64.129999999999995 110.896 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -68.39 -24.3 64.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.85 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.53 -59.3 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.759 -0.734 . . . . 64.400000000000006 112.514 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 112' ' ' LEU . 2.6 mp -61.03 -54.93 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 75.439999999999998 111.102 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -50.56 -31.39 15.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -78.4 -37.15 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.420000000000002 110.883 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -72.92 -32.0 65.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 75.549999999999997 110.92 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.622 ' CD2' HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -70.12 -51.61 30.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.926 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 39.3 mtt -51.82 -31.16 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.44 -27.3 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.881 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -46.82 3.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 55.509999999999998 110.908 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.715 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -113.39 74.75 2.18 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 73.319999999999993 111.167 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -13.21 34.45 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 70.310000000000002 112.353 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.13 -33.84 58.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.832 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.2 p -74.59 144.42 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 65.120000000000005 111.095 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -42.44 18.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 61.450000000000003 111.1 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -166.32 -170.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 35.310000000000002 111.109 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.22 149.76 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.151 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.547 ' CG ' HG11 ' A' ' 107' ' ' VAL . 8.8 mm-40 -116.14 95.7 45.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 64.310000000000002 110.885 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 179.26 3.83 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 64.049999999999997 112.378 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.24 129.06 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 111.111 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.8 t -63.69 135.24 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 72.530000000000001 111.135 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -174.4 162.82 3.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.0 110.873 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.34 141.68 57.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.923 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.38 -32.63 20.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.9 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -76.3 138.66 40.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 74.099999999999994 111.139 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 63.340000000000003 112.444 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.9 mtm . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.817 0.341 . . . . 62.100000000000001 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.65 -27.05 17.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 45.030000000000001 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp 62.88 160.66 0.12 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.62 0.724 . . . . 71.239999999999995 110.925 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -28.26 25.4 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.688 2.259 . . . . 62.340000000000003 112.347 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.713 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -147.41 139.91 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 70.299999999999997 110.957 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 75' ' ' LEU . 10.2 t -148.45 169.87 19.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.519999999999996 111.161 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.38 -29.09 9.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 111.113 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.29 -55.08 4.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 72.349999999999994 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' HB2' HD22 ' A' ' 75' ' ' LEU . 18.5 m-20 -61.67 -47.56 84.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 64.109999999999999 110.837 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.647 HG23 HD13 ' A' ' 134' ' ' LEU . 8.8 p -53.16 -31.37 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 62.210000000000001 111.146 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.39 -30.67 71.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.857 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -39.93 63.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG13 ' HD3' ' A' ' 137' ' ' LYS . 26.0 t -75.76 -44.47 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 50.530000000000001 111.144 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.637 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mp -71.52 -18.6 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.919 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -50.34 -25.78 4.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.87 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -73.26 -45.28 56.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.727 HG23 HG11 ' A' ' 98' ' ' VAL . 2.0 m -81.13 -13.62 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 65.129999999999995 111.154 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 5.2 ttt180 -50.51 -58.67 9.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.61 0.719 . . . . 73.120000000000005 110.905 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.5 Cg_endo -69.74 -35.11 13.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.746 2.297 . . . . 73.049999999999997 112.326 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -67.32 -25.45 66.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.93 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.82 -49.06 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.329999999999998 110.941 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 88' ' ' ARG . 76.2 p -61.73 -29.22 69.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 111.124 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.7 -25.36 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 54.130000000000003 111.146 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -93.75 -38.01 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 53.310000000000002 110.899 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.22 -40.36 0.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 64.219999999999999 112.464 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.38 -148.53 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.779 -0.724 . . . . 65.450000000000003 112.448 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -178.28 -176.65 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 62.310000000000002 110.88 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.849 HG12 HD23 ' A' ' 112' ' ' LEU . 33.4 m -137.25 133.14 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 111.096 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.02 105.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 71.530000000000001 111.074 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 77' ' ' ALA . 10.9 tp -54.84 119.94 6.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.049999999999997 110.959 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -78.9 -54.49 6.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 110.888 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 100' ' ' LEU . 2.8 tp10 -162.91 172.58 14.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.859 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.13 121.03 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 111.132 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.28 95.63 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 74.319999999999993 111.093 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.4 -123.39 27.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 74.329999999999998 112.489 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.02 -17.58 58.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 71.5 110.901 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.96 150.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 111.148 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -124.65 123.66 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 52.439999999999998 111.069 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -84.68 101.32 12.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 110.861 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 100' ' ' LEU . 2.3 mt -106.17 155.36 19.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 65.450000000000003 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.429 ' HE2' HG21 ' A' ' 147' ' ' VAL . 6.0 mttt -111.82 84.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.25 110.916 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 98' ' ' VAL . 3.8 mt -109.65 139.61 44.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 61.310000000000002 110.874 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -131.36 140.67 49.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 110.907 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.68 -69.36 0.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 61.030000000000001 112.464 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.43 177.18 10.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 71.230000000000004 111.093 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.88 154.73 45.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 42.450000000000003 110.892 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.74 -160.45 29.65 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.751 . . . . 61.509999999999998 112.515 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.8 m -61.49 -70.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.87 0.367 . . . . 42.009999999999998 110.876 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.1 t -143.26 70.47 18.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.595 0.712 . . . . 73.239999999999995 110.883 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -48.33 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.689 2.259 . . . . 64.209999999999994 112.319 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.6 m 61.6 26.51 16.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 110.874 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.71 -23.62 39.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 63.119999999999997 110.891 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.42 36.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 64.209999999999994 110.912 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.1 mt -80.47 -38.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 65.530000000000001 111.155 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.2 m -52.45 -39.76 61.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 71.409999999999997 111.099 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.479 ' O ' HD12 ' A' ' 130' ' ' ILE . 40.1 pt -86.36 -27.69 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 65.510000000000005 111.088 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -43.63 66.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.129999999999995 110.852 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -24.91 61.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.877 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.59 -57.75 5.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.010000000000005 112.53 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.707 ' CG1' HG21 ' A' ' 87' ' ' VAL . 4.4 mp -63.35 -53.3 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 72.099999999999994 111.164 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -52.02 -29.99 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.520000000000003 110.896 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -75.44 -50.66 15.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 72.010000000000005 110.887 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -63.66 -35.87 81.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 60.399999999999999 110.852 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.647 HD13 HG23 ' A' ' 80' ' ' VAL . 16.0 tp -70.25 -35.52 73.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.049999999999997 110.9 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.3 57.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.897 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.8 -38.27 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.227 -0.442 . . . . 62.100000000000001 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HD3' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -92.68 -32.02 14.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 60.140000000000001 110.895 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.713 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.2 mp -129.99 76.56 77.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 70.209999999999994 111.124 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -8.64 24.11 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 72.120000000000005 112.365 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -56.2 -25.99 49.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.150000000000006 110.858 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.1 150.08 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 50.109999999999999 111.104 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.86 -51.12 5.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 71.510000000000005 111.043 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -162.98 176.78 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.340000000000003 111.086 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.2 153.21 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 72.349999999999994 111.145 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -132.64 160.25 69.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.622 0.725 . . . . 72.150000000000006 110.924 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -170.88 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 74.120000000000005 112.334 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.429 HG21 ' HE2' ' A' ' 111' ' ' LYS . 7.0 p -90.81 -24.91 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 64.310000000000002 111.146 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.83 166.86 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 64.0 111.115 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -64.84 120.69 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 71.129999999999995 110.866 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -146.61 -48.45 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.899 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.04 -30.01 23.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 64.120000000000005 110.899 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 t -63.5 -35.92 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 71.519999999999996 111.129 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 51.219999999999999 112.468 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.9 ttm . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.798 0.332 . . . . 75.409999999999997 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.07 -107.16 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.712 -0.756 . . . . 53.43 112.499 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 HD23 ' HD2' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -105.02 160.31 26.41 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.588 0.709 . . . . 72.340000000000003 110.922 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HD2' HD23 ' A' ' 73' ' ' LEU . 54.1 Cg_endo -69.79 -26.16 27.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.642 2.228 . . . . 62.340000000000003 112.368 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.725 ' HB2' HG21 ' A' ' 138' ' ' ILE . 3.4 tm? -144.06 139.81 29.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 75.430000000000007 110.924 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.643 ' N ' HD13 ' A' ' 75' ' ' LEU . 9.0 t -153.5 169.62 22.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 51.43 111.18 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -50.3 -29.56 10.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.098 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.44 -62.44 2.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 51.310000000000002 112.526 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -56.23 -48.22 76.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 65.239999999999995 110.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.986 HG22 HD13 ' A' ' 84' ' ' LEU . 8.9 p -51.22 -31.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 70.0 111.125 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -62.35 -36.67 82.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.868 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.4 t -63.81 -41.55 97.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 53.409999999999997 110.875 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.02 -42.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 62.420000000000002 111.127 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.986 HD13 HG22 ' A' ' 80' ' ' VAL . 4.8 mp -70.67 -18.85 62.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 65.400000000000006 110.915 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -51.58 -26.88 9.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.881 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -78.5 -43.89 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 110.89 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.836 HG22 HD23 ' A' ' 91' ' ' LEU . 8.2 p -82.38 -1.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.132 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 92' ' ' THR . 13.3 ttt180 -65.88 -58.79 10.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.706 . . . . 73.430000000000007 110.843 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 54.1 Cg_endo -69.72 -8.17 22.91 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.653 2.235 . . . . 64.420000000000002 112.396 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -12.61 20.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.899 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.836 HD23 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -101.21 -66.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 64.140000000000001 110.934 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 88' ' ' ARG . 3.4 t -58.51 -20.1 43.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 50.130000000000003 111.116 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -51.23 -29.85 15.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 64.319999999999993 111.111 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.24 -31.64 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 110.889 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 151.22 -16.96 0.89 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 74.150000000000006 112.503 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.12 -138.89 2.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 63.140000000000001 112.518 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p30 179.85 -175.96 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.839 0.352 . . . . 41.439999999999998 110.921 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.673 ' HB ' HD23 ' A' ' 84' ' ' LEU . 27.9 m -141.17 127.06 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 111.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.69 133.42 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.399999999999999 111.16 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' HA ' HD23 ' A' ' 110' ' ' LEU . 17.9 tp -81.34 112.91 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 70.25 110.913 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -74.56 -73.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.896 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.62 171.14 13.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 110.901 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 HD21 ' A' ' 100' ' ' LEU . 56.6 mt -129.74 110.82 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.409999999999997 111.108 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.33 179.73 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.085 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.473 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.77 23.56 6.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 63.130000000000003 110.946 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -145.54 149.4 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.430000000000007 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -123.07 133.6 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.123 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 100' ' ' LEU . 8.5 mtt-85 -96.86 100.84 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 110.854 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 100' ' ' LEU . 31.3 mt -107.64 130.56 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.884 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -82.99 118.63 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.916 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.061 HD13 HD13 ' A' ' 130' ' ' ILE . 7.3 mt -142.19 123.69 14.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 110.928 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -111.79 115.29 28.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 62.25 110.957 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.69 -162.76 0.32 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 54.340000000000003 112.48 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.32 -75.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 60.340000000000003 111.108 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.15 -177.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 72.010000000000005 110.888 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.36 160.89 9.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 53.329999999999998 112.45 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.7 t -53.16 -28.87 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 71.140000000000001 110.871 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.5 p -144.07 156.54 58.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.59 0.709 . . . . 75.239999999999995 110.897 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 93.51 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 62.439999999999998 112.337 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.5 m -130.1 -39.9 1.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 63.329999999999998 110.869 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.38 -45.3 65.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 44.009999999999998 110.881 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.11 -29.9 23.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.128 -0.487 . . . . 55.25 110.903 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.1 mm -87.1 -39.64 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 71.340000000000003 111.099 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -57.78 -34.01 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.329999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.834 HD12 HD11 ' A' ' 91' ' ' LEU . 27.9 pt -86.13 -29.91 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 64.340000000000003 111.136 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -49.87 -58.31 5.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.88 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -24.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.06 -50.05 19.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 34.25 112.452 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.061 HD13 HD13 ' A' ' 112' ' ' LEU . 2.7 mp -68.51 -55.6 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 71.430000000000007 111.127 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.4 -32.05 24.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 71.049999999999997 110.849 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.94 -40.89 95.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.905 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -72.29 -37.34 69.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.891 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -65.02 -38.89 92.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 73.049999999999997 110.926 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 2.4 ttm -67.9 -25.46 65.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.239999999999995 110.86 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.84 -59.4 3.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.907 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 138' ' ' ILE . 9.3 mmtm -73.24 -51.2 18.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.865 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.725 HG21 ' HB2' ' A' ' 75' ' ' LEU . 5.1 mp -112.86 76.15 2.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.646 0.736 . . . . 71.230000000000004 111.137 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -12.8 33.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.254 . . . . 64.219999999999999 112.331 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.83 -36.18 47.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 64.329999999999998 110.86 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 138' ' ' ILE . 6.1 p -76.13 144.1 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.299999999999997 111.13 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.75 -51.45 8.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.349999999999994 111.064 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.84 -170.16 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 111.066 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.0 144.06 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 111.168 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -123.88 95.65 43.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 73.510000000000005 110.909 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -175.35 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.657 2.238 . . . . 63.329999999999998 112.393 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.22 120.46 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 111.13 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 t -51.71 133.93 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 60.130000000000003 111.141 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -157.1 173.98 16.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.848 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -75.37 82.48 2.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.450000000000003 110.935 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.58 164.15 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.549999999999997 110.863 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 23.1 p -126.27 153.03 45.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 73.450000000000003 111.139 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 73.040000000000006 112.515 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.1 ttm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.819 0.342 . . . . 73.540000000000006 110.874 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.19 163.34 23.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 64.530000000000001 112.511 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 mt -78.51 159.21 75.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 74.040000000000006 110.914 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HB2' HG23 ' A' ' 138' ' ' ILE . 53.6 Cg_endo -69.76 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.704 2.269 . . . . 72.409999999999997 112.36 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.028 HD13 HG21 ' A' ' 108' ' ' VAL . 5.2 tt -94.54 106.61 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 110.914 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -129.76 175.66 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 63.140000000000001 111.123 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -63.7 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.08 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.96 -43.76 10.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 62.100000000000001 112.475 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -71.83 -47.43 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 74.519999999999996 110.893 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.015 HG22 HD13 ' A' ' 84' ' ' LEU . 9.9 p -50.61 -31.13 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 111.144 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -61.25 -39.9 92.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.844 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -41.1 95.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 45.229999999999997 110.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 134' ' ' LEU . 74.3 t -77.28 -39.57 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 111.122 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.015 HD13 HG22 ' A' ' 80' ' ' VAL . 2.9 mp -69.87 -19.43 63.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.931 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -52.35 -27.08 14.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.129999999999995 110.853 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -76.85 -43.65 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.896 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.697 ' CG2' HD23 ' A' ' 91' ' ' LEU . 8.6 p -82.34 -4.51 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.153 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 9.3 ttp85 -61.26 -58.72 16.93 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.593 0.711 . . . . 74.420000000000002 110.892 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 53.7 Cg_endo -69.78 -8.47 23.69 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 71.439999999999998 112.353 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.23 -46.95 6.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 72.450000000000003 110.914 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.697 HD23 ' CG2' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -73.38 -43.56 60.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 73.219999999999999 110.963 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 88' ' ' ARG . 70.5 p -65.63 -23.16 66.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.19 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.68 -51.99 62.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 111.091 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -63.7 -29.25 70.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.843 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.47 19.21 3.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 74.019999999999996 112.467 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.58 -135.91 8.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.708 -0.758 . . . . 75.099999999999994 112.497 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -179.37 139.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 73.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.713 HG12 HD23 ' A' ' 112' ' ' LEU . 33.3 m -115.54 133.04 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 111.108 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.89 138.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 54.530000000000001 111.092 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 77' ' ' ALA . 11.8 tp -79.81 126.71 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 65.219999999999999 110.892 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.473 ' N ' HD12 ' A' ' 100' ' ' LEU . 85.1 t60 -88.36 -71.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.871 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -134.58 174.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.400000000000006 110.922 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.435 HD11 HD21 ' A' ' 100' ' ' LEU . 53.5 mt -132.35 110.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -83.9 -170.21 2.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 111.132 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.55 -89.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 71.140000000000001 112.467 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -95.12 21.04 8.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 52.439999999999998 110.886 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.26 150.28 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.099999999999994 111.141 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.028 HG21 HD13 ' A' ' 75' ' ' LEU . 92.4 t -114.46 139.83 38.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.120000000000005 111.155 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -102.27 100.87 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.430000000000007 110.848 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 100' ' ' LEU . 1.1 mt -105.92 178.17 4.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.922 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -134.01 120.25 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 63.549999999999997 110.909 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 130' ' ' ILE . 4.0 mt -138.25 143.15 39.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 64.010000000000005 110.945 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -118.99 106.71 12.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 65.420000000000002 110.916 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -115.8 83.58 0.34 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 72.340000000000003 112.461 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.77 117.96 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 72.25 111.069 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.06 -47.41 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 64.310000000000002 110.85 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.6 -69.02 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 43.399999999999999 112.473 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 t -75.82 -26.58 57.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.875 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.7 t -118.73 73.36 11.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.616 0.722 . . . . 71.219999999999999 110.892 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -16.92 37.6 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.657 2.238 . . . . 52.43 112.336 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.8 m -96.83 31.88 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 61.409999999999997 110.883 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.6 m -79.41 -25.74 42.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 75.230000000000004 110.837 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.86 -31.72 29.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 74.519999999999996 110.928 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 HH11 ' A' ' 128' ' ' ARG . 40.8 mm -79.49 -38.07 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.094 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.85 78.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.145 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 130' ' ' ILE . 25.8 pt -86.09 -26.97 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 73.400000000000006 111.116 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -50.68 54.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 72.200000000000003 110.902 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.506 HH11 HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -71.0 -24.83 62.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.230000000000004 110.858 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.66 -51.91 18.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 31.43 112.463 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.953 HD13 HD13 ' A' ' 112' ' ' LEU . 2.8 mp -64.06 -56.41 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.728 0.299 . . . . 60.43 111.13 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.49 -33.32 44.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.933 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -63.51 -33.54 75.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 75.219999999999999 110.859 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -77.02 -56.57 4.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 64.200000000000003 110.894 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.95 HD13 HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -53.8 -47.32 70.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 53.509999999999998 110.914 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 32.7 ttm -55.15 -39.43 69.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 65.230000000000004 110.879 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.37 -19.38 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.040000000000006 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.68 -33.13 9.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 72.129999999999995 110.932 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 141' ' ' VAL . 9.9 mm -111.49 78.8 2.08 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.635 0.731 . . . . 71.129999999999995 111.132 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -8.13 22.82 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.242 . . . . 45.539999999999999 112.324 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.31 -33.89 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 74.040000000000006 110.895 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 138' ' ' ILE . 7.4 p -74.43 155.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 111.149 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.41 -45.11 8.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 62.130000000000003 111.115 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -167.12 -169.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.36 160.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 111.121 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 146' ' ' PRO . 9.9 mm-40 -146.61 95.65 4.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.693 0.758 . . . . 74.140000000000001 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 145' ' ' GLU . 53.9 Cg_endo -69.77 179.21 3.86 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.613 2.208 . . . . 75.510000000000005 112.362 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.04 126.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 44.329999999999998 111.121 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 4.4 t -170.56 160.9 7.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 75.519999999999996 111.16 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -86.9 -50.12 6.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 110.864 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -124.31 149.89 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.924 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -157.41 129.45 7.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.918 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -163.5 135.59 5.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.510000000000005 111.173 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 63.509999999999998 112.528 179.938 . . . . . . . . 0 0 . 1 stop_ save_